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Abstract 
This thesis presents a Constructivist Grounded Theory study that explores the 
impact that life science specific intermediaries have on knowledge exchange and 
commercialisation. Many of the life science intermediaries (LSIs) that operate to 
bridge the divide between industry and academia receive public funding, and many 
have come and gone. It is important for us to better understand the reasons behind 
this turnover and how we can develop LSIs that have staying power. The research 
explores what LSIs are and the different ways they can impact on knowledge 
exchange and commercialisation. The study engaged 22 different LSIs sites from the 
UK, Holland and France. These 22 different LSIs have been placed into five different 
Case intermediary models, moreover, 30 interviews were conducted, informal 
observations were collected and field notes also known as memos were taken 
throughout the research process. Through the use of Constructivist Grounded 
Theory five theoretical concepts emerged, these included the following: that a LSI 
needed to have commercialisation targets, those with KEC objectives embedded had 
more chance of gaining further funding, and they require sufficient time and that 
funding resources are adequate and they should employ staff from both academia 
and industry within the LSI. A theoretical framework model that can be used to help 
design and develop a high functioning LSI is presented. Discussions with policy 
decision makers and the expectations from a range of stakeholders feed into this 
framework model. 
The theory development adds to the knowledge on innovation intermediaries and in 
particular the sectoral systems of innovation (SSI) which allows for a more focused 
xi 
 
approach on innovation intermediaries from a single sector viewpoint. Furthermore, 
the study feeds into more recent research on the reason why intermediaries fail. 
 
 
Keywords: Constructivist Grounded Theory, Life Science Intermediaries, Knowledge 
Exchange and Commercialisation, Expectations Gap,  
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Chapter 1 Introduction 
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1.1 Introduction 
There has emerged a new race between nations in recent years to drive innovation 
forward in order to establish a leading position as a technology innovator and 
thereby benefit from first mover advantages (Hauser 2010, 2014, Andersen, De 
Silva, and Levy 2013, Mazzucato 2011, 2013, Parker, Hine and Eastwood 2009). 
This has led to the drive in the UK and other European nations to commercialise 
innovative technologies in the hope of achieving this. There has been a wealth of 
research into how this is to be reached and it is now widely accepted that key to 
achieving this desired goal is to increase the interactions between academia and 
industry to help push technologies that may have languished in academia out into 
the market place (Lambert Review 2003, Kearnes and Wienroth 2011, Hauser 2010, 
2014, Wilson 2012, Higher Education Funding Council for England 2016, Kruss and 
Visser 2017). One method employed by governments in achieving this goal is the 
use of Intermediaries (Wilson 2012, Howells 2006, Lopez and Vanheverbeke 2010).  
Intermediaries generally work at the interface between academia and industry 
‘bridging the gap’ between the two sectors. They facilitate the transfer and exchange 
of knowledge (discussed later in Chapter 3) that drive the innovation process. 
Specifically, this research will investigate the role that the various life science 
intermediaries (LSIs) play, the part they play in the innovation process, and in 
particular how they impact on Knowledge Exchange and Commercialisation (KEC).  
Examining the factors that impact on stakeholder value will help to identify the 
competitive advantage that LSIs can bring. Their role in the development of 
entrepreneurship will be determined through their Knowledge Exchange and 
Commercialisation activities. Do they inhibit or facilitate KEC, are they an aid to 
entrepreneurs, or do they get in the way?  
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This research will examine the factors that influence effective KEC functioning within 
a range of LSI case models and how policy impacts on the success or failure of LSIs.   
1.2 Background and Context to the Research  
 What is an Intermediary? 
A wide range of intermediaries have been identified in the literature. These include 
consultants, think tanks (Meyer 2010), incubators (public and private), 
science/research parks (Wright et al. 2008, Lopez-Vega and Vanheverbeke 2010, 
Siegel, Westhead and Wright 2003, Phan, Siegel and Wright 2005, Bigliardi et al. 
2006), public funded network intermediaries, trade associations, research councils, 
and Technology Transfer Offices (TTOs) based in Public Research Organisations 
(PROs) like universities and research institutes (Siegel, Westhead and Wright 2003, 
Kearnes and Wienroth 2011, Andersen, De Silva and Levy 2013, Eveleens, 
Rijnsoever and Niesten 2016). The spectrum is broad, and some researchers even 
include consortia, foundations, patent firms, business angel networks and regional 
development agencies in their list of intermediaries (Metcalfe 2010). Trying to 
research all the different intermediaries would be a vast undertaking and it would be 
difficult to produce any meaningful results as they all have different cultures, work 
ethics, performance measures and business models. Therefore this PhD Study has 
been limited to intermediaries that are working to bridge the gap specifically in the 
life science sector. 
An intermediary is also referred to as a bridging organisation (Sapsed, Grantham 
and DeFillippi 2007) or as a broker (Hargadon & Sutton 1997, Wilson 2012, 
Smedlund 2006). It is essentially an organisation that facilitates connections between 
two or more organisations or sectors. Howells (2006) defined an intermediary as “An 
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organisation or body that acts as an agent or broker in any aspect of the innovation 
process between two or more parties” (Howells 2006, p.715) 
Commercial organisations using these intermediaries are usually those lacking in the 
quality relationships needed to achieve this unaided, such as new SME’s which do 
not have robust networks that they can easily tap into. They rely on an intermediary 
to connect them to suitable partners from either industry or academia. The main 
purpose of an intermediary is to carry out a bridging function as defined by Shohet 
and Prevezer (1996). They defined intermediaries as public and private 
organisations that act as agents transferring technology between hosts and users. 
More recently Wilson (2012) defined the role of an intermediary as: “organisations or 
individuals that occupy the space between the researcher and commercial 
exploitation of that research” (Wilson 2012, p.54).  
 Innovation Intermediaries 
“Innovation intermediaries are organisations or groups within 
organisations that work to enable innovation, either directly by enabling 
the innovativeness of one or more firms, or indirectly by enhancing the 
innovative capacity of regions, nations or sectors”.  (Dalziel 2010, p.2) 
The literature on innovation intermediaries has been steadily growing. Still only a 
relatively new area of research, it came to prominence in 2006 when Howells (2006) 
discussed a new class of overarching organisation he called the innovation 
intermediary. Since then a number of researchers have attempted to develop 
methodologies for measuring outcomes that are viable across different types of 
intermediaries (Dalziel and Parjanen 2011).  The differences in sectors and the vast 
array of business models that are employed make researching all innovation 
intermediaries an unmanageable undertaking.  
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In Howells’s (2006) seminal paper he examined the roles played by intermediaries 
during the innovation process by studying members of the Association of 
Independent Research and Technology Organisations (AIRTO). Members of AIRTO 
include brokers, gatekeepers and consultants. His paper examined the role that 
these innovation intermediaries play within four areas including: technology transfer, 
innovation management, systems and networks and as service organisations. 
Howells listed the ten most common features of innovation intermediaries. These 
are: 
1. scanning and information processing,  
2. knowledge processing and combining,  
3. gate keeping and brokering,  
4. testing and validating  
5. commercialisation,  
6. foresight and diagnosis,  
7. accreditation and standards,  
8. regulation and arbitration,  
9. intellectual property,  
10.  evaluation and training. 
Building on Howells research, Lopez-Vega and Vanheverbeke (2010) reviewed 32 
innovation intermediaries working in open and closed innovation markets. They 
concluded that innovation intermediaries help to facilitate the exchange of knowledge 
between partners and collaborators. In their research the role of innovation 
intermediaries was separated into 3 main functions: (1) connections, (2) 
collaboration and support, and (3) provision of technological services. These 3 
functions streamlined Howells’s 10 features. 
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Coeurderoy and Duplat (2008) used Howells’s (2006) 10 most common features of 
innovation intermediaries to link five different intermediary institutes with firms to 
examine their embeddedness within the networks they operate in. They examined 
their relational, structural and cognitive embeddedness, and sought to show how 
these intermediary institutes balanced the “learning” functions with the intellectual 
property (IP) “protecting” functions within the networks (Coeurderoy and Duplat 
2008). They concluded that both functions were protected within the strategic 
alliances that were formed between the intermediary institutes and the firms within 
the networks. 
The researchers referenced above have provided us with a good understanding of 
the role of a wide range of innovation intermediaries. This knowledge will be used 
and built upon by this PhD research study as it delves into some of these areas of 
the literature. 
Although a few researchers have explored some of the physical LSIs like science 
parks and incubators, most have focused their research on the many virtual or on-
line innovation intermediaries like NineSigma (Howells 2006), where the bridging 
process is carried out in a different way with many problem solvers working on an 
innovation problem.  
 What is a Life Science Intermediary? 
This research will focus on the innovation intermediaries operating within the life 
science sector called life-science Intermediaries (LSIs). They have a broad spectrum 
that covers biotechnology, agricultural biology, healthcare, medical devices and/or 
disease specific networks.  There are a number of well-established sector specific 
intermediaries operating within the life science sector across the globe as many 
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nations have invested in them as a means of improving their innovation processes 
(Hauser 2010, 2014, Dalziel 2010). This research will be focusing on physical 
intermediaries operating across the UK. An international perspective will also be 
brought by including life science intermediaries in Lyon (France) and Leiden 
(Holland). Five Case LSI models will be included and are listed in Table 1 below.  
They include regional and national LSIs that provide a bridging function for 
organisations within the network or cluster in which they are physically located. 
Although the researcher has had some access to LSIs in both Holland and France, 
there are too few international LSIs to justify a true comparative analysis. They have 
therefore been included to support the research findings. Had time permitted, a fuller 
international comparison that included LSIs from the USA would have been included. 
The Case LSIs that have been recruited for the study all fit into one of the five 
business models set out in Table 1 below. Details of the participant organisations in 
each of these cases are detailed in Chapter 4. The individuals from within the 
organisations are not revealed in this study. 
Table 1: The 5 Case LSI models included 
Case 1 LSIs Science Parks and Incubators 
Case 2 LSIs The Cluster Network Organisations 
Case 3 LSIs The Research Institutes and Innovation Centres 
Case 4 LSIs The Sector Specific Thematic Intermediaries 
Case 5 LSIs The Technology Transfer Offices 
 
The landscape in the UK for LSIs is changing rapidly, and there appears to be a 
focus on national rather than regional networks emerging (Lawton-Smith and Romeo 
2015). There are differences in the funding sources that underpin these LSIs, 
including:  
 Central Government,  
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 Economic development agencies,  
 Local councils, and  
 Membership fees.  
The trend in the UK at the local level is for the LSIs to close down once their funding 
runs out (House of Commons Science and Technology Committee 2011, Brown, 
Gregson and Mason 2016). Many of these networks had been given funding with the 
proviso that they became self-funding after a period of time: this has very rarely 
happened (this is discussed further in Chapters 5 and 6). However, the recent call 
from the Biotechnology and Biological Sciences Research Council (BBSRC) for the 
creation of an agricultural network focused on bio-energy, indicates in the 
requirements that the BBSRC does not expect the network to become self-financing 
beyond the funding period. This is a significant change in policy for publicly funded 
LSIs and appears more realistic (BBSRC 2013).  This research will allow us to 
review some of the LSIs that have recently closed down (House of Commons 
Science and Technology Committee 2011, Brown, Gregson and Mason 2016), we 
explore their impact and if they had a role in providing KEC. Through this we might 
understand why some LSIs do not continue beyond their funding period. 
 
 The importance of Life Science Intermediaries to the Economy  
Innovation has been identified as an important source of economic wealth (Wilson 
2012, Mazzucato 2013, Higher Education Funding Council for England 2016). 
Innovations that emerge from the life sciences sector have a potential to drive new 
company formation, increase employment, inward investment and to generate 
products that can be sold globally. It has become a priority sector for the UK and 
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many other countries (Shohert and Prevezer 1996, Hansson, Husted and 
Vestergaard 2005). 
Many Governments have looked at where other nations have been successful at 
translating life science innovation into economic benefit (Breznitz and Anderson 
2005). Many successful countries have used intermediaries to help bridge the gap 
between different sectors and grow their life science clusters (Morgan 1997, 2011, 
Smedlund 2006, Lopez-vegas and Vanhaveverbeke 2010, Suvinen, Konttinen and 
Nieminen 2010). Both academia and industry have traditionally found it difficult to 
bridge the sector divide between them. The German Faunhofer Centres (discussed 
later in Chapter 3) have been intensely scrutinized and many have tried to emulate 
them (Hauser 2010, 2014, Reid et al. 2010, Mina, Connell and Hughes 2009). In the 
UK there has been a debate as to whether we can do something similar and indeed 
we have tried to implement similar models, for example the Catapult Centres and the 
Intermediary Technology Institutes (ITI’s) (both are discussed later in this chapter). 
There is a belief that intermediaries can help in the drive for prosperity by bridging 
the divide between sectors, producers and users of knowledge.  Over a number of 
years, many have supported the view that intermediaries can help (Hauser 2010, 
2014, Brown, Gregson and Mason 2016). The continued investment into 
intermediaries including the new Catapult Centres, which will receive £250 Million 
over 10 years (Hauser 2010), and is worthy of further investigation to establish 
whether they are as effective and valuable as perceived. This research could 
potentially try to inform a range of interested parties including policy-makers, funders 
and practitioners from within the sector understand the effectiveness of LSIs. We 
discuss the specific aims of the research in the next section. 
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1.3 Research Aims and Objectives 
Based on an in-depth review of the literature on the life sciences sector and 
innovation intermediaries in addition to the researcher’s own experience of working 
in the sector, the decision was made to focus this study on life science specific 
intermediaries, with a focus on their impact on KEC processes. This will be crucial in 
understanding their overall value in terms of economic and societal benefits. In order 
to decipher their KEC potential a closer look at the relationship between the LSIs and 
their stakeholders, and how they operate, will help to determine the impact within 
each intermediary case being investigated in this study. More specifically this 
research will focus on the following research objectives: 
1. Investigate the role and function of a range of LS intermediaries within the UK 
and Europe (Holland and France) 
2. Explore the ecosystem in which each case LSI is located with respect to their 
stakeholders 
3. Explore the perceptions and expectations of LSI stakeholders 
4. Review how outcomes are measured and reported in each case LSI 
5. Explore the potential for commercialisation outputs from KEC, including: 
a. Spin-outs and start-ups 
b. Licensing 
c. Collaborations 
d. Inward investments 
 
1.4 The Research Questions  
While reviewing the literature for the first time, the following research questions were 
identified as below: 
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RQ1:  Are LSIs important for the commercialisation of research? 
RQ2:  What are the key perceptions and expectations of the KEC value that LSIs 
hold? 
 
After a thorough review of the literature on LSIs it became clear that the gaps in the 
literature were related to answering the above questions. A number of subsequent 
questions will also be answered. These emerged through a second deep 
examination of the literature and are linked to the objectives which help in answering 
the two main research questions. The two subsequent research questions identified 
are: 
RQ3.  Why do some LSIs fail to survive beyond their initial funding? 
RQ4.  How important is an anchor organisation to a LSI? 
 
The two main research questions were inspired by the research done by Suvinen, 
Konttinen and Nieminen (2010) who carried out research looking at innovation 
intermediaries operating in two different sectors: biotechnology and optoelectronics 
in Finland. They used the triple helix lens to determine the value of intermediaries in 
the two sectors and their commercialisation impact. Their research question asked 
whether intermediaries were necessary at all in the commercialisation of innovations. 
This PhD research study will address a similar question; however it would be 
focused on a range of LSIs in different regional and national innovation settings, 
which are either privately or publicly funded. By addressing the research questions 
we will explore how important LSIs are for the commercialisation of innovations 
rather than whether they are necessary at all. The research carried out by Suvinen, 
Konttinen and Nieminen (2010) concludes that innovation intermediaries are 
necessary in the sectors they explored. This PhD research study will address a 
similar question in RQ1. What this question asks is, can we achieve the same 
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outcomes without a LSIs. Moreover, it will assess the impact each case LSI has on 
KEC. This builds on the research by Suvinen, Konttinen and Nieminen (2010), 
however it takes a different slant in that it will focus on one sector and use Grounded 
Theory Methodology (GTM), rather than the Triple Helix Methodology as employed 
by Suvinen, Konttinen and Nieminen (2010). GTM allows for theories to emerge that 
may validate the earlier research. The decision to use GTM was supported by the 
conclusions of Suvinen, Konttinen and Nieminen (2010) that the Triple Helix had a 
poor analytic capacity. 
The subsequent research questions (RQ3 and RQ4) emerged from research carried 
out by Brown, Gregson and Mason (2016) who explored the reasons for the 
Intermediary Technology Institutes (ITIs) failure in Scotland from a policy 
perspective. This study will endeavour to address these questions, and they will be 
analysed and discussed in Chapters 6 and 7 of this thesis. The success or failure of 
an intermediary is determined by its commercialisation outcomes and the results 
from this PhD study will attempt to explore how success and failure for LSIs are 
determined. 
 
1.5 Methodology 
Grounded Theory Methodology has been chosen for this study. The researcher 
explored various approaches when deciding on the appropriate theoretical 
methodology for this research as a number of methodologies have been used by 
others and many are available and applicable. The literature on GTM is divided when 
it comes to researching a previously well explored area. Although Strauss and 
Corbin in their 1994 paper claimed that GTM had the ability to generate novel and 
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exciting ideas about things that have already been heavily investigated. O’Reilly, 
Paper and Marx (2012) said that GTM should not be chosen if the field has been 
heavily researched. They do however, also say that if the existing literature does not 
adequately explain the phenomenon then GTM can be used to develop a new 
theory. The researcher also had to decide if knowledge gained through earlier 
research of the sector would jeopardize the theory development stage of the 
research. However, providing that a researcher remains open to the data collected 
and avoids using any biases based on to pre-existing assumptions, it is possible to 
generate new theory based on the data collected (Goulding 2002, O’Reilly, Paper 
and Marx 2012).   Furthermore, there is an argument that previous practical and 
theoretical experience of the phenomenon should be viewed as an asset (O’Reilly, 
Paper and Marx 2012, Fendt and Sachs 2008). This is because in order to make 
judgements on theoretical saturation a deeper understanding of the field through 
active professional experience will enable the researcher to recognise when the 
saturation point has been reached. Therefore, prior experience can benefit the 
research (Goulding 2002). Based on this review of the issues it was decided that 
applying a GTM was fully justifiable. This will be discussed further in Chapter 4. 
Prior research on the sector comes from a range of literature, however, researchers 
Lopez-Vegas and Vanhaveverbeke (2010) suggested that due to the complex and 
idiosyncratic nature of innovation intermediaries, use of a single theoretical 
methodology to inform the phenomenon is simply not going to produce viable results. 
Investigating a range of LSIs and linking the literature on knowledge exchange and 
commercialisation with national and regional innovation systems and then the triple 
Helix, could generate theory that contributes to the existing literature on innovation 
intermediaries especially the literature on the sector specific intermediaries like LSIs. 
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However as discussed briefly previously, the decision was made not to use the lens 
of the Triple Helix methodology as previous research had deemed it insufficient in 
dealing with the analytical aspects of research (Suvinen, Konttinen and Nieminen 
2010), plus the better methodology for generating new theory would be GTM. The 
other reasons for choosing GTM is that this research adapts an inductive approach 
which fits well with the researcher’s philosophical stance including both epistemology 
and ontological views. This will also be discussed further under Research 
Methodology in chapter 4. 
 
1.6 The Justification for this Research 
Many researchers have studied innovation intermediaries that cover a number of 
different sectors. Few have examined sector specific intermediaries. This PhD 
research project will investigate and explore a range of physical innovation 
intermediaries involved in the commercialisation of life science innovations 
specifically. This qualitative study will link literature and theory on knowledge 
exchange and commercialisation (KEC), using a constructivist Grounded Theory 
Methodology that will focus on perceptions and expectations. To the researcher’s 
knowledge this has not been done before. Innovation intermediaries are believed to 
provide an advantageous stimulus to innovation processes, however, because of the 
lack of any acceptable metrics of intermediary performance, it is difficult for 
innovation intermediaries to provide any definitive proof of their contributions (Dalziel 
and Parjanen 2011). Using a Constructivist GTM as in this research has allowed for 
an in-depth view of the Case LSI models, which includes identifying the metrics used 
by the different LSIs to measure success and failures. 
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The innovation process is highly complex and in order to generate new innovations 
multiple players are often required. The different organisations within the life science 
sector like biotech companies, large pharmaceutical companies and public research 
organisation (PRO’s) don’t naturally interact and it is because of this that LSIs were 
first created (Wilson 2012, Shohert and Prevezer 1996). These different 
organisations have different cultures and organisation structures that make it difficult 
to communicate across the boundaries.  
This research study is motivated by the need to gain a greater understanding of the 
return on the investment in LSIs. It is not just the European and UK Governments 
who are investing in LSIs as a vehicle for transferring and exchanging knowledge, 
many other countries are following suit (Coeurderoy and Duplat 2008, Kodama 2008, 
Lee et al. 2010, Godfrey, Funk and Mbizvo 2010, Fornahl and Sorenson 2008, 
Dalziel & Parjanen 2012, Clausen 2013, Katzy et al. 2013, Smedlund 2012, Wu and 
Dalziel 2012). This study aims to illuminate the potential these LSIs have for KEC 
and for driving innovations out into the market place. 
The key contributions of this PhD research project will not only be a greater 
understanding of the role and value of these intermediaries, but a better 
understanding of the perceptions and expectations held by those funding them and 
using them. The concept of intermediaries has been around for some time, but they 
are only now becoming more formalised, more recognised for their value, and more 
targeted by those seeking to improve the flow of knowledge (Wilson 2012, Hauser 
2010, Howells 2006, Andersen, De Silva and Levi 2013). 
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1.7 Structure of this Thesis 
Chapter 1 introduces the study and provides some context through some 
explanation as to the phenomenon that was studied, which includes discussing the 
importance of LSIs to the economy. The research aims, research questions and 
methodology chosen are all discussed. Then finally the chapter ends with a 
justification for the research and the organisation and structure of the thesis is 
presented. 
Chapter 2 provides some background and historical context to the sector in which 
the phenomenon is placed. We discuss how the sector evolved and some context is 
provided for the use of patents within the sector. Finally we explore the different 
clusters within the UK, Europe and the USA. 
Chapter 3 begins with an explanation of different types of knowledge and where life 
science innovations comes from. This is followed by a review of the literature on 
current and past LSIs that help us capture the essence of why this project is justified 
and important. The literature reviewed gives us insights into what to expect from this 
research. It also helped to identify where the gaps lie and some of the issues 
encountered in dealing with terminology. 
Chapter 4 is the methodology and research methods chapter and here we start by 
delving into the aims and objectives of the research project. The research questions 
we have identified and our justification of choices made in the philosophical 
positioning of the research project are covered after the research aims and 
objectives. The chapter also provides an overview of the three main approaches in 
GTM and provides a comparison between them. The choices made are justified by 
the researcher. In the second half of the chapter we discuss the research methods 
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used and then we explore the design and analysis of the research project and the 
data. 
In Chapter 5 the results are presented and explained as are the coding procedures 
and how the different codes were identified for initial and focused coding. The 
chapter then presents the analysed data under each of the focused codes together 
with the observation data which is reviewed and analysed against the focused 
codes. 
Chapter 6 is the discussion chapter and we start off by discussing the different forms 
of telling and how it was applied to the life cycle of each LSI. Next we compare the 
different case models and review what constitutes a high-performing LSI. Some of 
the key variables are analysed in relation to LSI performance in KEC and 
expectations of and barriers to success are included. The theoretical concepts that 
emerged are then discussed and finally the research is evaluated for its quality. 
Chapter 7 is the conclusion chapter and discusses the contribution to knowledge that 
the study has made. It also links the literature reviewed with the research questions 
identified. The limitations of the study and recommendations for future research are 
also discussed. Finally reflections on the research process are made. 
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Chapter 2 Background History  
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2.1 Introduction 
This chapter looks at the history and evolution of the life science sector and the birth 
of the biotechnology sector. In addition, we also discuss the importance of patents to 
the sector and the emergence of university intermediaries and why other LSIs have 
emerged. This then leads on to a review of the literature on life science clusters with 
examples of successful clusters in the USA, Europe and the UK. 
2.2 The Evolution of Life Science Sector  
Technological innovation accelerated after the Second World War and this has 
continued through to the present day (Salter et al. 2000, Prevezer and Toker 1996, 
Prevezer 2001). In the early 1970s the USA found itself having to compete with 
emerging economies from the Far East. Until this point the USA held a clear lead in 
technological innovations. When it was realised that these new competitors where 
selling technologies developed in the US in direct competition to the products 
developed locally, the US government realised that something needed to change. 
The decade between 1970 and 1980 is now known as the ‘Competitiveness Crisis’ 
era (Prevezer 2001). This period saw the rise in the genomic revolution and was 
driven further by the use of legislation for the US to help maintain their global edge. 
The legislation helped to safeguard Intellectual property (IP) so that it could benefit 
the US economy. The government examined the innovation processes within 
universities and decided that new legislation was needed across all PROs that would 
protect IP coming out from them (Jung et al. 2010).  The ensuing legislation was a 
result of the perception at that time of the low rate on return on the investment on 
research and development and that the PROs were too ‘leaky’ when it came to 
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valuable IP (Sampat, Mowery and Ziedonis 2003, Eisenberg 1996, United States of 
America Senate Judicial Committee 1979, p.2).  
The Bayh-Dole Act of 1980 was a direct result of the drive to counteract the 
competitiveness crisis. It allowed universities to keep hold of any IP created from 
publicly funded research, thus creating the ‘Patent Age’ (Prevezer 2001), which is 
still in place today. The Act meant that the responsibility for patent filing would now 
rest with the university or institution. Prior to the Bayh-Dole Act universities were 
required to negotiate with individual funding agencies for various rights. This was 
time consuming and unnecessarily bureaucratic and ultimately impeded the transfer 
and commercialisation of publicly funded research (Sampat, Mowery and Ziedonis 
2002, Jung et al. 2010).  Before the Act came into force the reward system within 
academia was based on peer recognition and publication (Cohen et al. 2002, Rai 
1999, Rai and Boyle 2007). Publishing all research made discoveries available to 
everyone. The government came to realise that this allowed foreign competitors 
easy access to economically valuable information. Now in the Patent Age they 
patent first and publish later. The act has been credited for the rapid development of 
the life sciences sector since 1980 – in particular the biotechnology sector – and 
played a part in incentivising investment in downstream R&D. This facilitated the 
commercialisation of biotechnology products (Mazzoleni and Nelson 1998, Cohen et 
al. 2002). It was in California that the idea to commercialise these technologies was 
initiated.  With the discovery in 1973 of recombinant DNA techniques, LS innovations 
were further accelerated. The discovery was made in two US universities (San Diego 
and San Francisco) and two years later monoclonal antibodies were developed in 
the UK at the University of Cambridge. These discoveries signalled the start of the 
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Genomic Revolution and the biotechnology sector was born (Prevezer 2001, Hendry 
and Brown 2006, Salter and Martin 2001).  
The impact of the patent system on the LS sector and in the development of LS 
clusters will be discussed in later this chapter. Cohen et al. (2002) and Hendry and 
Brown (2006) said that this explosion in activity has not happened in other sectors 
and that it appears to be unique to the LS sector, they believe that this is because 
the sector is highly research focused. 
 
2.3 The Impact of Patents 
Over the last three decades patenting has become an increasingly important goal in 
public funded research. In 1980 when the Bayh-Dole Act came into force the focus of 
patent ownership changed from the individual to the institution (Sampat, Mowery and 
Ziedonis 2003, Prevezer 2001). There have been many papers written about the 
impact the Bayh-Dole Act has had on innovation and commercialisation of publicly 
funded research. The act achieved its goal in reviving US competitiveness (Sampat, 
Mowery and Ziedonis 2003) and other countries seeing the benefits have followed 
suit with similar legislation, for example the UK followed in 1985 with their own 
version of the legislation as did Germany in 2002 and Japan in 2004 (Jung et al. 
2010).  There has been great interest and debate surrounding the issue of  the 
quality of patents since the Bayh-Dole Act. Henderson, Jaffe and Tajtenberg (1998) 
argued that the quality of patents had declined, however the quantity had increased. 
However, Sampat, Mowery and Ziedonis (2003) concluded that there had been no 
decline in the quality. Their research is an indicator or measure of the impact patent 
quantity, quality and direction have had on publicly funded research outputs 
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(Azoulay, Ding and Stuart 2009, Stuart and Sorensen 2007). Other researchers 
worried about what the impact of commercial incentives would have on basic 
research. For example, would there be a shift to only fund research that is 
commercially viable or applications based research rather than on basic research 
(Sampat, Mowery and Ziedonis 2003, Calvert 2006, Christopherson, Kitson and 
Michie 2008, Salter and Martin 2001, Agrawal and Henderson 2002). Universities 
walk a fine line between balancing the scientific principles based on the ‘Mertonian 
Norms’ of science (Merton 1946) and funding for research (Calvert 2006, Salter and 
Martin 2001). There is relevant literature on the patenting system supporting both 
arguments. Heller and Eisenberg (1998) and Rai (1999) have argued against the 
patent system. Not filing a patent can have costly ramifications and there have been 
a number of well-known examples of what happens when inventors fail to patent an 
innovation. In the UK in the 1980’s the University of Cambridge and the Medical 
Research Council failed to recognise the global commercial and scientific value of 
their discovery of Monoclonal Antibodies (Prevezer 1996, Sir Greg Winter, 
presentation to the annual BIA conference, Nov 2007, London). This and other 
similar examples of missed opportunities are part of the reason why Technology 
Transfer Offices (TTOs) were created to help safeguard a universities intellectual 
property. The changes in legislation were intended to generate profit for universities 
that could re-invested in new research projects. However, questions have been 
asked recently about how successful this strategy has been. The Financial Times 
revealed that UK universities spend £50miilion per annum on patenting, but that the 
majority of these patents have proved commercially worthless (Grimaldi et al. 2011).  
 “the riches they were promised from protecting IP have not materialized” 
(Gold et al. 2008, p.28) 
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In nearly all universities licensing income has fallen short of investment in patents 
(Huggins, Johnson and Steffenson 2008). Only those few universities who have had 
blockbuster inventions see any significant revenue gains (Huggins, Johnson and 
Steffenson 2008).  
The impact of patents on universities since the Bahy Dole Act has been mixed (Rai 
1999).  The negative consequences of patenting are not just that universities spend 
more on patents than they receive through their commercialisation. They can also 
lead to uncompetitive behaviour, like buying competing IP to kill it and thereby 
preventing it from reaching the market (Rai 1999). Others have acquired a portfolio 
of patents not to develop or commercialise them, but used to prosecute others for 
infringements. This is called “patent trolling” (Rai 1999). Patents have become 
fundamental in the financing of the LS sector (Kieff 2000) and LS research. There 
has been an explosion of growth in the LS sector, with thousands of new LS 
companies created since 1980. Many of those who in the early days were against 
the Bayh Dole type legislation have had their minds changed by the sheer wealth 
that patents have brought. We have also seen the number of university LS patents 
grow from 250 in 1980 to 2,700 by 1992 (Rai, 1999). The patent count has been an 
important metric in determining how successful the sector has been since the 
legislation came into force. This increase in the number of patents filed has not 
brought the rewards first imagined, especially for PRO’s. This could be due to the 
fact that universities are not geared up to deal with the brokering of innovations 
effectively. The brokering role they have assumed has led to overvaluations of 
innovations in many cases which has resulted in a failure to see the return on their 
investments in patents.  
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2.4 Life Science Clusters 
Life science clusters are geographic concentrations of interconnected businesses, 
including biotechnology and pharmaceutical firms, patent agents, venture capital 
organisations, accounting firms and biomedical supply firms, and the local research 
base like universities research institutes and hospitals. Clusters reduce the risks 
associated with developing and commercialising new and emerging technologies 
and support the wider adoption and diffusion of these new technologies (Hendry and 
Brown 2006, Ketels and Memedovic 2008, Department of Business, Innovation and 
Skills 2011).  
LS clusters have developed and grown rapidly in the three decades since the start of 
the biotechnology revolution, these geographical agglomerations allow for 
knowledge spillovers to take place (Salter et al. 2000, Saxenian 1994, Hendry and 
Brown 2006, Sainsbury 1999). Spillovers are important to the growth of a cluster as 
they have been seen to accelerate the rate of new innovations taken to the market 
(Breschi and Lissoni 2001). These knowledge spillovers occur because of trust and 
collaboration that grows within a LS cluster (Asheim and Coenen 2005). Hendry and 
Brown (2006) found that the knowledge spillover effect is greater within LS clusters 
than any other sector.  
The central hub of a life science cluster is usually a university or other PRO (Breznitz 
and Anderson 2005). However, sometimes it may also be a large pharmaceutical 
company or large biotech company (Powell 1998; Stuart and Sorensen 2003, 2007, 
Fornahl 2007). Researchers have examined the reasons these LS clusters have 
been created and concluded that they are a result of the companies spun out of the 
PRO, the academics behind these spin-outs usually want to remain close to their 
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research base within the university (Zucker, Darby and Peng 1998, Breznitz and 
Anderson 2005). Universities have motivated academics to put more effort into 
commercialising their technologies, with the result that these activities will help 
supplement their research income (Breznitz and Anderson 2005). New 
entrepreneurs are attracted to locate in a LS cluster based on the following features: 
(1) The number of other biotechnology firms within the cluster (2) the research base, 
usually a local university (3) the presence of venture capital firms located within the 
cluster (Stuart and Sorensen 2003, Fornahl 2007). The work done by Stuart and 
Sorensen (2003) shows that although the university sits at the hub of the cluster, it is 
more important to a new entrepreneur to examine all the above features. Having 
access to qualified employees as well as funding is important to new companies 
(Owen-Smith and Powell 2004, Fornahl and Sorensen 2008). 
Hendry and Brown (2006) undertook an important study using survey data to look at 
how companies benefitted from networking in LS clusters. They explored specifically 
the networking patterns of different firms and the intensity of the networking they did. 
They found that new smaller firms who had fewer resources had to seek help from 
LSIs in order to make the connections locally. The larger firms tended to network 
less locally and needed the help of the LSIs less. This has also been explored by 
Cohen and Leventhal (1990) and Drejer and Vinding (2007), they explained the 
phenomena as being due to the absorptive capacity of firms. The smaller firms were 
more in need of the help that a LSI could provide as they have low absorptive 
capacity, while the larger more mature biotech firms had a higher absorptive 
capacity, probably due to the fact they were connected to global markets (Huggins, 
Johnson and Steffenson 2008, Cohen Leventhal 1990, Drejer and Vinding 2007).  
Hendry and Brown (2006) drew similar conclusions also noting that LSIs were used 
26 | P a g e  
 
less as the company matured and they too believed this was due to the need for the 
company to work more internationally, and that as they had grown they had 
developed strong relationships with pharmaceutical companies who operate globally. 
This is in line with some of the studies done on the subject of clusters (Saxanian 
1994, Senker and Sharp 1997, Porter 2003). These conclude that there is a need for 
clustering of companies in a sector as they facilitate the process of knowledge 
exchange and transfer for emerging organisations and that local clustering allows for 
face to face interactions – usually at events organised by LSIs. 
Therefore in summary, LS clusters are important for knowledge spillovers, and 
intermediaries within these clusters play an important dynamic role in helping to 
achieve this, which they do by increasing the social capacity of the organisations 
within their ecosystem. It is believed that clusters play an important part to the 
successful functioning of a LSI (Cooke 2002a, 2002b, Hendry and Brown 2006, 
Fornahl and Sorenson 2008, Prevezer 2008, Huber 2009). The next section reviews 
some high performing clusters in the USA and UK. Later in the chapter some of the 
Case LSIs that operate as cluster networks will be discussed, they are: BioDundee, 
One Nucleus and Lyon BioPole  
 The US Perspective - The Boston Life Sciences Cluster 
As discussed earlier, this study will look at LSIs outside of the UK in order to learn 
from any successes. The USA has been at the forefront in the biotechnology 
revolution and has had unrivalled successes in the sector. Three regions within the 
USA led the revolution in the sector, these were San Francisco, San Diego and 
Boston (Prevezer 1996, Etzkowitz 2002). Based on the East Coast of the USA, 
Boston has one of the first and arguably the most successful life sciences clusters 
globally (Prevezer 2001, Etzkowitz and Dzisah 2008). It is a hotbed of 
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entrepreneurial activity. The Boston life science cluster has recently outperformed 
the San Francisco Bay area (a West Coast LS cluster) and taken the top spot away 
from them (Weisman 2012). Since the foundation of these two clusters there has 
been competition for the leadership position (Weisman 2012). A closer examination 
of how Boston finally managed to topple San Francisco would add a depth of 
understanding of this successful progression and could reveal learning on the gaps 
we may encounter between the LS clusters in the USA and the UK and other 
European countries. This would indeed be an interesting area to research, however, 
it would require resources that are not available to this research project. 
The San Francisco cluster had for many decades held the top spot and had the 
advantage of being close to Silicon Valley; it is believed that it is this proximity that 
had given the San Francisco cluster its edge over Boston for the past two decades 
(Prevezer 2001, Owen-Smith and Powell 2004). Silicon Valley had a thriving venture 
capital community, which, when presented with commercial potential from the life 
science sector, extended their investment portfolios to include biotechnology 
(Saxenian 1994). In addition, Saxenian (1994) concluded that Californian universities 
like Stanford were much more used to working with commercial partners than the 
Boston universities. However, according to Breznitz and Anderson (2005) this has 
now changed within the Boston cluster and may have contributed to its rise to the 
top. 
There is literature on the region as an exemplary life science cluster and a number of 
researchers have written about the early history and evolution of this cluster 
(Prevezer 2001, Jung et al. 2010, Cooke 2002a). Cooke (2002a) discussed why the 
Boston cluster was so successful, concluding it was due to: 
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 “Proximity and common backgrounds from educational institutions and 
the level of inter-firm interactions is high, global linkages to other clusters, 
linkages to pharmaceutical firms, to partners and customers are all 
pronounced” (Cooke 2002a, p.139) 
 He concludes by saying that  
“the Boston region clearly functions as a well-integrated regional 
innovation system” (Cooke 2002a, p.140) 
Other researchers have also written about the biotechnology networks in Boston 
(Owen-Smith and Powell 2004, Rank, Rank and Wald 2006, Powell et al. 2005, 
Oliver and Liebeskind 1998). 
The Boston cluster has a rich history of academic excellence in the LS and PROs 
like Harvard University, Boston University, the Massachusetts Institute of Technology 
(MIT), Massachusetts General Hospital and the Whitehead Institute for Biomedical 
Research are all within the cluster (Powell et al. 2002). These PROs help attract 
world class talent to the cluster and a healthy venture capital sector has grown since 
the 1990s and has helped to fund the new start-up and spin-out companies (Powell 
et al. 2002, Owen-Smith and Powell 2004).  As a consequence of all this, world-class 
companies have been attracted to the cluster. The cluster has had its ups and downs 
(Porter, Schwab and Sachs 2004) but has always been a dynamic cluster. Porter, 
Schwab and Sachs (2004), outlined the growth of the Boston cluster and the 
companies that grew up there to become billion dollar enterprises like Genetech, 
Biogen, Wyeth and others. By the early part of the 21st century a large number of 
pharmaceutical companies had moved there too.  These pharmaceutical companies 
have further increased the attractiveness of the cluster and have drawn many to co-
locate (Porter, Schwab and Sachs 2004). There is now a diverse range of 
organisations all linked by formal and informal networks that are supported by the 
many intermediaries that are funded by the federal government or the local regional 
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government. This is in fact what makes Boston special, the extensive network of 
universities and intermediaries dedicated to supporting the sector (Lawton-Smith 
2005). 
It is hypothesised by Owen-Smith and Powell (2004) that a combination of factors 
including legislation, favourable funding, patent extensions and investing in niche 
markets have all had a positive effect on the region. Many of the biopharmaceutical 
companies that established in Boston, focused their R&D efforts on orphan drugs; 
this was a direct result of the 1983 Orphan Drug Act (Owen-Smith and Powell 2004).  
The orphan drugs market is very small in comparison to the blockbuster drug market 
that pharmaceutical companies usually aim for. A blockbuster drug has a much 
larger market and billion dollar sales potential. Big pharmaceutical companies are 
cautious about investing in R&D within the relatively low sales market for orphan 
diseases. This gap in the market and the favourable legislation and funding 
conditions allowed smaller biopharmaceutical companies like Genetech to move into 
this niche area. The risk these companies took has in many cases paid off and a 
number have been able to grow to the size of small pharmaceutical companies – 
helping to grow the Boston cluster to what it is today (Owen-Smith and Powell 2004). 
 The UK Perspective - UK Life Sciences Cluster 
The history of the evolving sector in the UK has been well documented (Prevezer 
and Toker 1996, Prevezer 2001, Cooke 2001, Lawton-smith 2005, Lawton-smith and 
Bagchi-Sen 2006, Papaioannou 2009, Jung et al. 2010). The biotechnology 
revolution started in both the USA and the UK almost simultaneously (Prevezer 
2001, Jung et al. 2010). Cambridge University was where the technique for creating 
monoclonal antibodies was discovered (Prevezer 2001). As discussed earlier the 
failure of the university to file a patent for this ground breaking and revolutionary 
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technology has led to loss of revenues amounting to many millions of pounds (Jung 
et al. 2010). Since that early failure to realise and benefit from these discoveries the 
UK government has been determined to draw on this and not allow it to be repeated 
(Lambert 2003, Lawton-Smith 2005, Lawton-smith and Romeo 2015).  
In the 1990’s funding for activities to link industry and academia, which included 
cluster development, fell (Lawton-smith and Bagchi-Sen 2006). However, things 
started to improve in 1995. In 1997 the new government endeavoured to address the 
funding shortfall and focused on initiatives that promoted industry/academic 
interactions. At that time they also introduced a regionalisation agenda making 
universities and Regional Development Agencies (RDAs) responsible for innovation 
in a geographical area (Lawton-Smith and Bagchi-Sen 2006), thus indirectly 
stimulating the growth of clusters. In 2003 the Lambert Review was published and 
provided a detailed review of the current industry/academic interactions taking place 
in the UK. The report helped to further establish the importance of these interactions 
to the UK economy. The report recommended that new forms of formal and informal 
networks between business people and academics should be encouraged at the 
regional level and that there should be a greater role for the RDAs in facilitating 
knowledge exchange in their regions. 
A number of LSIs have been established in the main UK LS clusters. These are 
mainly funded by central and local governments although there are a number of 
privately operated bio-incubators and business support networks that charge 
membership fees. 
In Oxford and Cambridge LSIs were established primarily to help provide business 
support in the form of finance, dedicated buildings and networking (Lawton-Smith 
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and Waters 2003, Waters and Lawton-Smith 2010). The outcome they were looking 
for was for companies to move from a research focus to the development of 
marketable products. Lawton-Smith and Bagchi-Sen (2006) discussed the creation 
of the Oxford network, which evolved from the Oxfordshire Investment Opportunity 
Network (OION) and a number of incubator parks. As the biotech sector evolved a 
number of these became sector specific and focused exclusively on the biotech and 
life science sector (Lawton-Smith and Romeo 2015). This included the Oxfordshire 
Biotech Net and the Oxford BioBusiness Centre, both of which shut down when 
funding was removed in 2005 (Lawton-Smith and Bagchi-Sen 2006). The Oxford 
Bioscience Network (OBN) was originally funded by the Government Office of the 
South East, however, has evolved into a membership organisation and is the main 
focus of networking in the LS sector in the Oxfordshire region (Lawton- Smith and 
Bagshi-Sen 2006, Lawton-Smith and Romeo 2015). OBN celebrates its 20th 
anniversary in 2017. Over the years it has grown its membership to over 400 
organisations reaching outward from its central Oxfordshire location now outwards 
and across the UK and internationally (Oxford Biotechnology Network 2017). 
Cooke (2002b) carried out a comparison between Cambridge Massachusetts and 
Cambridge UK. He explored the regional innovation systems of the two clusters and 
concluded that the UK Cambridge cluster, although smaller and less mature, had all 
the ingredients to make a successful LS cluster. It included a number of 
pharmaceutical companies like Glaxo Wellcome, SmithKline Beecham, and Merck, 
as well as large biotech companies like Amgen and Genzyme, which are important 
for getting access to funding and potential customers. In addition the Cambridge UK 
cluster has an abundance of science and technology parks including Cambridge 
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Science Park, St John’s Innovation Centre and the Babraham Bio-incubator (Cooke 
2002b; Papaioannou 2009).  
The proximity of all these organisations has helped the Cambridge cluster to become 
significant in regional, national and global innovations systems (Cooke 2002b). As 
previously discussed another important factor in the creation of successful clusters is 
the access to high quality staff. The PROs located in Cambridge produced suitably 
qualified employees that can feed the companies within the LS cluster. Waters and 
Lawton-Smith (2010) found that there was a high employee turnover rate in both the 
Oxford and Cambridge clusters. This was due to the density of companies located 
within these clusters. Employees could jump from one company to another when 
specific skills were in short supply (Waters and Lawton-Smith 2010). It is thought that 
it is inevitable that Cambridge would start to experience the same issues on the cost 
of space and the poaching of staff as the Boston Cluster in the US currently 
experiences (Breznitz and Anderson 2005). 
The main regional Cluster Network Organisation in Cambridge U was ERBI and it 
supported the sector by producing newsletters, conferences, training and links to 
other networks located nationally and internationally (Cooke 2002b). Like OBN, ERBI 
was originally funded by the RDAs and once that funding ended, they too had to 
evolve into a membership organisation. They merged with the London Biotechnology 
Network to become One Nucleus in 2010. 
Leibovitz (2004) looked at the Scottish clusters focusing on the two major cities of 
Glasgow and Edinburgh. He looked at the type of organisations located within these 
clusters, and he explained that the clusters in Scotland were still ‘embryonic’. In 
addition like Cooke (2002a) he concluded that a diverse mix of organisations 
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including public research organisations (PROs), biotech companies, patent agents, 
accounting firms and business support networks are all paramount. However he 
emphasises the fact that they need to be highly specialised and sector focused 
(Leibovitz 2004). Research into Sectoral Systems of Innovations will be discussed in 
more detail under later. Leibovitz argues that organisations need to be highly 
specialised to work in the LS sector; which fits with the justification for Sectoral 
Systems of Innovation. 
 Papaioannou (2009) who also studied the Scottish cluster and compared it to the 
Cambridge cluster, said that one of the problems with Scotland was that they had 
fewer entrepreneurs, network brokers and investors who would invest in high risk 
companies. Rosiello (2007) looked at Scotland as a case study for innovation in 
biotechnology, and concluded that Scotland had been at the forefront in promoting 
and investing in cluster development. He discussed the companies and business 
support networks that operate across Scotland and concluded that most of the 
companies and PROs had to look outside their cluster to find suitable customers and 
funders and therefore needed to get help from intermediaries to do so. 
The UK LS innovation ecosystem has been evolving over the last two decades. 
Government funding for LSIs like the Cluster Network Organisations (Case 2 LSIs 
from Table 1) has largely stopped, and as a result many LSIs have closed or have 
evolved in to membership organisations. Those that have survived include ERBI 
(now called One Nucleus), BioDundee and OBN. Both One Nucleus and BioDundee 
are included in this PhD research study. More recently, new regional Cluster 
Network Organisation have been created in the North of England (BioNow) and 
Wales (BioWales). It should be noted that in Scotland the Case 2 LSI model  that is 
still operating is BioDundee. The Scottish Government has invested in a new 
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intermediary model, the Innovation Centres. There are currently eight of these 
Innovation Centres, four of them within the LS sector: 
 The Scottish Aquaculture Innovation Centre 
 Stratified Medicines Innovation Centre 
 Industrial Biotechnology Innovation Centre 
 Digital Health and Care Institute 
These Innovation Centres were launched in 2012 and are overseen and funded by 
the Scottish Funding Council (Scottish Funding Council 2016). They have been 
allocated £120 million over a 5 year period (Scottish Funding Council 2017). An 
independent review commissioned to assess whether the Innovation Centres were 
on track and meeting their targets was published in September 2016 (Scottish 
Funding Council 2016).  
The review enabled the collection of evidence from a wide range of stakeholders 
from both industry and academia. It found that most of these Innovation Centres 
were on track for driving innovation between industry and academia. The criteria for 
success was based on the original delivery plan and the aims and objectives of the 
programme. The Innovation Centres are expected to leverage further funding from 
industry and other sources of public funding. They were created to be driven by the 
needs of industry, and to identify barriers to create economic benefit across 
Scotland. The Innovation Centres work with academia in a problem-solving 
consultancy capacity with industry to solve issues in product development and to 
utilise the science base to elucidate sometimes long-standing issues in certain 
industries (Scottish Funding Council 2016).  
In order to achieve these goals the programme funders, SFC, support capital 
equipment purchases and postgraduate funded positions. The idea is that there is a 
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fluid exchange of knowledge between the two sectors in the form of secondments 
and collaborations. The sharing of equipment between both sides is encouraged, 
and industry has access to technology within universities and universities can access 
technology and know-how in companies. In addition, the Innovation Centres have a 
focus on skills and training, up-skilling where gaps are identified (Scottish Funding 
Council 2016).  
From this researcher’s own 15 years’ experience in the LS sector, the skills gap 
issue has been identified as a constant barrier to progress in the sector. Training for 
specific specialist skills in industry are costly and SME’s are on tight budgets with 
most of their available resources being invested in product development; leaving little 
or nothing for training. Europe has been a valuable source of the skilled workers in 
the sector, but with Brexit on the horizon, industry, academia and Government need 
to start looking at measures to counteract a possible severe skills shortage in the 
UK. 
 The European Perspective – Holland and France Life Sciences 
Clusters 
The literature on European clusters is fragmented. There have been papers written 
on European clusters including those in Portugal (Fontes 2001); the Basque region 
of Spain and Scotland (Cooke, Gomez Uranga and Etxebarria 1997), Scotland, 
Sweden and Denmark (Rosiello 2007), Italy (Bigliardi et al. 2006), Sweden and 
Ireland (Angelakis and Galanakis 2016).  
Policy driven initiatives have played an important part in helping to grow the LS 
clusters in Europe. They specifically aid the connections between various players in 
a cluster (Rosiello 2007, Bruschi et al. 2011) 
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Two reports from KPMG have also proved useful on building a picture of clusters in 
Europe. From their report on site selection in Europe we can gain an understanding 
of the size and dynamism of the top 10 clusters (KPMG 2016). They rank 
Switzerland as the number one cluster, followed by UK, Holland, Ireland, Germany, 
Sweden and Finland.  For this study we are focused on Holland and France. France 
has not made it into their top 10 rankings, however they are noted for offering 
competitive salaries. France and Holland also have the second highest ranking 
universities (4 each) on a global table of 100 along with Germany and Switzerland 
(KPMG 2016). 
The two largest economies which include the UK and Germany have not attracted 
the same number of companies locating their regional headquarters, those countries 
who have surpassed the UK and Germany are Ireland and Holland (KPMG 2013).  
France and Switzerland have also been very successful at attracting LS companies, 
and France can offer lower R&D costs which provides an advantage to companies. 
When this research started the UK was still firmly placed within the European Union, 
since June 2016 this has changed and the UK is currently in the process of leaving 
the EU and as discussed earlier Brexit may bring sweeping changes. This PhD 
research study is mainly focused on LSIs across the UK, however, when exploring 
what constitutes a success or failure, the researcher did focus on the German 
Fraunhofers as examples of successful intermediaries. The research study has also 
collected data from two European clusters in France and Holland, both of which will 
aid in the review on success and failure. 
This section on clusters has provided some background on the sector and the 
location of the LSIs we will be exploring. The abundant literature on clusters has 
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focused on a number of aspects that have helped them flourish and some of the 
barriers to their growth. The next Chapter will review where knowledge comes from 
and we will look at some of the LSIs that are current and those that have gone. In 
addition we discuss the different theories in relation to past studies. 
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Chapter 3 The Literature Review 
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3.1 Introduction 
In the previous chapter in section 2.1 there is a review of the literature that provides 
some definitions as to what a life science intermediary is and why they are deemed 
important to the economy of the UK. 
We then looked at the knowledge exchange and commercialisation process itself 
and some of the barriers to this exchange mechanism are then examined. An 
understanding of where innovations come from in the life sciences and how it is 
commercialised will help us understand better how effective LSIs might be at doing 
this. This issue and other related issues will be discussed within this chapter through 
reviewing the relevant literature on this topic. 
3.2 Where Does Life Science Innovation Come From? 
Invention and innovation is often created in public research organisations (PROs), 
which include universities, government research laboratories and research institutes. 
Basic research is generated mainly in PROs, and is described as unpredictable or 
curiosity-driven research (Calvert 2006) but occasionally this research may have 
potential applications which could mean the generation of new discoveries that can 
benefit society and the economy (Calvert 2006). Applied research was traditionally 
carried out in industry, but there is a blurring now of the boundaries with R&D moving 
out of industry and into academia (Calvert 2006). 
It is notoriously difficult to get innovations out of PROs. In later sections of this 
literature review there will be a discussion on their mechanisms and how the various 
intermediaries like TTOs and bio-incubators have to engage with PROs and industry 
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to help facilitate the transfer of technology out into the market. Figure 1 below shows 
where life science innovation comes from and how it moves out of PROs into the 
external environment. All of these paths can then be accessed by LSIs (See Figures 
1 and 2).  
 
Figure 1. Getting Life Science Innovations Out 
 
Simplistic representation of where life science innovations come from and how they 
flow out from the research base to the market 
 
(Source: This Research) 
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Figure 2: The UK’s Research and Innovation Landscape 
 
 
 
The UK funding landscape and the pathways of knowledge flow within the UK 
innovation ecosystem. 
Source: The Dowling Review of Business-University Research Collaborations 
(Department for Business, Innovation and Skills 2015)  
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3.3 The Knowledge Transfer and Exchange Process 
The term Knowledge Exchange is a relatively recent phenomenon and has now 
superseded the term Knowledge Transfer. In the literature both terms are used - 
sometimes interchangeably. This has led to the popularity of the phrase ‘knowledge 
translation and exchange’ (Nutley, Walter and Davies 2007, Davies, Nutley and 
Walter 2008, Fox 2010) to describe knowledge exchange, since many in the field still 
want to hold onto the idea of the “translation” of knowledge or the movement of 
knowledge across boundaries (Davies, Nutley and Walter2008). 
Knowledge exchange represents a multidirectional flow of knowledge through a 
relationship model, involving linkages and exchange (Jung et al. 2010, Gagnon 
2011), whereas knowledge transfer is usually defined as the unidirectional transfer of 
information normally from producer to users of knowledge (Tait and Williams 1999, 
Davies, Nutley and Walter 2008, Christopherson, Kitson and Michie 2008 Jung et al. 
2010). Christopherson, Kitson and Michie (2008, p.169) states that: 
 “The link is more of an exchange than a transfer which is paralleled in the 
research literature on innovation as having a ‘systems’ approach with 
feedback loops and multiple synergistic relationships”.  
 
The reality is that there is much more complexity, and a variety of interactions are 
involved that had not been realised before.  
When examining the literature it is clear that there has been a progression from the 
unidirectional model of knowledge transfer to the bi-directional model. An early study 
carried out by Iles and Yolles (2002) illustrates this. They described a project looking 
at how effective SME’s are in the uptake of technological knowledge and identified 
43 | P a g e  
 
the problem of getting benefits out of academia and into the market place. They 
developed a two-way or bi-directional model in which both sides were able to learn 
about how the other worked (See Figure 3).  
 
 
Figure 3: The Bi-Directional Model 
 
 
Knowledge can flow from one sector to the other, so both sectors can gain 
knowledge of the other. Source: This research. 
 
 
 
 
 
Thus the academics gained insights into working with industry, for most of them this 
was an entirely new experience. Industry was able to learn about the untapped 
stores of knowledge within academia and how to work with academics to find 
applications for the research generated (Iles and Yolles 2002, Abreu et al. 2009). 
Each developed an understanding of what the other was looking for and learned 
more about their cultural differences. Although this early study revealed that much 
could be gained from Knowledge Transfer models, it was clear that the process was 
not a smooth one and that a knowledge intermediary was required to help bridge the 
gap between the two sectors (Jung et al. 2010).  LSIs work in a multi-directional way 
Industry Academia 
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gathering knowledge so that they can then pass it on. It is important to note that the 
high-tech imperative really requires this kind of knowledge exchange 
(Christopherson, Kitson and Michie 2008). 
Figure 4 below, shows diagrammatically the various interactions that you can get 
from this multi-directional model. It shows the various organisations types and how 
knowledge is thought to flow between them and the various LSIs. 
 
 
Figure 4: Knowledge Exchange Multi-directional Relationship Model.  
 
This diagram illustrates the formal and informal flows of knowledge 
Source: Based on Huggins, Johnson and Steffenson (2008) 
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 Barriers to Knowledge Exchange 
While Knowledge Exchange (KE) has received wide policy support it has been 
acknowledged that it may not always be as effective in facilitating the transfer of 
knowledge as theorised (Canadian Health Services Research Foundation 1999, 
Mitton et al. 2007). The differences in organisational culture and work ethics are 
among the barriers to successful knowledge exchange (Ward, House and Hamer 
2009b, Clark and Kelly 2005, Mitton et al. 2007). The literature provides some 
discussion on the challenges of working practices and in particular the need for 
researchers to adapt to the deadlines, milestones and deliverables based approach 
more commonly found in industry (Mitton et al. 2007). Although over the last decade 
universities have become more entrepreneurial there are still barriers in facilitating 
the effective exchange of knowledge (Lawton-Smith and Bagchi-Sen 2006). This, 
according to Xiao and Tsui (2007), is because academia is driven by personal rather 
than institutional agendas and there is a need for impartiality when it comes to 
research. With the focus on research that has potential applications, some have 
argued that this impartiality may be in jeopardy (Lawton-Smith 2005, Christopherson, 
Kitson and Michie 2008).  
As mentioned earlier this PhD research study is focused on multiple case LSIs and 
aims to explore specifically some of the barriers to knowledge exchange within the 
different models. What are the common practices and what are some of the LSIs 
doing that differentiates them from the norm? Can these differences have an impact 
on their KEC outcomes? It is hoped that by using GTM in this research that some of 
these questions will be explored. Answering these questions will hopefully go some 
distance to answer RQ2. 
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 Tacit and Codified Knowledge 
Tacit knowledge is difficult to collate and to communicate and the transfer of tacit 
knowledge involves social communications such as in networking (Christopherson, 
Kitson and Michie 2008). There is some evidence from a few studies that for 
effective knowledge exchange, intangibles like tacit knowledge, social capacity and 
relationship networks are important and are part of what is known as social capital 
(Zook 2004, Iles and Yolles 2002). Researchers who have looked at this, say that 
the greater the social capital the higher the quality of the brokerage outcomes (Xiao 
and Tsui 2007, Iles and Yalles 2002). According to Xiao and Tsui (2007) social 
capital is defined as information that can benefit the process and is a concept that 
refers to the connections within and between social networks. Burt (2002) describes 
social capital as a ‘bridge’ that connects actions which are not otherwise linked. The 
concept of social capital has become important in the literature surrounding regional 
and cluster studies and there is still some debate on a clear definition for social 
capital (Huber 2009). For the purposes of this research the definition of social capital 
is: deriving benefit from social interactions and networking (Christopherson, Kitson 
and Michie 2008).  
The opposite of tacit knowledge is codified knowledge which is easier to articulate by 
TTOs and they find it relatively easy to market this knowledge (Wright et al. 2008). 
Lockett et al. (2005) found that very few TTOs within universities have the expertise 
to act as intermediaries in the transfer of tacit knowledge. 
The exchange of tacit knowledge has been identified as one of the key components 
in the KEC process and in order for the exchange of tacit knowledge to take place 
social networking must be initiated. Therefore, the level of tacit knowledge exchange 
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that each case LSI holds will help to identify the overall potential for KEC that the LSI 
possesses (Iles and Yolles 2002). 
 The Open Innovation Model  
Open innovation was first brought to realisation by Chesbrough in 2003 (Chesbrough 
2003). This new paradigm has added to our understanding of the innovation 
process. Chesbrough (2003) described open innovation as the ‘purposive inflow and 
outflows of knowledge to accelerate internal innovation and expand markets for 
external use of innovation’.  The concept is not without its issues and a number of 
other researchers have criticised it (Chesbrough, Vanhaverbeke and West 2006). 
Open innovation has become linked to innovation intermediaries as it has grown in 
popularity. The open innovation model allows companies to combine both internal 
and external ideas and innovations to create value (Chesbrough, 2003). The concept 
has attracted both researchers and practitioners. Despite this wealth of interest 
researchers like Elmquist, Fredberg and Ollila (2009) and Trott and Hartmann (2009) 
have highlighted the negative aspects of the model. This is because traditionally 
companies keep R&D activities behind closed doors in order to prevent any leakage 
of ideas to the outside world; this is known as the ‘closed innovation system’ and 
there are still valid reasons for a closed innovation model. The open innovation 
model has become increasingly popular with intermediaries of all kinds, in particular 
those innovation intermediaries who operate online. This open innovation model 
intermediary requires no physical walls as they are virtual intermediaries. They are 
able to bring disparate technology developers together. A number of studies have 
looked at the strategies and the role of these virtual innovation intermediaries and 
their ability to create value (Howells 2006, Hossain 2012, Roxas, Piroli and 
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Sorrentino 2011). These innovation intermediaries function more as technology 
mediators when comparing them to those with a physical presence.  
The open innovation concept is believed to promote enhanced sharing of risks and 
benefits with partners. This is therefore what makes it a more ‘open’ system of 
innovation co-operation. The boundaries between partners become more porous to 
inward and outward flows of knowledge (Lee 2010). 
Within LS we have seen that this model has been taken up by a number of 
pharmaceutical and biotechnology companies. Driven by the high cost of drug 
development, a number of forward thinking pharmaceutical companies have 
embraced the open innovation model in the hope of advancing their drug pipelines. 
The closed system of drug development costs approximately $1.2 billion for each 
potential drug candidate. Most pharmaceutical companies have been looking for 
novel ways of developing new drug candidates that are less costly and one of these 
pathways is to focus their efforts on open innovation systems (Fitzgerald 2008, 
Spencer 2014). 
One successful implementer of the open innovation model has been the 
pharmaceutical giant GSK. They launched their open innovation policy in 2010, with 
the creation of ‘Open Lab’ based in Madrid Spain, where they are investing in 
malaria discovery with a focus on the developing world. In 2011, along with a triple 
helix partnership involving academia and Government, they helped to create the 
Stevenage Biocatalyst bio-incubator and accelerator. This bio-incubator was the first 
open innovation bio-incubator in the UK and is one of the Case LSIs in this research 
(Spencer 2014). 
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Open innovation has become an important model on the changing landscape of 
LSIs. RQ2 asks how effective the LSIs are at stimulating entrepreneurship through 
KEC activities. This study has managed to recruit two Open Innovation LSIs, the 
Stevenage BioCatalyst and RoCre at Rothamstem Research , this will allow for a 
review of the processes involved and how impactful they are at achieving KEC 
outcomes. 
In October 2012 the BBSRC announced that they too were embracing the open 
innovation model. Their flagship bioscience research campus in Cambridge, the 
Babraham research campus, was to become an open innovation campus. This was 
done in collaboration with the two pharmaceutical companies based in the cluster 
AstraZeneca and Pfizer. 
 
3.4 A Review of Literature on a range of Past and Current LSIs  
Some of the more interesting LSIs will be discussed here to provide a picture of the 
range of LSIs operating within the sector. These LSI are all specifically physical or 
institutional types of intermediaries that have a KEC strategy.  
 Technology Transfer Offices (TTOs)  
Nearly all US, UK and European universities have received funding by their 
governments to establish intermediaries known as Technology Transfer Offices 
(TTOs) (Ward, House and Hamer 2009a, 2009b, 2009c, Wright et al. 2008, Mina 
Connell and Hughes 2009, Howells and Edler 2011, Lawton-Smith and Bagchi-Sen 
2006). They act as gatekeepers of the universities intellectual property (Wright 
2008), by policing technological innovations that may have a commercial potential or 
to assess and protect IP and make it available to industry through licenses (Lawton-
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Smith and Bagchi-Sen 2006; Huggins, Johnson and Seffenson 2008). They search 
for commercial opportunities, carry-out market research and help academics with 
applications for funding, essentially acting as a bridge between universities, industry 
and non-governmental organisations (Siegel, Westhead and Wright 2003). Many 
funding bodies now require details of any commercial output for the research they 
fund and this is the part that TTOs have traditionally assisted with (Lawton-Smith and 
Bagchi-Sen 2006, Lee and Ohta 2010). However, there is growing evidence that 
academics are now developing an understanding of the need for this essentially 
business side of the application and are completing applications themselves, thereby 
reducing the need for assistance from the TTO (Lee and Ohta 2010).  
One of the primary goals of a TTO is to identify research that is patentable. Once the 
patent is filed they generally market technologies externally in order to license it to 
industry or to other PROs (Huggins, Johnson and Seffenson 2008, Lee and Ohta 
2010, Ward, House and Hamer 2009c, Bramwell and Wolfe 2008). In most instances 
the university will not have the resources to fully commercialise their innovations, for 
example taking a molecule that may have the potential to become a drug to the 
market, cost $1.2 billion of investment and a period of approximately ten to twelve 
years (Ernst & Young 2010), this is beyond the resources of a university. There has 
been a trend in the last two decades for TTOs to help in the creation of new 
commercial entities otherwise known as spin-out companies (Huggins, Johnson and 
Steffenson 2008, Lee and Ohta 2010, Boon et al. 2011, Boh, De-Haan and Strom 
2016). These new entities are usually incubated within the university to start with and 
then they are generally rolled out into a science park (Wright et al. 2008), remaining 
close by to the university, usually because the academic who founded the company 
can still be near to their research base within the university.  
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Over the years universities have generated many millions of pounds of income from 
licensing patented technology, which has helped to fund future research (Wright et 
al. 2008, Lockett et al. 2005). As discussed previously changes in legislation have 
given academics the freedom to found companies without jeopardizing their 
academic careers. A scientist can have nothing but a patent and depending on the 
strength of that innovation and the credibility of the academic they can obtain enough 
investment to create a company (Prevezer and Toker 1996, Prevezer 2001, Wright 
et al. 2008, Lockett et al. 2005, Calcagnini and Favearetto 2016). This is a simplistic 
view of spin-outs and start-ups, but it is essentially what happens. The TTOs help 
support the incubation period providing business guidance and funding pathways to 
these fledgling companies as they roll out of the universities and establish 
themselves. 
Although TTOs perform a useful role in the exchange of knowledge, they do have 
limitations. The TTOs are successful at transferring codified or explicit knowledge, 
(which is the knowledge you find in IP, contracts and licenses) than in transferring 
tacit knowledge (discussed earlier) (Wright et al. 2008, Lockett et al. 2005). 
 Tacit knowledge is an important element within the knowledge exchange process 
and this deficiency within TTOs has given rise to a diverse range of LSI models, who 
do exchange tacit knowledge. These LSIs can facilitate the transfer of tacit 
knowledge through social networking events like; seminars, conferences, training 
events and workshops; it is this that differentiates them from TTOs.  
There is a wealth of literature on the subject of TTOs and their growth within 
universities that in turn feeds the literature on industry-academic research (Siegel, 
Westhead and Wright 2003, Debackere and Veugelers 2005, Ward House and 
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Hamer 2009a, 2009c, Lee and Ohta 2010, Howells 2006, Howells and Edler 2011). 
Most authors consider that TTOs have a place in assisting universities to 
commercialise research and to facilitate the link between industry and academia, 
and are an important bridge that span the two sectors. It is possible that in the future 
TTOs may also start to help in the transference of tacit knowledge as well as codified 
knowledge. Of course the question is would this reduce or indeed remove the need 
for other models of LSIs?  
 Incubators and Science Parks 
Government policies helped to create the TTOs and they have also helped in the 
establishment of incubators and science parks. These two types of intermediaries 
are both key in the exchange of knowledge between PROs and industry (Huggins, 
Johnson and Steffenson 2008). The creation of incubators and science parks are 
key mechanisms in the facilitation of knowledge spillovers (Huggins, Johnson and 
Steffenson 2008, Huber 2009). There are 62 bio-incubators across the UK (UK 
Science Park Association 2016). They consist of small laboratories and offices 
suitable for the early incubation of spin-out companies from the PRO base and some 
are subsidised by the PROs and therefore are normally affordable to the young spin-
out companies that occupy them. The science parks range in size and provide 
services that include consulting, access to funding, access to venture capital, access 
to customers, and access to universities and networking within the local community 
(Huggins, Johnson and Steffenson 2008; Wright and Pardey 2006, Wright et al. 
2008,  Chan, Oerlemans and Pretorius 2009, Ahmad and Thornberry 2016). 
The role of these incubators and science parks appears to take up the slack from 
TTOs by providing a platform for the exchange of tacit knowledge, crucial in the 
transfer and exchange of knowledge in the innovation process. They can help by 
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finding funding opportunities for academic programmes, organising student 
placements and creating opportunities to help commercialise IP (Huggins, Johnson 
and Steffenson 2008, Cross and Thomas 2011). These opportunities are realised by 
hosting a range of events including seminars, workshops and training. Despite some 
evidence that mortality rates for the companies located in these incubators and 
science and technology parks have a tendency to fluctuate there has been an 
increase in the number of newly established incubators and science and technology 
parks across the UK (Huggins, Johnson and Steffenson 2008). It has been 
suggested by Huggins, Johnson and Steffenson (2008) that the mortality rate of the 
companies has been connected with real estate prices rather than novel science 
development within the companies. Huggins, Johnson and Steffenson (2008) say 
that these incubators and science parks can be linked to urban redevelopment and 
have been an important economic develop tool in ‘lagging or uncompetitive regions’. 
Many of the incubators are part of the universities and supported financially by them, 
which is one of the main reasons they are able to subsidise the rents.  University 
spin-offs have a close relationship with the university they spin-out from and are 
more likely to have university advisers than other firms (Cooke et al. 2006). Most of 
the management team from the spin-out companies are composed of academics 
who have a foot in both the new company and the university (Lawton-Smith 2005). In 
general, a longer time span is needed to develop LS products. This means that the 
spin-outs that are being incubated usually require a longer time to reach a more 
mature stage when they can transition into a science park. The incubation stage for 
the spin-out is fundamental to the success and sustainability of these small 
companies (Lawton-Smith 2005, Lawton-Smith and Bagchi-Sen 2006, Lawton-Smith 
and Romeo 2015, Kenney 1986, Shane 2004, Alsos, Hytti and Ljunggren 2011). 
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Owen-Smith and Powell (2004) found that biotech spin-out firms are strongly 
dependent on PRO’s for skilled labour and novel scientific competencies that feed 
the companies located within the incubators and science and technology parks. This 
means that proximity is an important factor for incubators and science parks. The 
questions surrounding proximity will help to answer RQ4. Universities are considered 
the anchor organisation for university incubators and science parks. 
RQ4. How important is an anchor organisation to a LSI? 
The interviews will address this question with all participant organisations within each 
Case LSI. The question of proximity has been a focus of previous studies, including 
Cooke (2002a, 2007), and Breschi and Lissoni (2001). However, it has never been 
explored as part of the KEC value in an LSI. In this study the participant 
organisations recruited include LSIs from those with and without an anchor in close 
proximity.  
 Fraunhofer Institutes  
The Fraunhofer society in Germany was created in 1949 (Howells and Elder 2011). It 
originally focused on geological research, however, soon spread to other fields. 
Today the society consists of 56 institutes with 14,000 employees in 40 locations 
(Mina, Connell and Hughes 2009, Fraunhofer-Gesellschaft 2008). Their main 
function is to ‘support and augment’ activities within universities for knowledge 
exchange (Howells and Elder 2011). They provide a bridging function between 
organisations working within applied research and those of technology 
commercialisation (Mina, Connell and Hughes 2009). The Fraunhofer Institutes are 
largely funded through contracts with industry and PROs, both of which account for 
two thirds of their funding. The remaining third of the funding is from direct 
contributions by the federal government (Mina, Connell and Hughes 2009). 
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The Fraunhofer Institute model has been admired as well as researched over the 
years as an example of best practice. A number of academics and policy-makers 
have considered emulating the model (House of Commons Science and Technology 
Committee 2011, Hauser 2010, 2014). However other academics like Jeremy 
Howells and Jakob Edler believe that this model would not work in the UK. The main 
reason is that the Fraunhofer Institutes are extremely wide ranging and therefore 
have a number of different bridging roles in operation; they are not a one-size-fits-all 
concept (Howells 2008). Even though they are deemed successful, there have been 
a number of Fraunhofer Institute sub-divisions that have been closed due to poor 
performance (Hauser 2010).  
A recent study by Betz et al. (2016) reviewed the German Fraunhofer Institutes with 
the intention of replicating the model in other countries, with a particular focus on 
South Korea. They developed a generalised model based on their Mittlestand triple 
helix model national innovation system, with ‘innovation intermediaries’ based in 
universities (Betz, Min and Shin 2014, Betts et al. 2016). The model is based on one-
third funding from the government Fraunhofer society, one third from project 
contracts and one third from industrial contracts. The projects normally arise from 
proposals defined by industry and academia jointly (Betz et al. 2016) 
They explored the Mittlestand triple helix Fraunhofer success through their national 
innovation systems. They explained that the German Government funds two different 
research organisations: 1). The Max Plank Institutes based within universities who 
receive funding for science research. These institutes generate new knowledge 
which is published in scientific journals (Betz et al. 2016). 2). In the universities with 
a  Fraunhofer Institute the engineering research for technology and product 
56 | P a g e  
 
development produced and institutes can produce commercially designed products 
and services, in addition to new production processes and tools (Betz et al. 2016). 
This study shows clearly why the Fraunhofer model is so successful in helping 
German industry to develop the products and services it needs for commercial 
success.  
Science indirectly benefits industry, but engineering directly benefits industry. 
Yet engineering research being based upon new science does not create a 
competitive advantage. This is why both Fraunhofer and Max Plank Institutes at 
German universities have been beneficial to the German economy, as 
innovation intermediaries –‘technology progress embedded in engineering 
product/process services and based upon scientific progress’ (Betz et al. 2016, 
p.598). 
 The Faraday Partnerships  
The 24 Faraday Partnerships covered many sectors and were first created in 1997 
as a means of increasing industry and academic interactions (House of Commons 
Science and Technology Committee 2011). Their creation was a direct response to a 
1993 UK Government white paper ‘Realising Our Potential’ and their purpose was to 
facilitate knowledge exchange between industry and the research base (Cabinet 
Office 1993). The Faraday Partnerships followed the premise of the Fraunhofer 
model (Howells and Elder 2011, Hughes and Kitson 2012). They functioned as 
bridging organisations to support the uptake of new innovation technologies from 
PROs and industry. Their other roles included facilitating capacity building and to 
provide a platform for the exchange of tacit knowledge from networking activities 
(Zook 2004, House of Commons Science and Technology Committee 2011). 
In a recent report on Technology Innovation Centres (TIC) commissioned by the 
House of Commons Science and Technology Committee (2011) the Faraday 
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Partnerships were examined in the context of lessons learnt from past initiatives. The 
research showed that by 2004 the Faraday Partnerships were being phased out as 
they had been classed as a failed initiative (House of Commons Science and 
Technology Committee 2011). The report outlined a number of reasons for this 
failure, highlighting the primary cause to be a lack of core funding, which meant that 
what funding they did have, was spread far too thinly. Another key reason was the 
lack of support from industry itself (House of Commons Science and Technology 
Committee 2011). Which forms an interesting question, why did industry not engage 
with them? This question will be reviewed later in chapter 6. 
 The KTN’s 
The Faraday Partnerships were replaced by the Knowledge Transfer Networks 
(KTN). The KTNs are funded from central government and are managed by the 
Technology Strategy Board, now Innovate UK (House of Commons Science and 
Technology Committee 2011). There were two life science KTN’s, they are the 
HealthTech and Medicine KTN and the Biosciences KTN. The two life science KTNs 
were created from a number of successful Faraday Partnerships, they are still 
operating as nationwide intermediaries and are overseen by the Technology 
Strategy Board/Innovate UK. Today there is only one central KTN that has been 
consolidated. Instead of having many (8) separate KTNs with separate operational 
functions, there is now only one central operating unit.  
 
 Intermediary Technology Institutes (ITIs)  
The ITIs were intermediaries created in Scotland in 2003 covering three different 
sectors, life sciences, digital media and energy and were also fashioned on the 
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Fraunhofer Institutes (OECD 2004, Rosiello 2007, OECD 2007, Papaioannou 2009, 
Brown, Gregson and Masson 2016). They were created to help bridge the gap for 
early stage innovative technologies. This meant working with PROs to identify 
technology that had a market potential (OECD 2007, Papaioannou 2009). ITI Life 
Sciences had some early successes. However, they started to flounder when they 
were unable to reach agreement with the TTOs on IPR ownership (Rosiello 2007, 
Papaioannou 2009, Brown, Gregson and Masson 2016). The ITIs were created as a 
10 year initiative with £450 million of investment over the period. In March 2013 a 
national Sunday paper in Scotland announced that the 10 year period was now over 
and that after investing £231 million of the total budget the royalties gained were a 
paltry £600,000. Like the Faraday Partnerships the ITIs have now gained a place in 
history as another failed intermediary model (Brown, Gregson and Masson 2016). 
This PhD study will aim to add to our understanding of why LSIs might fail to 
continue. A few of the LSIs recruited for the study had recently closed or were about 
to close, data collected from these LSIs will help answer RQ3.  
RQ3. Why do some LSI fail to survive beyond their funding stream? 
 
 Catapult Centres 
The new Catapult Centres (previously known as the Technology Innovation Centres) 
that have emerged in the UK, were originally going to be based on the Fraunhofer 
Institute model (Hauser 2010), however, the new Catapult Centres have a model that 
has been determined by the national innovation system operating in the UK (Reid et 
al. 2010, Wilson 2012). Their location is determined by the strength of the cluster of 
organisations working in the focus area within the UK. 
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The Government’s continued support for LSIs is evidenced in the creation in 2011 of 
a number of intermediary networks. One of these is the Cell Therapies Catapult 
Centre which was launched in early 2012 (Hauser 2010, House of Commons 
Science and Technology Committee 2011, Wilson 2012) and is housed within Guys 
and Thomas’s Hospital in London. The benefits to companies who engage with 
network organisations like the Catapult Centres are well documented (Reid et al. 
2010). Networks provide companies with knowledge of the sector, a network of 
contacts, the ability to identify funding, and access to the latest developments in the 
field. The Cell Therapies Catapult changed its name to the Cell and Gene Therapy 
Catapult in February 2016. They are one of the LSIs investigated in this research 
study. 
 
 Literature on other LSI models used in the sector 
All of the LSIs discussed here in this section provide a bridging function and one of 
those that have been used successfully is the complex Product Development 
Partnerships (PDPs) like that used in the International Aids Vaccine Initiative (IAVI) 
and the Medicine for Malaria Venture (MMV) (Chataway et al. 2007). They are 
funded by the Bill and Melinda Gates Foundation, and employ knowledge 
intermediaries (brokers), whose dual intermediary role is to make funding and 
commercialisation decisions for products that can benefit the world’s poor (Chataway 
et al. 2010). 
Within medicine and healthcare, knowledge intermediaries are often used to bridge 
the divide between healthcare researchers and policy makers (Canadian Health 
Services Research Foundation 2006). It is widely accepted that healthcare 
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researchers and policy makers operate within very different settings from each other 
(Clark and Kelly 2005, Kammen, Savigny and Sewankambo 2006, Carayannis and 
Campbell et al. 2011). Using a knowledge intermediary can help provide scientific 
analysis to support a policy decision that not only justifies that decision but also 
provides credibility and authority (The Change Foundation 2010) 
Another interesting LSI is the Biotechnology Industry Association (BIA), a trade 
association funded by fee paying members from the LS business community and 
whose primary aim is to lobby Government on behalf of the sector (Hughes and 
Kitson 2012, Cooke 2001). They have a range of public sector members, but it is 
mainly industry that makes up their membership. 
Within agriculture and environment there appears to be an increase in use of 
innovation intermediaries (Batterink et al. 2010, Holmes and Clark 2008). Both areas 
within the LS sector have started seeing increased funding for the provision of 
intermediaries and brokers. In February 2013 the BBSRC put out a call for groups 
interested in creating networks in industrial biotechnology & bio-energy they hope to 
establish agricultural and bio-energy biocatalyst networks in 2014 (Biotechnology 
and Biological Research Council 2014). In 2014 it was announced that £180 million 
in funding for these Agri-Tech centres and in 2015 the first centre called Agrimetrics 
was opened (Biotechnology and Biological Research Council 2015) 
3.5 Section Summary 
The literature review has looked into the background history of where LSIs came 
from and why they were necessary. TTOs were created and invested in, but they 
lacked the ability to transfer tacit knowledge. LSIs like the Cluster Network 
Organisation ERBI based in Cambridge and the Oxford Biosciences Network (OBN) 
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were the next to be funded and supported by the government. These LSIs had 
specific funding periods after which they were expected to become self-financed. 
With the onset of the austerity programme in the UK, the RDAs were disbanded 
along with many of the Cluster Network Organisation LSIs which received their 
funding through them. More national innovation intermediary initiatives were then 
created which included the Faraday Partnerships, the Knowledge Transfer Networks 
and then most recently the UK Catapult Centres and the Scottish Innovation 
Centres. The new national models which include the Catapult Centres will it is 
hoped, fast-track innovations to market. The Catapult Centres will receive sufficient 
expertise, funding and infrastructure and be a place where industry and academia 
can work together to achieve commercialisation and product development success 
(Reid et al. 2010). As seen in the literature there are a number of different LSI 
models that have been created over the years, many have evolved while others have 
merged to create new organisation structures and a few have fallen by the way side. 
This section has reviewed a number of LSIs that are past or current, this provides a 
picture of what success and failure look like. What constitutes failure and success 
and how it is measured are questions that led the researcher on this study path. The 
researcher had herself seen a number of LSIs come and go at quite an alarming 
rate. They all received substantial funding (the ITIs received £450 million over a 10 
year period) to stimulate the innovation ecosystem. The more recent LSIs, the UK 
Catapults and the Scottish Innovation Centres, again have been provided with 
substantial funding, understanding why we believe they will succeed where other 
LSIs have failed will be an important outcome of this research study. 
Have the intermediaries that have gone before failed because they were 
unsuccessful at meeting the targets set by their funders or did they fail because of 
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changes in funding streams and policy direction? Is there a simple way of 
determining success and failure? These question will be addressed in this research 
study. 
The House of Commons Science and Technology Committee (2011) report on the 
Faraday Partnerships contained evidence of unmet targets and failure from both 
academia and industry on engagement. This lack of engagement was particularly 
notable from industry and because of this the closure of the programme was 
inevitable. The UK Catapult programme has now replaced these defunct Faraday 
Partnership intermediaries. The aims and objectives are more or less the same, but 
their financial and operating model are quite different. Both the UK Catapults and the 
Scottish Innovation Centres follow the “a third/a third/a third” model. 
The Catapults and the Innovation Centres have been allowed to become ‘not-for-
profit’ commercial entities, this enables them to partner more easily with academia, 
which frequently has to partner with industry to apply for certain funding. In these 
partnerships they can then apply for other sources of public funding and including 
funding from industry.  
The question relating to success and failure will need to be reviewed and discussed 
later in this thesis. However, at this stage the researcher will review this constant 
change of LSIs and also consider the expectation that funding is for a finite period 
after which there is an expectation that the LSI will become self-financing. Another 
question worth considering is: what does it actually mean for the ecosystem to have 
a ‘not-for-profit’ commercial LSI? Will they just be competing with the organisations 
out there for the same pots of money from public funds and industry? 
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3.6 The Literature on Past Studies  
The literature reviewed for this research has been informed from a number of 
different disciplines including: Cluster theory, network dynamics, national and 
regional systems of innovation, innovation intermediaries, university-industry linking 
and the innovation management literature. The researcher has attempted to collate 
the different studies under the various theoretical methodological headings in order 
to clearly justify the logic for this study. To facilitate and explore in-depth the 
phenomenon under investigation the researcher has chosen a GTM and past 
research that uses GTM will be discussed later in this chapter. 
 The Triple Helix 
In 2000 the triple helix concept was first discussed in the literature by Etzkowitz and 
Leydesdorff (2000) as a mechanism within the knowledge economy that can be used 
within the regional and national context (Sun and Negishi 2010, Dzisah and 
Etzkowitz 2008). The triple helix concept involves the relationship between industry, 
universities and governments (Leydesdorff and Meyer 2006). It is very important in 
promoting innovation and similar to what we’ve seen with the evolution of knowledge 
exchange theory discussed earlier in this chapter (Sun and Nagishi 2010). Etzkowitz 
(2003) calls the Triple Helix model an interactive model rather than a linear model of 
innovation. 
A number of researchers have argued that there are other dimensions to the triple 
helix model that are missing from the original model proposed by Etzkowitz and 
Leydesdorff (2000) (Sun and Nagishi 2010, Brundin et al. 2008, Etzkowitz and Zhou 
2006). Sun and Nagishi (2010) believe the missing fourth sector to be that belonging 
to the international sector, whereas Brundin et al. (2008), suggests that yet another 
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actor is missing – that of the entrepreneur. Etzkowitz and Zhou (2006) believes that 
introducing another strand regardless of what it is, would mean the idea of the triple 
helix structure as originally created would vanish. With this in mind Etzkowitz and 
Zhou (2006) suggest that the model should be modified freely at a local level to take 
into account the different national and regional innovations systems, rather than add 
a fourth dimension, which would change the triple helix structure altogether 
(Etzkowitz and Zhou 2006).  
The triple helix is not a new concept as relationships between the three sectors 
existed before 2000 when the concept was first proposed by Etzkowitz and 
Leydesdorff (Etzkowitz 2003). However, the triple helix was promoted at a time when 
there was a need for it, and it is useful in explaining the many stakeholders needed 
to create an economically vibrant society driven by innovation. This meant that there 
was a rekindling of these relationships between the three sectors (Etzkowitz 2003). 
In the past the triple helix model has been useful in demonstrating entrepreneurship 
and growth, the three sectors in the model are supposed to co-operate jointly, initiate 
and convert innovation into growth (Etzkowitz 2003). This implies boundary spanning 
activities which has created hybrid organisations (Etzkowitz and Lydesdorff 2000, 
Etzkowitz and Zhou 2006, Brundin et al. 2008, Gulbrandsen 2011, Bellgardt et al. 
2014). The hybrid organisations which include incubators, venture capital firms, 
sector specific networks, TTOs, business support organisations, and cluster network 
organisations have been created at the interface between academia, industry and 
government Etzkowitz 2003) (see Figure 5). This Venn diagram provides a good 
visual of the three overlapping sectors and how where the three all overlap is where 
you will find the hybrid organisations located. These hybrid organisations 
communicate and interact with all three sectors. 
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Bellgardt et al. (2014) explored the transformation of a science park in to a science 
city using Berlin-Adlershof as a case study. They conducted the study using a triple 
helix lens, with the focus being on the social and cultural dimensions within an urban 
development. Like the study carried out by Sun & Negishi (2010), who examined the 
three sectors within the triple helix (industry, academia and government), they found 
eventual erosion of relationships over time.  Bellgardt et al. (2014) proposed that the 
use of intermediaries as an alternative model would improve facilitated interactions 
and connectivity within the three sectors of the triple helix model and would help to 
overcome the erosion seen. 
The hybrid organisations that Etzkowitz and Leydesdorff (2000) discuss are, as 
previously explained, located at the intersection of all three sectors of the model and 
it is there that we find all the intermediaries that we are examining in this PhD study. 
The intermediaries chosen for this study have a remit to interact with all three of the 
local or national regional triple helix actors, building relationships and benefiting from 
engagement with them in order to flourish (Bellgardt et al. 2014). Metcalfe (2010) 
said that the intermediaries found at the intersection of the three helices or actors 
were ‘intentionally’ situated there. 
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Figure 5: The Triple Helix Model 
 
 
A Venn diagram demonstrating the triple helix. The LSIs in this study all fall within 
the Hybrid organisations triangle 
Adapted from Etzkowitz and Leydesdorff (2000)  
 
    
Government 
Industry Academia 
Hybrid Organisations (Incubators, Science Parks, TTOs, 
Business Support & Network Organisations) 
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This research is focused on examining the role of some of these hybrid organisations 
(see Figure 5) including the incubators, science parks and the business support and 
networking intermediaries like the cluster network organisations. A study by Suvinen, 
Konttinen and Nieminen (2010) looked at intermediary organisations in Finland 
working in two different sectors; the optoelectronics and biotechnology sectors. They 
asked whether intermediary organisations were needed for the exchange of 
knowledge and for commercialisation to take place. They used the triple helix 
framework to help arrive at the answer. Using empirical analysis they concluded that 
if each of the separate helices was working at full efficiency it would preclude the 
need for an intermediary to help bridge the gap (Suvinen, Konttinen and Nieminen 
2010). 
Suvinen, Konttinen and Nieminen (2010) concluded that little research on the 
functions of intermediaries had been explored, despite their growing importance 
within the literature. They further concluded that research should be focused on 
specific sectors rather than multiple sectors, like in their study, where they 
comparison the two different sectors. They interviewed key personnel based on their 
official position and activity in the commercialisation of knowledge. Additional 
interviewees were identified using the snowball technique and background work. 
Their results showed that the commercialisation of knowledge had been more 
successful in the optoelectronics sector than in the biotechnology sector. 
They used the triple helix as the methodology to explore if intermediaries are 
necessary in the commercialisation process and concluded that the market situation 
along with local culture and institutional character will have more impact than the 
links between the three helices of Government, industry and academia. They 
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concluded that commercialisation will succeed without support infrastructure like 
intermediaries. In order to help validate this claim and take on board the suggestion 
that sectoral systems of innovation have a part to play, this PhD research study will 
endeavour to review this claim and to see if this is true for LSIs or whether the fact 
that the optoelectronics sector was indeed more successful at commercialisation 
than the biotechnology sector. 
They discuss some of the issues of using the triple helix as a research methodology. 
These include the fact that the triple helix concept is too general and doesn’t take 
into account different types of organisations which belong to regional or sectoral 
innovation networks. Their strategy raised other issues that were beyond the scope 
of the triple helix model to explain, and finally the model didn’t provide a deep 
enough analysis or provide a deep explanation of the phenomena.  
Both Bellgardt et al. (2014) and Suvinen, Konttinen and Nieminen (2010) used the 
triple helix as their methodology to explore the phenomena they were investigating. 
Neither study provided compelling results by using this methodology, which resulted 
in this PhD study not implementing it. 
The triple helix literature has been explored as the helices play an important function 
within the innovation process. All of the LSIs models explored within this research sit 
in the interstitial space between all three helices as seen in Figure 5. Understanding 
better their role and function within the triple helix model will allow for a greater 
understanding of their value to the innovation ecosystems in which they reside. 
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 Sectoral Systems of Innovation 
Sectoral Systems of Innovation (SSIs) in relation to LSIs have been explored by a 
number of researchers, including Malerba and Montobbio 2003, McKelvey 2004, 
Metcalfe and Ramlogan 2005, Tait 2007. 
The sector for LS has evolved over time and now includes large and small firms, 
which include Venture Capital firms, Patent firms, NHS and PROs (Malerba 2003). 
Therefore, it is not just the traditional LS organisation like the PROs and companies 
that are part of the sector, but also the sector support organisations who have 
specialist knowledge to enable them to work in the sector. The work ethos and 
cultural dynamics within the sector differentiates it from other sectors and makes 
comparing sectors difficult. 
When comparing how we develop a product within the ICT sector with the 
development of a drug in the LS sector, the differences become apparent. The cost 
of developing a new drug is $1.2 billion from bench to patient and any failure along 
the drug discovery pathway can prove very costly. On top of this there are a number 
of regulatory hurdles that need to be overcome along that pathway; not traversing 
these hurdles will contribute to a costly failure. In the case of the ICT product 
development any failures encountered along the way are less costly, and 
development timelines are much shorter (Tait and Williams 1999, Pisano 2006, Tait 
2007). There are fewer regulatory hurdles to deal with, if any (Tait 2007). This 
example emphasises the major differences between the two sectors and how 
attempting to compare them will skew the results. 
Suvinen, Konttinen and Nieminen (2010), as previously mentioned, compared the 
Optoelectronics cluster with the Biotechnology cluster based on a science park in 
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Finland. Their results indicated that there was greater KEC success in the 
Optoelectronics cluster. Applying the differences identified using the SSIs we can 
see that timelines for product development (commercialisation) would have been 
different. Optoelectronics although regulated is not as heavily regulated as the 
Biotechnology field. This was one of the main reasons that Suvinen, Konttinen and 
Nieminen (2010) concluded that future research should take note of this fact. 
However, Arocena and Sutz (2014) argue that SSIs are starting to unravel. They 
believe that the pharma and agritech sectors are sufficiently different and therefore 
should not be placed in the life sciences sector and should be analysed separately. 
Their research study is based on LS organisations in the Southern Hemisphere and 
they believe that there are three different areas within the LS sector that should be 
reviewed and analysed separately, they are: 
1. Agrarian 
2. Environmental 
3. Industrial 
These Southern Hemisphere countries included peripheral countries. Where 
legislation and the economic environment was sufficiently different in each of the 
three areas, they argued against using SSI (Gregersen and Segura 2003, Arocena 
and Sutz 2014). Moreover, they acknowledged that their additional segmentation 
justified the National Innovation Systems (NISs) that the organisations they were 
studying were based in. 
In this PhD research study the LSIs used all conform to similarities such as having a 
physical presence, working within Knowledge Exchange and Commercialisation 
(either separately or jointly) and with only minor differences in targets. The 5 Case 
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models of LSIs were chosen carefully in order to provide a comparison, although 
they all sit within the same sector. Hence the SSI theory is applied in this PhD study. 
With regards to the NIS, all of the LSIs within this study are located within the 
Northern Hemisphere and, including those LSIs from France and Holland, are within 
similar NISs. For example, regulatory systems will include: MHRA and FDA for 
regulation, the patenting system, quality assurance and CE markings on medical 
devices. The market forces will include: Venture Capital, Angel Networks, local and 
central government and European funding. These elements of the NIS apply to all 
the LSIs within this study. 
 Cluster Theory and Network Dynamics 
There is now a wealth of literature on the networks of companies that develop 
around clusters. They mainly focus on the process of innovation within these 
networks (Swan and Scarbrough 2005; Owen-Smith and Powell 2004, BIS 2011). 
The network dynamics literature has focused on the relatively new biotechnology 
sector since its inception some thirty years ago (Powell 1998, Powell et al. 2005). It 
has been easier to follow the growth and development of the sector because of its 
‘emergent nature’ (Powell1998). Recent research on the importance of networks of 
inter-firm co-operation in the LS clusters shows that network co-operation is a critical 
factor in the exchange of information and knowledge (Rank, Rank and Wald 2006; 
Owen-Smith and Powell 2004). Owen-Smith and Powell (2004) looked at knowledge 
networks in Boston as channels and conduits for the flow of knowledge through a 
network. The knowledge transferred through linkages in the network determines 
broadly whether innovation benefits can be passed on to the organisations within the 
cluster (Owen-Smith and Powell 2004) and is a means of measuring 
commercialisation outcomes. 
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Another variable examined is location and proximity of networks of organisations 
within a cluster. Not all researchers however, believe that location and proximity 
within a cluster are necessary for a company to allow it to grow.  Two of these 
researchers are Hendry and Brown (2006) who believes that there is not enough 
evidence to support any claim that LS firms will grow because of where they are 
located and their proximity to other firms. Others have claimed that clusters have 
developed and grown artificially due to government funding (Callon 1994, De Solla 
Price 1984). Specifically, policy, in addition to financial support, has created 
favourable conditions for these LS clusters to grow. Oakey, West and Manchester 
(2007) examined a number of clusters in various parts of the world including Silicon 
Valley (IT) and the Route 128 Corridor (Biotech). He concluded that policy had 
actually forced LS firms to adopt collaborative networking behaviours that were 
inconsistent with natural business processes (Oakey, West and Manchester 2007). 
In contrast the firms he looked at in Silicon Valley and Route 128 had grown 
organically mostly due to strong internal team working and not from networking 
within a cluster. He concludes that the highly popular cluster policy that many 
European countries and other nations are using to stimulate R&D collaborations in 
high-technology sectors like life sciences will not work and there is no evidence to 
support these policy efforts (Oakey, West an Manchester 2007). Finally he suggests 
that any capital investment in cluster development should be diverted to R&D 
collaborations between specific firms based on their management styles, strategies 
and their technologies rather than on their physical proximity within the cluster. The 
question of proximity to an anchor organisation is an important one and this question 
will be addressed by the RQ4 below. 
RQ4. How important is an anchor organisation to a LSI? 
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Michael Porter in his seminal 1990 book ‘The Competitive Advantage of Nations’ 
(Porter 1990), looked at what constituted a successful cluster. He looked at cost and 
quality factors as well as the services and supply supporting services that serve 
common needs within the cluster. Another important factor identified by Porter was 
the need for competition. He said it was needed to drive improvement in quality and 
efficiency (Porter 1990, 2003, Breznitz and Anderson 2005). Other academics like 
Gulati (1995), Powell, Walter and Smith-Doerr (1996), Maskell and Malmberg (1999) 
and Mowery et al. (2004) have identified the need for linkages, relationships, ties, 
face to face encounters and partnerships. Piore and Sabel (1984) who studied a 
North Italian cluster noted that co-operation was equally important too, if not more 
important than, competition. Another important study by Saxenian (1994a) 
specifically stressed that networking, was an important contributor to the success of 
a cluster.  
Therefore to sum up the literature on LS Clusters and network dynamics, there is 
important early literature that looks at the competitive behaviour of companies 
(Porter 2000), but more recently there has been more focus on the linkages, 
networking or communications and collaborations between the companies and 
PROs – or in other words the social capacity at work and in operation within these 
clusters. Some of this has been reviewed by other researchers including Huber 
(2009), Christopherson, Kitson and Michie (2008) and Hendry and Brown (2006). 
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 Absorptive Capacity 
Absorptive Capacity was first explained by Cohen and Levinthal (1990) and is 
defined as the ability of an organisation to see or recognise knowledge from external 
sources and to then assimilate it within the organisation and translate it into 
commercial benefit for the organisation. 
A number of researchers have looked at the absorptive capacity of firms, these 
include Powell et al. (2005), Dahlander and Gann (2010), Clausen (2013), Cohen 
and Levinthal (1990), Chen and Wang (2008), Spithoven and Teirlinck (2010) and 
finally Spithoven, Clarysse and Knockaert (2011). 
 They have all postulated that external knowledge can only be used effectively to 
benefit an organisation if it has robust internal mechanisms to do so. Another 
researcher, Kodama (2008), reviewed the role of TTO’s in the intermediation process 
in university – industry linkages. He explored how efficient the TTO’s were at 
transferring technology under an absorptive capacity lens.   He concluded that the 
absorptive capacity of all the organisations within the knowledge exchange process 
must have a level of absorptive capacity in order for effective exchange to take 
place.  
Although this study is not focused on viewing LSI’s under an absorptive capacity 
lens, it is an important factor within the ecosystem that each case LSI is located in. 
Part of the knowledge exchange process will involve the effectiveness of the LSI at 
identifying, assimilating and transferring relevant knowledge to its network of 
companies or members. 
Absorptive capacity and the integration skills of firms are key factors when it comes 
to procuring the benefits from collaborative university-industry relationships. This 
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transfer of knowledge from external collaborations allows companies to adapt and 
use the new skills and knowledge gained from these interactions to their benefit 
(Cohen & Levinthal 1990, Chen and Wang 2008, Spithoven & Teirlinck 2010, 
Spithoven, Clarysse and Knockaert 2011). 
Absorptive capacity as a methodology to study how organisations learn is seen to 
help researchers measure how companies interact with a variety of organisations to 
strengthen their core service offering. Various ways of enhancing absorptive capacity 
of firms have been discussed and studied in previous literature. Spithoven, Clarysse 
and Knockaert (2011) have shown how collective research centres can act in order 
to increase absorptive capacity in traditional industries such as textiles and 
construction. 
 
In order to benefit from absorptive capacities a company needs to have systems in 
place in order to capture these benefits from the engagement in border-spanning 
collaborations and open innovation processes (Fabrizio 2009). Firstly, organisations 
need to have the ability to recognize and make use of external knowledge. 
Experiential learning and investment of resources including time are important for 
this to happen (Cohen and Levinthal 1990). Moreover, building absorptive capacity 
entails developing three important conditions:  
1. structures of communication within organisations as well as towards external 
environment  
2. distribution of expertise in the organisation and 
3. individual employees’ absorptive capacities  
(Cohen and Levinthal 1990). 
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 The National and Regional Innovation System. 
The UK was greatly influenced by what had been happening in the US with the 
Bayh-Dole Act, which removed IP ownership from the individual academic and 
placed it with the university (Lawton Smith 2005, Lawton-Smith and Bagchi-Sen 
2006). However, research carried out by Jung et al. (2010) showed that despite the 
UK emulating and adopting the features of the Bayh-Dole Act, the successes that it 
created in the US were not found in the UK. They believed that this was because of 
the differences in the national innovation systems of the two nations (Jung et al. 
2010). Lawton Smith (2005) did a comparison of commercial success between 
organisations working in the gene therapy sector in both the USA and UK. This study 
highlighted the major differences of the national innovation systems at work in the 
different countries. She listed the top five reasons the USA had outperformed the UK 
these are listed below. 
1. Easier access to seed capital in the US 
2. More active role played by US venture Capitalist in the creation of new firms 
3. Financial incentives and government support for high-tech companies in the 
USA 
4. A lack of entrepreneurs in the UK 
5. A larger more mature biotech sector in the USA 
Another key difference between the USA and UK is the difference in experience and 
accumulated knowledge which is greater in the US due to the longer time span of 
their knowledge transfer activities. Another important reason was that their 
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universities like MIT and Stanford were historically used to working with industry 
(Huggins, Johnson and Steffenson 2008, Cohen et al. 2002).  
A number of researchers have studied the regional and national innovations systems 
at play within the UK clusters, including Dolereux and Parto (2005). There are a 
number of successful life science clusters in the UK; these include Cambridge 
(Papaionnou 2009, Cooke 2005), Oxford (Lawton Smith 2005, Lawton-Smith and 
Bagchi-Sen 2006), London (Shohet and Prevezer 1996) and Scotland (Rosiello 
2007, Papaionnou 2009, Leibovitz 2004). The universities in these locations are 
usually co-located with top hospitals and are in receipt of the bulk of the research 
funding from the state, charities and the pharmaceutical industry (Lawton Smith and 
Bagchi-Sen 2006, Gertler and Vinodrai 2009). This means that funding is less of an 
issue than those universities outside of these areas. 
The national and regional innovation systems theory will provide guidance to support 
the interviews that were conducted in this PhD research study. This links to the 
Lopez-Vega and Vanheverbeke (2010) suggestion that more than one literature 
should help to inform the phenomenon in order to achieving robust results.  
 Actor Network Theory 
A number of researchers have focused their attention on biotechnology networks 
looking at inter-firm co-operation, including Rank, Rank and Wald (2006), Pittaway et 
al. (2004) and Swann et al. (2007). Rank, Rank and Wald (2004) collected data from 
relevant organisations in the southern part of Germany’s BioNet cluster of 
organisations.  They specifically examined the ties between actors and their different 
relationships; however the value of these ties was not examined as part of their 
research. Swan et al. (2010) did an exploratory study to identify mechanisms 
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influencing biomedical innovation in two different nations the UK and the USA. They 
wanted to examine more closely the macro level relational and integrative 
capabilities that occur in the two nations. On examining the role of integrative and 
relational capabilities they were able to put forward a framework that would help 
explain the likely impact of such capabilities for innovation projects found at the 
micro level. The first part of the research consisted of field work which was based on 
interviews focussed on Boston in the USA and on the Oxford-Cambridge-London 
triangle in the UK. By doing this they establish how different innovation projects were 
organised in these two clusters. The second part consisted of longitudinal case 
studies of innovation projects (six in the USA and four in the UK). 
They discussed some of the limitations of their study in their paper, including the 
sample size and fine tuning the modes so that they were less broad. This paper and 
the previous one by Rank, Rank and Wald (2006) both look at the relationships 
between stakeholders. In the Swan et al. (2007) paper they say that the UK needs 
better mechanisms for building bridges to allow knowledge to flow between PROs 
and  commercial organisations as they all have different cultures. 
 
3.7 Past studies Using GTM in relation to LSIs 
This section will review and discuss some of the research that has been done using 
Grounded Theory as a methodology, although none are specifically focussed on the 
LS sector. 
A study carried out by Lopez-vega and Vanheverbeke (2010) used a cross-case 
comparison to determine the typologies of intermediaries in open and closed 
markets. Their approach was that of grounded theory as their data analysis on 
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theory-building trade-offs arose from the overlap between data collection and data 
analysis (Glaser and Strauss 1967, Van Manen, 1988). They were able to identify 
possible categories and relationships by simultaneously combining data collection 
with data analysis of their chosen case studies.  
The case studies they used fell into 4 categories: innovation consultants, innovation 
traders, innovation incubators, and innovation mediators. They researched 32 
intermediaries that identified with one of the 4 categories. The intermediaries used 
were from a range of different sectors involved in the intermediation process, and 
included Pfizer and Pharmalinks from the LS sector. They mapped their different 
strategies and business models from secondary data collection activities, including 
websites and periodicals. They made a decision to study the business models as it 
facilitated the inflow and outflow of knowledge and showed how the intermediaries 
helped to provide value to the firms they worked with. Their results suggested that a 
single body of literature could not explain the mechanisms used by heterogeneous 
forms of innovation intermediaries. Their research falls into 2 bodies of the literature 
relating to innovation intermediaries, that of Open and Close systems of innovation. 
They suggest that the best way to research them is to integrate or combine different 
literatures.  The researchers in this study recognise that the intermediary sector 
generally is evolving rapidly and new yet undiscovered models are appearing that 
will need further investigation. They have listed a number of research questions that 
arose out of their research, these are: 
1) What are the factors enabling successful intermediation for each 
intermediary? 
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2) How do companies identify, select and interact with innovation 
intermediaries? 
3) How do innovation intermediaries facilitate the generation and integration of 
knowledge among various innovation players? 
The second study to use GTM in its research was conducted by Baker, Edwards 
and Doidge (2012). They examined the factors that are attributed to the success 
of biotechnology firms in Malaysia. They choose GTM as an approach as little 
had been done on the sector in Malaysia and the approach is suitable when little 
or nothing is known about a phenomenon. Both research groups, Lopez-vega 
and Vanheverbeke (2010) and the Baker, Edwards and Doidge (2012) studies 
were the only two that used a GTM approach in their research in the LS sector 
found from the literature reviewed. 
3.8 Gap Analysis  
Table 2: Calls for Future Research 
Call Author and Publication Title 
Our data does not allow us to conduct 
direct comparative analysis. They 
said their findings are suggestive of 
comparative differences and new 
theoretical propositions which future, 
more deductively oriented work could 
follow-up 
Swan et al. 2007 
 
Modes of organising biomedical 
innovations in the UK and US and the 
role of integrative and relational 
capabilities 
From a more empirically driven 
research approach it would certainly 
be possible to derive more detailed 
results, which may be of considerable 
value with regard to further 
developing theories of 
interorganisational corporate 
networks 
Rank, Rank and Wald 2006 
 
Integrated Versus Core-Periphery 
Structures in Regional Biotechnology 
Networks 
The meaning of higher education 
institutions for regional networking 
Brenner and Patzelt 2008 
Regional Innovation Systems. 
Clusters and Knowledge Networking 
81 | P a g e  
 
and clustering needs further 
investigation. 
A new innovation process model is 
needed in which the external 
knowledge intermediary plays a 
greater role than today 
Gassmann, Daiber and Enkel 2011 
 
The Role of Intermediaries in Cross-
Industry Innovation Processes 
Management studies on networks 
need to adopt a broader view than 
investigating the interfirm 
relationships within networks and to 
consider the role of players other than 
the firms in the network. 
Coeurderoy and Duplat 2008 
 
The Strategy and Governance of 
Networks 
Contributions to management science 
ISBN 3790-820571 pp311-323 
Several other data sources and 
methodologies are needed to 
disentangle the true impact of public 
research on industrial R&D 
Lawton-Smith and Bagchi-Sen 2006 
 
University-Industry interactions: the 
case of the UK Biotech Industry 
Further research is needed to 
examine in-depth the complexity of 
this phenomenon and in particular, to 
draw attention to the following 
question: do different forms of 
combined knowledge determine 
different brokerage models? 
Abbate, Coppolino and Schiavone  
2013 
 
Knowledge creation through brokers: 
Some anecdotal evidence 
Research that will explain the 
founding, growth and survival of 
innovation intermediaries 
Dalziel 2010 
Why do innovation intermediaries 
exist? 
A closer more in-depth review of 
sector specific innovation 
intermediaries and not using the 
Triple Helix as a methodology 
Suvinen, Konttinen and Nieminen 
2010 
How necessary are intermediary 
organisations in the 
commercialisation of research? 
The relationship between networking 
and third party support networks 
Pittaway et al. 2004 
Networking and innovation: a 
systemic review of the evidence 
Innovation scholars need to scrutinise 
failure as well as successes 
Brown, Gregson and Mason 2016 
A post-mortem of regional innovation 
policy failures: Scotland’s 
intermediate technology initiative (ITI) 
 
The above table shows the gaps that have been identified from the literature that 
have been reviewed for this research study. 
 
Pittaway et al. (2004) reviewed network intermediaries and concluded that several 
gaps were found in the literature and that further exploration was needed that looked 
at the relationships between networking and different forms of innovation and in 
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particular the role of third parties as they put support networks like professional trade 
associations and regional networks in the life sciences. Pittaway et al. (2004) looked 
at the extent to which UK companies engaged in networking activities when seeking 
to develop their innovative capacity. They examined the networking, relational ties or 
social capacity of companies located within clusters. There is a gap in the literature 
and Pittaway et al. (2004) and Coeurderoy and Duplat (2008) made a call for future 
research to examine in more detail the networking activities between companies and 
LSIs, which has not been done before. 
Gassman, Daiber and Enkel (2011) said that the role that LSIs played needed further 
investigation. Abbate, Coppolino and Schiavone (2013) suggested examining the 
different brokerage roles in the transfer of knowledge and Brenner, Cantner and Graf 
(2011) suggested exploring the role of clustering and knowledge networking.  
Suvinen, Konttinen and Nieminen (2010) who studied the optoelectronics and 
biotech sectors in Finland believed that if the triple helix model functioned efficiently 
in a regional or national innovation system there would be no requirement for 
intermediaries, which conflicts with the conclusions of Hendry and Brown (2006), 
who studied UK biotech clusters, that small biotech companies would probably not 
survive without the LSIs.  
Dalziel’s (2010) call for future research into the survival aspects of innovation 
intermediaries will hopefully be explored in relation to RQ3 (see below). 
This PhD study will help us to understand better the impact that LSIs may have on a 
cluster of LS companies. The research questions identified for this research are: 
RQ1. Are LSIs important for the commercialisation of research? 
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RQ2. What are the key perceptions and expectations of the KEC value that LSIs 
hold? 
RQ3. Why do some LSI fail to survive beyond their funding stream? 
RQ4. How important is an anchor organisation to a LSI? 
 
These research questions have arisen from the literature as gaps in the knowledge 
relating to innovation intermediaries.  
 
3.9 Terminology 
Completion of this literature review has been prolonged by the issue of semantics. 
This was due to the multitude of terminologies used to describe the various 
organisations that operate as bridging organisations. This section examines some of 
the terminologies used within the literature search for this PhD research study. 
The terminology highlighted in this section is only a proportion of that found in the 
literature. This search produced papers from literature on network dynamics. Many 
like Freeman (2009), Hagedoorn and Cloodt (2003), Hagedoorn (2002), Saxenian 
(1991), Mowery and Rosenberg (1989), Oliver and Liebeskind (1997), Swan and 
Scarbrough (2005) and Callon et al. (1991), have looked at the dynamics between 
networks of firms working in high-tech clusters, although not specifically in the life 
science sector. Their research is valuable in providing insights into inter-firm 
relationships. However there are also a number of researchers who have written 
extensively about the life science sector, in particular the biotechnology sector. They 
include Powell, Koput and Smith-Doerr (1996), Powell (1998), Powell et al. (2002), 
Owen-Smith and Powel (2004) and Saviotti and Catherine (2008) who have all 
written extensively about inter-organisational collaborations and the impact it has 
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had on the commercialisation outcomes of biotechnology firms. All of these 
researchers have provided depth and insight into the still only relatively new 
biotechnology sector. 
Finally the search focused on the term intermediary. This revealed many new 
streams of terminology used in describing intermediaries, most of which have been 
discussed within this chapter. The aim of this section is to provide a synopsis of the 
terminology on intermediaries within the life science sector. 
Howells (2006), Lopez-vega and Vanheverbeke (2010), Dalziel (2010) and 
Coeurderoy and Duplat (2008) all use the term innovation intermediaries in their 
research studies. An innovation intermediary is defined as: ‘individuals or 
organisations providing the bridging function in a high-tech setting’. Their research 
has provided rich literature on the nature and role of an innovation intermediary, 
which has helped to inform this research on LSIs. 
Other researchers who have used terminologies to describe an intermediary include 
Yusuf (2008) who discusses the working of four different types of intermediaries 
including universities which he categorises as ‘a general purpose intermediary’. Yet 
another terminology is Technology Transfer Intermediaries which is another name 
for a technology transfer office (TTO) that Pollard (2006) uses. The role of ‘bridging 
institutions’ in sectoral systems of innovation is discussed by Hargadon and Sutton 
(1997), Howells (2006) and Sapsed, Grantham and DeFillippi (2007) and is yet 
another name for an intermediary. These bridging institutions are helping to bridge 
the divide between networks from a variety of organisations including SME’s, 
Pharmaceutical companies and PROs like universities and research institutes. They 
are also given the name ‘boundary spanners’ as they work between organisations 
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that do not usually overlap (Wright et al. 2008, Levin and Cross 2004, Kostova and 
Roth 2003). Metcalfe (2010) uses the term interstitial organisations to describe 
intermediary and intermediate functioning organisations. These organisations are 
intentionally situated between the state, industry and high education, which feature in 
the triple helix model that was discussed previously in this chapter.  
The terms ‘broker’ and ‘gatekeeper’ are used to describe both individuals and 
organisations that operate between users and producers in brokerage or 
intermediary relationship (Sapsed, Grantham and DeFillippi 2007, Schiffauerova and 
Beaudry 2012, Abbate, Coppolino and Schiavone 2013, Stuart and Sorensen 2007, 
Obstfeld 2005). ‘A technology broker’ is an individual or organisation who brings 
together two disparate pieces of knowledge to create a novel technology (Stuart and 
Sorensen 2007). In addition ‘knowledge broker’ is yet another variation on the term 
‘broker’. Malecki (2010) and Howells (2006) describe ‘knowledge brokers’ as a key 
catalyst in knowledge regions, who build bridges among people and ideas. 
Further additions include, Stuart and Sorensen (2007) who used the term “Value-
added intermediary” to describe biotechnology firms which they say act as 
intermediaries between universities and pharmaceutical firms. They show that 
biotech firms behave like intermediaries as they occupy the middle within a LS 
tripartite alliance structure. This is the case for biotech companies which have good 
connections both upstream with universities and downstream with pharmaceutical 
firms. While this may be the case in the USA, it has not been shown in other parts of 
the world (Stuart and Sorensen 2007).  
‘Knowledge networks’ are described as intermediaries who provide engagement 
between academia and practitioners (Hughes and Kitson 2012, Nutley, Walter and 
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Davies 2007, Davies, Nutley and Walter 2008, Owen-Smith and Powell 2004). 
Knowledge networks are usually sector specific and involve a range of actors 
working in a specific area. Hughes (2011) looked at formal and informal knowledge 
networks, the formal ones tended to be fee paying while the informal ones were free.  
There is no doubt that the plethora of terminologies used in describing intermediaries 
can cause confusion. This issue will be encountered by policy makers, practitioners 
and other researchers in the field and therefore the use of standardised terminology 
should be considered within the sector to assist with the sourcing of information. 
Table 3 was created from the typologies used within the literature on intermediaries 
reviewed for this research and represents only some of the terminologies from within 
the body of literature.  
Table 3: Confusing Terminology 
Terminology Used Author and Publication 
Association Hughes 2011 
Boundary spanning organisation  Wright et al. 2008, Levin and Cross 
2004, Kostova and Roth 2003, Lee and 
Ohta 2010 
Consultancies  Billington 2010, Lopez-vega and 
Vanheverbeke 2010, Wright et al. 2008 
Faraday Partnerships,  House of Commons Science and 
Technology Committee 2011, Howells 
and Edler 2011 
Fraunhofer Institutes Mina, Connell and Hughes 2009, 
Howells and Edler 2011 
Gatekeeper or broker Sapsed, Grantham and DeFillippi 2007, 
Schiffauerova and Beaudry 2012, 
Abbate, Coppolino and Schiavone 
2011, Stuart and Sorensen 2007, 
Obstfeld 2005 
Intermediary Shohet and Prevezer 1996, 
Intermediary Technology Institutes (ITI)  Papaioannou 2009, Rosiello 2007 
Innovation Incubator/Bio-Incubators Lopez-vega and Vanheverbeke 2010, 
Yusuf 2008, Cooke 2002a, Huggins, 
Johnson and Steffenson 2008 
Innovation intermediaries Howells 2006, Lopez-vega and 
Vanheverbeke 2010, Coeurderoy and 
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Duplat 2008, Daziel 2010, Dalziel and 
Parjanen 2011, Wilson 2012 
Innovation network Smedlund 2006, Malecki 2010, Saviotti 
and Catherine 2008, Owen-Smith and 
Powell 2004 
Knowledge broker Malecki 2010, Howells 2005 
Knowledge brokerage organisation Abbate, Coppolino and Schiavone 2011 
Knowledge intermediary Hughes 2011, Nutley, Walter and 
Davies  2007, Davies, Nutley and 
Walter 2008, Owen-Smith and Powell 
2004 
Knowledge network intermediary Hughes 2011; Nutley, Walter and 
Davies 2007; Davies, Nutley and Walter 
2008; Owen-Smith and Powell 2004 
Networks Malerba 2006, Powell 1998, Hendry and 
Brown 2006 
Product Development Partnerships  Chataway et al. 2007 
Regional network  Iles and Yolles 2002 
Research and technology Intermediary Mina, Connell and Hughes 2009 
Sciences parks/Research parks Wright et al. 2008, Etzkowitz 2003, 
Huggins, Johnson and Steffenson 2008 
Technology Innovation Centres/Catapult 
Centres 
Hauser 2010, House of Commons 
Science and Technology Committee 
2011, Howells and Elder 2011, Reid et 
al. 2010, Wilson 2012 
Technology transfer office (TTO)  Meyer 2010, Siegel, Westhead and 
Wright 2003, Ward, House and Hamer 
2009a, 2009b, 2009c, Lee and Ohta 
2010, Huggins, Johnson and Steffenson 
2008 
Think tanks  Meyer 2010 
Value-added intermediary Stuart and Sorensen 2007 
 
This table shows the range of terminologies used in describing intermediaries for this 
research in alphabetic order. 
3.10 Conclusion  
This is a long and detailed chapter that reflects the literature that was reviewed for 
this research. The chapter starts off by asking about and where LS innovation comes 
from. There is an explanation of the knowledge transfer and exchange (KT & E) 
process and then the different types of knowledge and the different ways it can flow. 
There is a discussion on tacit knowledge exchange and open innovation models. 
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The chapter then moves on to a review of the literature that relates to LSIs, like 
TTOs, incubators, science parks and Catapult Centres all of which are explored in 
this research study. There is then a review of other LSIs that are currently operating 
in the LS sector and some past LSIs that have come and gone. 
The literature review then moves forward to look at the various past studies relating 
to various theoretical concepts in order to show what has already been studied and 
what may need validating or identifying through a gap analysis. 
The review on GTM research that has relevance to the sector, helps to justify the 
trajectory of this research. The subsequent gap analysis helps to show why GTM 
was chosen. The chapter concludes with a discussion on terminology and some 
description of the difficulties encountered while doing the literature searches due to a 
confusing terminology landscape. The researcher hopes that her call to standardise 
the terminology will lead the reader to understand why she created the new 
terminology LSI, which will provide a collective name for the intermediaries within the 
LS sector. 
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Chapter 4 Methodology and Research 
Methods 
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4.1 Introduction  
 The Aims and Objectives of the Research 
Innovation has been identified as an important source of economic wealth (Lambert 
2003, Hauser 2010, Wilson 2012). Innovations that emerge from the life science 
sector have a potential to help create economic wealth by creating new companies, 
employment, inward investment and products that can be sold globally. This market 
runs into billions of pounds and because of this, it has become a priority sector for 
many nations globally. 
There is a belief that intermediaries can help in the drive to prosperity by bridging the 
divide between sectors, including producers and users of knowledge and over a 
number of years many have committed to this belief (Hauser 2010). The continued 
investment into intermediaries requires research in to whether they are as effective 
and valuable as perceived. This PhD research study aims to develop theories based 
on the evidence gathered of the value of a range of life science intermediaries from 
across the UK and with data from Holland and France for comparison purposes. This 
can potentially help to inform policy and funding decision-makers of the effectiveness 
of LSIs. 
 The Research Questions 
This research has a focus on the role of the knowledge exchange and 
commercialisation (KEC) processes that take place within the different 
intermediaries. This is crucial in understanding their overall value in terms of 
economic and societal benefits. In order to decipher their KEC potential a closer look 
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at the relationship between the LSIs and the actors within the networks in which they 
operate will help to determine the level of KEC operating within each intermediary.  
Four main research questions for this PhD project have been developed based on 
the review of the related literature. 
RQ1.  Are LSIs important for the commercialisation of research? 
RQ2.  What are the key perceptions and expectations of the KEC value that LSIs 
hold? 
RQ3.  Why do some LSI fail to survive beyond their funding stream? 
RQ4.  How important is an anchor organisation to a LSI? 
 
As discussed in chapter 1, these research questions were inspired by the literature 
on innovation intermediaries. The study by Suvinen, Konttinen and Nieminen (2010) 
looked at innovation intermediaries operating in two different sectors, biotechnology 
and optoelectronics in Finland. Suvinen, Konttinen and Nieminen (2010) had 
discussed the issue of ‘Sectoral Systems of Innovations (SSIs) in their research 
paper and like Malerba and Orsenigo (2002) concluded that SSIs differ significantly 
in each sector and they recommended that future research projects should consider 
comparing sector-specific intermediaries, which has been done in this PhD research 
study. 
This section will delve into how and why the RQs have been derived plus their 
importance to the research study as a whole. 
RQ1.  Are LSIs important for the commercialisation of research? 
This question was asked in a similar way to that in Suvinen, Konttinen and 
Nieminen’s (2010) paper. The research compared two intermediaries from two 
different clusters, one in Optoelectronics and the other in Biotechnology. At the time 
of reading this paper, the KEC movement across intermediaries had been initiated 
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by the BBSRC. This led to the researcher wanting to investigate the value of LSIs in 
the commercialisation process. 
This RQ is linked to research on Open Innovation research. The idea is that there 
will be more interactions between industry and academia that will lead to 
commercialisation outcomes. 
RQ2.  What are the key perceptions and expectations of the KEC value that LSIs 
hold? 
This question arose through discussions with other academics. The idea of the 
expectation gap emerged from all these discussion. The researcher had been 
articulating the question differently until she discovered that it was used in the 
accounting literature specifically in audit work.  The researcher believed that 
answering this question could possibly lead to a greater understanding of why so 
many of the UK LSIs were deemed as failures. 
The researcher understood the basic financing of an LSI, having previously 
managed a couple of LSIs herself. Public money is handed over and there is certain 
expectation from the funders that the targets set will be achieved. 
RQ3.  Why do some LSI fail to survive beyond their funding stream? 
This question is about the LSIs that are considered to be successes. Why do some 
of the LSIs survive and thrive beyond their funding period? This research will try to 
understand what they do differently that allows them to continue operating. 
RQ4.  How important is an anchor organisation to a LSI? 
This question emerged via the literature, including Hendry 2006, however, only after 
the first interview had taken place. 
The first interview was at the Stevenage Bioscience Catalyst based on the grounds 
of a GSK, a large pharmaceutical company. The researcher was curious about the 
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impact the proximity to such an anchor had on the LSI. Later the researcher built this 
question into all the different LSI questionnaires. 
RQ3 and RQ4 were identified and included along the research journey, and were 
therefore late additions. They have been included as the researcher believes they 
will be important in answering the overarching question of this research study: of 
what impact do LSIs have on KEC. They help to create a better overall picture of the 
Case LSI models, allowing for comparisons between those LSI, which in the Case of 
RQ4, have an anchor and those that do not. 
This chapter will review the methodology chosen for this PhD study. The research is 
placed within the interpretative paradigm and is therefore a qualitative research 
study. There is some detailed discussion on the overarching Grounded Theory 
Methodology (GTM) and the Constructivist Grounded Theory (ConGT) approach that 
has been followed. This chapter follows a logical flow and justification for decisions 
and philosophical assumptions that are included along the way. 
 
4.2 Research Paradigm 
The research paradigm is the overarching framework that helps to define and guide 
the study (Collis and Hussey 2003, 2009). A research paradigm is defined as: 
“A framework that guides how research should be conducted, based on 
people’s philosophies and their assumptions about the world and the 
nature of knowledge” (Collis & Hussey 2009, p.55) 
In science and philosophy a paradigm is simply a term to explain how we perceive 
the world. It was Thomas Kuhn would made the term scientific paradigm fashionable 
by adopting the word to refer to a set of concepts and practices that define a 
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scientific discipline. He explained that a scientific paradigm is a framework containing 
the basic assumptions, our perception or way of thinking of the world and 
methodology that are commonly accepted by members of a scientific community. 
There was only one research paradigm for many years and this was found in the 
natural sciences (Kuhn  1962). Kuhn’s seminal book ‘The Structure of Scientific 
Revolutions’ (1962) discusses the history of scientific revolutions, the domination of 
the natural sciences and the paradigm shifts that brought forth new ways of thinking 
and new paradigms.  
“The successive transition from one paradigm to another via revolution is 
the usual development pattern of mature science” (Kuhn 1962, p.12). 
A paradigm shift will emerge as a response to a build-up of critical differences and 
when a new model is proposed. Kuhn provides examples of how this shift happened 
within different sciences, which he uses to justify the shift away from the natural 
sciences. Within the natural sciences, the methods used employ observation and 
experiment which means they observe the nature of discoveries and establish an 
understanding of why they have emerged (Kuhn 1962, p.57, Carey and Smith 1993, 
Collis and Hussey 2009). The paradigm of the natural sciences sits in the realm of 
the positivists, which has its roots in the philosophies of realism (Collis and Hussey 
2009).  
This shift in scientific thinking led ultimately to the development of a second research 
paradigm, that of the social sciences. Initially the new social sciences followed 
methodologies used in the paradigm of the natural sciences, however it soon 
became clear that the methods employed did not allow for discovering meaning 
within the social world and did not fit well with the social sciences paradigm, as they 
were based on observation and measurement. In due course the social sciences 
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developed methods based on an interpretivist stance, which can be thought of as 
opposite to those of a positivist paradigm (Collis and Hussey 2009). 
A few years after Kuhn had written his seminal book on ‘The Structure of Scientific 
Revolutions’ (1962), another important social sciences argument came to the fore: 
that of the ‘Social Construction of Reality’ which was first introduced by Berger and 
Luckmann in 1966. Their work was greatly influenced by Schutz’s work on 
phenomenological approaches to sociology. In fact Berger and Luckmann’s work 
was actually a continuation of Schutz’s work that led to the breakthrough work done 
by Berger and Luckmann in better understanding human culture and reality that they 
defined it as the ‘The Social Construction of Reality’ (Berger and Luckmann 1966, 
Holstein and Gubrium 2008). The Social Construction of Reality has stimulated a 
vast swath of research in the social sciences and this PhD Research Study has also 
been influenced by it. We will discuss this further later in this chapter. 
 Interpretivism and Positivism: The two main paradigms 
Positivism used in the natural sciences utilises more ‘scientific’ methods. These 
methods are also regularly used in the social sciences, alongside the new 
interpretivist based methods. A researcher will need to clarify the paradigm that the 
research sits within before the research starts. The two main paradigms are 
positivism and Interpretivism, they are positioned at either end of a spectrum along 
which there are many other paradigms that forms a “continuum” of paradigms as 
described by Morgan and Smircich (1980), which move between positivism and 
Interpretivism. 
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Positivism as mentioned previously has its roots in the natural sciences, where 
introspection and intuition are rejected. What is important to positivists is to gather 
data that can be observed and measured. 
“Positivism is a paradigm that originated in the natural sciences. It rests 
on the assumption that social reality is singular and objective, and is not 
affected by the act of investigating it. The research involves a deductive 
process with a view to providing explanatory theories to understand social 
phenomena.” (Collis & Hussey 2009, p.56) 
“Every rationally justifiable assertion can be scientifically verified or is 
capable of logical or mathematical proof.” (Walliman 2001, p.15) 
Interpretivist assert that social reality is subjective rather than objective and is 
shaped by our own understanding of reality. 
“Interpretivism is a paradigm that emerged in response to criticisms of 
positivism. It rests on the assumptions that social reality is in our minds, 
and is subjective and multiple. Therefore, social reality is affected by the 
act of investigating it. The research involves an inductive process with a 
view to providing interpretive understanding of social phenomena within a 
particular context.” (Collis & Hussey 2009, p.56) 
Many researchers (Collis & Hussey 2009, Morgan and Smircich 1980, Kuhn 1962) 
make a distinction between the two types of paradigms, positivism is positioned in 
the natural sciences and interpretivism in the social sciences, although, as 
mentioned previously, researchers can also carry out positivistic research within the 
social sciences.  
 Considering The Researcher’s Philosophies 
In order for a paradigm to emerge the researcher must first consider their own views 
and position on the epistemological, ontological and methodological properties of the 
research they wish to undertake. All of these different components are connected, 
(Guba and Lincoln 1994). Therefore, how we decide on what methodology to use for 
our research is influenced by the ontology and epistemology within which the 
97 | P a g e  
 
researcher has positioned the research, and it is therefore important to understand 
each of the three components before making that decision. 
The epistemological stance involves the relationship between the researcher and 
what is being researched. This is about the researcher’s basic belief about 
knowledge or “how we know what we know” (Crotty 1998). The word epistemology 
derives from the Greek ‘knowledge about knowledge’.  With a quantitative paradigm 
the researcher endeavours to be detached and independent of what is being studied, 
while in the interpretive paradigm the researcher is encouraged to take a more 
interactive stance through participation or observation (Creswell 1994), thereby 
decreasing the distance between the researcher and what is being researched 
(Collis and Hussey 2009).  
The Ontological stance is concerned with the nature of reality – the central part of 
the phenomenon under investigation. The researcher needs to consider the two 
approaches, which are objectivist and subjectivist. Positivists believe that reality is 
objective and external to the researcher and therefore there is only one reality. 
Interpretivist believe that social reality is subjective because it is socially constructed. 
Therefore each person has his or her own sense of reality and there can be multiple 
realities (Lincoln and Guba 1985, Collis & Hussey 2009) 
The Methodological stance is concerned with the processes used in the research. If 
you are a positivist researcher you will focus on objective facts and formulate 
hypotheses. Your analysis will look for associations between variables and or 
causality, where one variable may affect another. An interpretivist would examine a 
small sample over a longer period of time. A number of different research methods 
will be used in order to gain different perceptions of the phenomena. During the 
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analysis stage patterns within the data will be explored that have the potential to be 
repeated in different situations (Collis and Hussey 2009). 
It is paramount that the researcher fist considers the epistemological stance and 
their ontological stance, as both will lead to the best methodological stance for the 
research and therefore which research paradigm the research aligns with.  
Table 4: The Two Main Research Paradigms 
Assumption/Stance Positivism Interpretivism 
Epistemological  
(what constitutes valid 
knowledge) 
The researcher is 
independent of that being 
researched 
The researcher interacts 
with that being 
researched 
Ontological  
(that nature of reality) 
Reality is objective and 
singular, separate from 
the researcher 
Reality is subjective and 
multiple, as seen by the 
participants 
Methodological 
(the process of 
research) 
The process is deductive 
 
Focused on objective 
facts and formulate 
hypotheses. 
 
Results are accurate and 
reliable through validity 
and reliability. 
The process is inductive 
 
Study of emerging design 
that leads to the 
identification of categories 
during the research 
process. 
 
Patterns and theories are 
developed for better 
understanding  
Findings are accurate and 
reliable through 
verification 
 
Adapted from Creswell (1994, 1998), and Collis and Hussey (2009) 
 
Table 4 explores the different aspects of the two main paradigms of positivism and 
Interpretivism. Reviewing the researcher’s stance pertaining to their understanding of 
what constitutes knowledge, the world around them (reality). The processes they feel 
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would suit these areas are outlined by the table and can help the researcher make 
choices relating to the phenomenon under investigation. 
Researchers who have chosen a positivistic paradigm must deal with issues 
pertinent to the methodology such as: sample accuracy, reliability, validity of 
measures and generalisability. Researchers who have chosen an interpretive 
paradigm must deal with more fundamental issues, these include: argument and 
justification on what constitutes reality, the validity of the chosen paradigm. They 
need to debate epistemological questions about the relationship between the knower 
and what can be known before even getting to the methodological issues (Lee, 
Saunders and Goulding 2005).  The complexity of the issues that must be addressed 
in the interpretivist paradigms has led many business and management researchers 
to choose a positivistic methodology (Shanker and Goulding 2001). 
Generally researchers believe that a positivist paradigm applies to quantitative 
methodologies, while the interpretivist paradigm applies to qualitative methodologies 
that are not derived from quantitative data (Strauss and Corbin 1997, Creswell 1994, 
1998).  However, research is not always clear cut, both quantitative and qualitative 
methods are often used in the same paradigm (Table 5). The use of more than one 
method like this is known as mixed methods. This allows for triangulation of the data, 
which is believed to add viability and reliability to the research process (Denzin and 
Denzin 1978, Guba 1990, Collis & Hussey 2009). Carey and Smith (1993) also says: 
“In quantitative research facts act to constrain our beliefs, while in interpretive 
research beliefs determine what should count as fact.” (Carey and Smith 
1993, pp.245-246) 
As mentioned previously the paradigm chosen will determine the researcher’s 
methodological stance. Table 5 compares the main features of the two main 
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paradigms and details the methods and instruments used for data 
collection/generation, common to both. This more holistic view helps to place the 
research within the paradigm that best suits the research and that of the researcher’s 
philosophical assumptions. 
Table 5: Features, Methods and Data Collection Instruments for the 2 main Paradigms 
Paradigm Positivism/Quantitative Interpretivism/Qualitative 
Features Use of large samples 
Use artificial locations 
Focused on hypothesis 
testing 
Produces specific, 
objective quantifiable data 
reliability is high but 
validity is low 
Results can be 
generalised from sample 
to population 
Use of small samples 
Use of natural locations 
Concerned with generating 
theories 
Produces rich, subjective 
qualitative data 
Low reliability but high 
validity 
Results can be 
generalised from one 
setting to another 
 
Methods Quantitative methods 
predominantly, but 
qualitative methods can 
be used 
Qualitative methods 
predominantly, although 
quantitative methods may 
be utilised 
Data collection 
instruments 
Surveys 
Experimentation 
Questionnaires  
Testing 
measuring 
Scales 
Interviews 
Observations 
Document analysis 
Visual data analysis 
Source: Adapted from (Collis & Hussey 2009, Mackenzie and Knipe 2006) 
 
For this study the researcher will take an interpretivist stance and utilise a qualitative 
methodology. The instruments that will be used to collect data will be those that fall 
within the qualitative research methods. These include interviews, observations and 
document analysis. The sections below discuss the pathway to these choices and 
the justification for them. 
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4.3 Research Methodology 
The research methodology is the central framework and is determined by 
philosophical assumptions and the methods chosen (Duberley, Johnson and Cassell 
2012). It is important that a researcher chooses a research methodology that relates 
to their understanding of reality (Guba 1990). This means they must decide on the 
paradigm in which the research sits. 
The research paradigm will impact on the researcher’s choice of methodology and 
methods for collecting and analysing the research data (Hussey and Hussey 1997). 
There is a huge range of both methodologies (Table 6) and methods (Table 5) to 
choose from. Consideration of the researcher’s background, their skills and 
experience, how the researcher will engage with the phenomenon, the nature of the 
phenomenon itself and finally the audience to whom the research will have relevance 
to, should be reviewed carefully (Creswell et al. 2003). 
Choosing the right methodology can take time to get right. The researcher should 
shortlist a number of suitable methodologies and carry out an in-depth review of 
each of them before making a decision.  
Table 6: The main methodologies used within the discipline of business and management. 
 
Positivism               Continuum of Paradigm                      Interpretivism 
Methodologies 
Experimental studies Hermeneutics 
Survey’s (using primary or secondary 
data) 
Ethnography 
Cross-sectional studies Participative enquiry 
Longitudinal studies Action research 
 Case Studies 
 Grounded theory research 
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 Feminist, gender and ethnicity studies 
Source: Collis & Hussey (2009) 
 
 The Research Position and Factors Influencing that Choice 
After careful consideration of the ontological, epistemological and methodological 
stances pertaining to this research phenomenon, as outlined in Table 5, the 
researcher concluded that this PhD research fell within an interpretive paradigm and 
would follow a qualitative methodological approach. 
 The Philosophical Justifications and the Link to the Phenomenon 
The Triple Helix was considered, however the research carried out by Suvinen, 
Konttinen and Nieminen (2010) outlined some of the weaker aspects of this 
methodology and their challenges in trying to use it to answer their research 
questions (see the sections 3.6.1 and 3.8). As was discussed in section 3.6.1, the 
Triple Helix methodology does not work well in studies that are focused on Sectoral 
Systems of Innovation and Regional and National Innovation Systems. 
Other methodologies considered include the Actor Network Theory and Case Study 
Theory. Both of these methodologies would require an in-depth knowledge of each 
of the LSIs being explored. The level of access to the individual LSI organisations 
required was not available in this study.  
 The Argument against Case Study Methodology 
The researcher had initially intended to use a Case Study methodology in this PhD 
study. She explored past research pertaining to LSIs (as seen in Chapter 3, section 
3.6), and discovered a paucity of research using Case Study methodology in the 
literature to answer specific question like the 4 RQs identified in this study.  
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Eisenhardt (1989) says that central to theory building in Case Study research is 
replication. She explains that each case is its own unit and is able to be analysed as 
such. Case Study research also provides a holistic view as a detailed picture of the 
case organisation is built up from a number of different sources (Yin 1994). This all 
sounded promising at the initial stages of this research study. 
Eisenhardt’s 1989 paper makes 2 contributions to the academic literature, the first 
was to build a roadmap for extracting theory from Case Study research, and the 
second was in positioning theory building from Case Study research into the social 
science research arena. Her paper explored strengths and weaknesses of theory 
building from Case Study research. 
On further review, both GT and Case Study methodologies start off the same way: 
by identifying the RQs normally. For the Case Study research these are extracted 
from available literature in the substantive area. In the traditional GTM there are 
RQs, however there is normally expected to be scant literature. Again this would 
work for this PhD study as there is literature available on the substantive area 
although there is there scant theory in the literature as is the case for this research 
study (Harrison and Leitch 2000).  These two methodologies required time to 
analyse the different processes in each in order to apply the philosophical 
justification required. The question was which methodology should be used as the 
primary one?  
As previously discussed it did appear initially that the Case Study methodology could 
be applied to the this PhD study and there had been previous research within the 
University group under Professor Kouhy who had successfully carried out a case 
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comparison using a Grounded Theory Methodology, hence expertise within the 
group. 
On researching GTM a number of different approaches were uncovered and one of 
these allowed for the researcher to have experience of the phenomenon under 
investigation and allowed the RQs to be identified through available literature (see 
section 4.1.2 for details on this). Therefore although Case Study research allows for 
extant literature and traditional GT does not, the new identified approach meant that 
a wholly GT methodology could be applied. Another major negative was Eisenhardt 
and Graebner’s (2007) claim that Case Study research does not always come close 
to answering the RQs.  
Other reasons for deciding against a Case Study methodology are that the bottom 
up approach required, produces theory that is generalizable and this PhD study is 
sector specific and focused, and therefore not generalizable (Eisenhardt 1989, 
Malerba  and Orsenigo 2002). This means the theory will only apply within the life 
sciences sector. The second reason is that this methodology results in overly 
complex empirical data being produced. The volume of data created impacts on the 
theory, and by using all of the data in theory building it becomes unwieldy.  
This could therefore produce theory rich in detail, but would lack the simplicity 
of the overall perspective (Eisenhardt 1989, p.546).  
Another reason for not choosing the Case Study methodology was that much of the 
process defined by Eisenhardt in her 1989 paper include methodology drawn from 
GT, where the data collection methods include theoretical sampling, saturation, 
coding and analysis (Eisenhardt 1989, p.546). Eisenhardt (2007) says that a close 
location to the unit under study reduces bias and keeps the researcher honest, this is 
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also achieved in GTM as memo taking is an integral part of the process and memo-
taking allows the researcher to remain close to the data and reduces any bias. 
However, the main reason for this decision is that the Case Study research 
framework proposed by Eisenhardt takes a definite positivist view, whereas this PhD 
study sits is in the realm of the interpretivist (Eisenhardt 1989, p.546).  
 
 The Argument for GTM 
This PhD research will follow a Grounded Theory Methodological (GTM) approach 
throughout with the intention of generating theory. GTM is one of the methodologies 
that falls within the interpretive paradigms (Table 6), and best fits with the research 
envisioned. The selection of GTM has come about after a detailed review of a 
number of other research methodologies that could fit with the researcher’s 
philosophies.  
This PhD project did however allow for a comparison between the LSIs and this was 
one justification for choosing a GTM. 
In addition GTM can provide rigour and a systematic process and analysis, while 
permitting flexibility and freedom to explore the phenomenon and allowing for the 
emergence of any issues (Bryant 2002, Glaser 1978, Jones, Coviello and Tang 
2011). Moreover, GTM has been chosen as it allows for theory to develop and 
emerge from the research, where there was none previously. 
The researcher considered the issues carefully before deciding on the appropriate 
theoretical methodology for this research, as there has been extensive research 
using a range of methodologies on many aspects of the life sciences sector. The 
literature on GTM is divided when it comes to researching a previously well explored 
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area. Strauss and Corbin in their 1994 paper claimed that GTM had the ability to 
generate novel and exciting ideas about issues that have already been heavily 
investigated. O’Reilly, Paper and Marx (2012) says that GTM should not be chosen if 
the phenomenon has been heavily researched. However, they also say that if the 
existing literature does not adequately explain the phenomenon then you can use 
GTM to develop new theory. The researcher also had to decide if prior knowledge 
and experience of the sector in which the phenomenon was located would 
jeopardize the theory development stage of the research. However, found that 
providing the researcher remained open to the data collected and avoided 
introducing bias based on pre-existing assumptions, it is possible to generate new 
theory based on the data collected (Goulding 2002, O’Reilly, Paper and Marx 2012). 
The use of Memos throughout the study process helped to reduce the element of 
bias and opened the researcher to new pathways that led to potentially novel theory.  
There is an argument that supports this reasoning: if the researcher has previous 
practical and theoretical experience of the phenomenon it should be viewed as an 
asset rather than as a liability (O’Reilly, Paper and Marx 2012, Fendt and Sachs 
2008). This is because in order to make judgements on theoretical saturation a 
deeper understanding of the field through active professional experience will enable 
the researcher to know when the saturation point has been made, therefore prior 
experience can benefit the research (Goulding 2002, Finch 2010). Based on this 
review of the issues it was decided that applying a GTM methodology was fully 
justifiable.  
There are many unanswered questions regarding the lack of success of the UK life 
sciences sector, and this study seeks to address some of these. The researcher has 
only identified a limited number of studies looking at LS intermediaries. The study 
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carried out by Lopez-vega and Vanheverbeke (2010) has already been discussed in 
Chapter 3 under Past Studies using GTM. They explained how they used GTM to 
enable them to identify categories by simultaneously comparing the data collected 
during the analysis process. 
To date, and to the researcher’s knowledge, there has not been any research on a 
comparative analysis between different models of LSIs to explore their value in KEC. 
This paucity encourages the need for theory-generating approaches such as GTM to 
be considered (Idrees, Vasconcelos and Cox 2011, Mehmetoghu and Altimay 2006, 
Binders and Edwards 2010). GTM calls for an  
“In-depth understanding of the phenomena where little is known and where 
the focus is on the participant’s experiences and their interactions” (Glaser 
1998, p.136). 
Lopez-vega and Vanheverbeke (2010) suggested that due to the complex and 
idiosyncratic nature of innovation intermediaries, use of a single literature to inform 
the phenomenon will not produce viable results. Investigating a range of LSIs and 
linking the literature on knowledge exchange and commercialisation and the extant 
literature will hopefully generate new theories that will add to the literature on 
innovation intermediaries especially the literature on the sector specific 
intermediaries like LSIs. The justification for choosing GTM is that this research 
adapts an inductive approach and will take into account the researchers prior 
knowledge of the sector and the current literature within the sector.  
This is a summary of the key factors for choosing GTM (O’Reilly, Paper and Marx 
2012, Goulding, 2002; Charmaz, 2006) 
 The main objective is in theory building rather than theory testing 
 The literature reviewed had no clear theories that could be identified for 
testing 
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 GTM is positioned within the Interpretivism  paradigm (Table 6) 
 GTM allows for a more holistic approach to data collection 
 GTM allows for interaction and observation with participants, which fits the 
Interpretivism paradigm. (Goulding 2002) 
 The researchers understanding and knowledge of the sector to be 
investigated is beneficial 
 The amount of research already done in the LSI sector can be referred to 
A number of researchers have advocated for the increased use of GTM in business 
and management research. This is because of the formalised structure of the 
methodology which means that itself rigorous and therefore provides greater validity 
(O’Reilly, Paper and Marx 2012). Moreover, the method allows for a context-based 
description of the phenomenon to be developed (Myers and Avison 2002) 
Before moving on to the rationale for choosing to use GTM in more detail, a brief 
look at the evolution of Grounded Theory will help to illustrate the reasoning behind 
the decision. Once we have discussed the history and the different approaches to 
GTM, we will look at the justification for the choice of GTM approach for this 
research. 
4.4 The Background to Grounded Theory (GT) 
Grounded Theory as a new methodology was first developed and proposed by 
Glaser and Strauss (1967) as a response to the use of positivistic methodologies 
that were prevalent at the time in social sciences research. This new methodology 
was quite different to other methodologies that used a deductive (usually seen in 
quantitative methodologies) rather than an inductive means for collecting and 
analysing data – as was proposed in Classic Grounded Theory (CGT). Theory 
testing rather than theory generating also made CGT stand out. They believed that 
the traditional positivist methodologies used by social scientists were unable to 
109 | P a g e  
 
effectively draw out meaning from the actors in social settings. They believed that 
methodical data collection could be used to develop theories that address the 
interpretive realities of actors in social settings. 
In addition they believed that new theory could be built by observation and 
interaction with the actors in social settings for an inductive understanding of the 
phenomenon derived from the participants themselves (Charmaz 2006, Locke 2007, 
Suddaby 2006).  
 The Hybridization of GT methods 
The prescriptive nature of GT allows researchers to choose to follow different 
methodologies, while using GT methods in their research. This hybrid use of GTM 
methods has been encouraged more recently (Annells 2006, Birks and Mills 2011). 
Although initially it was known as ‘Methodology muddling’ (Baker, Wuest and Stern 
1992) and was frowned upon (Locke 1996), this has now changed, and it is accepted 
for researchers to use GT alongside other methodologies, although they must justify 
this hybridisation (Wilson and Hutchinson 1996, Lee, Saunders and Goulding 2005). 
The use of GTM must of course fit with the researcher’s methodological goals and 
philosophies to ensure the successful completion of the research. 
Besides this hybridisation where the GT methods are used with other methodologies, 
GT methods has also been used in Mixed Methods research projects. This is where 
the researcher uses both qualitative and quantitative methodologies (Wells et al. 
2008). GT methods have been used successfully in these mixed methodology study 
too (Birks and Mills 2011) and is seen as one of the strengths of GTM. 
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 Approaches to Grounded Theory 
It has been five decades since Grounded Theory (GT) was introduced to the world 
as a new methodology in 1967 by Glaser and Strauss. It is then not surprising that 
GT has undergone a number of iterations. 
Initially both Glaser and Strauss spent time delivering seminars on GT. However, 
they found it difficult to convey the essence of the methodology to students and 
colleagues, as this new methodology went against all the common methodologies 
used by social scientists (Glaser 1978).  
Researchers new to GT found the concepts difficult to understand and to apply. As a 
response to these difficulties Glaser wrote a book called Theoretical Sensitivity 
(1978), where he hoped to explain more on how theory can be built. Unfortunately 
this new book did little to reverse the problem, and it still proved too difficult and left 
unresolved the main issues faced by novice researchers. Glaser said that in order to 
successfully do GT the researcher would need to become an expert in 
conceptualisation, but most researchers have no training to allow them to do this 
(Glaser 2001). 
In 1990 Strauss also published a book called Qualitative Analysis, again in the hope 
of addressing the issues that novice researchers to GT had with the methodology. 
Then in 1997 Strauss along with Corbin published their booked called The Basics of 
Qualitative Research, which added to the GT methodology.  They believed their 
approach was more prescriptive and structured and therefore addressing one of the 
issues with the original approach, particularly for novice researchers. They provided 
a definitive structure that needed to be strictly followed that would eventually lead to 
theory generation. The Strauss and Corbin version of GT is known as Straussian GT 
(SGT).  
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This new approach caused a rift between Glaser and Strauss. Glaser thought that 
this addition to the methodology endorsed the ‘forcing’ of theory generation as 
argued in his published book The Basics of Grounded Theory Analysis: Emergence 
v Forcing (1992).  Another major divergence between Glaser’s and Strauss’s 
different approaches is that Strauss and Corbin encourage the researcher to consult 
the literature and be influenced and guided by it, whereas Glaser prescribes that the 
researcher should not consult the literature as preconceptions will emerge that will 
have an impact on theory generation. 
Although the debate continued between the two founding fathers of GT, the use and 
strength of GT continued to grow and evolve. There are now numerous approaches 
that have been proposed, mostly by students of the two founding fathers, the list of 
researchers include: Bowers 1989, Clarke 2005, Charmaz 2006, Ghezeljeh and 
Emami 2009, and Morse 2009. They believed that GT was still too positivistic and 
have shifted it towards the interpretivist side.  
These various approaches have added to the time that a researcher needs to take in 
order to choose the best approach. All these approaches are known as GT and the 
researchers have to familiarise themselves with each approach in order to decide 
which would best fit with the researcher’s epistemological and philosophical 
positioning (Suddaby 2006, Hunter et al. 2011, Birks and Mills 2011) 
Constructivist GT, developed by Kathy Charmaz in 2006, has gained in popularity 
and has been compared with the GGT and SGT in Table 7 found later in this 
chapter. Each of the three different approaches are discussed and then finally 
compared in the next section. 
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Figure 6: The Three Main Approaches to GTM 
 
 
 
 
The development of the three main approaches to grounded theory that emerged 
from the classic grounded theory, both sides gave rise to Constructivist GTM. 
 
Source: This research  
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 The Classic and Glaserian Grounded Theory (CGT) Approach 
The original work by Glaser and Strauss in 1967 is considered classic grounded 
theory (CGT). Glaser has always defended this original methodology (Glaser 1978, 
1992, 1998, 1999, 2003), and the central concept that discovery will lead to theory 
generation. From 1992 onwards CGT became known as Glasserian Grounded 
Theory (GGT). Glaser disassociated himself from Strauss, who he believed was 
promoting qualitative data analysis rather than grounded theory (Glaser 1998). 
In the GGT approach the researcher does not start with the research question, as in 
more traditional methodologies, instead the focus is on the social area of interest 
within the phenomenon under investigation. GGT also recommends that a literature 
search is not carried out at the start of the research, this is to prevent any 
preconceptions that may be formed from the phenomenon under investigation (van 
Niekerk and Roode 2009). As previously mentioned Glaser has always defended the 
CGT methodology. One concept Glaser (1992) advocates is for the researcher to 
embark on the research with an ‘open mind’, which Dey (1999) equated to a 
researcher having an “empty mind”. Glaser countered this statement by explaining 
that the researcher did not embark on the research journey with an “empty mind”, 
instead with an educated open mind that was attuned to patterns and regularities 
within the social setting. This means that the researcher is guided by what he finds 
while doing the research, and the theory will become apparent as the research 
progresses. 
In the original book on CGT by Glaser and Straus (1967) they presented the concept 
of theoretical sensitivity. Theoretical sensitivity is one of the main tenets of CGT. It 
was explained as coming in two parts, the first is based on the researcher’s insights 
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into themselves and the area they are researching and the second reflects their 
intellectual history and how they think about the area they are researching (Birke and 
Mill 2011). What this implies is that the researcher has the ability to extract meaning 
from the data as it relates to the emerging theory. This is probably linked to what 
Glaser refers to as the researcher having an “open mind” or as he argues later an 
“educated openness”.  Birke and Mills (2011), discuss three key features of 
theoretical sensitivity, these are: 
1. A reflection of intellectual history, both personal and professional 
2. It can be enhanced by various techniques, tools and strategies 
3. It will increase as the research progresses 
 
Along with theoretical sensitivity there are four other important tenets that make up 
the analytical guidelines for GT. They are: 
1. The constant comparative method, 
2. Theoretical coding, 
3. Theoretical sampling, and 
4. Theoretical saturation.  
These four analytical techniques make GT a unique methodology (Charmaz 2006). 
From the original work by Glaser and Strauss (1967, p.237) they laid out specifics for 
the analytical work that needed to be done and what the researcher should be 
looking for at the different stages. 
1. Fit – is there a good fit between the substantive area and the theory? 
2. Understandability – Will the theory be understood by lay persons? 
3. Generalisability – will the theory apply to a wide range of situations in the 
phenomenon under investigation? 
4. Control – is their control over structure and process over time? 
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GGT allows for research to be fluid, flexible and evolving in nature, which has many 
advantages over more traditional methodologies. In addition its strength lies in its 
ability to develop theory through the use of prescribed, yet flexible, tools that are 
used for analysis (Charmaz 2005). 
Another advantage of this approach is that the researcher can collect data from 
multiple sources of data. This allows for increased validity and can provide a better 
explanation of the phenomenon. These different sources may include: interviews, 
articles, websites, newspapers and other media that relate to the phenomenon being 
studied. This new methodology wanted to help bring rigour to the processes and at 
the same time allow the researcher to interpret social meaning through rigorous 
consideration of the evidence. This can happen with multiple sources of data that are 
available and permissible within the methodology. The researcher has more 
evidence available in order to build concepts and explanations relating to the 
phenomenon (Hunter et al. 2011). GGT strategies are particularly suitable for 
research that take place in areas that are not well understood and have not been 
researched extensively (Hunter et al. 2011). This would have been an issue for this 
research study as the substantive research area has been extensively investigated. 
 Straussian GT (SGT) - Strauss and Corbin’s Approach 
The Straussian approach has, since its appearance in 1990, become very popular 
with a wide range of disciplines, including business and management and especially 
in healthcare research. In the SGT approach the two authors recognised that the 
researcher would have both their own professional experience and knowledge 
gained from literature they had reviewed on the substantive area; they understood 
this and incorporated it within their approach. This was a major divergence from 
Glaser’s belief that the researcher should not engage with the phenomenon. Strauss 
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and Corbin believed that engagement with existing literature would help the 
researcher identify various elements along the stages of the methodology, including 
reaching saturation points and identifying theory from the data (Strauss & Corbin 
1990). The caveat was that the researcher must “maintain an attitude of scepticism” 
(Strauss & Corbin 1990) and not allow this to influence the theory that emerges. 
In their book Basics of Qualitative Research: Grounded Theory Procedures and 
Techniques (1990), Strauss and Corbin took a more prescriptive formulaic approach 
to GT.  There are a number of key differences between SGT and GGT approaches. 
One of the main ones is the addition of coding to the analysis stage and these 
additional coding stages are Open Coding, Axial Coding and Selective Coding. They 
presented eleven different procedures that the researcher would need to follow 
(Strauss and Corbin 1990), these procedures are as below: 
1. Data collection are interrelated processes 
2. Concepts are the basic units of analysis 
3. Categories must be developed and related 
4. Sampling in GT proceeds on theoretical grounds 
5. Analysis makes use of constant comparisons 
6. Patterns and variations must be accounted for 
7. Process must be built into theory 
8. Writing theoretical memos is an integral part of doing GT 
9. Hypotheses about relationships among categories are developed and verified 
as much as possible during the research process 
10. A grounded theorist need not work alone 
11. Broader structural conditions must be brought into the analysis, whatever the 
size of the research 
It is clear that SGT follows GGT to a point and includes many of the original 
procedures from GGT. However it is not just the addition of coding that makes it 
different. While both support sampling based on theoretical grounds as in point 4 of 
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the list above, SGT allows the researcher to influence the phenomenon with pre-
knowledge, while GGT states that it should come from the data and not the 
researcher. 
Moreover, in GGT there is an abductive element to processes for identifying patterns 
and variations that emerge from the data. Abduction is a mix of both induction and 
deduction. The SGT approach has a focus on deductive processes and embedded 
verification. In SGT verification (Point 9 of list) is a continual process and is 
embedded within the entire methodology processes. This is a major difference in 
philosophies between the two methods. In GGT there is no element of verification 
built in to the process as Glaser believes that verification is part of quantitative 
research and not qualitative – although Rennie (1998) suggests that GGT has 
verification built-in, through the ‘symbiosis of induction and abduction during the 
constant comparison of data’. 
Many researchers find the SGT approach a little too structured and ridged, especially 
the need for extensive coding, which makes it seem less flexible than GGT. 
Moreover there is a focus on deduction, verification and validation. This has been 
defended by Corbin and Strauss in a more recent publication. 
 “Techniques and procedures are tools not directives. No researcher 
should become so obsessed with following a set of coding procedures 
that the fluid and dynamic nature of qualitative analysis is lost. The 
analytic process, like any thinking process, should be relaxed, flexible and 
driven by insight gained through interaction with data rather than being 
overly structured and based only on procedures.” (Corbin and Strauss 
2008, p12) 
 Constructivist Grounded Theory Approach 
Another researcher Kathy Charmaz  (2000, 2006) proposed a more constructivist 
approach to GT that would incorporate a mutual understanding between the 
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researcher and the participant. With the Constructivist Grounded Theory (ConGT) 
approach, the research lies directly within the interpretive paradigm of research. 
Although not intended both GGT and SGT have gained some recognition from 
quantitative researchers who have taken to using it in mixed methods studies 
because of its positivistic assumptions (Charmaz 2006). This was an unintended 
consequence and did not sit well with qualitative researchers because of the 
“objectivity” of the researcher. In both SGT and GGT it is assumed that the 
researcher’s preconceived ideas are purged by use of the methods (Glaser 2002). 
This detachment of the researcher from the process is more related to a positivist 
paradigm than an interpretive one. 
The Constructivist movement first introduced by Berger and Luckmann (1966) 
dictates that social constructivists deal mostly with ‘what’ people construct and the 
‘how’ it is all explained. Charmaz states that the ‘why’ of Social Constructivism is not 
clearly explained and this is fundamentally why ConGT has emerged (Charmaz 
2008, p.397) as all three of What, How and Why are embedded within the ConGT 
methodology. Her reasoning was that most qualitative research had not addressed 
these three questions before this.  
GTM starts with an inductive strategy for collecting and analysing data that leads to 
theory development (Charmaz, 2008). One advantage of GTM is that the social 
continuance of the research participants is maintained while the researcher is 
carrying out his or her investigation.  The GTM theorist is able to focus on the data 
gathering and analysing with the two questions at the heart of the research - ‘What’ 
and ‘How’. Interacting with the substantive area allows for theory to emerge. A Social 
Constructivist approach to GT allows us to address the ‘Why’ questions while 
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preserving the complexity of social life (Charmaz 2008, p.397). Charmaz developed 
the ConGT approach specifically to address the ‘Why’ question. She explained that 
the ConGT researcher develops his or her studies in a way that allows for greater 
explaining and understanding and allows for all three questions to be answered.  
Glaser and Struass’s more classic approach to GT adopts a less constructivist 
element than the ConGT approach outlined by Charmaz. Their methodology allows 
for generalisation and objectivity rather than the reflexivity and relativity found in 
CoGT (Charmaz 2008, p.399). Reflexivity is a key component of this constructivist 
revision and renewal of classic GT, and permits the research to be entrenched within 
the process, rather than separate to it (Charmaz 2008). 
In ConGT the researcher is involved in the theory building. The logic here is that the 
researcher’s understanding, interpretation and experiential learning, impacts on the 
theory that is created or constructed and considers knowledge to be constructed in 
nature and inextricably linked to the researchers interfaces with others and the 
environment (Lincoln, Lynham and Guba 2011). Unlike SGT and GGT, the 
researcher is not ‘purged’ from the process. In ConGT the theory generated will 
incorporate the researcher’s views (Charmaz 2014). 
“…it is not the research methodology that aims to discover a theory 
despite the researcher, but it is the researcher who aims to construct a 
theory through the methodology” (Charmaz 1990, p.1162) 
 
Charmaz (2006) explains that both GGT and SGT provide the building blocks for the 
research process and she brought the methodological assumptions from GGT into 
the twenty-century. She views GGT not as a prescriptive package, but as a set of 
principles and practices that allows for the many divergences.  
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The basis of the Constructivist approach is that concepts are constructed rather than 
being discovered. Unlike GGT and SGT in ConGT there is no assumption made that 
data and theories are discovered, and 
“We construct our grounded theories through our past and present 
involvements and interactions with people, perspectives, and research 
practices” (Charmaz 2006, p.10).  
 
ConGT places much more emphasis on the people and participants than on the 
processes and the methods. However, saying that ConGT does still put some value 
to various practices, like data gathering, memoing and using theoretical sampling. 
Additionally, like SGT, ConGT starts with a literature review and research questions 
from a substantive area. This is in contrast to GGT where there is no need to know 
more about the substantive area nor to determine what research has already been 
carried out and there is no need for any research questions. 
 
ConGT follows many of the same principles as GT, however, there are differences; 
these have been summarised by Charmaz (2006, p.178) as her constructivist 
approach to GT: 
  
 The grounded theory research process is fluid, interactive and open-ended 
 The research problem informs initial methodological choices for data 
collection 
 Researchers are part of what they study, not separate from it 
 Grounded theory analysis shapes the conceptual content and direction of the 
study, the emerging analysis may lead to adopting multiple methods of data 
collection and to pursuing inquiry in several sites 
 Successive levels of abstraction through comparative analysis constitute the 
core of grounded theory analysis 
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 Analytic directions arise from how the researcher interacts with and interpret 
their comparisons and emerging analyses rather than from external 
prescriptions.  
 
 The Main Differences between the Approaches (Emerged, Forced and 
Constructed) 
There is current literature on GT methodologies and approaches. All provide 
information on the history of GT, the main divergent pathways and the many other 
approaches. This has made it very confusing for a novice researcher to clearly 
identify which approach to use.  
Table 7: The three different approaches to GT 
 Classic/Glaserian Straussian Constructivist 
Identifying the 
problem area 
Emergent 
No initial Literature 
Review 
Previous 
experience 
Pragmatism 
Literature 
reviewed 
Sensitising 
concepts 
Discipline- specific 
Conduct of 
research and 
developing 
theory 
Laissez-faire 
theory generation 
No verification 
necessary 
Paradigm model 
theory. 
Verification (built-
in to process) 
Co-construction 
and reconstruction 
of data into theory 
Relationship to 
participants 
independent active Co-construction 
Evaluating theory Fit, work, 
relevance and 
modifiability 
Validity, reliability, 
efficiency and 
sensitivity 
Situating theory in 
time place, culture 
and context. 
Reflexive 
rendering of the 
researcher’s 
position 
Coding Substantive 
Theoretical coding 
Open coding 
Axial Coding 
Selective coding 
Line-by-line 
conceptual coding  
Focused coding to 
synthesis large 
amounts of data. 
Open, focused and 
theoretical 
Source: Adapted from Hunter et al. (2011) 
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Table 7 shows that there are some differences in terminology. For example 
theoretical sampling in the ConGT is the merging of concepts into groups, which 
takes place throughout the process. In GGT theoretical coding is part of the selective 
process which is used to integrate the grounded theory (Hernandez and Andrews 
2012). 
According to Ng and Hase (2008), Classic GTM was never intended for the 
researcher to enter the substantive field without knowledge of it. They say this is a 
misconception. Their interpretation does not however follow through with the process 
as outlined by Glaser and Strauss in their original guidelines to the approach. 
Figure 6 shows pictorially how the Classic and Straussian approaches have fed into 
and help create the Constructivist approach. Charmaz brought relativity and 
subjectivity into the epistemological discourse on GTM (Charmaz 2014). Charmaz 
(2014) explains that social constructionist researchers viewed construction of the 
worlds they studied as accurate translations rather than as a construction and did not 
account for the processes involved. They ignored the subjectivity they brought to the 
process and failed to engage in reflexivity, this did not sit well with Charmaz. In the 
Constructivist approach to GTM, Charmaz acknowledges the researchers and 
participants involvement with the research process and hence the research, and is 
defined as, co-constructed: theory is reconstructed from the data. Basically, the data 
is broken in to component parts and then reconstructed in order for the theory to 
emerge (Hunter et al. 2010). 
 Research Methodological Approach 
Having worked in a number of LSIs over the last fifteen years, the researcher had 
questions that were based on the success of the phenomenon being investigated. 
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Initially a prolonged literature search and review was carried out, and GTM was 
chosen as no clear theories had emerged from the literature that had been reviewed.  
 Natural Sciences and the Social Sciences 
Qualitative research has had much criticism for not being rigorous or verifiable. 
Glaser says that verification belongs in quantitative research rather than qualitative 
research.  The researcher is keenly aware of this issue as the audience for this 
research would mostly understand the philosophies based on quantitative research 
paradigms more common in the natural sciences. The researcher also comes from a 
natural science background, so validation is important for this research. GTM 
techniques and protocols, provide a demonstration of the analytical strengths that 
justify the process as being reproducible (Goulding 1998). Both SGT and ConGT 
have rigor and validation built in to the process. Both approaches were reviewed in 
detail before making a decision on the research approach. 
Initially, the suitability of GTM was not clear to the researcher as GGT states that the 
researcher must not do a literature review nor start with a research question, and in 
addition the researcher should be naïve of the substantive research area. The 
researcher worked in the substantive area and the fact that research questions were 
identified, the literature searched and gaps were identified meant that the GGT 
approach was dismissed. It was the Straussian approach that appealed to the 
researcher initially. In particular the idea that prior knowledge of the substantive area 
was thought to be beneficial in identifying categories and for simply allowing the 
researcher to know when the saturation point had been met.  In addition the 
structure of the processes and the focus on validity appealed to the researcher. 
This research has always been about the experiential journey, and on a more 
detailed review of the Constructivist approach to GTM the researcher has now 
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realised that this approach is a better fit with the researcher’s philosophical 
assumptions. SGT after refection appears to be overly complicated. This is mainly 
because of the additional coding stages required in SGT methodology. These 
include the addition of Open, axial and selective coding stages, making a total of 11 
procedural stages. This makes the SGT methodology highly prescriptive and 
although the researcher found a structured methodology appealing, the overtly 
prescriptive nature of the methodology did not allow for the researcher to apply her 
own experiential learning from the sector to the theory building, which is a feature of 
ConGT. In addition SGT has a more deductive approach to the process, while in 
ConGT the concepts are constructed rather than discovered. Therefore in conclusion 
the researcher believes that knowledge is constructed from the data, from the 
participants and from the researcher’s knowledge of the phenomenon. 
4.5 Research Methods 
The research methods that are used for this PhD project are directly related to the 
methodology chosen as the overarching process to be followed. For this research 
GTM has been chosen as a qualitative methodology (Table 5) and in-turn the ConGT 
approach will be employed. 
The choice of research methods should be appropriate to the choice of methodology 
for GTM: the data collection instruments include tools that suit an interpretivist 
paradigm such as interviews, observation and document analysis (Table 5).  
Grounded theory allows us to broaden and extend the social world of our 
participants. 
“These methods provide a tool to enhance seeing but does not provide 
automatic insight” (Charmaz 2006, p.15) 
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The tools themselves will not generate good analysis; you also need a keen eye, an 
open mind, a discerning ear and a steady hand to help you make sense of it all 
(Mitchell and Charmaz 1996). Charmaz (2006) says that methods are merely tools, 
so when combining them with insights, GT methods can help to make sense of the 
data that is generated. 
 Comparative Analysis between Multiple Cases 
 
The Case Study methodology has become more widespread in GT research as it 
can be used in the development of theory. As discussed previously, the researcher 
had fully intended to follow the Case Study methodology, but it became apparent 
after a detailed review of the literature on Case Study methodology that there was a 
disconnect with certain elements of this methodology and the researcher’s 
philosophical stance.  
A number of researchers have used SGT together with Case Study Methodology 
and the researcher had access to this expertise in the University academic group. 
However, deciding to go with ConGT (as it fit the researcher’s philosophical stance) 
was a big decision, as there was no experience in the academic group of this 
approach to GT. After researching ConGT the researcher was convinced that this 
approach to GT was the most appropriate. The issue, after this decision was made, 
was how she would continue to compare the Case LSIs? Comparing the Case LSI 
models was part of the research design and incorporating this comparative analysis 
within the research was a major part of the research study. Charmaz (2006) explains 
that comparisons are possible, between individuals, organisations and even nations. 
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In the case of this PhD study the participant organisations would be recruited and 
then placed strategically into the appropriate Case LSI model. This aspect of Case 
Study research was very appealing and using multiple cases in each Case LSI 
model would allow for replication of data. This is a major outcome of Case Study 
research (Gersick 1988). The careful recruitment of participants in order to compare 
and contrast variables is also very important. In addition, for multiple case studies 
the emerging theory can be replicated and compared (Yin 1994). 
Yin (2003) discusses the two different approaches to case study methodologies, one 
where the researcher is involved in the case study and the other where the 
researcher is detached from the case being investigated. In this PhD research study 
the researcher has a detached approach to each of the Case LSIs, this is because 
no time was spent immersed in the case organisation other than the time spent 
doing the interviews.  
These comparative cases are also viewed in the literature as multiple case studies. 
In these comparative cases (as they will be referred to in this research), the same 
questions are asked within each Case LSI model, so that differences can be 
identified. This will be done within each case comparator type and between the 
cases themselves. This research will compare each of the 5 Case LSI and look for 
where KEC is being done and which LSI has effective strategies in place. Each case 
comparator has similarities and differences; the differences are taken into account 
and will help answer the research questions. A few of the questions developed for 
each LSI has been customised to take into account their specific role and function. 
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4.6 The Research Process 
The diagram in Figure 7 represents the various stages of the process within 
ConGTM and shows the flow of the process in a sequential order. Some of these 
processes will take place within the next chapter and will be addressed further there. 
The diagram represents the constant comparative methods starting from the 
beginning of the period of data collection and runs through the different stages right 
up to the thesis writing stage. Memo-writing follows the same pathway as the 
constant comparative methods. In other words, this activity takes place throughout 
the research process. The constant comparative process requires the use of memos 
and field notes. These allow the researcher to capture his or her own ideas and 
thoughts on what they are observing or hearing. Charmaz says these Memo-taking 
stages matter and will allow for more in-depth analysis (Charmaz 2014).  Within 
Chapter 5, the results and analysis chapter, there are inserts of memos that are 
relevant to the discussion and then in Chapter 7, when the researcher has to link the 
data obtained from the entire research project to the literature that has been 
reviewed. Memo-taking is used here to collect ideas gained while undertaking this 
exercise, it is a lynch-pin tool of ConGTM and allows for a more robust and reliable 
project overall. This will be discussed in more detail later in this chapter. 
One important stage was that of choosing the GTM approach that would be used to 
aid the analysis of the data. This started at the Transcriptions and Advanced Memo-
writing stage and before the Initial and Focused Coding took place. This process 
required reading the literature on all the main approaches. A more in-depth 
discussion on these approaches are found earlier in this chapter. The choice has to 
128 | P a g e  
 
reflect the researcher’s raison d'etre in terms of philosophies, ontological and 
epistemological stance. 
Figure 7: The Research Design Process 
 
The different stages of the methodology process, incorporating the research 
methods, the memo-taking activity and the return to the literature. Progression is 
seen through the coding and the memos to finally build the theory and to finally write 
the thesis. 
Adapted from Charmaz (2006, p.11, 2014, p.18) 
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 Research Design  
The initial plan for this research would be to compare LSIs between different 
countries including France, Holland and USA to the UK. The researcher was able to 
gain some interviews from 2 different LSIs in Holland and France. However, it 
became clear that it was too difficult to gain access to more LSIs in these countries 
in terms of expense and time. It was therefore decided that the data that had been 
gathered would benefit the research to help justify assumptions and theoretical 
direction of the research, but could not be used as an equal comparator between 
these countries and the UK. As previously discussed under National Innovation 
Systems (NIS), both France and Holland have sufficiently similar NISs to allow for a 
comparison to benefit this research study. 
Figure 8 provides an overview of the data collection locations and the tools used to 
collect this data. For France there were 2 and Holland 3 LSIs that were used in this 
PhD project.  For the UK there are 5 Case LSI models which between then have 22 
individual LSI organisations. The last two data collection areas are in the USA where 
primary data from a conference was added. This is discussed further in Chapter 5 
under observational results. The last location is the BBSRC which is discussed in 
more details in the next section. 
Figure 7 represents the design of the research. This has been customised for this 
PhD research study and is adapted from Charmarz (2006, 2014). The process charts 
the different stages that the research goes through. The researcher liked this flow 
diagram as it captured the continuous memo-taking activities that flow through-out 
the process that allows for the constant comparison of data. The large arrow clearly 
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shows that there is a return to the literature at the writing up stage of the process, 
which is an important feature to capture here. 
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Figure 8: Data Collection Locations and Tools used  
 
 
 
 
 
 
 
 
 
 
The different data collection sites and the tools used in the process 
Source: This research 
  
Grounded Theory Allows for Widespread 
Data Collection 
5 Case 
Comparators 
3 LSIs  2 LSIs  
Data Collection Tools 
Interviews, Document Analysis, Observations, Conversations 
& Memo-writing 
France Holland UK USA BBSRC 
Interactive session at 
conference in 
Philadelphia 
Experiential 
learning from 
within a LSI 
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 Research Data Collection Tools 
This section will provide an overview of some of the tools that helped in this PhD 
project to collect data. A discussion on each of the tools is provided. 
4.6.2.1 Interviews 
The primary tool for data collection used in this research was in-depth semi 
structured interviews. Using interviews to collect primary data is used extensively in 
qualitative research and is very useful in understanding a person’s experience and is 
therefore invaluable in an interpretative research paradigm. 
“In an ideal world, ‘good’ researchers plan and conduct interview sessions 
such that ‘good’ interviewees feel compelled to share openly their 
considerable knowledge” (Alevesson, Ashcraft  and Thomas 2008, p.257). 
Identifying high calibre interview participants is paramount. Careful recruitment of 
participants is important and needs to fit the epistemological stance and the 
substantive area for the research (Alevesson, Ashcraft and Thomas 2008). The 
researcher needed to be aware that recruitment of leaders such as CEOs and 
directors of LSIs (or those in power) can be a barrier to extracting experiences rather 
than ‘public relations rhetoric’ (Charmaz 2006, p.27). These participants may view 
the researcher suspiciously and distrust the intentions of the research. 
Interviews can range from highly structured, complete with detailed interview guides 
(so-called speaking questionnaires), to loosely structured or semi-structured 
interview questions. For this research, careful planning and thought was used to 
build the semi-structured list of questions. The interview questions would have 
appeared from the outside as structured neo-positivists, however the tactic was to 
present open-ended questions to the participants in order to help them understand 
the mode of questioning and to gain their confidence that the process would not be a 
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critical interview of them or of their intermediaries function. The researcher was able 
to build on these opening questions with other questions that specifically related to 
the role and function of the intermediary case. Therefore the participant was happy 
to provide a more in-depth view by willingly answering the follow-on questions.  
“By creating open-ended, non-judgemental questions, you encourage 
unanticipated statements and stories to emerge.” (Charmaz 2006, p.26) 
The benefits of having a semi-structured list of questions is not just for the participant 
to see the line of questioning that will be asked during the interview, but to help the 
researcher to focus on what is being said and to have a list of follow-on questions 
waiting to be used when needed. These follow-on questions helped to confirm and 
clarify the emerging data, allowing the researcher to probe for specific experiences 
from each participant. As the process continues new ideas and understanding of the 
phenomenon will emerge.  
The emergent nature of interviewing as a tool fits well into GTM. In-depth interviews 
also fit with the other modes of data generation like observation and document 
analysis. Charmaz (2006) discusses how interviews fit with GTM, she says: 
“Interviewing is a flexible, emergent technique, ideas and issues emerge 
during the interview and the interviewers can immediately pursue these 
leads” (Charmaz 2006, p.29). 
She believes that the combination of control and flexibility that is characteristic with 
in-depth interviews are a good fit with GTM. The analytical processes involved in 
GTM prevent any preconceived ideas from entering the analysis. This is done 
through the different stages of coding and sampling of the data and allows for an… 
“analytical incisiveness of the resultant analysis” (Charmaz, 2006, p.29). 
The interview was structured in three parts. The first part consisted of questions that 
helped to break the ice and to ease the participant into the interview. The second 
was a cluster of questions that were related to function and operations and the final 
batch of questions were centred around their thoughts and insights on the 
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phenomenon under investigation. The researcher always ended by asking the 
participant if there was anything further they wanted to add and if not the digital 
recorder was switched off and the participants were assured that the details would 
be anonymised. They usually offered to help with any follow-up questions that the 
researcher may have post interview. 
4.6.2.2 Document Analysis 
In this research it was clear that data would not just be collected from a single 
source. The main tool for data collection was in-depth interviews as described 
above, however, throughout the research other methods were used, including 
observational data, (from events, meetings and conferences attended) and 
secondary data from written material pertaining to the research area. The data from 
the analysis of documents is used to verify and amplify evidence of data gathered 
from other sources (Yin 2003). 
The researcher used a range of secondary data from a variety of sources including: 
websites, journals, and reports that were available on the different LSI case 
comparators; all of the information was available in the public domain. This is in line 
with Glaser’s (1978) assumption that “all is data”. This rich source of data was 
collected and includes the memos that were taken throughout the research process, 
which can then be triangulated with other data during the analysis phase of the 
research.  
4.6.2.3 Observation 
There are two ways that observations can be included within the research: 
non-participant and participant observation (Hussey and Hussey 1997). The 
researcher used non-participant observation to gather data. The idea was to observe 
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in a covert way in order to capture behaviours and actions without influencing either. 
The researcher catalogued what was observed through memo-writing.  
Observations made during the interview process were noted on memos. In addition 
the interviews were recorded with the participant’s consent. At the transcription 
stage, memos were created after carefully listening to each recording, which allowed 
the researcher to position the conversation and thereby pick up any ideas or 
concepts not originally captured. This meant that important observations were 
transcribed into memos by the researcher. This in-turned allowed the researcher to 
capture important facts relevant to the research. 
4.6.2.4 Field notes  
All of the tools used for data collection used (interviews, document analysis and 
observation) required field notes or what within GTM is known as memo-writing. 
Memo-writing is a vital part of the GTM process. In GTM memo-writing will start 
when the research begins, and according to Birks and Mills (2011) is basically an 
audit trail. These memos are used to collect information on the actual research 
surrounding the research, capturing the thoughts and ideas that the researcher had 
during the process. In addition the researcher can make notes on their interpretation 
of what is being said or observed. They can also note any interesting environmental 
or political activity at the time the memo was made. It is also used later in 
determining coding. Memo-writing is also part of the data analysis in GTM and is 
discussed in more detail later in this chapter. 
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 Working with the Biotechnology and Biosciences Research Council 
(BBSRC) 
At the point where the data collection had just started the researcher was offered a 
secondment at the BBSRC to work on their innovation campus strategy that feeds 
into UK policy development. After discussions on the opportunity they offered, it 
seemed sensible to take up the offer as the work would be directly related to the 
research study area and the benefit and exposure that the role would afford seemed 
to present a great opportunity for this PhD research study. Instead of a secondment 
the researcher was given a one year part-time employment contract.  
 The Outcome of Working with the BBSRC  
As the researcher was using a grounded theory methodology for the research, she 
was able to collect observable data (from visits and conferences) and documentary 
evidence that benefited the research. In addition, the BBSRC was very supportive of 
the interviews that had already been arranged and provided some excellent contacts 
for interviews with additional participants. The work the researcher carried out for the 
BBSRC included a review of its documents on research and innovation campuses 
across the UK. This was considered to be an exerciser in document analysis with the 
intention of providing a gap analysis.  
The many events, conferences and workshops attended provided a great opportunity 
for observation and for memo-writing, ideas thoughts and suggestions that could 
benefit the theory development aspects of this research. The BBSRC itself is an LSI 
and although the researcher was unable to get any interviews from the BBSRC, she 
was able to observe and experience real life in an LSI. The whole experience 
provided access to rich data that has been invaluable to helping to answer the 
research questions and in developing novel theory. The support of an organisation 
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such as the BBSRC was very encouraging for the researcher. A list of all the 
activities, which includes the events, workshops and conferences attended can be 
found in Table 8 below. 
Table 8: Events and Meetings Supported by the BBSRC for the duration of 1 year. 
Date Activity Outcome 
February   Attended Scottish Enterprise 
Life Science Awards Dinner 
(5.2.14) 
 Attended Auril meeting on 
intermediaries in Edinburgh 
(20.2.14) 
Networking 
opportunity – 
Spoke to CEO 
from Cell 
Therapies 
Catapult (agreed 
to take part in 
study) 
March  Edinburgh BioQuarter Seminar 
with J&J (17.3.14) 
 Research seminars from Jason 
Whalleu and Core Values from 
the Wood Group (19.3.14) 
 Research and Innovation 
funding, commercialisation and 
infrastructure in the UK 
conference, Westminster, 
London (27.3.14) 
Made contact with 
J&J regarding my 
research 
 
 
 
May  Presented a talk to the 
BBSRC on my research 
(7.5.14) 
 Attended the 
BioDundee Conference 
(20/21.5.14) 
Attended by KEC 
team at BBSRC 
 
 
 
June  Meeting with business 
associate life sciences 
 Innovation Conference, 
Camden, London 
(10.6.14) 
 Harwell Campus visit 
(17.6.14) 
 
 
Met Prof J. 
Howells and A. 
Weatherley 
Talk from catapult 
centre and tour of 
Diamond centre. 
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Met key STFC 
people. 
introduction made  
to Gordon Duncan 
at Harwell (4.5.14) 
 
July   Meeting at Dept of Business 
Innovation and Skills 
(Victoria, London) (4.7.14) 
 BBSRC Shared Value 
workshop (8.7.14) 
 UKSPA conference 
Birmingham (10/11 July) 
 Glasgow event on life 
sciences (22.7.14) 
Report on UK 
Life science 
Cluster Network 
Organisations  
 
Met CEO of 
UKSPA David 
Hardman 
 
 
August   Meeting with SE Julia Brown 
(4.8.14) 
 Kate Rowley - Nexxus 
(6.7.14) 
 Marilyn Robertson –Stem 
Cell Network (8.8.14) 
 Edinburgh BioQuarter –
(20.8.14) 
 
 
Interviewed for 
study 
Interviewed for 
study 
Interviewed for 
study 
 
September  BioDundee interview 
(11.9.14) 
 Meeting with SFC (12.9.14) 
 Head of Entrepreneurship at 
UoD Alastair McGill (15.8.14) 
 Rothamsted (22.9.14) 
 
 Cell Therapies Catapult 
(24.9.14) 
Interviewed for 
study 
 
 
 
Interviewed for 
study 
Interviewed for 
study 
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 Organised a talk at the 
BBSRC by the Sir Francis 
Crick Institute (25.9.14) 
 Queen Margaret University 
Innovation Hub visit (29.9.14) 
Introduced 
Speaker 
 
Interviewed for 
study 
October  Meeting Deputy CEO of 
BBSRC Steve Visccher 
(1.10.14) 
 
 
 
 Attend BBSRC meeting in St 
Andrews University 
 Pentalnds Science Park 
(7.10.14) 
 BioCity (17.10.14) 
 BioDesign Workshop 
(18.10.14) 
 Dundee Technopole 
Incubator (23.10.14) 
 Glasgow University event on 
Scottish Innovation Centres 
(27.10.14) 
 Roslin BioCentre campus 
(28.10.14) 
 One Nucleus CNO 
28.10.14) 
Assigned project 
to look at how 
BBSRC can 
help the 
campuses with 
International 
activities. 
Invitation to visit 
their Innovation 
Hub 
Interviewed for 
study 
Interviewed for 
study 
 
Interviewed for 
study 
 
 
 
Interviewed for 
study 
Interviewed for 
study 
November  Innovate UK 
conference London 
(5.11.14) 
Attended 
workshops on 
intermediaries.  
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 Queen Mary 
Innovation Centre, 
London (7.11.14) 
 Senior member from 
SE (11.11.14) 
 Royal Society of 
Chemistry seminar 
(12.11.14) 
 University of Dundee 
Incubator (13.11.14) 
 BBSRC International 
Brainstorm event 
(14.11.14) 
 University of Dundee 
TTO (18.11.14) 
 University of 
Edinburgh TTO 
(27.11.14) 
Interviewed for 
study 
 
 
Invited to James 
Hutton 
Innovation hub 
discussions 
Interviewed for 
study 
 
 
 
Interviewed for 
study 
Interviewed for 
study 
 
December  Entrepreneurship 
Manager UoD 
(3.12.14) 
 MBM on 
Entrepreneurship 
(3.12.14) 
 James Hutton 
Innovation Hub 
Meeting (8.12.14) 
 
 
The use of secondary data within this research has been extensive and together with 
the primary data, allows for the reconstruction of the data into theory at the analysis 
stage. Table 8 on the events and activities that took place during the 1 year 
employment with the BBSRC outlines all the events that were made available to the 
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researcher, however, the BBSRC also made available many reports, journals and 
internal documents relevant to the substantive area of the study.  Although the 
details of these reports could not be set out explicitly within this study due to 
confidentiality, the researcher was able to inform this study through document and 
content analysis, and through other secondary data translated into memos and field 
notes, which played an important function in the analysis and subsequent re-
construction of data into theory. 
The data was collected from individual interviews and then observations, document 
analysis and conversations were gathered from the time spent at the BBSRC. The 
conference in the USA was an interactive conference where a range of questions 
(see Chapter 5, (section 5.9.5)) were presented to the audience and then the data 
was captured. These questions related to a range of different LSIs. The conference 
is the largest gathering of life science delegates in the world, although the majority of 
the audience was from the USA. Unfortunately due to a technical fault outside the 
researcher’s control, the data that was hoped for was not captured as originally 
envisioned. The researcher had to capture this data as observational data rather 
than primary data from the participants in the audience. The details of this attempt at 
collecting data has been included within this thesis as it would have been an 
innovative means of collecting this data. The questions were carefully crafted to 
generate results pertaining to answering the research questions and to help build 
new theory.  
 
 
142 | P a g e  
 
 Site and Participant Selection 
 
The next section will discuss the decision process for placing intermediaries into the 
5 Case LSIs. Most of the participants already had a professional rapport with the 
researcher, which made the case selection process easier and some of the 
participants were recommendations via the BBSRC or other sources. 
The sites chosen were based on the specific case which are all different by nature. A 
list was made of LSIs the researcher could access easily and which she might have 
known professionally or had been associated with her in the sector. Each LSI was 
bounded by a specific requisite: each had to be an organisation with a physical 
building whose main function was that of a “bridging organisation”, they could be 
private or publicly funded or both, and they had to work specifically in the life 
sciences sector. These selection factors were developed after the researcher had 
reviewed the literature. It is important to identify the unit for selection prior at the data 
collection stage (Patton 1987). There had been a number of researchers working on 
different innovation intermediaries, however, none were specifically working in the 
life sciences sector and none were comparing different intermediaries within the LS 
sector. 
Once most of the participant LSIs were recruited, the researcher then had to decide 
how they could be compared. On exploring the role and function of each of the 
individual LSIs the researcher was able to place into batches the 22 different LSIs. 
These batches evolved into the Case LSIs. The researcher had created 5 different 
Case LSI comparator models, and each of the 30 participants from the 22 different 
LSIs were placed in one of these Case LSI models. These boundary cases would 
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allow for comparisons between them; an important feature of the study. The 5 
different Case LSIs, the multiple case comparators, and each of the LSIs fit within 
one these 5 Cases LSI models. Tables 9 to 14 are the 5 different Case LSI models 
and these have been determined based on the role and function of each individual 
LSI. This differentiator places each LSI into the different case models. 
The sample selection was carefully reviewed once the list of individual LSIs was 
determined. The researcher then made her selection based on the results she hoped 
to see from each Case LSI model and where they might help with answering the 4 
RQs. A comparison between publicly funded and privately funded LSIs would, it was 
hoped, provide insights into how well each model operated against each other. 
Location was another factor that was considered espcially to be able to evaluate the 
importance of locating an LSI in close proximity to an anchor organisation. These 
variables would ensure a good comparison was made and was important to the 
choices made on recruitment of participant LSIs. A  number of lists were made and 
reviewed before the process started. 
Having worked in the LS sector for 15 years the researcher was able to place the 
individual LSIs in to the 5 different Case LSI models quite easily. In addition to this 
the researcher was able to gain a better understanding of the individual LSI from 
researching their organisation’s websites. Creating a bounded Case LSI model, 
helped to ensure that the study did not have too many LSIs recruited. On review, and 
in discussion with the supervisory group, it was clear that a good mix of LSIs had 
been recruited which would generate interesting and good comparative data. As 
previously discussed under the Triple Helix, every one of the 22 different LSIs who 
participated in this study were located at the intersection of the 3 sector helices in the 
‘hybrid’ organisation space. See figure 5 the Triple Helix Model. 
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This next section provides an overview of the organisations where primary data was 
collected. 
Table 9: A break-down of the case comparators  
Case 
Comparator 
Science 
Parks and 
Incubators 
Technology 
Transfer 
Offices 
(TTOs) 
Sector 
Specific 
Thematic 
Intermediaries 
Cluster 
Network 
Organisations 
Research 
Institutes 
UK 6 3 4 3 1 
France 0 0 0 1 1 
Holland 1 1 1 0 0 
Total 7 4 5 4 2 
 
Table 9 above shows the numbers of organisations from which data was collected. 
The tables below are LSIs that participated in this research. They are sorted into one 
of the five different cases and put into the correct case comparator. 
 
 
Table 10: Case 1: Science parks and incubators 
Science Parks and Incubators 
BioCity Nottingham 
Stevenage Bioscience Catalyst 
Dundee Technopole 
Leiden Science Park, Holland 
Pentlands Science Park 
Queen Mary Innovation Centre, 
London 
Roslin BioCentre 
 
Table 11: Case 2: The Cluster network Organisations 
Cluster Network Intermediary 
One Nucleus 
BioDundee 
Lyon Biopole 
Nexxus 
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Table 12: Case 3: Research Institutes and Innovation Centres 
Research Institutes and Innovation 
Centres (RICs) 
BioAster -France 
Rothamsted Research (Agri) 
 
Table 13: Case 4: Sector Specific thematic intermediaries 
 
 
Table 14: Case 5: Technology Transfer Offices (TTOs) 
Technology Transfer Offices 
University of Dundee 
University of St Andrews 
University of Edinburgh 
University of Leiden 
 
 A total of 22 participating organisations (n=22) took part (see Figure 9, which 
provides a summary of the case organisations taking part). Besides Edinburgh 
BioQuarter who allowed for 4 individuals to be interviewed there was generally only 1 
interviewee from each of the 22 participating LSIs. The number of interviews that 
were completed was 30.  Originally 36 email letters requesting uptake to the study 
were sent out. The 61% participation rate achieved was encouraging, and there was 
concern that there would be too many wanting to take part. Some of those 
organisations who had signed up and later changed their minds stated that time and 
workload had been the issue for their withdrawal. 
Sector Specific Thematic 
Intermediaries 
Stem Cell Network 
Medicine Initiative  Leiden, Holland 
Edinburgh BioQuarter-Medicine 
Cell Therapies Catapult 
Knowledge Transfer Network 
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Figure 9: Summary of the Case LSIs organisations who took park  
 
 
A visual for the total number of case organisations (22)  
Source: This research 
  
Case 5 – Technology 
Transfer Offices  
(n=4) 
Case 1- Science parks 
and incubators (n=7) 
Case 3 –Research 
Institutes and 
innovation centres 
(n=2) 
Case 2 Cluster 
network organisations 
(n=5) 
Case 4 – Sector 
specific intermediaries       
 (n=7) 
 
UK+ France + Holland = 22 
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Each of the thirty-six participants were contacted initially by email to discuss the 
research aims and objectives. Once agreement to participate had been received a 
copy of the interview questions was sent to them as a guide to the questions that 
would be asked of them. They were also informed that they would have to sign two 
copies of a consent form (see Appendix 1 for a template that was signed by each 
participant) and that the interviews would be digitally recorded. Dates and times were 
arranged for face to face interviews at the premises of the participant. At the 
interviews the researcher went over the consent form with the participant and 
explained that the data obtained would be confidential and it would be anonymised, 
they were also informed that they could stop the interview at any time if they wished. 
A number of participants wanted to only do the interviews over the telephone, this 
was usually due to time issues.  
The information provided helped to inform the participants at the invitation stage, this 
approach produced a healthy cohort of participants, all at the leadership level, and 
allowed them to feel that they could trust the researcher, which was an important 
part of the success of the recruitment process. 
4.7 Data Analysis 
 Grounded Theory Coding Procedures 
 “Coding gives you tools for interrogating, sorting and synthesizing hundreds of 
pages of interviews, field notes, documents and other texts” (Charmaz 2014, 
p.113) 
Through coding you define what is going on with the data and then eventually the 
meaning will crystallise (Charmaz, 2014). Coding is pivotal between collecting data 
and generating new theory: put simply, the developing theory helps to explain the 
data. 
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Coding within ConGT consist of two main phases, these are: (1) initial coding, and 
(2) a focused selective coding (Charmaz 2006). The next section will explain these 
two main areas of coding used within ConGT. 
 Initial Coding 
The initial coding involves a close scrutiny of the data, this involves naming each 
line, segment or word found in the data collected. This ‘line by line’ coding, as it is 
sometimes referred to, brings the researcher closer to the data. This initial stage of 
the coding process has an element of data mining, in that certain areas are identified 
to pursue for further analysis or new data to be collected. 
This form of coding involved reviewing each of the interview transcripts, to identify 
possible codes. These codes take the form of gerunds or words ending in ‘ing’ or 
action words. This helped review the role of the case LSI that was interviewed.  
This close scrutiny of each word on each line help to ensure that the data is derived 
from the participants and to eliminate any preconceived views that the researcher 
may have (Charmaz 2006) 
 Focused Coding & Categorising 
The focused coding is a streamlining phase, where further investigation is made into 
data that has been identified as significant. This essentially means that the most 
frequently used initial codes are used. The ongoing constant comparative method 
allows for some of the early initial codes to be subsumed by more relevant focused 
codes. 
Some of the initial codes once analysed can also become elevated to a category. A 
category is a theme or variable that allows us to make sense of what the data is 
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saying. Categories help by clarifying ideas, actions or processes within the data. 
Charmaz (2011) describes categorizing as  
“the analytical step in GT of selecting certain codes as having overriding 
significance” (Charmaz 2011, p.341). 
 
More will be discussed on this level of coding within the next chapter as many of the 
significant categories are likely to be the basis for the theories derived. 
 Constant comparative Method 
Constant comparative method has been mentioned previously within this chapter. An 
understanding of the method may have already been gleaned from this previous 
information. It is however important to help present and define the fundamentals of 
the process involved and help the reader understand where this process will lead. 
The constant comparative method is used from the onset of a research study, and 
the outcome is that it will enable the researcher to generate new theory. This is done 
by comparing data with data, code with code, category with category and category 
with a concept (Charmaz 2011). Using this method enables the focused coding part 
as well as the categorizing stage of the analysis process to all for theory to emerge,  
This element of the process is important as the research will be comparing each of 
the case comparators with each other as the research forms a comparative analysis 
study. Comparing each case comparator in order to assess the value will be part of 
the analysis stage of this thesis. 
 Memo-writing 
We previously discussed field notes which we call memos in GTM. They are 
however more than just notes; they are a way to capture our informal analytical 
thoughts and ideas as they are formed. 
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There is no prescription on how many memos there should be or even the format 
they are written in. These aspects of memo-writing are all determined by the 
researcher (Kenealy 2012). Kenealy suggests that researchers should write up field 
notes after each interview is completed. In this research, some notes were taken 
during the interview, but most were hand written post-interview and then 
incorporated as a comment during the transcription phase. Within the text these 
comments are highlighted and titled “memo”. The transcription of the interviews 
involved listening to the recording of the interview and then transcribing word for 
word. Listening to the interviews again, helped to bring to mind the thoughts and 
ideas the researcher had during the interview process. It also allowed the researcher 
to pick up any curios said or intonations or emphasis made at the time and write a 
memo. These memos will aid the analysis process and allow the researcher to 
understand the meaning of a statement, an intonation or even a word. Many of the 
codes and categories that are used within the process are derived from analysing 
these interview memos. 
 
 Validity and Reliability 
With GTM the issue of validity and reliability is addressed by a number of techniques 
that are built-in to the methodology. One of the techniques is that of constant 
comparison of the data (as discussed earlier), this is where the researcher is 
constantly comparing and contrasting data that is emerging. This technique is 
believed to help towards removing any bias (Loonham 2014). 
 Another tool used for ensuring validity and reliability are the memos created 
throughout the research process. It is considered to be the most significant factor in 
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ensuring quality in GT (Charmaz 2006). These memos help to reduce the 
researcher’s bias and help in maintaining an audit trail by providing a record of 
events, and more importantly providing a record of the process for the reviewer.  
It is important to demonstrate rigour throughout the research process, ensuring that 
the research will stand up to the scrutiny of reviewers is an important factor. The 
main reasons that GTM is attractive to many researchers is because it follows 
procedural precision and takes into account the researchers own experience and the 
methodological congruence (Birks and Mills 2015).   
 Theoretical Sampling 
Theoretical sampling helps to guide where the researcher goes, whereas initial 
sampling helps determine cases, situations, and or settings before you enter the field 
(Charmaz 2011). In addition Charmaz (2011) says that one should not use 
theoretical sampling as in the traditional sense. Within qualitative research 
traditionally a:  
 Sample is used to address the initial research questions and 
 Sampling is carried out until no new data emerges 
In ConGTM the assumption is that theoretical sampling should allow for flexibility in 
the research process. This flexibility allows the researcher to change direction or add 
a participant, or even remove one. In addition observations from conferences, events 
and various meetings can also be used (Glaser 1978, Strauss and Corbin 1990). 
Memos made will include all the wider secondary data collected. Only when 
saturation is reached will the data collection cease. 
Memo-writing aids the process of theoretical sampling. Theoretical sampling aids the 
collection of data that elaborates and refines the emerging grounded theory. It 
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directs the researcher where to go based on the theoretical analysis. This is a pivotal 
strategy that helps to identify and develop the properties for your categories 
(Charmaz 2011). 
Theoretical sampling also involves the use of abductive reasoning by the researcher. 
This is when the researcher identifies something strange or confusing and where the 
researcher then invokes their imagination in order to make the inferential leap to 
consider all possibilities for the observed data. This analytical stage will require a 
return to the data for further examination and at this point it may require the 
collection of further data. 
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Figure 10:  The Theoretical Sampling Process 
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The theoretical process diagram shown in Figure 10 provides a visual of the process 
from the initial identification and selection of the participant LSIs from the literature, 
to the theoretical sampling - the more strategic identification of the LSIs for the study 
that will help to answer the RQs and for which a comparison between the Case LSI 
models can help generate relevant data. 
Memo-taking, as previously described, is central to GTM and it is used extensively to 
interpret ideas and observations throughout the research process. Haslam (2002) 
describes Memos as the ‘the building blocks’. Once saturation has been reached the 
use of constant comparative methods (which includes comparing data with data 
(including memos) will allow the categories to be identified. Once the categories 
have been identified, all the data is sorted. In the case of this study, post-it style 
notes were used as memos. This made it easier for theoretical sorting by identifying 
similarities, connections and concepts (Glaser 1978). 
Through this theoretical coding and analysis the data is once again re-constructed 
then checked against the theoretical memos to identify the emergent theory. 
4.8 Conclusion  
This chapter begun with a journey to understand better which methodological 
approach, along with the researcher’s philosophical assumptions, is linked to the 
research phenomenon itself. A qualitative study was decided upon and then based 
on ontological, epistemological and philosophical choices, a GTM was thought to be 
the best way forward, 
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At the start of the research the researcher had assumed that the Strauss and Corbin 
approach would best suit the research study, however on further reading and 
exploration of the literature on GTM, the constructivist approach was found to better 
suit the researcher’s philosophical beliefs. 
After the decision and justification for these choices were made, the discussion 
moved on to research methods. The next section was the research design and 
process section, this covered information on the research participants and how they 
were selected for the study. The section also covered discussions on the choice of 
research tools like, interviews, observations and document analysis The final part of 
the chapter covered data analysis. Here the different stages of coding were 
discussed as well as some of the strategies employed within GTM like the constant 
comparative method and theoretical sampling. 
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Chapter 5 Results and Analysis 
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5.1 Introduction 
This chapter discusses and analyses the results obtained from both interviews 
conducted and with senior managers from individual LSIs within the 5 Case model 
LSIs and observational data that has been analysed.  
In addition a description of the approach taken to coding and an explanation of how 
under the initial coding eight main categories and sub-categories were identified. An 
example of the initial coding has been included as appendix 9 in this thesis. 
Much of the discussion is centred on the five main categories that constitute the 
focused codes. Detailed analysis for each Case LSI model is outlined which includes 
interview data and memos presented within the analysis and discussion of the 
findings.   
The chapter will end with the observational data which is reviewed and analysed in 
relation to the main categories of the focused codes. 
It should be noted here that although the participants were happy for their LSIs to be 
included and disclosed in this PhD research study, their individual identities and 
those of any organisation that they may be have discussed as part of the interview 
have been redacted to protect these identities. 
Finally please note that the results do not correspond to the list of individual 
participants within each Case LSI.  
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5.2 Approaches to Coding 
Line by line Coding       Initial Coding    Focused Coding 
 Coding procedure:  
Each of the transcripts have been scrutinised using the line by line method. This 
highlighted the important aspects from the interviews, and has revealed the initial 
codes that the researcher has used. Eight main categories have been developed 
and some have additional sub-categories, where the researcher deemed it 
necessary to sub-divide the main category (Charmaz 2014). As discussed in Chapter 
3, ConGTM is very much a procedural method, although it does allow for flexibility. 
This is because the methodology is still in flux and new refined additions are made 
continually. Therefore there is some procedural elements to ConGT, what it is not is 
a set process or prescribed method (Goulding 2002).  
 Deriving Initial Coding Results 
The categories identified came from a detailed analysis of the raw data. This 
involved careful line by line scrutiny.  Charmaz (2014) suggests the use of ‘gerunds’ 
or words that end in ‘ing’ (doing words) when choosing your initial categories. This is 
not as easy as it sounds when having to apply it to data with a basis in business 
management rather than nursing, psychology or research where the participants are 
talking freely about a personal experience. The researcher did where possible try to 
incorporate this suggestion.  
Another consideration was whether to use Axial Coding, which was recommended 
by Strauss and Corbin (1997), as they believe that this type of coding helps to relate 
the categories to the sub-categories, by asking how they are related. After some 
researching and considerations, it was decided that Axial Coding was not necessary 
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in order to explain the relationship, the researcher felt that the relationship between 
the categories and the sub-categories were self-explanatory.  In fact, below is what 
Charmaz says about this decision: 
“Those who prefer simple, flexible guidelines – and can tolerate ambiguity 
– do not need to do axial coding. Instead they can follow the leads that 
they define in their empirical materials.” (Charmaz, 2014, p.148) 
 
Table 15: Initial Coding 
 Category Sub-category 
1 The life cycle of the 
project/funding 
 
Coming to an end 
Just starting 
2 Engaging stakeholders 
 
Engaging with academic stakeholders 
Engaging with Industry stakeholders 
3 The power of brands 
 
 
4 Being in a membership 
Organisation 
 
 
5 Measuring success 
 
 
6 The main barriers to success 
 
 
7 The Expectation Gap 
 
Customers 
Funders 
Government Bodies 
8 The KEC Activities 
 
 
 
Table 15 is divided into eight categories and the sub-categories that constitutes the 
initial coding. 
Once the categories and sub-categories were identified the researcher proceeded 
with comparing data with data for each of the Case LSIs of which there are five 
different Case LSI models. 
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 Deriving Focused and Theoretical Codes  
Moving forward in the analytical process from the initial codes and the sub-
categories, which were more descriptive in nature, to the next stage of the ConGT 
method is to identify the more ‘focused’ codes. These codes are derived from a more 
analytical perspective; the researcher is removed from the close scrutiny of the line 
by line data (Charmaz 2014). The focused codes can be more conceptual in nature 
and not resemble the codes that have gone before. According to Charmaz (2014) 
you gain greater theoretical sensitivity as you delve deeper asking more pertinent 
questions of the initial codes. 
The focused coding analysis follows the suggested criteria by Charmaz (2014) in 
identifying these codes. 
 What do you find when you compare your initial codes with data? 
 In which ways might your initial codes reveal patterns? 
 Which of these codes best account for the data? 
 Have you raised theses codes to focused codes? 
 What do your comparisons between codes indicate? 
 Do your focused codes reveal gaps in the data? 
(Charmaz 2014, p.140) 
Table 16: Focused Codes  
Focused Codes 
Bridging the divide between academia and industry 
Recognising the power behind the brand 
Understanding the factors for success 
Understanding the expectations of stakeholders 
Assessing how realistic commercialisation targets are 
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Table 16 is the list of the five focused codes that have been used throughout this 
PhD study. Some of these codes are derived from an amalgamation of more than 
one initial code or have been inspired by the initial codes. 
5.3 Results, Analysis and Discussion from Case 1 LSIs  
 Case 1: Science Parks and Incubators 
These include the following: 
 Stevenage Bioscience Catalyst is an incubator that is based on the grounds of 
the Pharmaceutical Company GSK and was initially funded by the Wellcome 
Trust, GSK and East of England Development Agency (EEDA).  
 Roslin BioCentre is an incubator that was created with the help of Scottish 
Enterprise, the University of Edinburgh and the BBSRC. The BBSRC and the 
University have commissioned a new incubator to be built that will be 
positioned near to the Research Institute. The new incubator will open in 
2017. 
 Queen Mary Innovation Centre is a level 3 bio-incubator with tenants within 
who are at the level 3 stage of incubation which means they have more than 5 
employees, already have had £1-2 million worth of investment, have solid IP 
and are now ready to move into science parks. 
 Pentlands Science Park is a life sciences park based in Edinburgh. Moredun 
research institute, a world-class animal health research institute, is based in 
the centre of the activities on the park. 
 Leiden Science Park is a biotechnology science park and has been in 
operation for more than 30 years. The city of Leiden is a fifteen minute train 
ride outside of Amsterdam. 
 Dundee Technopole is the incubator for the University of Dundee with a main 
focus on life sciences. 
 BioCity, a self-funded life science/biotechnology incubator that has separate 
sites in Nottingham, Scotland and Chester 
 
 Introduction 
The analysis of the data demonstrated that the Case 1 LSIs have a range of different 
abilities when it comes to their function and role as knowledge brokers and 
facilitators of KEC. All of the LSIs in this model, house a range of LS companies of 
varying size.  
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 Bridging the divide between industry and academia 
The incubators have very young fledgling companies with only 1 or 2 employees 
when they first move in. Many had been incubated within universities first before 
going into the incubators. 
1d: It is absolutely positive we are linked to the TTO and so we get access to 
what’s coming through from the academic community. 
1d has a more traditional incubator model which is focused on spin-outs coming from 
the university that the incubator is attached to; the university here is the anchor. In 
the case of 1a the incubator is not linked to a specific university and this does have a 
downside to it, as the incubator management is not always aware of potentially new 
spin-outs. 
1a:  We tend to interact with a whole raft at different levels, so from the Tech 
Transfer Office, so we don’t always see what’s coming out  
1a does however believe that more engagement with the universities will not just 
help them to fill their incubator, it will also help the young company to develop and 
grow and in so doing the university would be on track for achieving its 
commercialisation goals. 
1a: Whatever opportunity comes into 1a we could pick it up and develop 
it, so that’s quite valuable for the TTO to be able to tap into. Which helps 
them get their job done. Then we have the academic groups, these are 
the ones who are working with companies.  
MEMO – They feel they could work with the university to benefit the spin-
outs and the universities agenda in commercialisation 
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At the time of interview the researcher noted the different models of incubation from 
the different incubators visited. 1b is positioned very close to a global pharmaceutical 
company and have been marketing their incubator to the academic community 
across the UK as somewhere to come and develop innovations, with close proximity 
to a pharma company there could be more collaboration and funding for technology 
that the pharma company believe worthy of investment 
MEMO- Universities are taking space in 1b because they see the benefit 
of incubating near to a big pharma company. 
Some of the incubators especially 1a believe that there is no need to have a 
university as an anchor for the cluster, although they concede that the local 
university produces high quality graduates for the companies in their incubator. 
1b: if you look at the portfolio that we’ve got, there isn’t anything like the 
portfolio that we’ve already created in 18 months which includes having 2 
universities ... so we have Xxxxxxx in and they have the labs opposite 
they have 2 projects one in MS and the other in pain therapies’. Xxxxxxx 
are going to take 3 labs on the top floor and they are doing spin-outs so 
very different models for different universities, Xxxxxxx are doing pre-
company projects and we love that, because the University takes the 
lease and then they will take in and take out projects as they see fit to 
accelerate. 
 
Then 1c says they chose to have a pharma company as their anchor rather than a 
university or research institute. 
1c: The bridging is very short. The bridge between the pharma company 
and the SME is deliberately short. 
MEMO- It takes a company who does not mind ‘interference’ from 
Xxxxxxx to happily locate there.  
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 Recognising the power behind the brand 
This focus code also appeared as an initial code in its own right, although other initial 
codes also impact on this focused code too, including: Being in a membership 
organisation, measuring success and engaging stakeholders. 
Nearly all the incubators and science parks interviewed have either their own brand 
that they can capitalise on or have anchor organisation located near to them. They 
all have a strategy that uses brand spill overs. 1b is located on the grounds of big 
pharma and definitely uses the big pharma brand to attract new tenants. Their 
tenants have not just been SMEs but universities who want to utilise the incubator 
and accelerator facilities there. Collaboration with the big pharma company is also 
important and the technological infrastructure of the Pharma Company can help 
progress products along the developmental pipeline.  
Memo-They use the labs based within the incubator as a testing ground 
for commercialisation.   
Likewise 1h can use the world famous Xxxxxxx brand, made famous from the 
creation of Xxxxxxx and is synonymous with the Xxxxxxx brand. The interviewee 
from 1h explained that the brand had been discussed by the funders recently and the 
thinking was that it should change. He explained that it seemed to make no sense to 
him to throw away such a valuable brand and fought to keep it.  
1f is a well-established science park that has the world renowned Xxxxxxx Research 
Institute on site. The Xxxxxxx brand brings in tenants who want to work with 
researchers in the animal research field to locate within the science park. 
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1d and 1g utilise the universities they are associated with. 1d in particular houses 
most of the university spin-outs from the life sciences because it can accommodate 
labs that small spin-outs from the university need. 
1d: It’s absolutely positive we are linked to the TTO and so we get access 
to what’s coming through from the academic community.  
Using the brand to benefit the aims of the incubator can be used to the advantage of 
the incubator, but not using the university brand can also help the incubator to 
achieve its business objectives. They have the ability to choose how they want to be 
associated with the university. 
1d: Because we’re not the same as a TTO to internals and externals that’s 
lost so we can take on a different persona as required and which can build 
relationship, neutrality, separate identity the flexibility we can offer as an 
intermediary, the relationships  
 Understanding the factors for success 
This focused code is a combination of the initial codes about the life cycle of the LSI 
and the LSIs engagement with a range of stakeholders. 
1h in particular will be moving out of their current premises by 2018 and the 
companies located within this incubator will be expected to re-locate to new sites. 
This means that this incubator is in the process of winding down. One of the other 
incubators 1b which had only been in operation for 18 months at the time of the 
interview and 1g which was built at the onset of the recession in 2008 has been 
operational for six years at the time of the interview. They had their initial funding 
from their various stakeholders however, because of specific strategies’ for attracting 
new tenants they have been successful at leveraging their funding.  
1d, 1e and 1f have been around for a longer period. 1e was set up at the start of the 
Biotechnology revolution and has continued to grow. It is considered one of the more 
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successful LS focused sciences parks in Europe. They are not just anchored to the 
University Medical School and Hospital, but have big pharma within their science 
park too. This LSI has been in operation over 30 years now and continues to attract 
companies of all sizes to locate there. 
Most of the older LSIs when they were created would have been located near to a 
University or a hospital. The idea was that a cluster of companies would eventually 
spring up to tap into these research rich organisations. This has been the case for 
some of the Case1 LSIs. As discussed previously 1d, 1e, 1f, 1g and 1h are located 
with a university, a research institute, a hospital or a combination as their anchor. 
The question that has to be considered here is how successful has this strategy 
been for attracting and keeping companies within a cluster. 1a was established 
without an anchor as its focal point and 1b has a global pharmaceutical company as 
its anchor. 1a is clear that having an anchor is not necessary.  
1a:  Universities are useful and they are sources of skilled people , so we 
don’t need to be on the campus having a university nearby as they’re 
churning out skilled experience people, in Xxxxxxx we have the university 
that produces graduates, post-graduates  and those who have started 
companies. So I think that they’re a limited source of new business 
opportunities and people aren’t that bothered by interacting with 
universities…………. Universities usually have an internal perspective, 
focused on significant research that’s going on ……..  
1a: There are academics who are outward facing and who are doing 
things. One of the main issues with academics is that they are not 
responsive. People think it’s something else but it often takes 2 months to 
get a response to a question via email and they never return a phone call, 
which makes it difficult for collaborations, the ones that are responsive  we 
have good relationships with .  
 
1h also believes that the new focus on locating near to the research base will not be 
as successful as expected. 1h believes that the tenants don’t necessarily work with 
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the researchers and that despite being located nearby they have limited 
engagement.  
Researcher: The Innovation centre will be located next to the research 
institute. 
1h: That’s exactly it  the idea there is that it should have a commercial and 
academic approach, in my opinion the link with the commercial side is not 
going to work as when the commercial organisation sets up they are not 
going to look backwards,  
1h: The only thing is that SMEs tend to keep to themselves and it’s a bit of 
a challenge to get them to engage. 
MEMO-(Expectation Gap at work – if the idea is to have business entities 
working alongside academia, Xxxxxxx predicts that won’t happen) 
1b/c’s approach to their anchor is clearly beneficial to SMEs, they have really 
considered the needs of the tenants and what resources can help to grow these 
companies. 
1c: whole idea was to have a pharmaceutical company as an anchor 
tenant rather than a university because the senior people here know that 
Biotech companies don’t really know much about development and 
regulatory needs, that’s not their forte, they are so busy driving their 
technology early on and what we have here are people who live and 
breathe that stuff and can act as non-execs or in a non-exec type function 
and give advice to people and they can help bounce ideas and put some 
specifications on the outputs. The last thing we want is for all these 
companies to be dependent on Xxxxxxx, that’s definitely not what we 
want. 
1b: We do business support we do incubation. Incubation is not about 
physical infrastructure it’s all about mentoring, coaching, developing and 
either sign posting to funding or providing funding and incubators across 
the UK vary. Some have their own funds and some don’t. 
 
1a has a similar approach, but they do it without an anchor organisation. They are 
very focussed on providing the ingredients to help the fledgling company grow. Many 
of the tenants are spin-outs or start-ups whose founders are usually PhD scientists 
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without the knowhow and skills to build and grow companies. 1a provides 
management training, skills development, procurement and in finding suitable 
investors for the SMEs.  
1a: we provide the facilities and service that they need, so what we have 
is very efficient. 
This next section was written as a result of interviewing the LSI that was built and 
grown during the recent recession in 2008. 
The following memo was written at the time of the transcribing phase: 
MEMO- If there’s a will there’s a way! This incubator was built during the 
financial crash of 2008. The university has invested solely in this 
endeavour.  
1g: A huge contribution by 1 small university to build companies and grow 
jobs. By far the largest in Xxxxxxx. I came in 2009 and this building was 
built in the 2008 crash. The VCs have vanished. This is all financed 
through the Uni. 
The researcher interpreted this statement to mean if we have the right champions 
then we can make a success of our LSI despite the economic environment we have 
to work in. Having thought about what the ingredients to success means for all the 
LSIs this has been the biggest revelation. Individuals with energy and passion who 
craft and make their LSI a success virtually by a force of will, has to be one of the 
most important ingredients for success. 
 Understanding the Expectations of Stakeholders 
The initial code of The Expectation Gap was divided into the three main 
stakeholders, customers, funders and government bodies. For some of these Case 1 
LSIs the funders and government bodies were the same. For instance the funders 
maybe a government department like Innovate UK (formerly the Technology 
Strategy Board (TSB). 
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Each stakeholder has a different expectation from the LSI, for example the tenants in 
the incubators and science parks are attracted to a location not only because of the 
anchor tenant there, but also because of any potential customers, the facilities and 
services provided to them. 
1f: Aside from that we try to keep the park full and ensure that people pay 
their rent and also that there are support services on site, things like 
security, catering, waste disposal and IT support all these things. So all 
these services are provided for the Xxxxxxx group and for the tenants and 
some of the tenants can opt in to buy services but some services are 
mandatory others are paid for on a user basis, what this does is free up 
the tenants from having to worry about these types of services so they 
can focus on their core work. 
From the above insert from the interview transcript from 1h a whole range of services 
and facilities are provided and even these can be flexible for each specific tenant.  
At one incubator it was clear that some of the potential tenants, specifically those 
looking to make the transition from being incubated within universities and research 
institutes, balk at the cost of making the transition.  
1f: Sometimes but the challenge that we have with start-up and spin outs 
have been initially set up by the university and then been allowed to 
incubate in university labs and when you quote the price to them they run 
a mile because they’re just not used to it. 
This early incubation space is highly competitive and another LSI was explaining that 
sometimes aggressive marketing can mean that a tenant is housed despite the LSI 
not being suitable.  
1h: The councils are more concerned with the infrastructure and that we 
retain the tenant base here and I think we do that. Xxxxxxx frankly have 
no interest in us what so ever and that’s because their interest is geared 
to their own facilities, it doesn’t hurt us as such but.. 
1f: Things are quiet now. Everything is going to Xxxxxxx and not to us. A 
company was a veterinary company and didn’t come here! So that’s 
annoying as we’re trying to raise our profile and it’s like they are working 
against us.  
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MEMO- The incubator at Xxxxxxx Xxxxxxx was built by Xxxxxxx and they 
are aggressively marketing it and filling the incubator. Currently building a 
second one as the first one is full 
1f was clearly upset about losing a suitable tenant that would fit very well into their 
LSI and would benefit from the research going on in the Institute there. What they 
find interesting is that the competitor was an original funder of the 1f LSI.  
This insert was taken from a question asked about the barriers to success within the 
initial coding. This initial code helps us to understand the focused code of 
‘Understanding the Expectations of Stakeholders’. 
1f:  Money, Xxxxxxx are a hindrance they can be a derisive org. But 
saying that we had lots of support in the early days. So Xxxxxxx really 
isn’t as good as it could be. We do Ok with the Xxxxxxx Government they 
continue to value our input. 
The expectations from the perspective of the funders varies with each LSI within the 
Case 1 LSIs investigated. The funders from 1d are not doing it for the money; it’s 
more about the growth of companies and the economic value of the region. 
1d: We don’t do it for the money, but there is definitely income generation. 
The economic benefit is important, creating jobs and often the funders 
……………………. 
Whereas 1h’s funders are about ticking a box and about reputation objectives. Both 
funders of 1d and 1h want to see the LSI fully occupied but they have additional 
expectations from the LSI they fund. 
1h: Our other stakeholders are the Xxxxxxx and the Xxxxxxx are much 
more about reputational interested.  For the Xxxxxxx we’re a few steps 
removed from the academic research they’re much less concerned with 
that and more with the tech transfer aspect of it. For the Foundation their 
main concern is to realise value to the investment that they’ve put in over 
the years and also with their charity aims in the sector which again I think 
we tick that box.  
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The funders from 1a and 1b have a different expectation from their LSI.  
Researcher: So you do have plans to evolve the site, will you have a 
science park too? 
1a:  No we see companies growing there. What we found is that 
companies that like the environment for example we have companies with 
12/130 employees and they started out with 3 on our site, so we want to 
stay one step ahead and build that will enable them to stay with us, we will 
evolve in to keeping companies for longer, but our focus is on the next 
generation of businesses coming through. Some will fail and some fall by 
the way-side and then a proportion of them will grow. In Xxxxxxx that site 
will have 1000 people working on it and it was 450 people from Xxxxxxx 
working on it. So as Xxxxxxx was concerned that closure was a disaster 
and actually it’s one of the best things that could happen to it 
When 1b was asked about performance measures, it was clear that this included the 
normally seen metrics that show investments into the tenant companies and 
employee numbers within them.  However, there was some indication from the 
responses that careful triaging of tenants takes place, which is demonstrated in the 
response about filling the building with quality tenants. Therefore we can deduce that 
choosing the tenants for the site is linked to the funder’s expectations. In the case of 
1b one of the funders is a pharmaceutical company who will invest in SMEs with a 
high potential in the therapeutic areas linked to their own R&D interests. 
1b: That’s a good question. So most incubators across the UK, including 
ourselves have some element of public funds, so we have some metrics 
around job creation and sales by tenant companies or in this space into 
investment into companies. So there are already 20 million £ in Venture 
capital investment in this building today. There’s 2/3 million of Catalyst 
funding and there’s already 100 people within these site passes in this 
building today. The building will only hold 200 people. 
1b: I want more options at an early stage but I don’t want it to become an 
excuse for the flood gates to open there should always be that quality. I 
would get fired here if I fill the building with things that are considered to 
be not of quality and that they have a chance, and it’s only a chance as 
only 1 or 2/10 will make it all the way to the end game, so you just have to 
give yourself a better chance. 
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Expectation from the government bodies for many of the LSIs is tied into the funding. 
As 1b has said above 
1b: That’s a good question. So most incubators across the UK, including 
ourselves have some element of public funds…… 
This public funding normally comes directly from central Government or via one of 
the Government departments like Innovate UK. 
 Assessing how realistic commercialisation targets are 
In Chapter 3, we discussed the importance of knowledge exchange in the 
commercialisation process and the different types of knowledge exchange, Codified 
KE and Tacit KE. The funders of many LSIs believe that locating an incubator close 
to the research organisation like a university will enable this exchange to happen. 
The reality is probably something quite different. What we need to understand is that 
the culture within tenant companies are governed by business needs and not public 
sector organisation culture or needs which have different drivers. The funders may 
include the private sector, however, generally they consist of public sector 
organisations. For the most part the LSI manager usually has to manage these 
commercialisation expectations from its funders and governing bodies. 
1g: The idea of exchange of ideas around the water cooler is not true, our 
people here are highly secretive. So Late stage incubators are all about 
business processes, business continuity and usually infrastructure focus. 
Their clinical wastes needs to be stored or are their equipment being 
maintained. 
As 1g suggested in the exert above, the tenants of late stage incubators have a 
different set of requirements, for instance their products and services may be more 
developed than for those companies in the early stage incubators like in 1d. 1a has a 
range of young start-ups and spin-out companies as well as the older more 
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established company of 3 years and older. This mix will be helped by inspiring 
younger companies to emulate the older more established tenants. 
The KEC element can be broken down into two parts, the KE and C. Most of the 
LSIs in Case1 engage in KE activities, putting on events throughout the year to help 
educate and allow discussion to flourish and therefore facilitating tacit KE. 
1b: yes we do a lot of that, there are three to four major events that we do 
in a year .. so we have an Open Innovation summit, we had a summit on 
medical technologies and Sir William Castells chaired it and brought a 
panel of the good and the great. They talked about what convergence is 
all about and what the future looks like and that’s the kind of quality thing 
we want to do. Then our marketing manager is doing all the ‘how too’ 
events, which is something that every incubator does, supplemented by 
information around funding, portals so there’s also lots of things going on. 
1a: Yes that’s really important it’s part of the plan. We bring everyone 
together and we bring people in from outside. It’s about quality not bums 
on seats. 
From the commercialisation side many of the LSIs interviewed have put in place 
specific focussed people who deal with the commercialisation aspects.  
 1a: We get very involved in the commercialisation process, we help find 
funding and people. I would rather have 1 good company rather than 10  
1f: looking at ways to develop that field and to generate new revenue 
streams from that. So aside from the research institute the Xxxxxxx has 2 
commercial subsidies – Xxxxxxx which is a commercial company…. 
1f: So they’ve created a business enterprise team to exploit the work 
going forward and to do that we want to create a commercialising hub so 
we want people to come in and interact. So there will be an interface. 
 
Commercialisation has a different meaning to different LSIs and it will be interesting 
to see how this part of KEC is achieved by each of the Case LSIs when we come to 
comparing them all later in chapter 6. The next section will look at applying the 
Focussed Codes to Case 2 LSIs.  
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5.4 Results, Analysis and Discussion from Case 2 LSIs  
 Case 2: Life Science Specific Cluster Network Organisations  
These include the following: 
 One Nucleus covers the SE of England and was created in 2010 by the 
merging of the London Biotechnology Network and the Eastern Region 
Biotechnology Initiative (ERBI), centred in Cambridge. One Nucleus is a 
membership organisation, whereby members have to pay a fee depending on 
the size of their organisation to join. 
 
 Nexxus is a cluster network organisation that has now closed. It started in 
Glasgow and was based within the University of Glasgow. They had funding 
from Scottish Enterprise, European Regional Development Funds and the 
local council. They eventually expanded to include Edinburgh and were 
talking to BioDundee to join forces with them in order to cover the East Coast 
of Scotland. 
 
 LyonBiopole is a cluster networking organisation that straddles the region of 
Rhone-Alpes and encompasses the cities of Lyon and Grenoble. Their 
network like BioDundee is also referred to as an umbrella organisation and 
have 17 institutes and 168 life sciences SMEs. Within LyonBiopole there are 
four biopharmaceutical companies that contribute towards the funding. 
However, the main source of funding is from the regional and National 
Government.  
 
 BioDundee covers the Dundee region within Scotland and was the second UK 
cluster networking organisation to be created after ERBI. This organisation is 
free to join and has been funded by the European Regional Development 
Fund and Dundee City Council. They receive nominal amounts of funds from 
some of the members including the universities and institutes.  
 
 Introduction 
Case 2: Cluster Network Organisations.  
LSIs 2a and 2b have been around for more than 17 years, although 2a underwent a 
metamorphism in 2006 when it merged with the London Biotechnology Network to 
create a new branded entity. 
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2d is based in the Southern region of France and was only created in 2006, this LSI 
has been included here to help explore the Cluster Network Organisation model of 
LSIs within a different national innovation system (NIS) (but not dissimilar), although 
the main focus in this thesis is on the UK innovation systems. 
The Case 2 LSIs have different business models and different streams of funding. 2a 
is a membership funded organisation that before undergoing its metamorphosis was 
funded by the Regional Development Agency and European Regional Development 
Fund. 2b, 2d and 2e all receive public sector funding. 2d has in addition 4 different 
private sector companies who contribute funding to this LSI, although, the bulk of the 
funding comes from Central Government. These differences have a dramatic effect 
on the services and operational models of each of these LSIs. 
 Bridging the divide between industry and academia 
When it comes to the life cycle of these LSIs they have all changed. The brand for 2b 
has remained a constant over the years, however, changing political and economic 
impact has forced the 2b LSI to evolve. 
2b: We never stand still, it changes from year to year adapting to what the 
needs are, which is why we’re looking at widening out into the healthcare 
and beyond biotechnology… 
2b: That has changed slightly because in the area because we used to 
work much more closely with Xxxxxxx as they had a local focus, there 
was a lot more Bus Dev activity in terms like working with companies and 
that doesn’t happen anymore . The companies we work with are the ones 
we’ve met through the networking and have identified through networking. 
We are careful not to step on the toes of the account managers within 
Xxxxxxx, so there’s no point us getting in the middle of that. 
2b LSI had previously been funded by the local economic development agency, this 
is no longer the case. They invite all stakeholders to attend their steering group, 
including Xxxxxxx, however are unsure why they attend. 
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2b: We need to make sure they know what’s going on locally, like they 
attend the steering group, but we’re not clear what for. 
MEMO- engagement with industry appears to be non-existent now. It has 
very little involvement with companies, except through training and skills 
and networking opportunities. 
2b have little direct engagement with the companies except through KE events. 
Since losing their local economic development funding they have partnered with the 
University to apply jointly for ERDF. 
2b: We’ve tried to work with the academic agents and do it in a way that 
they’re happy with, so for eg with the University of X Xxxxxxx it is Xxxxxxx 
and they can act like gatekeepers, well that’s their role and that’s fine, 
they’re the ones who give us funding so we have to work around that. 
LSI 2b had originally started out working with all the universities under its umbrella 
and had over the years developed a very good rapport with not just the business 
community but also the academic community. However as the life cycle of the LSI 
has progressed so too has their ability to operate like they originally had. 
2b: One of the things that helped Xxxxxxx to move forward was that we 
had identified that we had these kind of superstar scientist, who were 
willing to back the idea of this life science community to just beyond the 
walls of the university.  
LSI 2e’s lifecycle ground to a halt in 2013 nearly a year before the interview was 
carried out. 2e and 2b business models were very similar in that they were both 
there to serve both the academic and business communities equally for 2a this was 
also the case up until 2010 when they took on their current business model. For the 
French LSI they have just turned 10 years and have many achievements under their 
belt. Their funding covers a range of business development staff as well as 
marketing executives all focused on the goal of growing their cluster. They have 4 
large biopharmaceutical companies located within their cluster who are fully engaged 
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with the LSI. The aims and objectives started out the same for all of these LSIs, with 
each evolving in a different way and one closing its doors. 
LSI 2e just like 2b had a good rapport with the academic community. They appealed 
to academics who wanted to get involved in more entrepreneurial things, but who 
normally couldn’t afford to attend. 
2e: We had an excellent relationship with the academic community, 
mostly because everything we did was free to attend and it’s incredibly 
difficult for academics to find the money unless it comes out their own 
pocket to attend something. 
2e: The typical spilt of people attending events was around 50:50 and we 
had a high profile amongst academics at that time 
In addition to appealing to the academic community 2e also found a niche with the 
smaller SMEs who were not account managed by the local economic development 
agency. Although these small SMEs were not account managed by the local 
economic development agency they did help to market these companies. The LSI 
often wrote the case studies used to market the SME, as they got to know these 
companies. 
 2e:  I would say especially for the business side that we were more 
focused on the SME than the large industry and this is more because of 
the types of things we used to do. For small companies important 
information on things like access to Clinical Trials, IP and funding 
mechanisms. 
2e: Xxxxxxx offices would be working with. They would be working with 
kind of driving at the top highegians working with large pharma, large 
corporations. That said a lot of the PR and marketing that they used to do 
was for smaller companies and individuals. 
MEMO- Xxxxxxx are looking to work with more established firms, which 
leaves a gap for the less established firms to get support from Xxxxxxx 
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 Recognising the Power behind the Brand 
Linked to the life cycle of these Case 2 LSIs is the changing brand for some the 
more mature LSIs. 
We have discussed a little that 2a changed its name and rebranded itself in 2010.  
2a: The name change has been fundamental to the company.  We gave 
the sector 2 months’ notice before merging the brands of Xxxxxxx network 
and Xxxxxxx. We wanted to get it known that we were changing the brand 
and refocusing. We had 2 board members who didn’t agree one from 
each network. 57% of our members thought it was time for a name 
change. 
This re-branding has been significant as the business model for 2a has also 
changed. It is now completely self-funded by re-creating itself as a membership 
organisation. They have a large number of companies who can join at different levels 
(bronze, silver and gold), this is linked to employee numbers.  
2b has had their brand for over 17 years although they no longer provide the same 
services for the LS community, which appears to be due to dramatic changes to their 
funding over the years. 2b is hosted by the City Council and they have managed to 
continue to justify the continued investment in 1 full time employee (FTE) for a 
business development officer to co-ordinate the LSI.  
2b: The brand is internationally recognised. People have heard of it. So 
we haven’t tinkered with it we haven’t ermm it’s still our brand and ask if 
it’s still relevant to the sector we ask ... because it is Xxxxxxx and because 
it geographically places us, that’s why we invest in it. Local initiatives are 
really important, because that’s where you get buy-in from politicians from 
the local community, we’re much closer to hand to understand the 
problems and have that sense of community. Although in Xxxxxxx it’s not 
hard to do that. So there is a Xxxxxxx community, but saying that 
underneath that there is a heart which is Xxxxxxx, I think….. 
The aims of 2b to market the brand internationally has resulted in higher than normal 
brand recognition for them. This early investment is now paying off and although the 
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funding has been reduced so has the cost of marketing. 17 years ago when the LSI 
was first launched e-marketing and social media did not exist, these forms of 
marketing cost nothing compared to producing quarterly newsletters to distribute 
nationally and internationally, which they did early in their life cycle. 
There have been many successful brands that due to a changing funding, economic 
and political landscape have been allowed to die. 2e is one of those brands. It was 
considered hugely successful while in operation and connected a large regional 
cluster of companies and academic organisations, bringing information and KE to all 
at no charge. In the Literature Review chapter we discussed the fact that many of 
these publicly funded LSI have a caveat built-in at the onset, that they must become 
self-financing after the period of funding is completed. 2e failed to secure funding to 
continue to operate and had to accept it had come to the end of the line. 
 Understanding the factors for success 
All of the Case 2 LSIs were originally created to facilitate KE to bridge the divide 
between industry and academia and to help grow their respective clusters. Over time 
however the older LSIs have either evolved into something new (2a) or provide a 
reduced service to the sector (2b). 2e as discussed previously did not survive 
beyond the time of their funding period. They had received funding from the local 
economic development agency and from the local council and a few of the 
universities within the cluster. They were never allowed to market themselves 
internationally and therefore had no bandwidth outside of Scotland. Was this a 
crucial missing ingredient?  
2e: We didn’t have much of a profile outside of Xxxxxxx. We did have 
traction with Xxxxxxx Xxxxxxx Xxxxxxx offices globally, so some of those 
offices used to receive the Xxxxxxx newsletter and they gave us feedback 
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and they thought it was really useful, but in terms of an international brand 
it wasn’t tremendously huge. 
Although 2e and 2b (from 2005) were not allowed to do international marketing, 
Xxxxxxx did some of this on their behalf. A question that has emerged is, was taking 
away the ability for these LSIs to market themselves international resulted in 2e’s 
demise and the loss of engagement with the SMEs within their cluster and therefore 
their perceived value to the business community? 
2a and 2d continue to market themselves, which effectively means that both 
businesses and academic organisations within these LSIs are being promoted 
internationally. 2a has signed specific memoranda of understanding with a number of 
international LSIs and economic development agencies, with the specific aim of 
raising the profile or all the organisations within its cluster and to facilitate smooth 
collaborations and business interactions. 2a has similar arrangement and in addition 
has membership of a number of European and other partner organisations. 
2a: On the International front we talked Xxxxxxx and worked out an 
agreement with them and now we attend Bio each year. We also have 
relationships Xxxxxxx Xxxxxxx Xxxxxxx, and others in Europe. This 
enhances our membership with companies from these international 
companies who are in turn members of these international cluster 
organisations. Just last week we had Xxxxxxx who were over to find out 
how we work and how we do things. Which means we are well known and 
respected. Other than those types of activities there’s loads of stuff going 
on.  
 
Within the Xxxxxxx a new Cluster Network Organisation has emerged, it is called 
Xxxxxxx, I was unable to organise an interview with the LSI at the time of the data 
collection interviews. 2a who is a business partner of Xxxxxxx discussed the 
following: 
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2a: Xxxxxxx was created from a development agency. They have 500 
plus members between them. They were asking how they go from a 
regional non-paying organisation to a membership one, charging a 
membership fee. We discussed what the added value would be and said 
that they could be part of our purchasing consortium. Xxxxxxx emerged 
about 18 months ago but they don’t have an international focus. 
It will be very interesting to see if the fact they don’t have an international focus will 
impact on their membership and their alliance with 2a. 2a was clear that their 
members could determine the kind of services they required and they believed this is 
where their value lay.  
2a: Members have to decide if they can justify the spend on membership 
therefore; membership is a good measure of our value. 
When asked if they had considered becoming a similar organisation to 2a in order to 
prevent themselves from closing down, 2e had this to say: 
2e: We enjoyed a respected position in the community and that was 
because we didn’t have a subscription model. I think when you have a 
subscription model you get too much buy in from people who are paying 
for the subscription. The universities will never contribute as much as 
SMEs collectively and therefore you’ll be constantly be working for the 
customers who are paying for it. Doing what they want as that’s what they 
are paying for 
MEMO – barriers to why they didn’t go down the subscription path 
An important factor to SMEs working in the life sciences sector are international 
markets. For many companies their greatest markets are overseas. This would 
eventually have ramifications for any LSI who is not working internationally or who do 
not have partners who deliver this service on their behalf. 
The UK Government has put a huge emphasis on helping our companies to reach 
overseas markets and with the Brexit vote in 2016 and the strength of the pound 
being reduced, exports have been seen to have increased. This will have positive 
consequences for the LS sector overall. 
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 Understanding the expectations of stakeholders 
The LSIs that were locally funded by the local government and universities it meant 
there was an expectation that they would operate exclusively in that local region. 
This is an alien way of thinking and working with many of the scientists and business 
professionals working within the LS sector. LS reaches beyond borders. The 
experience of the interviewee of 2e reflected this phenomenon. 
2e: Working locally in Scotland seemed bizarre to me, prior to XxxxxxxI 
was connected to people in Xxxxxxx at Xxxxxxx and the EU bio networks 
and it never dawn on me that I would have to only work in Scotland. 
However, the interviewee from 2b who is not a scientist and where the LSI is funded 
from the local council, believes that staying local has been key to their longevity. This 
parochialism has not always presented them in the best light with the business 
community across the region. 
2b: Some of the industry players on these boards don’t like 2b Xxxxxxx 
This is because we’re not seen as team Xxxxxxx, but we have been 
successful at promoting ourselves, but we are absolutely team Xxxxxxx 
and that’s always been the misunderstanding.  
When asked to join a more countrywide approach to LSIs in Xxxxxxx they were 
pushed to consider what the benefit would be to the local region. The expectations 
from the local stakeholders in 2b had to be considered first. 
2b. So why would we put 20K into something that wasn’t promoting 
Xxxxxxx.  
So from the customer’s perspective for the Case 2 LSIs the expectations should be 
looked at from the perspective of academia and then business. 
Both 2b and 2e were expected to identify research worth promoting from the 
academic community. This is also the case for the French LSI they would market the 
research being done in their LSI, however, 2a as noted previously had very little 
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interaction with the academic community once the merger had taken place and the 
new self-financed model had emerged. 
2e: The expectations from academia were that we would have the 
quarterly meetings with them and provided them with updates, they 
wanted to see their work getting the PR and the academics getting the 
exposure. We very much would take from them what they made available 
to us , so none of them could really say none of this ...a few times they 
would say “this is not fair, this university is getting way more exposure 
than we are” and our counter argument would be ‘then give us some more 
stuff’.  
The expectations from the business community varied between 2b and 2e. 2e said 
there was an expectation from the SMEs that they would get a case study written 
about them and then 2e would promote them 
2e: The business perspective, we did the same sort of thing. So we did 
case studies for them, we did PR for them and introductions and the 
international awareness raising that we did. 
2b worked with their funding partners including the universities, specifically their 
Research and Innovation Services to assist with any commercialisation 
requirements. 
2b: It’s all about growing into something bigger, but underneath that its 
identifying what’s needed for that, so that can be support in infrastructure 
it can be lab space, so that’s where we would come in. So that’s why we 
work with Xxxxxxx to help them achieve their commercialisation goals. 
The 2b LSI sits within the local council who are the main funder and therefore this 
LSI has an expectation that will impact on economic development within their region. 
2b: For the funders it’s about their expectations for jobs and growth. 
All of the Case 2 LSIs including the French one have an expectation from the 
Government to help grow companies.  
2e: from the government perspective we met with a couple of government 
advisers who would advise in Xxxxxxx, on diff issues.  
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2b: The stakeholders have an interest in growth, so from a government 
perspective and from a business perspective it’s about growing 
businesses 
Like Case1 LSIs the Case 2 LSIs may have funding from the local or central 
government, therefore the expectations are linked to growing companies and 
increasing employment in the local region. Interestingly is the LSI that is a self-
financed membership organisation and who has the most involvement with the large 
companies in their LSI are providing fewer services that will focus on these economic 
targets when compared to those receiving local government funding. This is because 
the companies are expecting to get value from their membership fees and recieve 
value through procurement and other services where the value is derived by utilising 
economies of scale. 
Reporting on targets met and successes generally for all these LSIs has been 
difficult. Capturing anecdotal evidence has never been easy. 2b discussed this issue 
and how they were exploring new ways of data capture which would show the value 
to the LS community, as well as to all their funders including the European Regional 
Development Fund (ERDF) that the LSI receives. 2e explained that reporting on 
successes was extremely important to them to justify their existence. 
2b: It’s more difficult to do that, but we do know we need to say and show 
what our outputs are.. Our outcomes, so saying that several people 
attended is fine, but what did that actually mean?  We are looking at 
clever ways of doing this, like quotations from people, which is kind of the 
next step really. 
2e: Yes we did but that was because we had to as it was part of our 
metric. A lot of the time it was a long process from introduction to actually 
doing something  
2e: ……….. we were able to demonstrate through interviews with 
individual people that we were helping to increase the number of people 
employed 
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2e: So we had economic drivers eg numbers of FTE positions created 
then we had more soft metrics around the number of events and the split 
between the attendees between the balance between academic vs NHS 
vs industry, the number of articles, pieces of PR , PR that’s been picked 
up and circulated through a wider press and the number of cases we’d 
produced. 
 
  Assessing how realistic commercialisation targets are 
When looking at the data gathered for KEC for these Case 2 LSIs it’s actually difficult 
to see how they could effectively meet any commercialisation targets. The KE 
element of the KEC is the primary occupation for these LSIs. 2b had said it 
succinctly that their purpose was not to directly help in commercialisation but to help 
facilitate others who would be better equipped to do this part, like the TTOs. 
When thinking about commercialisation in LS it involves IP held by universities and 
academics, which means the process of spinning-out a company can be very 
contractually heavy and complicated. These LSIs are very good at facilitating tacit 
knowledge exchange as they host a number of events, including both scientific and 
social networking types of events. The mixing of both types of events means that 
entrepreneurs can engage with the scientists in the hope that a spark is ignited. 
The LSIs have a specific function in helping with developing skills and closing the 
gap for many of the smaller SMEs in their LSIs. These KE events are varied and 
include skills in project management and other management areas in contracts law 
and IP. 
2b: New companies come in they always want new stuff, esp if we have 
new spin-outs they come to everything that they can because they want 
knowledge and skills.  Especially if the sector is calm, you may not get the 
same attendance, but there’s certainly lots of interest in Project 
Management Training and other things they need for within their 
companies. The scientist want presentation skills for presenting whatever. 
We wouldn’t do it if there was no take up.  
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2b: Where we add value is by getting everyone to come along. It lowers 
the cost across the board and sometimes they get that interaction with the 
community that they wouldn’t otherwise get. 
2e: We also did a whole seminar series on IP and patents, which I know 
we got feedback on from one SME that found it incredibly useful to send 
their staff to, so that their staff were made aware of when they were 
developing an innovation. What do they need to do to make sure that 
innovation was protected and to make sure that knowledge was recounted 
to clients? 
 
5.5 Results, Analysis and Discussion from Case 3 LSIs  
 Case 3: Research Institutes and Innovation Centres  
These include the following: 
 Rothamsted Research is a research institute working in agriculture based in 
Harpenden, just outside of London. It is the oldest agricultural institute in the 
UK. It is funded by the Laws Trust and is a BBSRC strategically funded 
institution. 
MEMO – The BBSRC has established that there is a clear distinction 
between innovation centres and incubators. This difference being that an 
innovation centre will be in close proximity to a world class research 
institute. 
 RoCRE is a newly built innovation centre that is located next to Rothamsted 
Research Institute. The building was funded by the BBSRC, the Laws Trust 
and Rothamsted Research to house companies that want to be located near 
to a world class research institute.  
 
 Plant Impact, is an SME that relocated from Nottingham to Rothamsted to be 
close to the academic researchers.  
MEMO – this is not a LSI so the researcher will not be using this data. The 
interview was carried out with the idea that customers would be able to 
provide some insights, however, it was clear that the information gained 
did not add to the data in any significant way. 
 BioAster, is a research institute that is focused on infectious diseases that is 
based in Lyon, France. 
 
187 | P a g e  
 
 Introduction 
After reviewing the LSIs in Case 3, it is clear that although 5 interviews were carried 
out, there were only 2 different LSIs explored here. The researcher while working at 
the BBSRC worked on a number of other research and innovation campuses. The 
BBSRC were keen to promote these new infrastructure models as being significantly 
different to traditional incubators (Case 1 LSIs). The rational for this distinction was 
simply the fact that all of their innovation centres were located in close proximity to 
the research institute that they funded. Some of the data gathered from this period 
will be covered in the section on observational data later in this chapter. 
 Bridging the divide between industry and academia 
The 2 main LSIs in this case are both relatively new. Both the French and British 
Governments have identified that investment needed to be made in helping to 
commercialise innovative technologies from the research base. 3a was built as a 
new research institute and opened its doors in 2013, the model differs from the 3b 
and 3c model, 3b is the research institute and 3c is the new innovation centre 
(similar to an incubator) that sits in close proximity  to the research centre which 
happens to be the oldest agricultural research institute in the UK. 3a does have a 
KEC function built into its model, however, unlike 3b/3c the incubation of any 
innovations is done in-house. 
3a has a specific ambition to build new companies and to help them grow. 
3a: Academic invention which has already been developed particularly in 
France but not necessarily in Xxxxxxx. There is also the development of 
improving the applied infrastructure of applied research in Xxxxxxx by 
building a strong Xxxxxxx that can help multiple companies SMEs and 
large companies. 
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3a aims to focus on how they as an LSI can provide innovations and services to help 
companies develop and grow further. 
3a: Strategic aims including assisting industry to better develop products, 
with a public health perspective, but also from a commercial prospective 
to improve the industry aims. 
3a: We can also perform contract research for partners and in that case 
the IP, belongs to the industrial partner 
3c will maximise its location to help create networks that will attract companies. 
3c: Yes that’s correct, we work with industry partners, SMEs and other 
universities. We will act as a central hub and hope that some of the SMEs 
will relocate here 
Both of these LSIs are focused on the bridge between industry and academia. 
 Recognising the Power behind the Brand 
LSI 3a is a relatively new organisation with a new brand. The founding members 
include large pharmaceutical companies with well established brands. 3a has said 
that they will use these more established brands to bolster their own brand. 
3a: What we have are significant brands that are the brands of our 
founders. So Institute Pasteur for infectious disease has a very strong 
brand.  
3c has a similar strategy for strengthening their new brand, they are positioned to 
use the more established brand from 3b to their advantage. 
3c: We have been careful with the branding. The Xxxxxxx brand has been 
treated as an identity within the Xxxxxxx brand. 
There is nothing unusual here, leveraging the new initiative against a more 
established brand is common practice in organisations found in both the private and 
public sectors. This was seen in the data from 1b and 1c. 1b was the new incubator 
189 | P a g e  
 
that was built on a site in close proximity to 1c and was able to leverage the branding 
from 1c to attract new companies and funding. 
 Understanding the factors for success 
The interviewees from LSIs 3c and 3d explained that their departments are both 
fairly new within the established research institute and as 3d explained the work that 
he and his KEC department do was already being done within the research institute, 
although in a much smaller way prior to the opening of the KEC office. For both the 
Case 3 LSIs it is important to have effective engagement with the academics within 
the research institutes, 
3d: We are a fairly new office and our interactions with the scientists have 
been very positive. 
3d: We are a small institute and are therefore very close to the academic 
community plus we’re not obscured from them by various layers of 
bureaucracy, so I would argue we are close. 
3a: Our inputs with academics can range from simple consultation to 
managing a bioassay work that they conduct 
The interviewee from 3c wants to have more access to the academics within the 
research institute at 3b. He is effectively seen as the incubator manager by the 
academics and although they are friendly enough, probably don’t see any need to 
get involved. 
3c: I have a good relationship with the heads of the teams but not sure 
how that’s getting cascaded down into the various teams. Researchers 
are very single minded and focused, so the challenge is to let them see 
that the money being spent here is of benefit to them. 
The incubator building was built on the premise that it would be filled by companies 
and spin-outs who want to locate close to academic science taking place within the 
world class centres of research excellence and that engagement and collaboration 
between the science base and that these businesses would take space within the 
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innovation centre/incubator. For interviewee 3c he understands that knowledge of 
the science taking place is an imperative for this to happen as he can then do 
brokering between the companies and the academics. This is a key ingredient for the 
3c LSI to work. 
Engaging with industry is equally important to these Case 3 LSIs. For 3c this 
engagement will hopefully attract companies to relocate to the campus. 
3c: Yes that’s correct, we work with industry partners, SMEs and other 
universities. We will act as a central hub and hope that some of the SMEs 
will relocate here 
3c: I’m growing a network within the SME world and I’m using networks to 
help me do that. So I’m going to the Xxxxxxx world and I will be speaking 
with various SMEs. With the corporate I’m reliant on Xxxxxxx to allow me 
to do that because they have relationships with certainly 5/6 Xxxxxxx 
companies and as they come on the site giving them information as they 
come out of meetings and actually giving information to the scientists 
themselves.  
3c understands that the research institute has a long history with engaging with the 
business sector and wants to capitalise on these relationship in order to help 3c 
achieve its aims. 
For the 3a LSI they have a mission to educate and help the business sector to grow. 
They can also provide services to industry that will enable them to become stronger 
and more robust 
3a: Strategic aims including assisting industry to better develop products, 
with a public health perspective, but also from a commercial prospective 
to improve the industry aims. 
3a: We can also perform contract research for partners and in that case 
the IP, belongs to the industrial partner 
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 Understanding the expectations of stakeholders 
Because these Case 3 LSIs were relatively new LSIs there was some confusion and 
reluctance from various stakeholders to engage with them. 
3a: I would say the major barrier to Xxxxxxx is that it is a new model and 
it’s taken a while for both industry and academia to understand what it’s 
about. It’s not just a grant to industry as industry originally thought. It’s a 
joint investment by the government to develop applied research. 
3a: It took them a while on the academic side to realise that Xxxxxxx is 
not a competitor and brings money and technology to the party to help 
with the academic inventions, but as a quid pro quo the academic has to 
cede IP 
3a: A lot of people working in TTOs come from industry and when you 
come from industry what you’re doing is fundamentally of great interest to 
your company to get the best deal. So you find often that TTO officers 
delay things and they want to maximise the potential return. Often they’re 
view of the return is not realistic given where it is. Even when these 
people have come from industry. They emphasize too much the 
placement aspect of making sure these industrial partners pay enough …. 
Expectations from the funder of 3c would be that based on 3c driving industry and 
academic interactions that would spark innovation that would then facilitate 
commercialisation, however, this is not a key driver for either of the 2 sectors. As 
discussed on ingredients needed for success 3c needs to engage with the 
academics to effectively broker interactions between the two sectors. The 
experience of the interviewee is that companies want to speak with other companies. 
3c: If you speak to companies down in the Xxxxxxx parks they will tell you 
that they have very little interactions and business engagement with the 
university. They are more interested in talking B2B rather than business to 
academic and that’s why the clustering actually works, the other thing is 
they were the first to do it and they know what they’re doing. 
Another reason 3c has to manage expectations from the funders at 3c is because of 
the competitive nature of the business. The interviewee also believes that having a 
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sector specific LSI might actually work against them, however, only time will them if 
this is actually the case. 
3c: : Barriers are there are market forces so people may not chose to go 
here they may choose to go somewhere else, they may chose a non-
sector specific cluster, the geographical area, our scientists don’t get it. 
3c knows that the incubator space has been built and funded on the premise that 
companies want to locate close to the great science base, this expectation must add 
to the pressure in convincing suitable tenants to locate there. We’ve seen from Case 
1 LSIs that what is important to tenants is not just the science, it’s the facilities and 
offering generally of a raft of services. On top of this there is the added extra of 
networking opportunities with academics working in the field. The idea is that 
knowledge will be exchanged. 
3c: They (plant Impact) have the facilities of a much larger company that’s 
why they’re here, their growing but their competitors are very big and by 
being here they can. 
The company believes that they will be able to grow because of this location and the 
proximity to the science base. 
For 3d the customers expect that the researchers will come up with novel 
innovations that would help to improve their productions and farming methods.  
3d: The end users the farmers etc believe that we are churning out 
research by the bucket loads that we could and should be using to 
influence best practice on the ground. And because they are not changing 
their best practice on a daily basis means that there is somehow a failure 
in the system. 
For 3a the founders, funders and Government bodies include all of those rolled into 
one. The main expectation is to help SMEs where 3a can. The LSI itself has the 
objective to carry out high quality science 
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3a: they operate more in this area of economic development and helping 
SMEs to develop etc.. 
MEMO – as part of the discussion of expectations from funders 
3a: There is as I said at the beginning one of the objectives is economic 
development for the region which could mean simply for example a 
programme with an industrial partner, we create a new technology 
platform at Xxxxxxx that can then be made available to SMEs, that one 
example, so in other words they’ve created something new which didn’t 
exist before as a result of the project, which also means that the industrial 
partner will have access to it too, but it could also be a spin-out company. 
3d believes that the KEC department is able to manage expectations from the 
funders/Government bodies with whom they report to. He believed they took a long 
term view on achieving their objectives and the only issue was developing ways to 
report achievements. 
3d: I don’t see an expectation they understand what we can’t and can do. 
The gap maybe about money. They understand it’s a long term thing the 
difficulty is trying to measure. They don’t necessary have a mechanism to 
get the message out there about what a good job we’re doing. 
 Assessing how realistic commercialisation targets are 
3a because it’s a relatively new LSI has a role in KEC. They do KE in that they have 
specific expertise in certain areas where they can deliver training. 
3a: There is a second remit which is wider which is that we have a 
significant training and teaching objective. Because we’re working in very 
applied areas, so for example the application of  MRI in infectious 
disease, so MRIs are not in areas where you can work in infectious 
disease, because you need to have biological protection . So we can also 
train people to use MRI in infectious disease as we have the facilities and 
we can welcome students from other courses. 
The commercialisation work that 3a do is strategically directed by the 
founders/funders. 
3a: Involving both industrial and academic partners. There are 15 projects 
with value of 3million in a short period of time. Bringing disparate parties 
together in an efficient way of working in a collaborative project. We’ve 
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developed a standard commercialisation policy that has buy-in from all 
founding partners (so basically industry and academic partners) who have 
agreed on how research from Xxxxxxx would be commercialised 
3a: Economic return can mean for example, if we do a project with a 
financial partner or with multiple industrial partners, there are specific 
clauses in the collaborative agreement between Xxxxxxx and those 
parties, whereby if the project is successful and it leads to successful 
products or processes or something else, there has to be a financial 
return to the project, that can be flexibly written usually in the form of 
royalties or success fees or some other financial return. It’s not just 
creating jobs it’s a financial return to Xxxxxxx 
3a: Xxxxxxx has objectives in KE in the sense that depending on the 
project it can vary. One aspect is that if we do a project that results in a 
new technology rather than a product, so that’s usually exclusive. But if 
you develop a new way for screening the pharma company would want 
access to it but there may be an opportunity to spread that process or 
technology to other partners or CEA or to whatever so. There’s a strong 
requirement that inventions that are developed by Xxxxxxx should be 
commercialised to the fullest. 
These policies help them to benefit as many organisations as possible within the 
region. There also appears to be an understanding that one of the benefits is also 
that of economic returns from their KEC activities. 
3d was set up specifically to facilitate KEC work within the research institute. The 
interviewee previously explained that it had been taking place in a much smaller way 
with no organisational structure. The new KEC department are aiming to recruit and 
develop a high performing team with the KEC remit 
3d: We’ve recently employed a KE officer to facilitate and promote KE in 
xxxx, it’s not just about telling people what we’re doing, our KE 
programme involves developing closer links with local farmers, with 
farming orgs and those who promote best practise in agriculture, 
developing better links with the research association and developing that 
so we have a pretty active KE programme. 
3d: The events we do at the moment are pure Xxxxxxx events and tend to 
be focused on developing Xxxxxxx and we work with Xxxxxxx on that , 
these events are focused on SMEs. There are a lot of events like this out 
there and we work with others like Xxxxxxx East on events programmes 
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that they’re doing, we’re also involved with programmes run by NiAB and 
others. 
3d: We’ll probably run 2/3 events a year other than that it’s more about 
going out to external events and exchanging knowledge at these. 
3d: We actually dev software that will help people improve farming 
practice, so we’re putting a product out there in the market, but we would 
never sell such a product, we don’t have the capacity to sell. Most of the 
technologies that do get out there, get out because of a commercial 
partnership and we leave the commercial partner to do the selling 
5.6 Results, Analysis and Discussion from Case 4 LSIs  
 Case 4: Sector Specific Thematic Intermediaries  
These include the following: 
 The Scottish Stem Cell Network (SSCN), were based in Edinburgh, however 
worked across Scotland. They were operational from 2003 to 2013. A non-for 
–profit free membership organisation focused on Stem Cell research. 
 
 The Knowledge Transfer Network (KTN), was divided up into many different 
sector networks all working nationally in the UK. They had different locations 
for the 15 different sector networks. At the time of the interview the KTN had 
been consolidated to 1 central network that worked across the innovation 
sectors. The LS KTN was considered one of the most successful ones and 
has more or less been left as it was. They are funded by Innovate UK 
 
 The Cell Therapies Catapult (more recently it has been renamed the Cell and 
Gene Therapies Catapult) is a national thematic centre based in London at 
Guy’s and St Thomas’s hospital, but have a remit to work across the UK. 
They are funded through Innovate UK, initially for 5 years with a potential for 
further funding. Their aim is to identify potential innovations that have the 
potential for commercialisation or for further development to progress them. 
 
  Leiden Medical School initiative. This is a sector specific network project that 
works across 2 different cities in the Netherlands, Leiden and Delft. They are 
regionally funded and operate as a bridging organisation between industry 
and academia, with the expressed aim of getting innovations to the patients. 
 
 Edinburgh BioQuarter (EBQ), is based within the University of Edinburgh 
Medical School, They were funded by both the University of Edinburgh and 
Scottish Enterprise NHS Lothian, University of Edinburgh, College of Medicine 
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and Vet medicine, SE,. Their aim is to spin-out as many medical innovations 
as possible in to companies from the academic base. They have 5 years 
funding and an initial target to spin-out 40 companies over this time. The 
partnership is about improving commercialisation of IP coming out of 
Edinburgh University and NHS Lothian, alongside that and almost part of that 
is helping to strengthen the BioCluster in Edinburgh. They get funding from 
NHS Lothian, although the majority of the funding comes from SE and the 
University of Edinburgh. 
 
 Introduction 
The Case 4 LSIs are all relatively new, one 4a closed a year before the interview 
took place. It was useful to hear about what had worked, what had not and where 
improvements could have helped and where areas of learning from their experience 
were. 
 Bridging the divide between industry and academia 
4a was perceived by both the academics and industry players in the sector as an 
organisation who could help them to grow or to access funding in the case of 
academics. 
4a: It varied; I’d say we started out positively, the academic groups can be 
quite mercenary, if you can give them something or fund something for 
them then they tend to like you. 
This sector specific thematic network was working in a growing a relatively new area 
of research. The network had funding from the local economic development agency 
and many of the key leaders in the field were asked to participate in a number of 
show casing events to promote the companies and the research taking place in the 
region. 
4a: I was quite sensitive too I was in a small field like Xxxxxxx  Xxxxxxx 
there’s actually quite a small number of experts and they tend to get 
drawn on incredibly frequently by Government, visiting inward visits by 
parties from China, America, etc,etc and there’s quite a lot of time and 
effort that the academic puts into these kinds of things or actually put in 
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freely and they don’t always see the outputs coming out from the other 
end and I was quite sensitive to that too. 
4a: it tends to be the same people who are asked. It’s always Ian Wilmut 
or Paul DeSousa, always the same people. We were able to go to SE or 
Scot Govt and say well actually there’s these guys who’s working in 
Aberdeen and he’s doing some really hot stuff, you kind of spread it out a 
bit too. 
They were able to help bridge the divide and help with some of the demands made 
on the scientists by protecting their valuable time. They were able to work with their 
funding stakeholders to provide an effective service and were able to effectively 
communicate the needs of all their stakeholders. 
The 4b LSI is based in Xxxxxxx Xxxxxxx and is a project set up and funded to work 
in 2 hospitals across two cities Xxxxxxx and Xxxxxxx. They have a specific bridging 
role between industry and academia with the aim to benefit the end users, in this 
case the patients. The projects had been deemed to be successful and had reached 
a stage where further funding was sort to continue operating. The interviewee felt 
confident that this would be achieved.  
The next LSI included interviews from four different individuals from the same 
organisation. The roles of each interviewee within the organisation varied and 
provided a different perspective on their function and ability to bridge the divide 
between industry and academia. 
Initially the researcher had believed that this LSI had a model similar to a TTO and 
had been prepared to allocate it to Case 5 LSIs, however, it became clear from the 
interview that 4c,d,e,f consider themselves as a sector specific thematic LSI as they 
work exclusively in the field of medicine. The funding for this LSI had another six 
months to run at the time of the interview. 
198 | P a g e  
 
4c explained that the aim of the LSI was focused on the KEC activities and that they 
spent a lot of time engaged with both industry and academic stakeholders. They 
believed they were bringing business practises to academia therefore bridging the 
divide and sometimes that was met with negativity  
4c: Its horses for courses some will feel that its working for them and 
some will feel that they’re not particularly interested in getting involved in 
commercialisation activity and for those its fine, so some embrace it with 
open arms and some carry on to do what they’ve always done and some 
are slightly negative about getting involved in anything that’s commercial. 
When the interviewer asked if he had better engagement with the younger 
academics within the medical school he was quite keen to point out that those who 
had initiated and supported the creation of the LSI were themselves academics from 
an older generation. 
4c: Yes I would agree that the younger academics are more commercially 
aware. However, if you remember the whole of the Xxxxxxx project was 
driven by the senior academics in the college, so the likes of xxxxXxxxxxx 
and Xxxxxxx Xxxxxxx Xxxxxxx is head of the college and Xxxxxxx 
Xxxxxxx has now moved on to be a Vice Principal for research service 
and still does research, so there’s two extremely senior academics who 
have totally and utterly got it and who felt that we needed to be doing 
more commercially driven work. People like Xxxxxxx the head of the 
Xxxxxxx totally gets it as well. I’m not sure that age is necessarily the 
deciding factor I think personality is.  I think some academics like to feel 
that they’re doing pure research, which is not being influenced by 
industrial considerations in any way and other researchers believe that 
you can combine the two things. 
 
4g had a similar experience engaging with the academic community within their 
sector specific LSI. They appear to choose academics with specific characteristics  
4g:  So we work with the academic base with those that we think have got 
the characteristics that we want to see moving forward 
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4g again like 4c are very focused on the commercialisation potential of research. 
Engaging with the academic community has not been easy, there has been a high 
level of expectations from all stakeholders on what to expect from 4g and, as 
explained by them, a certain level of suspicion. In the past these types of LSIs like 
the ITI’s previously discussed in chapter 2, were awarded significant funds in order 
to use their sector specific expertise to identify suitable academic projects to fund 
and to lead to a commercial outcome. The academic community were invited to put 
forward proposals for projects that had market potential. Once approved the 
academic group was funded and researchers employed. Based on these previous 
experiences the academic community had perhaps a different operational view of the 
new 4g LSI. The 4g interviewee explained that they have a different approach now 
and had definitely learnt from the mistakes made by the ITI LSI that was considered 
a failed intermediary initiative.   
4g: initially when the xxxxxx first came out there was certainly an idea that 
the universities would capture them as a university system or be an 
extension of them. So some the universities certainly the early ones we 
engaged with tried to rule the Xxxxxxx. Now they understand, now you’re 
dealing with the corporate parts of the universities and not the TTOs and 
academics. 
4g: The academics are always a bit suspicious and you have to find 
projects that people want to work with you, find models that meet TTO 
and academic aspirations and at the same time the Xxxxxxx will 
accelerate the project and if they’re not accelerated or in fact if people 
don’t want to accelerate things which may sound like a strange thing but 
some people are quite happy to go slow. So accelerating things with 
properly controlled trials are essential. We found there are sufficient 
people who want to work with us. 
Both 4c and 4g have been created to bridge the divide between industry and 
academia, they are both using a more focused approach, one that will they hope will 
create many more commercialisation outcomes. 4a and 4h also had the remit for 
bridging the divide, however, a lesser focus on the commercialisation of the 
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research. This lack of commercial outcomes was possibly one of the reasons why 
they did not receive further funding. The two newer LSIs 4c and 4g have been 
created and funded by public money to focus on the untapped economic benefits 
that these LSIs can bring. 
4a: If were starting now (bearing in mind the industry was a lot less 
mature back then) but if we were starting now we would use that money 
now to help more companies, more like a Spark award or pre-award. 
On a deeper analysis of this data and based on a MEMO that was written at the time 
of the transcription, it seems that the bridging function would work better with a mix 
of employees from both sectors. This would improve the teams working on projects 
many of which have a requirement for both sectors to be involved in the 
collaborations. 
MEMO- I think that having a focus on people who have come from 
industry means they have no real understanding of the sector they need 
to work with academia! It becomes just like before industry and academia 
who don’t have any understanding of each other’s sectors. For an 
intermediary it would be good to have mix from both industry and 
academia and from social sciences qualitative and the scientific 
quantitative side to get a higher performing team.  
 Recognising the Power behind the Brand 
For 4a the brand recognition came fairly quickly for them when they first came. The 
thematic science of the network was part of their name, which made it easily 
identifiable. The other reason for this was that the science they were focused on was 
very in-vogue at the time of their creation. There was high expectation for innovation 
in healthcare from this area of science. 
4a: The impact we seemed to get everywhere. Recognisable pretty 
quickly……………………………… 
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As explained above they did tap into a hugely successful company, the one that was 
associated with Xxxxxxx and were able at least early on in the lifetime of the LSI to 
use the companies brand to raise their profile. 
4a: Early on we used the Xxxxxxx branding and we had a successful 
conference under that brand. It is still remembered and the values it stood 
for are still understood. 
4c struggled with their brand, there was a misconception as to the type of 
organisation they were. This general public perception of being something that they 
weren’t was apparent at the interview. 
4d: It was difficult to establish primarily because Xxxxxxx means different 
things to different people, if we were starting again now, we would not call 
it Xxxxxxx because Xxxxxxx is associated with the science park, for 
example if you get in a cab and ask to be taken to the science park they 
don’t bring them here. So the feeling is that we should have identified the 
branding better and made it more distinct from the science park. But then 
again the Xxxxxxx is seen by other communities as not being just the 
science park, but the science park, the hospital and the medical school 
and the greater environment all the way down to Xxxxxxx. 
Those employed within the LSI were not involved with the creation of the brand 
name, they just inherited it. This was experienced first-hand by the researcher, who 
approached this LSI for an interview thinking it would be placed under Case 5 LSI as 
one of the Technology Transfer Office models. In reality the LSI 4c-f has elements of 
a TTO and an accelerator model, where they germinate very early stage ideas and 
take then through to the proof of concept (POC) stage, before moving them into the 
incubator nearby, however they were very clear throughout the interview process 
that they were not a model of TTO (Case 5 LSIs) 
When this LSI was interviewed it was very near to the end of their five year funding 
and they still had the issues of perception surrounding their brand. If they had 
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addressed the brand issue early on, would it have helped them establish themselves 
better and perhaps achieve more?  
4d: No its public sector and industry who view it as the entire area. The 
academics view it as the hospital, the medical school and the science 
park. External people coming in are not sure how to view it and it depends 
on who they speak to first. We could have done with a better brand. It 
could have helped with having a different name. Being the Xxxxxxx 
helped to us to differentiate ourselves with Xxxxxxx and that was a major 
help. 
The 4g LSI at the time of the interview was only 18 months into a five year funding 
package, therefore still a relatively new LSI. One of the advantages that 4g had with 
regards to branding is that they have a brand that is recognised nationally as it was 
supported by Central Government. National promotional activities alerted both the 
business and academic communities to the brand and of course raised certain 
expectations in both sectors. 
4g: yes that’s right. It’s all about credibility you see because you’re known 
to a certain extent we were able to establish credibility by being people at 
... and of course the asset that we’ve created here is very impressive and 
the more opportunities we generate and credibility, will impact on our 
investors who really like the Xxxxxxx because we have a big reach into 
the US and Japan  
LSI 4h at the time of the interview had only in the last six months undergone a 
contraction of their LSI. The LSI previously had 15 sector specific arms that covered 
a range of sectors from the financial to digital and included 2 LS sector LSIs. They 
received funding for their LSI from the Government too and with funding becoming 
scarcer they were made to contract into one single central organisation with one 
administrative centre that worked across all the sectors. They still retained their 
brand which still had good amount of impact. The 2 LS sector LSIs had been the 
strongest performing parts of the 15 LSIs and many of the staff working in them were 
kept on to continue the work under the centralised brand. 
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 Understanding the factors for success 
Looking at the data it is clear that the interviewees had lots of opinions with regards 
to the elements that work and help them to succeed and at the same time those that 
don’t work or act as a barrier to success. 
The newer LSIs like 4c-f and 4g were focused on what they needed to help create 
new commercial entities, whereas 4a and 4h had a focus on only some of this. 
A general statement about what they are looking for to create successful outcomes 
is qualified staff and the finance to make things happen. Another interesting point 
made was that they also felt that the companies they had created did better when 
they were located closer to them. 
4f: Barriers: lack of cash and experienced management teams. Xxxxxxx 
programme, located close to academics to us have done better. Remote 
companies are not as good. 
The interviewee went on to discuss in more details the issues around finance. The 
LSI is located in Xxxxxxx which has a thriving Angel Investor Network community. 
These are individuals who have done well themselves and made money that they 
can now re-invest into smaller local companies. However, as was pointed out below, 
this has its downside too, in that it is a ‘drip feed’ type of system. 
4f: That’s why I say that local Angels are a blessing, but they can also be 
a curse because they haven’t got enough capital to see the company 
through and the whole thing becomes the living dead and you…. 
4g believes that good technologies and innovations are missed all the time because 
of the lack of knowledge within the TTO community. This was also identified by 3a 
previously who also said that the TTOs could unintentionally delay progress within 
commercialisation. 
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4g: A recent example in Xxxxxxx as around the fact that the technology 
had been missed by the TTO but had been obvious to the commercial 
sector. In fairness to them it’s about specific knowledge and about the 
potential for a technology which you get from in-depth knowledge. 
4g: There’s an overvaluation of early stage research, by and large. The 
values can’t be achieved.  
4g: We only work with TTOs to get high level messages. I think we would 
be working with the academics directly.  
(MEMO this shows a similar message from two different LSI model types (taken 
the from previous section)) 
3a: A lot of people working in TTOs come from industry and when you 
come from industry what you’re doing fundamentally of great interest to 
your company to get the best deal. So you find often that TTO officers 
delay things and they want to maximise the potential return. Often they’re 
view of the return is not realistic given where it is.  
Even 4d had something to say about TTOs overvaluing the innovation 
4d: They felt it was an easier path to access the IP one of the big 
complaints about TTOs is that they make accessing the IP more difficult 
rather than facilitating it and they do that by massively overvaluing the IP 
that they have  
 Understanding the expectations of stakeholders 
From the customer perspective there were various expectations that impacted on the 
LSIs. For 4a it was clear that their stakeholders from both the industry and academic 
sectors had a perception of what they could do for them. For industry it was 
signposting and introductions and for the academic sector it was paying for and 
hosting scientific KE events. 
4a: the expectations from us from business were quite a lot actually, they 
wanted us to introduce them to lots of people who would use their 
products and services and basically were just grateful for anything they 
got and didn’t have massive amounts of strings attached to it.  
4a: From academia it was ‘give us money’ and to run high quality free 
events for everybody and pay travel awards and that kind of thing, I felt 
that up to a point it was worth doing that because when you needed to 
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use your academics for something else you could. It was the only carrot 
that we had. 
4c-f encountered a different set of expectations, from their funders who were the 
local economic development agency they inherited a business plan and a brand 
name. They had to spend some of the 5 years that they had of funding to educate 
their funders on what was and wasn’t possible to achieve. 
4c: When I came into this job and inherited the business plan that had 
been produced by Xxxxxxx and signed off by the university, it was 
nonsense. So one of the expectations for eg was that we were going to 
spin out 42 companies in 5 years and stuff like that, so I re-wrote the 
business plan and part of it frankly is education and part of our culture 
change is as much changing the culture of our Government as it is the 
academics frankly so it’s getting everyone on the same page. 
They were able to agree on most things and both the funders of 4c-f and the LSI 
itself agreed on new targets in order to move forward. As the economic development 
agency wanted to expand their science park they needed to ensure that 4c-f 
continued to create new commercial entities. 
4d: As part of the ongoing discussions at the time Xxxxxxx were building 
the Xxxxxxx science park and they were interested at the same time in 
increasing commercial outputs from the college of medicine because 
primarily Xxxxxxx was going to be a LS park in particular Translational 
Medicines oriented science park. 
For the 4g LSI the expectations were tied in with their targets and agreed upon from 
the onset of the project. Again these targets were expectations on the income and 
matched funding they would need to get in order to succeed. 
4g: The second 1/3rd is expected to come from external forms of funding 
like TSB and Horizon 2020.  So its collaborative R&D funding 
competitively won or judged by some criteria. The last 1/3rd  is expected to 
arise out of contract research. 
4g: Enthusiasm is high at moment. We’ve created a vision and a plan that 
everyone can buy in to. We are recognising stakeholders and how they 
react is really important. We recognise we are part of a larger innovation 
206 | P a g e  
 
programme. We have the structure in place for industry and academic to 
feedback as to whether we are performing.  
From the Government bodies side of things the expectations were also high and in 
some cases like for 4a unachievable. 
4a: After the 5 year period they were expecting there to be a multimillion 
pound investment into the Xxxxxxx opportunity in Xxxxxxx. Well if you’re 
only putting in a million quid that’s not going to happen. More would allow 
us to identify strategically research wise what we should be putting in the 
infrastructure which they are now doing. They have the infrastructure 
there with GMP. They thought everything was going to happen in 5 years. 
This was quite difficult. They wanted a ROI in that time. 
This is a stark warning from the experience of 4c, expectations need to be curbed, 
and need to become more realistic and the fact that much of the hype does not 
become a reality should be an eye opener. 
4c: I think that Xxxxxxx in a very simplistic view of life thought Great if we 
put a campus here and the university is on site and we put up a multi 
occupancy building that people can move in to, people will just come, well 
guess what there are sites like that all over the world and all over the UK 
now and unless you differentiate it in some way that’s not going to 
happen. 
4c: There has been massive overselling of the promise of LS in the early 
1990’s and a lot of things didn’t come through. 
 Assessing how realistic commercialisation targets are 
LSIs 4a and 4h both had a KEC remit, however, were not only focused on the 
commercial outcomes but on the exchange of scientific knowledge both in and out of 
their LSI. 
4a felt that they could manage funding SMEs in a much less bureaucratic way that 
was welcomed by the SMEs they engaged with. 
4a: with the ERDF funding we were able to support the small start-up 
companies which wouldn’t have made it otherwise they would have 
struggled 
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4a: With SE and pump priming they had so many strings attached to the 
money received whereas with us if we gave them £1000 to test chips or 
something, they couldn’t believe there were no strings to it and that would 
allow them to go on and get the next round of funding. 
Reviewing the data from the 4c-f LSI it is clear that they feel very passionate about 
the KEC aspects of their work. They clearly have an understanding of how to do the 
work effectively in order to reach the targets they set out for themselves. Many of 
those who were interviewed at this LSI have come from industry and although 
previously discussed that this may in fact be a disadvantage when understanding 
academic drivers, it appears to be invaluable to the company creation function of the 
LSI. 
4d: We would like to think of ourselves as more of an accelerator so that 
is more to develop IP assets along commercial lines   
4d: the important translation of that research is its all got to be 
commercialised if you don’t commercialise the work it’s never going to get 
to the patients. 
4c: So we have to be very proactive because we come from a biotech 
background and we’re used to deal making basically and we treat this in 
exactly the same way. So most TTOs don’t function in this way. 
4d: But is not just KE, you have to add value, it’s no good like in the old 
days saying, look we’ve found something here does anybody want to buy 
it? 
Tied into the KE are the events they host with the objective around the 
commercialisation of innovations. One clever event was the annual competition 
where the young academic teams would create a company with guidance from LSI 
mentors. The companies would if they succeeded get finance to spin-out of the 
University. This KEC activity provided training in management skills as well as 
support in product development. 
4d: Yes we do have seminars, we bring experts in who discuss the 
advantages and pitfalls of going in various ways. What has been very 
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successful, is that we have an innovation competition every year, where 
we invite people to apply and things are short listed and we assign people 
from the team to work with them to explain the commercial programme 
and to get things commercialised that’s been very successful. We get 
many repeat customers, people will come with an innovation competition 
entry and even if it doesn’t succeed they will come with another one and 
another one 
Emphasised again here the difference between what this LSI does and what a TTO 
LSI does. 
4f: so in terms of the spin-out process, its finding funding, finding 
management team, appointing management team, finding investors, 
negotiating the terms of the deal and negotiating the terms of the licensing 
deal so it’s fair to all. Helping them find advisors, we do all of that, so to be 
honest we are a million miles away from a TTO, we add a huge amount of 
value to these companies. 
The 4g LSI didn’t specifically have a remit that included KE, after discussing this with 
the researcher 4g said that they had started to do this and he understood that KE 
was linked to commercialisation 
4g: We don’t have a KE department it’s embedded. We do joint 
workshops with HI and we’ve had a lot of success. We work out how to do 
something and then we disseminate with a 1 page. We do have 
conferences and sponsor them. We have one tonight that we co-
sponsored and co-organised. The world stem cell conference is annual 
conference and GE healthcare and investor day. So it’s hand in hand with 
the commercialisation activity. 
5.7 Results, Analysis and Discussion from Case 5 LSIs  
 Case 5: Technology Transfer Offices  
These include the following: 
 Research and Innovation Services (RIS) based in the University of Dundee. 
Although RIS works across all sectors, they are very focused on the life 
sciences and medical innovations from the University. 
 
 LURIS, is the knowledge exchange office for the University of Leiden, Holland 
and the medical school based within the University. They represent all 
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scientist by helping to find partners and research funding. They deal with 
entrepreneurship and legal matters for the academics. 
 
 Knowledge Transfer Centre (KTC) at St Andrews University, provides a one 
stop shop for academics in entrepreneurship services. In 2008 the KEC 
function was moved to the KTC with 4 staff. 
 
 Edinburgh Research and Innovation (ERI), is a standalone limited company 
that is the central TTO for the University of Edinburgh. It covers all sectors, 
but has a particular focus on life sciences and healthcare. 
 
 
 
 
 Introduction 
These LSIs have been around for years and have not always been perceived as 
providing any value. They do however recognise that changes are needed in many 
areas they work in. Clever ways of bridging the divide are needed.  
5a:  TTOs have been bashed for years due to poor data out there, it 
depends on what you’re doing for the academic and if you’re liked, the 
TTO is there to serve the University… 
5b: There is a culture change with PIs and postdocs being asked to think 
about what the impact will be now. 
 
 Bridging the divide between industry and academia 
So what strategies have they employed to better facilitate the engagement and the 
relationship with the academics? 
5c: CRC model where we embed people in the schools has been running 
for 12 or so years. It’s up for review just now in terms of how we make it 
more productive, but through close engagement and that means 
embedding our people next door to scientists brings the whole KT agenda 
to the surface, how inclusive are we able to be? I guess with a broad 
spectrum office we do a lot, if a scientists has got a consultancy or 
research query or commercialisation query we channel it through one 
area, we can backfill it to some extent, so, we’re able to be fairly inclusive, 
210 | P a g e  
 
there’s maybe somethings we just don’t cover and sometimes this can 
cause issues because we’re there we can do something which we can’t. 
Embedding expert staff to be close to the academics. Constantly 
reviewing these strategies will help to identify where the areas for 
improvement lie, which is something they seem to be doing in the xxxxx. 
Working closely with the academics is an imperative for these LSIs, however, at the 
same time as doing this they must also engage and develop relationships with 
industry. The TTOs do have a role in bridging the divide between sectors and appear 
to find different ways to achieve this. 
5a: We have long relationships with a number of Pharma companies which is 
unusual, we also have a lot relationships through the innovation portal. 
5b: We have 2 staff who are funded to be outward facing engaging with 
industry. We have had funding from the EPSRC for this activity and have 
35 projects with 28 engagements with companies, this would never have 
happened before we got this funding 
5b: It’s a frog kissing exercise to find an SME who needs a problem 
solved and where we can in academia can help them 
Problem solving for industry seems to be helping theses LSIs develop their long term 
relationship with industry partners. 
5a:  New models of working with industry is one of our successes. We’re 
too small in Xxxxxxx to be thinking about just Xxxxxxx, many of our 
companies go out and export. Most SMEs don’t have the resources to 
develop new technologies  
5b gave an example of how they managed to engage with an SME whose mother 
company was a big US company and instead of encouraging this relationship the 5b 
LSI was shut out. The local economic development agency took over and excluded 
the TTO LSI from further engagement as they account manage these large 
companies themselves. 
5b: We had helped a postdoc working on an innovation to link with a local 
company and got them a follow-on voucher. Once the voucher stopped or 
we could not do anymore in the way of finding funding our links to the 
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company became very much diminished. The company who had a mother 
company in the USA was seen by Xxxxxxx as a priority account managed 
company because of this. We are kept out of the loop. 
 Recognising the Power behind the Brand 
These TTOs are situated or linked to Universities. There has been some success for 
TTO because of the reputation and brand of the University themselves. 
5a has used branding to its’s benefit at international conferences and events. While 
writing the transcript the researcher wrote a memo about why they appear more 
successful than one would predict for such a small University. The TTO benefited 
from the regional Cluster Network Organisation, Xxxxxxx who had a remit to market 
the science from the University in the early stages of its own life cycle, they did this 
very effectively, and this has had lasting effects and benefits for those associated 
with the Xxxxxxx brand. They promoted through marketing channels the high profile 
science and scientist within the cluster. 
5a: No , but we do marketing support and will do more with a new post 
we’ve had approved from Uni Xxxxxxx has a brand. For example when I 
go to Bio, people don’t turn us down for a meeting because we’re Xxxxxxx 
MEMO- my thinking is that because of the marketing done by Xxxxxxx or 
is it purely the Universities reputation or a combination of both. 
 Understanding the factors for success 
This an extremely difficult thing to determine here and no one size fits all, each TTO 
appears to operate differently. Generally speaking they are there to help protect the 
universities IP and to help drive KEC. 
Some of the ingredients for success include helping to create momentum within the 
LS cluster locally. 
5a: If there’s enough companies that people can work for like Xxxxxxx 
then it will attract biologists. So building activity that will bring people in to 
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live here. So that’s not such an issue. We have created the bio cluster 
here and people have started to move between industry and academia, 
this is the same for managers as well as it gives them more opportunity   
They use case studies to capture their successes. 
5a: we have anecdotal stories, plus getting repeat business. How many 
times have they come back and done something?  
Some of the ingredients that are in short supply according to 5c are: 
5c: The main barriers: (1) investment fund; (2) lack of strong management 
teams (3) transition funds 
One of the key hurdles for success according to 5d is the lack of opportunities, which 
means when an opportunity arises, everyone is after it. This means that there is 
competition between different LSIs in the same regions. 
5d: We have a fragmented landscape in terms of strategies. All vying for 
same ops. 
Therefore it must be important to attract a wider range of opportunities. Although 
finding an exact match with what industry is looking for and what academia is 
working on might be difficult. 
5d:  It is not always easy to find companies with similar interests in the 
research here, so we have a mixmatch and it has become the biggest 
barrier. So what the companies are working on and what the researchers 
are working and the outputs align then that’s great but we have a gap. 
 Understanding the expectations of stakeholders 
These Case 5 LSIs had little to say about managing expectations 5c just simply said 
yes we do! 
5c: We manage expectations with all our stakeholders 
The interviewee from LSI 5d explained that in his experience there was an 
expectation from the academics that the TTO would handle all the commercialisation 
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of their research for them. They appeared to be happy to hand over the reins to the 
TTO with little involvement from them. 
5d: The scientists have an expectation of the TTO that we will 
commercialise it. They think we will have 10 companies looking at the 
technology without them being involved. I found this over the 6 years that 
happens. So we need to make them aware of what they can expect from 
us. 
5d believes that the TTO does not have all the answers and he would like to see the 
academics getting more involved as they are the experts in the field not the TTO 
managers. 
5d: If I have 10 technologies and I engage with 5 companies and 1 leads 
to a collaboration is that a good thing or a bad thing?  What are the 
expectations of the government, the scientists and the University? We 
haven’t been able to pick the winners, it’s not something we have been 
able to do. So it’s about trying. So lately I have been thinking about how I 
can stimulate the scientists to become more involved.  
 
 Assessing how realistic commercialisation targets are 
We discussed earlier that the LSIs were looking at different strategies for 
engagement, this strategy impacts on their commercialisation targets 
5a: So strategic corporate getting co-operations. Set up a relationship with 
half a dozen major corporates around the world and set up a real 
relationship with them and do it multi-stranded with placements, CPD, 
enterprise research excellence and licensing and populate the company 
with connections with Xxxxxxx. Eventually something will come here 
because of it./ So multidisciplinary relationships with major corporate, 
that’s what we’re looking at. 
5c explained that as part of their commercialisation activities they encourage and 
support early stage incubation of ideas. 
5c: We do have in school incubation. We encourage them into TEC 
managed incubation, therefore they get a lot of the service stuff is handled 
for them. In terms of pricing it is quite low in year 1 and goes up in year 2 
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and as the company becomes more commercially viable in year 3 it goes 
up again. We want them to move on then. 
They have a system that encourages entrepreneurship from across the country and 
they provide the same level of support to everyone who participates. 5c wanted to 
see good practices spread out to everyone and as 5a pointed out the region is too 
small to be successful in just one city. 
5c: We have a programme here of supporting graduate and 
undergraduate students and Enterprise Campus is focused on any 
postgraduates from across Xxxxxxx, they can have access to the same 
level of support that people in Xxxxxxx currently have, which is a great 
thing. 
5c: I think we need far more sharing of best practice between institutions, 
far more of shared working, I think Enterprise Campus is a good example 
of a programme that works, we’re now rolling it out and every University 
can participate. So Xxxxxxx and Xxxxxxx are geographic hubs and we 
Xxxxxxx clearly, so between the 3 of us we cover every University. More 
of this kind of thing is what’s needed, to roll out good practice. 
5c: We bounce things off them. We also have our own investment fund. 
Created by money made on one of university spin-outs, so we have a 
£2million fund, which allows us to invest hard cash into some of our spin-
outs, sometimes we can help. We engage investment professionals 
looking at technologies they can decide without input from our office. It is 
not an emotional decision, it’s about whether it makes money which is it a 
good thing. 
Some very good and innovative ideas for facilitating commercialisation from the 
TTOs. Most of the TTOs around the UK have now employed a KEC lead within their 
TTOs. This is probably because of the policy work done at the research councils to 
encourage this strategy within TTOs. This links directly to the return on the 
investment of tax payer’s money on research. The research must be more focused 
on a commercial outcome. 
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5.8 Analysis from Observational Data collected 
 Introduction 
The observational data includes a number of talks that were attended including three 
specific talks on different areas that affect different intermediary models from the 
Innovate UK conference that took place in November 2014. One that looked at 
Research and Innovation Campuses and the clusters these intermediaries are a part 
of. The other two conferences are Bio2015, where the researcher attempted to 
collect primary data and the PraxisUnico Conference 2015 in Dublin. 
From: Innovate UK Conference 5-7 Nov 2014:  (Presentations and slides can be 
downloaded from: http://innovateuk2014.policyreview.tv/conference/993.html)  
What UK Innovation campuses can offer you? (Day 2, 2.45pm) 
Chairs: Tim Bestwick, Executive Director of Business and Innovation, Science and 
Technology Facilities Council; Celia Caulcott, Executive Director, Innovation & 
Skills, BBSRC; 
 
Panel: 
Mike Lawton, Oxford Space Systems; 
Will Spooner, Chief Science Officer, Eagle Genomics; 
Alison Johnson, Director, Food Forensics; 
Heather Dunlop-Jones, IBM, Distinguished Engineer and Chief Technology Officer. 
 
 
 Synopsis of the Discussion on UK Innovation campuses  
This panel of speakers was chaired by two Research Council directors, one from the 
Science and Technology Research council (STFC) and the other from the BBSRC. 
The four panellist were from companies that are located in the various Research 
Councils strategically funded Research and Innovation Campuses (RICs). There was 
emphasis made on raising the profile of the benefits of locating in one of these RICs. 
Celia Caulcott from the BBSRC, said that “they were a carefully constructed 
environment”.  
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The four panellist were introduced to the audience. Most went on to describe that 
their reasons for locating within a RIC was not simply to be close to the academic 
science, additionally it was infrastructure like computing power for Eagle Genomics 
and a close proximity to a large teaching hospital. For Alison Johnson, what was 
important was the ability to find suitably qualified graduates. Mike Lawton explained 
that his company had moved from Culham Science Park to Harwell Science Park 
because of the new Satellite Catapult opening up there and the European Space 
Centre location there. They were attracted to move for the potential to collaborate 
with these organisations. 
The IBM panellist Heather Dunlop-Jones said that for two decades they had been a 
supplier to organisations within the Daresbury Science Park which is managed by 
STFC. They now have the ambition to make their super computer more consumable 
and are now working with Unilever in formulation work, with Rothamsted Research a 
BBSRC funded research institute on their 2020 Wheat project. They have gained by 
being part of a RIC and can rub shoulders with SMEs to partner with them. 
 The Fit with Focused Codes 
This session was hugely influential to the researcher’s decision to create a separate 
case for the research institutes and the innovation campuses (Case 3 LSIs). The 
Research Councils put up a strong case for this, however, as previously noted on in-
depth analysis that was required for the focused coding stage of this process it was 
clear that the different elements of the Case 3 LSI could have been divvied up 
between the other cases.  
Table 17: Focused Codes (Copy of Table 16) 
Focused Codes 
Bridging the divide between academia and industry 
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Recognising the power behind the brand 
Understanding the factors for success 
Understanding the expectations of stakeholders 
Assessing how realistic commercialisation targets are 
 
Observational data can be applied to the focused codes we have previously used for 
the Case LSIs, see Table 17.  The RIC assist in bridging the divide and from the 
notes it is clear that there is assistance to the companies located within these RIC 
with introductions (rubbing shoulders), KE networking events to bring people 
together and the possibility of tapping into public sector research funding. 
The companies with the brands like IBM don’t need any help with utilising the brand 
of the research institute. It’s more the factors for success that comes across as more 
important to the companies here, which were outlined in the talks and include: 
 Proximity to a large teaching hospital 
 Super computing power 
 Infrastructure  
 Networking with like-minded individuals and companies 
 The potential to collaborate 
 Being in-close proximity to potential customers 
The data collected for this research did not include that from any companies located 
within the LSI and on reflection that may have provided a more rounded picture of 
the value of the LSI itself, however, the focus of this study was on the value of KEC 
within these LSIs. 
The RICs are themselves creating expectations within their current and potential 
customers/tenants base and from the talk it is clear they intend to do more marketing 
to raise their profile and differentiate themselves. 
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The cluster effect  
Chair: Will Hutton, Chair, Big Innovation Centre; 
 
Panel 
John Womersley, Chief Executive Officer, Science and Technology Facilities 
Council; 
Simon Andrews, Executive Director, Fraunhofer UK Research Ltd; 
Professor John McCanny, Director of ECIT, Queen's University Belfast; 
Naomi Krieger Carmy, Director, UK Israel Tech Hub 
 
 Synopsis of the Panel Session on the Cluster Effect 
The chairman introduced four panellist from four different LSIs, each was asked a 
number of different questions about how their LSI impacted on the local and global 
innovation ecosystem. Although the panellists were not from LS specific LSIs it was 
an interesting talk and fed in to the research from the literature review of this thesis. 
Many of the LSIs interviewed appeared to be growing a cluster of sector specific 
companies. This ties in with the academic discussions on cluster-based economic 
development and innovation (Ketels and Memedovic 2008). This paper talks about 
the modern economic policy around clusters and the move for companies to work in 
cross-company interactions, therefore utilising economies of scope rather than 
economies of scale. This panel session had examples of how these LSIs are helping 
to facilitate these strategies for scope. 
At the end of the discussion the chairman made a plea to the audience for continued 
support for the investment into the UK Catapult initiative and saying they had hardly 
begun and we need to follow through on them. There seems to be an understanding 
of the political influence on these LSI. The UK Fraunhofer director was one of the 
panellist and as previously discussed in the literature review (Chapter 3) these 
Fraunhofers have had been around since World War 2 whereas we have had a 
multitude of LSIs come and go. The chairman made reference to the recent report on 
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the Catapults when he made his plea for continued support of the Catapult 
programme. This plea was made to the audience, however, it was likely meant for 
the ear of Government who are the funders of the Catapults.  The longevity of the 
Fraunhofer’s is validation of their success and can be linked to our definition of 
success and failure in the past and current LSIs.  
 Bio2015 15-18 June, Philadelphia 
5.8.5.1 Background 
In January 2015, the researcher put forward an application to host and organise a 
panel session as the Bio 2015 conference in Philadelphia. This was supposed to be 
an exercise in data collection as the conference had the facilities for live audience 
polling. This would have added depth to the research from collecting primary data. 
On the day the polling facility did not work due to a WiFi issue which meant that this 
effort failed to gain primary data. This effort has now been placed alongside the 
observational data because no answers were captured for the questions in Table 18 
below. 
5.8.5.2 The Bio2015 Conference Panel Session Details 
Title: The unsung heroes - life science intermediaries, how they provide value in the 
knowledge exchange and commercialization of innovations 
Abstract: Nearly all economies around the globe are looking to the science base in 
order to positively impact their society and economies. Key to achieving this is 
moving innovations from the knowledge base to the market. In order to overcome the 
challenges this presents, emphasis has been placed on the use of life science 
intermediaries (LSIs) particularly to help bridge the divide between industry and 
academia. Life science intermediaries come in different guises and include a range 
220 | P a g e  
 
of different organisation types. Our 3 cases will include an Open Innovation Bio-
incubator located in close proximity to a pharmaceutical company, the second will 
look at the role of Research and Innovation Campuses and the final case is a high 
performing international Cluster Network Organisation. This session will discuss how 
these 3 different case studies of life science intermediaries are successfully meeting 
the challenges to drive the commercialization process and have become the unsung 
heroes within the sector. 
Methodology: 
The panel moderator will present a short overview of the life science intermediary 
space, explaining what constitutes these unique entities and why they have become 
such a valuable asset in the war in bridging the innovation divide. The first panellist 
will present on how the pharmaceutical sector is experimenting with life science 
intermediaries and what they can gain from this. GSK has invested in an Open 
Innovation bio-incubator that they helped build in a Triple Helix partnership on one of 
their R&D sites. The second panellist will explain the role of a Research and 
Innovation Campus and what competitive advantage this model brings to companies 
located there. The final panellist will explain how they address market needs. By 
identifying, targeting and investing in areas that stimulate commercial growth, by 
harnessing the academic excellence in the region. These 3 speakers will be 
introduced by the moderator before they speak and there will be an opportunity for 
Q&A to the panel  
Speaker 1 
Malcolm Skingle CBE, DSc, PhD, Director, Academic Liaison, GlaxoSmithKline, UK 
Speaker 2 
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Celia Caulcott, PhD Executive Director Innovation and Skills, Biotechnology and 
Biological Sciences Research Council 
Speaker 3 
Florence Agostino-Etchetto, General Manager, Lyonbiopole 
Moderator 
Deborah Spencer, Senior Innovation Manager/Doctoral Researcher, Dundee 
Business School, University of Abertay, Dundee 
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Table 18: Audience Questions at Bio2015 in Philadelphia 
Why is it appropriate for Government to invest in space for companies?  
Do you work in an intermediary?  
What type of Life science Intermediary do you work in?  
Why does having knowledge exchange and commercialisation activities an important 
tool for Bio-incubators and science parks?  
Are partnerships between companies (SMBs, industrials…) and Research Centres a 
good way to develop innovation in Life Sciences?  
What would your region look like if it did not have a Cluster Network Organization?  
Which of these Life Science Intermediaries do you believe are heroes?  
Do you think that it is appropriate that government funding is used to underpin what, at 
the end of the day, will result in several commercial concerns?  
What makes you believe that an academic start-up will do better at an incubator that is 
anchored close to a major pharma site rather than being next or, or part of, a 
university?  
What makes you optimistic that the SBC will be a success and which metrics will you 
use to demonstrate this success?  
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In summary, the audience only half-heartedly took part in raising their hands to these 
questions. The idea with that the electronic data capture would have been done 
anonymously and therefore no one wanted to really participate and for everyone to 
see how they were answering. It was a sad conclusion to months of preparation.   
 The PraxisUnico Conference 10 -12 June 2015, Dublin 
5.8.6.1 Synopsis of key points from field notes from Incubation session 
1. A discussion on why intermediaries struggle to engage with universities 
a. Competition 
b. Lack of opportunities 
c. Small teams 
2. Academics are not team players they are individual researchers. They want 
money to do more research  
3. The speaker had worked with some academics and described them as sneak-
outs as they were circumventing the TTOs. 
4. We put entrepreneurship first with an exciting accelerator programme 
i. We put students into teams 
ii. Then build on ideas and opportunities 
iii. Push and validate the process 
iv. With customers by 12 months period 
The example given here was very similar to a programme created in Stanford 
University in California called BioDesign. This is where a multi-disciplinary group of 
individuals come together as a team to solve specific medical healthcare problems. 
They are given funding to work on the solution for 12 months and hopefully end up 
with a solution in the form of a prototype that is ready for market testing. 
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These initiatives will impact on Case 5 LSIs. A recent paper by (Stumpf, Sandstrom 
Swanger 2016) claims that there is evidence that shows that the initiatives from 
within the TTO are highly unlikely to generate innovations and any real economic 
growth.  They go on to say  that “We find that academic entrepreneurship initiatives 
are characterized by conflicting goals, weak incentive structures for universities and 
academics, and are contextually dependent upon factors such as university 
strength.” (Stumpf, Sandstrom and Swanger 2016, p.1) 
This feeds into the focus code category on ‘Assessing how realistic 
commercialisation targets are’.  This PhD research study found that this particular 
element was difficult for TTOs to achieve targets set for commercialisation.  
5.9 Conclusion of Chapter: 
The thrust of this chapter was to present the data and analysis. In addition an 
explanation of the process of coding used within the analysis was provided and then 
the categories required to review the data under the initial codes was given. This 
required the laborious matching of all the transcribed data against first the initial 
codes and then the focused codes. This was the same for the secondary data and 
for the memos. 
The focused codes were derived from an intensive exercise of scrutinising the initial 
coding data once it had been applied to all the transcribed data. Focused codes 
using gerunds were determined, and were sometimes either a combination of more 
than one initial code or taken directly from the eight categories of the initial codes. 
Once the focus codes were applied to the data including: primary, secondary and the 
memos, the researcher was able to construct the theoretical concepts. The 
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theoretical concepts will be discussed in the next chapter as will the comparisons 
between the five Case LSIs. 
The structure of this chapter allowed for discussion to take place at the same time as 
the analysis, however, there will be further discussions in the next chapter that will 
link to many of the discussions started in this chapter.  
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Chapter 6 Discussion 
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6.1 Introduction 
Chapter 6 will add to the discussions within the analysis chapter and will include 
some further explanations on processes leading to the emergence of theory or 
theoretical concepts.  
A key part of this research has been to compare the LSI models in order to 
determine the model LSI that would be best suited to delivering KEC. This is outlined 
within this chapter along with a comprehensive evaluation of the research quality 
applied along the way. 
6.2 Forms of Telling 
On analysis of the data, the researcher discovered that the interview data revealed 
some quite interesting results similar to the Forms of Telling that Charmaz had 
encountered in her own research and had recounted in her 2014 book. Her study 
involved investigating patients experiences in hospital and she found that people 
invoked different forms of telling, which led her to look more closely at why, how and 
when her participants changed their earlier forms of telling or recounting of their 
experiences. She noted that the subjective stake in telling exceeded the researcher’s 
ability “to plot along a simple continuum” (Charmaz 2014, p.149). 
On closer inspection of the data, the researcher discovered that there were clear 
similarities to what Charmaz had found in her research and had called Forms of 
Telling. This discovery was made on carrying out the analysis at the initial coding 
stage and before the data was applied to the focused codes. One of the eight 
categories from the initial codes, The Life Cycle of the Project/Funding (Table 15), 
was included in The Funding Life Cycle (Figure 13) which illustrated the forms of 
telling. 
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This particular category, on closer and deeper analysis revealed some links to Forms 
of Telling, and have links to the why, when and how a LSI is deemed successful. 
Understanding this has been beneficial to understanding the motivations for telling.  
The researcher had expected to find that participants were guarded in what they 
were relaying to her. What was found was that the life cycle of funding for the LSI, 
and the subcategories identified, have been linked to the participant’s ability to speak 
either openly or guardedly. They spoke openly when the life cycle of the LSI was 
already ended or close to ending and cautiously when the LSI was still in operation 
or had just started and were basically reciting the corporate line. 
What was unexpected was the openness that appeared when the LSI had already 
closed down or when the funding was close to the end. The researcher was 
interested to note that this was something that Charmaz (2014) had also come 
across in the course of interviewing participants and had not expected. This led to 
her reviewing the different forms of telling. The main difference here is that the 
participants have recounted more strategic information than biographical information 
from their patient experiences, with Charmaz’s participants.  What is apparent that 
the participants from this study were passionate in the telling, with the hope that by 
conveying this information they will make a difference to future strategy. Examining 
this section of the research into forms of telling made the researcher look at how this 
could relate to answering the research questions. One of the four main research 
questions is  
RQ2. What are the key perceptions and expectations of the KEC value that LSIs 
hold? 
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Thinking about the life cycle of the LSI is in fact useful in the context of better 
understanding the motivations and conditions at play that have allowed the 
researcher to glimpse these few unexpected revelations. 
The following is a couple of excerpts from the initial coding category of the life cycle 
of the LSI. The memo made at the time of the transcription of the interview has been 
included. 
1h: I actually feel that Xxxxxxx are blockers in this process, in that the 
public sector has an overbearing influence. Here … with account 
management of the companies.  
MEMO- Not many people would be willing to say this about Xxxxxxx this 
organisation. 
1h spoke passionately about something he felt was a major barrier to success of the 
LSI. This LSI is due to close in 2017, so the participant wanted to pass on the 
experiential knowledge gained and felt unencumbered enough to be critical of their 
stakeholders. 
1g: Everyone knows that patents are worthless without the scientists to 
explore them. The Government is focused on job creation, but should 
actually be focussed on IP that is sticking to the country. And of course 
Biotech is very good at producing IP driven businesses. The 3rd thing is 
infrastructure and bottle necks, delivering money will not get these solved. 
Gigabytes is really important, super broadband infrastructure technology 
is needed and Superfast trains, cross rail we need these things. 
1g spoke passionately about the barriers as he sees them. His LSI is in the middle of 
the life cycle, his delivery was passionate and informative. The researcher 
interpreted this as an identification of where the gaps were from someone on the 
ground. There is an element of passionate disclosure given by both these 
participants that are linked to the stage of their intermediary’s life cycle.  
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Reviewing the data once all the case models were coded, only one LSIs from Case 5 
LSIs were not impacted by the life cycle of the LSI. In hindsight these TTO LSIs from 
Case 5 are not funded in the same way as the other case LSIs and do not have the 
same issues relating to funding cycles as the others do. They tend to be embedded 
within the Universities core administrative functions even when some of them are 
subsidiary companies like ERI in Edinburgh which became a limited company in 
1998. 
The link with this category to the research question elements of perception and 
expectation is clear, it provides depth to the analytical process. A diagrammatic 
representation (Figure 11) shows how the different stages of the life cycle of an LSI 
links to the different forms of telling. 
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Figure 11: The Life Cycle of an LSI 
 
 
 
 
 
 
 
 
 
 
 
 
Life cycle stages of a LSI that links to forms of telling. Adapted from Constructing 
Grounded Theory (Charmaz 2014, p.149) 
  
Life Cycle of LSI 
Passionate telling 
Start 
Middle Renewed 
End 
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At the start of the life of a LSI, strategic accounting is the form of telling employed by 
the participants. During the middle of the life cycle the form of telling is more of 
informing and trying to get across more information as the LSI is heading towards an 
end point. The delivery at this stage can be a passionate telling. When the 
participant is talking about an LSI that has ended or closed down or is very near to 
being at that stage the telling becomes disclosing, as in disclosing information and 
thoughts in a passionate way. If the life of the LSI is renewed, like in the case of One 
Nucleus then the form of telling again becomes strategic accounting. There is a hint 
of passionate telling, especially when discussing how the LSI evolved into its 
currently revitalised form. 
Figure 12: The Stages of Telling as Applied to the 22 LSIs 
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Figure 12 above shows where the 22 individual LSIs fall within the different stages of 
telling.  For both the Start and Renewed criteria, the LSI participants recited the 
corporate line. For those in the Middle criteria the participant was much more 
informing and for those that had ended or were near the end they passionately 
disclosed information.  
This analysis led the researcher reflecting further on what success and failure meant 
for LSIs. In the literature review on the past LSIs the researcher assumed that the 
closure of these LSIs, either because the funding had been stopped by the 
stakeholders or the funding period had ended, represented failure.  
It should be noted here that the TTOs have not been added to the Middle criteria 
because they receive their funding in a different way from the Universities they are 
linked to. 
Below in Figure 13 the researcher has assigned each of the 22 LSIs to one of the 3 
criteria on the funding Life cycle in relation to whether the LSI falls in:  Successful (at 
the middle of its funding life cycle); Failed (near the end or at the end of its funding 
life cycle) and Too early to Judge (at the start of a new or renewed funding life 
cycle). 
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Figure 13: The Funding Life Cycle in Relation to Success and Failure of the 22 LSIs 
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The TTOs again are separated as they receive funding in a different way to the other 
LSIs.  
The researcher understands that this distinction is still somewhat subjective and is 
based upon assumptions made by the researcher on the data analysed. The 
“Successful” category is represented by those in the Middle criteria of their funding 
life cycle. However these may still fail. This success is therefore assumed. The 
criteria for ”Failing” is an LSI whose funding has been stopped or whose funding has 
come to an end, but is this a good enough definition of failure? 
The researcher would argue, based on the literature reviewed on the German 
Fraunhofer Centres and the UK Catapult programme discussed previously, that 
longevity has a part to play in defining success and failure of the LSIs. 
6.3 Comparing the 5 Case LSIs 
The process of constant comparison has allowed the researcher to review the LSIs 
that perform best in carrying out KEC. As discussed previously the 5 Case LSI 
models varied, as did the individual LSIs themselves. When it came to Case 3 LSIs 
the researcher came to a hurdle: should these LSIs be distributed to the other four 
Case LSIs or keep it as a Case in its own right. One of the discoveries here was that 
the Case 3 model LSIs should not be a standalone Case model. The researcher 
decided to keep it as it had originally been set out. Conducting a ConGTM means 
that by delving into the data you make discoveries (Charmaz 2014). Then there was 
the promotion of the research and innovation campuses by the Research Councils. 
The observational data collected (see the Innovate UK conference data in the 
Chapter 5) on this was very compelling, hence the decision to keep them as they 
were. 
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Most of the LSIs were there to support and help young companies grow. This means 
you need to arrive at the LSI with the idea for a company or an already established 
one. Only the Sector Specific Thematic LSIs (case 4 LSIs) had funding, resources 
and targets geared towards commercialisation or in other words creating new entities 
like spin-out companies. These Case 4 LSIs believed their LSI model worked best as 
all their staff had experience of working in industry and as one participant from these 
LSIs said they considered themselves “industrialists”. 
Each of the 5 Case LSIs were reviewed and compared under the headings of each 
of the focus codes, then put into a simple table to show how the researcher has 
graded each of the Case LSI models. 
Table 19: Comparison of the Case LSIs using Focused Codes  
Focused Codes Case 1 
LSIs 
Science 
Park & 
Incubators 
Case 2 LSIs 
Cluster 
Network 
Organisations 
Case 3 
LSIs 
Research 
Institutes 
and 
Innovation 
Campuses 
Case 4 LSIs 
Sector Specific 
Thematic 
Intermediaries 
Case 5 LSIs 
Technology 
Transfer 
Offices 
Bridging the divide 
between academia 
and industry 
 
2 
 
1 
 
2 
 
3 
 
3 
Recognising the 
power behind a 
brand 
 
1 
 
1 
 
2 
 
3 
 
5 
Understanding the 
factors needed for 
success 
 
3 
 
4 
 
2 
 
1 
 
4 
Understanding the 
expectations of 
stakeholders 
 
2 
 
2 
 
1 
 
1 
 
2 
Assessing how 
realistic 
commercialisation 
targets are 
 
3 
 
4 
 
3 
 
1 
 
4 
Totals 11 12 10 9 18 
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The scale:  
 1 = High to 5 = Low  
 A low score = Best overall performance 
 A high score = Worst overall performance 
Table 19 clearly shows that not one single Case LSI model stands out above the 
others, although one Case LSI model has scored a total of 18 points in total, which is 
much higher than the other four, this reflects the worse performing LSI in this 
research study. They appear to all have some areas where their performances are 
very good and others that are poor. The lowest score was 9 and that was Case 4 
LSIs the Sector Specific Thematic Networks (Table 19). These LSIs were able to 
function best in creating value in KEC activities. The stakeholders had set targets 
and provided resources so that the LSI could achieve its goals. Case 3 LSIs followed 
with a score of 10, again these LSIs were given targets and resources to enable their 
KEC activities. Cases 1 and 2 LSIs score 11 and 12 respectively. Having completed 
the analysis it was clear that these LSI models say they provide KEC activities, 
however, the reality is that it is really KE and very little C or none at all that are 
supported, in particular Case 2 LSIs. 
A recent study by Brown, Gregson and Mason (2016) claim that entrepreneurial 
spillovers from universities have been overstated and that there is evidence that 
expectations from universities for commercialisation activities have just not 
materialised. The results from this research support this claim. Stakeholders from 
policy-makers and economic development departments have high expectations from 
university TTOs to generate entrepreneurial or commercialisation outcomes that are 
being questioned (Brown, Gregson and Mason 2016). From Table 19 we can see 
that Case 5 LSIs scored 18 points which is 6 points higher than the second highest 
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scoring LSI model. A HEFCE report (September 2016) presented a framework for 
KE and good practise in TTOs. The report explored why universities were doing KE 
and compared them to how well they did against other countries. The conclusion 
was that this LSI model would always be subject to ‘vigorous debate’ (Higher 
Education Funding Council for England 2016). Expectations and outcomes varied in 
the different regions of the UK, with peripheral regions performing worst. 
6.4 What constitutes a high-performing LSI? 
There are a number of elements that need to be considered when creating a new 
LSI, one of the important ones to come through from the data, is branding. LSI 2b 
has had a 17 year history and have continued based on the strength of their brand 
both nationally and internationally, despite fluctuations in their funding. Successful 
brands can be created and with investment like some of the new LSIs like 2a, 3c and 
4g, who are well funded and have the resources to ensure targets for KEC are met, 
they can invest in activities to strengthen their brands. 
 Reviewing the KE and C 
On examination of the data, can we decide on which LSI model is stronger at 
performing the KEC function? The answer is quite straightforward, the LSIs who 
have been given KEC targets at the onset are in a stronger position as they have this 
function built-in to their processes. Many of the older LSIs particularly those in Case 
2 LSIs, the Cluster Network Organisations are designed for KE but not for the C – 
commercialisation element. Commercialisation is defined in a different way in each 
of the 5 Case LSI models. 
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Table 20: The Different Forms of Commercialisation Employed by the LSIs 
 LSI Model Commercialisation  
Case 1 
LSIs 
Science Parks and Incubators Growing  sustainable 
companies and inward 
Investment 
Case 2 
LSIs 
The Cluster Network Organisations Growing  sustainable 
companies and inward 
Investment 
Case 3 
LSIs 
The Research Institutes and 
Innovation Centres 
Spinning-out new companies 
and proof of concept  
Case 4 
LSIs 
The Sector Specific Thematic 
Intermediaries 
Spinning-out new companies 
and proof of concept 
Case 5 
LSIs 
The Technology Transfer Offices Commercialising research 
through licensing, Patents and 
spin-outs 
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Table 20: The Different Forms of Commercialisation Employed by the LSIs above 
helps us review the different model of commercialisation that are used by the 5 
different Case LSI models. We can see that Case 1 and 2 LSIs have a requirement 
to grow and develop companies and to attract inward invest into their LSI and region.  
Case 3 and 4 LSI models both have a remit to spin-out companies and to help move 
innovations out of the research base through proof of concept funding. Case 5 LSIs 
do have an expectation for spinning-out companies as well as commercial gains 
through licensing and patenting activities. They are expected to cover a full range of 
commercialisation activities, which could be why they are considered less efficient at 
the KEC element. 
Having unrealistic targets on commercialisation will set up the LSI for failure and it 
will join the other LSIs who have come and gone like some of those discussed in 
Chapter 3 like the Faraday Partnerships and the Intermediary Technology Institutes. 
This leads us into the discussion in the next section on stakeholder expectations. 
 Reviewing Stakeholder Expectations 
The expectations from stakeholders is another area where LSIs have had to 
overcome issues. The analysis showed us that even in the high performing LSI 
models, like Case 4 LSIs, there were still barriers to overcome. One of the Case 4 
LSIs was given very high commercialisation targets that needed to be negotiated by 
the management team to something that could be realistically achieved. This has led 
to the simple formula being created. 
Stakeholder Perception – reality = Expectation Gap 
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Many of the stakeholders for each of the LSIs have contributed to the expectation 
gap. This has sometimes been done simply through a perception that the LSI can 
provide more than it was created to do.  
Some of the unrealistic expectations that have been seen in this PhD study include 2 
LSIs Nexxus and Scottish Stem Cell Network where the funders and government 
stakeholders had the expectation that the LSI would become self-financed at the end 
of the funding period. Despite a valiant effort by the LSIs to achieve this, it did not 
happen and the LSIs were shut down and, as we noted in the previous section, this 
corresponds to the perception of failure. 
 In Figure 14 we can see the LSIs that fall in the left hand boxes will have a high 
failure rate caused by them either failing to achieve the set targets (which were 
probably unrealistic or unachievable) or by them not becoming self-financed. We 
have seen that both Nexxus and the Scottish Stem Cell Network failed to receive 
follow-on funding in order to continue. 
The box on the top right side of the diagram (Figure 14) shows us that a company 
can still fail even if the stakeholder buy-in was high, but the expectations were still 
high. The ideal place to be for LSIs is in the bottom right hand box where the 
stakeholder buy-in is high and expectations are also realistic. The expectation gap 
will be reduced to zero here. This is an important message for policy-makers, 
funders and government bodies who create these LSIs, however, it is also important 
that LSIs better understand the realities of these perceptions and subsequent 
expectations and that they manage these expectations from the start of the life cycle 
of the LSI. 
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Figure 14. The Expectation Gap 
 
 
This diagram illustrates the perceived expectations of the LSI in relation to the 
realistic expectation and stakeholder buy-in. 
 
(Source: This research) 
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 Reviewing other Barriers to Success 
Most of the LSIs encountered barriers to their success which they have to overcome. 
One observation made of a number of the new LSI models is that there is a 
particular focus on recruiting employees from industry. These particular recruits 
experience difficulties in engagement with the academic sector. It is nothing new to 
hear about the cultural differences and the differences in working between the two 
sectors, and it is clear that this will not change. In addition, the barrier of not having 
insights or specific academic contacts can also make it difficult to engage with 
academia, which is a primary function of LSIs. 
Comparing the Case LSIs has assisted in helping to understand and construct the 
theoretical concepts that are discussed later in this chapter. 
6.5 Theory Development 
Charmaz (2014) asks the researcher in constructivist GT to consider their own 
understanding of what theory is before presenting the emergent theory from 
interpreting the data. Thornberg and Charmaz in their 2014 paper provided a 
simplistic definition of what they see as theory: 
“A theory states relationships between abstract concepts and may aim for 
either explanation or understanding.” (Thornberg and Charmaz 2014, 
p.41) 
In a positivist study the researcher views theoretical concepts as variables and then 
the focus is on the observable evidence (Charmaz and Belgrave 2013). This 
research is based in the realm of the interpretivist and the theoretical concepts that 
have been developed come from this philosophical perspective. Therefore, with the 
interpretive approach the researcher interprets the participant’s meanings and 
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actions and understands that the participant would have in turn interpreted the 
researcher’s meanings and actions.  
“Knowledge and theories are situated and located in particular positions, 
perspectives and experiences.  
Interpretive theory calls for the imaginative understanding of the studied 
phenomena. This type of theory assumes emergent, multiple realities; 
indeterminacy; facts and values as linked; truth as provisional; and social 
life as processual.” (Charmaz 2014, p.231) 
First, the researcher collated all the disparate parts of the collected data, 
including: 
 Primary interview transcription data 
 Secondary Data 
o Websites 
o Reports and Documents 
o Events (conferences, meetings and workshops) 
o Observations and memos 
Then, applying all the data to the first set of coding the initial codes, the focused 
codes emerged and the data was then applied to these codes. The final part 
was in reconstructing the data using this information and the researcher’s own 
understanding of the substantive area - incorporating her own assumptions and 
interpretation of the results to construct the emergent theory. This led to the 
development of the theoretical concepts. 
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6.6 Emergence of Theoretical Concepts  
Five theoretical concepts have emerged from the above analysis, each has been 
identified as the theoretical saturation of the data was reached and the categories 
emerged, and was constructed to form these theoretical concepts. Charmaz (2014) 
says to “Offer an imaginative theoretical interpretation that makes sense of the 
studies phenomena” (Charmaz 2014, p.231) 
1 LSIs who are given specific KEC targets from the onset are more effective 
and therefore are perceived to be of greater value in the KEC opportunities. 
It was clear from the data that LSIs who were provided with specific targets were 
able to focus on achieving these through their KEC activities.  
2 LSIs who are created to provide opportunities for tacit KE only, have less 
chance of continuing beyond the funding period. 
 
The majority of the funding for many LSIs is from public funds and return on this 
investment is governed by economic drivers, like company creation, employee 
numbers and inward-investment. The two options for these LSIs are to find new 
funding with different partners, become a self-financing membership organisation 
or accept the end of the LSI.  
 
3 LSIs who employ staff from both sectors have a greater ability to understand 
working practices and cultural differences, which will enhance the bridging 
function of the LSI. 
Most of the LSIs work at the interface between industry and academia and need to 
bridge the divide. One suggestion for a more effective LSI is to recruit an equal mix 
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of employees from both sectors. This would provide a better understanding of the 
academic drivers and allow the LSI to work more effectively with the academic 
community. Academics appear to be highly suspicious of industry in general. It would 
be seen to be a good thing to have a few academic insiders working within the LSI. If 
anything, the LSIs are seen as a source of funding to the academic community and 
are reluctant to work with them for fear and suspicion leakage of IP; this suspicion 
was seen by the previous interactions between the two sectors in some of the now 
defunct LSIs. For example, the Intermediary Technology Institutes (ITIs) that were 
based in Scotland – where the issue of IP ownership came between the two sectors 
(Brown, Gregson and Mason 2016). This led to poor engagement between the LSI 
and the academic community generally that has been associated to the demise of 
the ITI LSI. 
The current focus is to employ staff from industry, as the perception is that they will 
understand industry drivers. Getting staff from both sides will provide an equilibrium 
within the LSI and go some distance in changing perceptions of the LSI from both 
sectors. 
4 LSIs who are provided with realistic and sufficient resources will achieve their 
targets and meet stakeholder expectations.  
 
After the completion of the literature review it was clear that the expectation gap was 
going to be an important feature of this research. The resulting analysis has shown 
that many of the LSIs are insufficiently resourced to be able to achieve the 
commercial, social and economic outcomes that are expected, despite in many 
cases a worthy effort.  One of the LSIs interviewed provided details of how they had 
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to justify to their funders the much lower targets they believed they could achieve 
during the funding period. 
5 LSIs need to be provided with sufficient timescales in order to make an impact 
and to help change the innovation landscape. 
The changing political landscape and the pressures of short termism on LSIs was 
seen in the literature and linked to the failures of many past LSIs. The most notable 
observation from the data that led to this theoretical concept was the pleading nature 
of a leading academic to continue with the programme for the UK Catapults 
programme during a conference in 2014 (Chapter 5, section 5.8.4). However, it is not 
quite that simple. In order to gain further funding for the LSI, the funders will need to 
determine how successful the LSI has been and if it has realised all agreed targets. 
Therefore yes, time should be factored in, but there needs to be justification for 
further funding of the LSI.  
Figure 15 is a diagrammatic representation of the five theoretical concepts that 
provides a visual that shows clearly the important factors required to ensure a high 
value LSI and one where KEC is fully embedded.   
The five theoretical concepts derived from the data are: 
1 LSIs given specific KEC targets from the outset are more effective and are 
therefore perceived to be of greater value. 
2 LSIs created to provide opportunities for tacit KE only, have less chance of 
continuing beyond the funding period. 
3 LSIs that employ staff from both sectors have a greater ability to understand 
working practices and cultural differences, which will enhance the bridging 
function of the LSI. 
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4 LSIs that are provided with realistic and sufficient resources will achieve the 
targets and meet stakeholder expectations. 
5 LSIs need to be provided with sufficient timescales in order to make an impact 
to help change the innovation landscape. 
A simple framework has been created to show how the variables that have emerged 
from the data can impact on the KEC of a LSI and the subsequent performance of 
the LSI  
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Figure 15. Theoretical Framework Model 
  
Realistic and 
Achievable 
Targets 
Personnel from 
both Industry & 
Academia  
Time enough to 
make things 
happen 
Sufficient Funding 
5 
3 4 
Increased 
Potential for 
funding 
Resources 
Provision 
of KE & C 
1 2 
A High 
Performing 
LSI 
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 Preconceptions and their Impact 
There has been criticism of theorizing in GT (Dey 1999, 2004, Layder 1998, Glaser 
1992, 2002, 2003, Burrawoy 1991). The challenges from these academics are varied 
and include the assumption of preconception, procedural application and theory 
based on pure induction. Burrawoy (1991) says this methodology produces 
generalisations, and argues in favour of Case Study methodology as he says it 
uncovers the specifics from a situation. Bryant and Charmaz (2010) counter this by 
saying that 
 
“GT resides in its applicability across substantive areas.” (Bryant and Charmaz 2010, 
p.133). 
 
A deep familiarity with the research phenomenon and the application of constant 
comparative methods as a core feature, allows for the emergence of theory. It should 
be noted that these theories are mere suggestions and it is for this reason that the 
researcher has chosen to call them Theoretical Concepts as they are not the final 
theory (Remenyi 2013, Charmaz 2014).  
 
Remenyi (2013) talks about the fit and grab of theory. He explains that fit means that 
the theory adequately describes the data that is linked to it. In an explanation of 
grab, he says that if the theories suggested are used in the real world by 
practitioners, then this goes someway in validating these research findings.  
Acknowledging the fact that Constructivist theorist must consider their beliefs and 
how they affect the research is an important factor in conducting Constructivist GTM.  
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 “Engaging in reflexivity about preconceptions and holds special significance 
in focused coding because these codes shape our analyses” (Charmaz 2014, 
p.155).  
Throughout this research process and particularly during the interviewing and 
analysis of the data, the researcher was keenly aware of her own interpretations and 
those of the interview participants. This reflexive approach has been an important 
feature towards undertaking this PhD research study and one that would be viewed 
as being of high value and high quality by the researcher and hopefully the reader. 
6.7 Evaluating the Research Quality 
The quality of the research has been an important theme throughout this research 
study. This is the stage, according to Charmaz (2014), where the researcher should 
look back at the research process and forward to envision what the final product will 
look like to the various audiences. Evaluating the research quality is basically an 
audit of the research and Charmaz in her more recent book published in 2014 has 
outlined specifically the criteria to examine the research process under the following 
four headings. Each criteria will be explored using the specific questions as outlined 
by Charmaz (2014, pp.337-338) and discussed under each of the following 
headings: 
 Credibility 
Q. Has your research achieved intimate familiarity with the setting or topic?  
A. The research is focused on elucidating the value from the activities and the 
organisational processes of the 5 different LSI models. This focus throughout the 
research has been a familiar theme from the onset.  
Q. Are the data sufficient to merit your claims? Consider the range, number, and 
depth of observation contained in the data? 
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A. Although some of the LSIs have larger numbers of individual LSI – for example 
Case 1 LSIs, the incubators and sciences parks – there was a sufficient number of 
quality participants. This is the case for nearly all case LSIs – apart from Case 3 LSIs 
which had only 2 different LSIs. Although the observational data in this case 
provided a little more clarity on some of the expectations relating to KEC from the 
Research Councils that fund these LSIs as strategic campuses, it became clear at 
the analysis stage that these Case 3 LSIs should be considered Case 4 LSIs rather 
than a standalone Case model. 
Q. Have you made systematic comparisons between observations and between 
categories? 
A. The researcher, by using constant comparative methods and field notes/memoing 
throughout the research process, was able to compare the data from the 
observations and relate them to the categories identified. These comparisons helped 
to reinforce the analysis by interpreting the data.  
Q. Do the categories cover a wide range of empirical observations? 
A. The categories identified for the initial codes were wider ranging, which allowed 
for a more in-depth review of each Case LSI and in-turn each LSI within the case 
model itself. The focused codes were then identified. These had five main 
categories, which represent an amalgamation of sometimes more than one of the 
initial coding categories. Whether there should have been more categories is hard to 
say, the researcher spent time immersed in the coding in order to ensure that the 
categories chosen would be focused on answering the research questions and 
would be beneficial to practitioner’s and other researchers.  
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The ConGT process itself has built-in processes to allow for the exploration into past, 
present and future (Charmaz 2014). This in itself allows for wide ranging empirical 
interpretations. The researcher used the methods to seek out knowledge on the 
sector and on the LSI participants interviewed. The observational data included 
reports written, newspaper articles, newsletters and various network websites. For 
the events and conferences attended the researcher made field notes and memos 
on all pertinent information that may have impacted on the research during the data 
collection process. This level of rich data, hopefully validates the number and quality 
of the categories that were identified. 
Q. Are there strong logical links between the gathered data and your argument and 
analysis? 
A. The researcher has been fortunate to have been able to gather such a large 
amount of primary data from participants who are the leaders of their LSIs. The 
ability within ConGT for interpretative analysis, which includes the understanding the 
researcher has with the participant’s sector, allows for there to be strong ties 
between the data gathered and the argument. 
Q.  Has your research provided enough evidence for your claims to allow the reader 
to form an independent assessment – and agree with your claims? 
A. The reader will hopefully be able to follow the logic of the arguments and 
assessments as the justification for statements have been made using data from the 
transcripts of the interviews themselves. As Charmaz has said each reader will 
interpret the data differently based of their own understanding of the sector that the 
research is located. 
With ConGT it is accepted that the research will be revised.  
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“ Not only does a Constructivist approach help you to remain clear about 
the antecedents of your constructed theory, this approach helps other 
researchers and policy-makers to establish the boundaries of the 
usefulness of your grounded theory and possibility to ascertain how and 
where to modify it.” (Charmaz 2014, p.339) 
 
 Originality 
Q. Are your categories fresh? Do they offer new insights? 
A. The five LSI Case models that have been used in this research have been studied 
by other researchers on an individual basis. To the researcher’s knowledge there 
has not been any research study that evaluates and compares all five against their 
ability to add value to the KEC processes within their organisations. This in itself has 
presented new insights and will hopefully prove useful in particular to funders of LSIs 
considering the role and function of these LSIs and what to expect from them given 
the resources provided.  
Q. Does your analysis provide a new conceptual rendering of the data? 
A. We are in the age of evidence-based research and it is hoped that this research 
study will add value to those looking to support new and improved LSIs. One of the 
focused codes was to explore what the factors were for success. It included a 
number of different categories from the initial coding process, which included 
branding, barriers and the life cycle of the LSI. This system of coding and analysis 
within the ConGT methodology did as was predicted by Charmaz and revealed 
concepts previously unthought-of . This type of data has never had ConGTM applied 
to it and it is hoped that the readers will understand the originality of the interpretive 
process as applied. 
Q. What is the social and theoretical significance of this work? 
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A. Many of the LSIs receive funding from Government, which means it is tax payer’s 
money. We have a moral duty to invest in initiatives that will benefit society and help 
to improve our economy. The LSIs are funded as a way to help create new 
enterprises to ensure our innovations make it out of the universities and can 
encourage wealth generation. The theoretical significance is to provide concepts that 
will help policy makers make the right decisions. Research, if deemed to be of 
quality, can have an impact on decision making. 
Q. How does your grounded theory challenge, extend, or refine current ideas, 
concepts, and practises? 
A. The importance of reviewing the literature once the analysis is completed is a 
common occurrence in research studies. This study has been no different. In this 
fast paced sector things change rapidly, it is important that current ideas are 
reviewed against the theoretical concepts from this research study.  
The key features that this research will bring to current practises includes exploring 
the expectation gap more thoroughly before policy-makers and practitioners embark 
on any new proposed LSIs. What is really achievable given the resources including 
funding and time? Finally those LSI that have a poor record for commercialisation 
need to find solutions to address the issue, like in some TTOs 
 Resonance 
Q. Do the categories portray the fullness of the studies experience? 
A. As mentioned previously in this chapter, the analysis of the data was particularly 
lengthy and could have gone on longer, having more categories would have tipped 
the research over the approved time limits. The categories and codes used within 
the study provide a balanced portrait of the studies experience. 
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Q. Have you revealed both liminal and unstable taken-for-granted meanings? 
A. This has all been part of the interpretative nature of the study. Much of the 
unbalanced or unstable meanings have been explained in full to help the reader 
understand the reasoning behind an argument.  
Q. Have you drawn links between larger collectivities or institutions and individual 
lives, when the data so indicate? 
A. This question probably does not apply here, as the majority of the research 
studies that Charmaz was involved in have been in relationship to nursing or medical 
support practices and not to business management studies. However, in order to 
answer this question, the researcher can confirm that the individual or participant 
was considered in the context of the larger organisation. This chapter discusses the 
link to the funding life cycle stage of the LSI and its importance. This was described 
in this chapter under ‘Forms of Telling’. With new LSIs there was a more targeted 
approach to the interview, while those at the end of their funding life cycle, there was 
more information provided on what could have been done better by the institutions or 
funders. 
Q. Does your grounded theory make sense to your participants or people who share 
their circumstances? Does your analysis offer them deeper insights about their lives 
and worlds?  
A. Before being granted the time to conduct the interview, the researcher had to 
contact the participant, all of whom are leaders in their respective LSIs and explain 
the purpose of the study and what the research hoped to achieve. They would not 
have agreed to take time out of their busy schedules in order to gain nothing. 
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In addition, the interviews themselves provided an opportunity for the participants to 
review their own LSI processes and discuss their aims, their strategies and to review 
the expectations from a variety of stakeholders. Towards the end of the interview 
with 4a, the CEO was telling me about plans to create a new manufacturing facility 
as an extension of their LSI. The researcher who had interviewed participants at 
LyonBioPole in France was able to inform the CEO of a manufacturing hotel there 
that the CEO was not aware of. This was an example of the benefit that the 
participants gained from taking part in this study. For 4a they had ambitions to be the 
first in Europe to provide this kind of service. If nothing else it compelled them to 
research this further. 
 Usefulness 
Q. Does your analysis offer interpretations that people can use in their everyday 
worlds? 
A. When discussing if knowledge should transform practice and social processes, 
Charmaz (2014) gives a resounding yes! She says that ConGTM can contribute to a 
better world. She says that knowledge is not neutral, nor should it be separated from 
the real world. When embarking on this research project the researcher, who had 
worked in the sector for 15 years previously, had the ambition to make this research 
impact on the everyday lives of practitioners within the sector. 
Q. Do your analytic categories suggest any generic processes? 
A. Yes, because the research is a comparative analysis between the five different 
LSIs there are codes or categories that repeat in each Case LSI model. This is an 
important feature for comparing the different LSIs and has been useful in identifying 
the problems in Case 3 LSIs and the subsequent conclusion that this Case does not 
258 | P a g e  
 
warrant a standalone Case model and the LSIs within it should be distributed to 
Case 4 LSIs. 
Q. If so, have you examined these generic processes for tacit implications? 
A. The issue of time has prevented a return to speak to participants to validate any of 
the analysis, this will of course feed into the discussion on future research, discussed 
in the next chapter. 
Q. Can the analysis spark further research in other substantive areas? 
A. The subject of further or future research in relation to this research study is 
discussed in the next chapter. 
Q. How does your work contribute to knowledge? 
A. The hope is that some of the questions asked are those asked by practitioners, 
policy-makers and funders, and therefore answering questions relevant to them. The 
contribution to knowledge is twofold, both to the literature on life science specific 
intermediaries, of which there is scant literature, and to the contribution to the 
business management literature by applying the ConGT approach to this qualitative 
study. Again, the researcher encountered very little research available to business 
management students to guide them through a ConGT study. Please see the next 
chapter for a more detailed discussion. 
6.8 The Researcher’s Reflections 
Reviewing the overall data has revealed some interesting and unexpected results. 
The nature of ConGT methodology is that a closer relationship to data collected is 
part of the process.  
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In addition to the emergent theories or the theoretical concepts there are a few 
additional things that are worth some focus and will help to build a picture of the 
elements needed in addition to the key ingredients found in the theoretical 
framework. These include the following: 
 Having the right champion for the LSI – individuals with energy and passion 
who are driven to make a success of their LSI. For example, the Queen Mary 
Innovation Centre was built at the height of the recession and yet has become 
hugely successful. The fact that this level 3 incubator is full is an indicator of 
its success and many of the companies that reside within have grown 
significantly. At the time of the interview the idea was that the larger 
companies would move out to science parks elsewhere to allow them to grow 
effectively. However, in a recent conversation with the LSI, it seems that the 
companies are reluctant to move out as they have complex equipment and 
facilities and have requested that the incubator finds a way to keep them 
there.  
This is a divergence from the traditional progression of companies, as they 
would normally seek to expand elsewhere. Biocity and the other LSI 
participants with tenants have Biotech companies that want to remain on the 
incubator sites. This is worthy of further investigations. Perhaps the complex 
infrastructure of wet labs, office and cleanrooms is contributing to the lack of 
movement out of the incubators. 
 The next revelation may turn the idea of the exchange of tacit knowledge on 
its head. A few of the LSIs including BioCity, Queen Mary Innovation Centre 
and RoCRE at Rothamsted Research, indicated that gathering around the 
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water cooler to spark the exchange of ideas does not happen in reality. This is 
potentially inconsistent with the idea of having an anchor organisation and the 
idea of building an innovation hub located close to a research centre of 
excellence is to allow for this kind of KE to take place.  
Perhaps it will work for companies who are still at the very early stages of 
incubation, but when they get to a certain level, and in particular when they 
have their own IP, they become a little more guarded about who they speak to 
and about what. 
 The Cluster network organisations over 15 years old were created before 
social media existed. Newsletters were in hardcopy format and websites were 
clunky. They were created to largely focus on the KE side of KEC and even 
though they have survived, mostly as self-financed membership organisations 
that have no commercialisation targets set, their business model does not 
sustain the commercialisation aspect of KEC.  
Again further investigation as to whether this would be possible would be of 
value as the membership of these Cluster Network Organisations has grown 
substantially over the years. One of the Cluster Network Organisations said 
that they helped to facilitate commercialisation by those more focussed 
directly on it, such as the TTOs. Therefore, it could be that this symbiotic 
relationship would work. 
 The final item of interest revealed during the analysis stage was that inward 
investment activities were a low priority for most of the LSIs interviewed. The 
impression was that they had to take time out of their busy schedules, and in 
many cases they had to rally senior academics and CEOs from companies to 
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take part in visits that invariably resulted in no take up. Many felt such 
activities were a waste of time. 
 
6.9 Conclusion  
Those practitioners who have conducted quality assurance in their work will 
appreciate the detailed audit that this chapter presented. This will in particular help to 
reinforce the issues of quality to other researchers and those in particular from the 
natural sciences, who have a penchant for the reproducibility and the validation of 
research.  
The earlier discussions on Forms of Telling and comparing the 5 Case LSI models 
brought some insights into the 5 LSI models and allowed for greater comprehension 
on the specific roles of the LSIs and their provision of KEC. 
Theory development was explained from an interpretivist point of view and then the 
theoretical concepts were discussed and the 5 main theoretical concepts that 
emerged from the data were explored.  
Some of the unexpected responses were discussed under the researcher’s 
reflections. This provided some further food for thought and will lead on to the final 
concluding chapter. 
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Chapter 7 Conclusion of Thesis 
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7.1 Introduction 
This final chapter begins by looking at how the research has contributed to 
knowledge within the field of innovation intermediaries.  We then look at how and if 
the four research questions have been answered and if the aims and objectives of 
the research have been met. A deeper discussion follows on how the data links to 
the literature reviewed. Next, we look at the limitations of the research and the 
recommendation of future research and how it could be of further benefit to 
practitioners and policy-makers. The final reflections and concluding remarks are the 
two final sections of the thesis, here the researcher provides some critical thinking on 
the study. 
7.2 The Research Contribution to Knowledge 
Intermediaries are important in brokering KEC between the industrial and academic 
sectors and much has already been written about different aspects of these 
intermediaries (Wilson 2012, Hauser 2014, Lopez-Vega and Vanheverbeke 2010). 
KEC is an essential component within the economic development agenda (HEFCE 
2016). This PhD research study aimed to further our understanding of the value that 
intermediaries bring to the innovation process, and through empirical evidence 
determine their true value in relation to our investment in them. 
In addition, the theoretical framework model based on the five theoretical concepts 
derived from the coding and analysis aims to help practitioners and policy-makers 
understand better the key factors needed to create a high-value LSI. 
An extensive review of past research has generated evidence of only a few studies 
using GT in business management or innovation intermediary research. None have 
been found that use a constructivist GT approach. Most of the innovation 
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intermediary literature has not focused on a single sector (Howells 2006, Suvinen, 
Kottinen and Nieminen 2010, Lopez-Vega and Vanheverbeke 2010). This study 
satisfies Suvinen, Kottinen and Nieminen’s (2010) call for sector specific innovation 
intermediaries to be explored. This also covers the call from Lopez-Vegas and 
Vanheverbeke (2010) to investigate ‘yet undiscovered’ modes of intermediaries. This 
research has added LSIs to the literature as discussed in chapter 3 under 
‘Terminology’. LSIs are a collective name given to intermediaries operating within the 
life sciences sector. 
Swan et al. (2007) had determined that it was important to carry out a comparative 
analysis, which has been done in this study. This analysis led to the creation of the 
five theoretical concepts, something Rank, Rank and Wald (2004) proposed in their 
call for future research when they explored biotechnology networks. They wanted 
future research to be done where it would be possible to derive in-depth details in 
order to develop further theories. Others like Gassmann, Daiber and Enkel (2011) 
were interested in future studies on the innovation process models. The framework 
model based on the five theoretical concepts from this research achieves this (Figure 
15). 
Past research has stressed the need for studies to explore the role of stakeholders 
other than companies (Coeurderoy and Duplat 2008, Lawton-Smith and Bagchi-Sen 
2006). This was achieved in this study as the interview data came from the CEOs 
and managers of the LSIs themselves. Access to the companies the LSIs worked 
with was limited, and the one that was interviewed did not add anything significant. 
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 This research assessed the expectation gap (or perhaps it should be called the 
‘reality gap’) that comes from having high expectations from the LSI stakeholders 
compared to what can, in reality, be achieved (Figure 14). 
Finally, the differences between LSIs and the brokering roles they carry out was 
explored in this study, addressing the call from Abbate, Coppolino and Schiavone 
(2011) to review in more detail the brokering function in the KE process. 
Novelty comes from the fact that although much has been written about LSIs, mostly 
from the single case and non-sector specific perspective, there has been no attempt 
to try and compare them. Yet policy-makers ask questions about which would be the 
best intermediary model to facilitate specific actions, without fully understanding their 
ability to achieve the task set with the resources allocated. There is a paucity of 
literature using ConGTM in the area of business management, this PhD study 
followed the ConGTM approach and has therefore added knowledge to the field in 
this research methodology. The researcher believes that the immersion in the data 
during the coding process helped identify a number of emergent theoretical concepts 
that will add to our knowledge of these LSIs and although no substantial theory has 
emerged, these theoretical concepts are a step closer to new theory development.  
“Inductive theorising opens up the possibility of novel understanding. And 
increasingly researchers acknowledge that 1) their observations include 
how they see and define the observed phenomenon 2) they move 
between creating inductive categories and making deductions about them 
and 3) explicitly invoke abductive reasoning.” (Charmaz 2014, p.243) 
Five theoretical concepts were developed and presented in chapter 6, these are: 
1. LSIs that are given specific KEC targets from the outset are more effective 
and therefore are perceived to be of greater value in realising KEC 
opportunities. 
266 | P a g e  
 
2. LSIs that are created to provide opportunities for tacit KE only, have less 
chance of continuing beyond the funding period. 
3. LSIs that employ staff from the private and academic sectors have a greater 
ability to understand working practices and cultural differences, which will 
enhance the bridging function of the LSI. 
4. LSIs that are provided with realistic objectives and sufficient resources will 
achieve their targets and meet stakeholder expectations.  
5. LSIs must be given sufficient time to make an impact if they are to help 
change the innovation landscape. 
The five theoretical concepts are fundamental to the framework model (Figure 15), 
and provide a checklist of factors important in the creation of new LSIs or indeed 
updating existing LSIs. Importantly, they would go some distance in creating high 
performing LSIs where KEC is embedded. 
The contribution this study has made to new knowledge has been to focus on the 
substantive area of the life sciences sector by carrying out a study based on the 
sectoral systems of innovation. The new terminology of LSIs has been added to the 
literature and hopefully will be taken up and used within the life sciences innovation 
intermediary organisations and those working with them.  
The next key contribution has been the five emergent theoretical concepts that make 
up the framework for high-performing LSIs. In addition, the data allowed us to 
identify the different forms of telling that helped to link the funding life cycle to 
success and failure. 
267 | P a g e  
 
Using a multiple case comparator and focusing the research study within the LS 
sector the researcher has brought new knowledge to the field of study. The initial 
question as to why so many of the LSIs fail in the UK has been the main focus. In 
addition, what constitutes success and failure and the ingredients needed for 
success have been identified and will allow us to measure future performance. 
7.3 Addressing Research Questions & Linking to the Literature 
In this section we will review the four main research questions in relation to the data 
collected and analysed. First we will determine if our objectives have been achieved 
 The Research Aims and Objectives 
The research aims and objectives identified in chapter 1 are listed below, they are 
designed to help focus the research by illuminating the research path to help answer 
the research questions. These aims and objectives are: 
 Investigating the role and function of a range of LS intermediaries within the 
UK and Europe (Holland and France) 
 Exploring the ecosystem that each case LSI is located in with respect to their 
stakeholders. 
 Exploring the perceptions and expectations of LSI stakeholders in respect of 
targets. 
 How are outcomes measured and reported in each case LSI? 
 Exploring the potential for commercialisation outputs from KEC, including: 
e. Spin-outs/ start-ups 
f. Licensing 
g. Collaborations 
h. Inward investments 
This list of aims and objectives were factored into the interview process, either being 
embedded within the questions or as specific questions to the interviewee. All of 
these aims and objectives were fulfilled by this PhD research study. The study was 
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able to recruit participants from all the countries identified in the first objective. There 
was some concern that using the data collected from the 2 LSIs in France and 3 in 
Holland would have been inappropriate since they could not be used for a full and 
equal comparison with the many UK LSIs. This was largely down to the lack of 
resources both in time and finances to allow the researcher to recruit equal numbers 
of LSIs that would be comparable to the numbers recruited in the UK. The solution 
was to utilise the data from them to support that collected in the UK. Doing this 
highlighted no differences in national innovation systems: the LSIs in France and 
Holland have similar NISs that apply to them – for example the patenting system, the 
system for drug approvals and the innovation ecosystems. LyonBiopole has many 
more examples of successful Triple Helix partnerships than the UK, this was the only 
noticeable difference.  
This also ties in with the second objective, where the ecosystem of the LSI was 
taken into account. The last three objectives were built into the research questions 
and have subsequently fed in to the theoretical framework that resulted from the 
emergent theoretical concepts.  
 
 The Research Questions 
As discussed in Chapter 1 the first two research questions were identified early in 
the study, while the other two research questions were identified after a further stage 
of the literature review process.   
The four main research questions this PhD project endeavoured to answer were: 
RQ1. Are LSIs important for the commercialisation of research? 
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RQ2: What are the key perceptions and expectations of the KEC value that 
LSIs hold? 
 
RQ3. Why do some LSI fail to survive beyond their funding stream? 
RQ4. How important is an anchor organisation to an LSI? 
7.3.2.1 RQ1. Are LSIs important for the commercialisation of research? 
As previously discussed in Chapter 6 when comparing the different LSI models, they 
varied in the type of support for commercialisation that they offered (see Table 19). If 
we explored each Case LSI a little further to help clarify and review the importance of 
the level of commercialisation activity in each LSI. These differences have had an 
impact in their commercialisation performance.  
The Case 1 LSIs are the incubators and science parks. They do not specifically offer 
commercialisation services to their tenants, they can offer KE and a range of 
services that help an SME to grow and develop – all valuable services.  Although this 
appears to be changing as incubators, like BioCity, and Science Parks, like the 
Pentlands Science Park, have engaged commercialisation business development 
managers. This could be a new trend, as the Business Development Managers work 
with the tenants to look for funding for them to grow, thereby adding value. Therefore 
it is not just about creating new spin-out companies, it is also about company growth. 
Most of the Case 1 LSIs are focused on filling their incubators and sciences parks. 
They are therefore interested in the inward locating companies rather than 
specifically themselves spinning-out companies. If they are located near to an 
anchor organisation such as a university or research institute they would welcome 
any spin-outs from these organisations. 
The Case 2 LSIs are the cluster network organisations, and again like the Case 1 
LSIs they do not generally offer support for commercialisation activities. Their main 
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focus is in the KE and connecting companies to customers and to research 
collaborators. 
The Case 3 LSIs that were interviewed had clear commercialisation targets set by 
their funding stakeholders. Commercialisation activities for these LSIs include 
helping to grow the companies already located on site and attracting new inward 
locating companies. Their main objective, however, is to commercialise new 
innovations coming out of the research based at the nearby research institutes and 
universities. The LSIs interviewed in this Case LSI model included both Rothamsted 
and BioAster who were fairly new LSIs therefore both had specific targets for KEC 
from the onset. As mentioned previously these Case 3 LSIs should both be placed 
within Case 4 LSIs. 
The Case 4 LSIs are the sector specific thematic intermediaries. These LSIs are 
expected to have KEC embedded within them. The Case 4 LSIs do have 
commercialisation within the heart of their main function. The evidence provided by 
Edinburgh BioQuarter shows that without their LSI very little in the way of new 
innovations and new spin-outs were making it out of the University they work with. 
This LSI had a high success rate in creating new spin-outs. The metric by which they 
were measured was the number of spin-outs over a period of time, however they 
also had a programme of KE events that they disseminated to the sector. When 
reflecting on the university’s previous history of low commercialisation outputs, it 
does appear to validate RQ1 and in the case of the most recently created Case 4 
LSIs like the Edinburgh BioQuarter the importance of the LSI to commercialisation of 
research can be seen. Therefore, in this case, LSI support was valuable. However, 
when speaking with the Cell and Gene Therapy Catapult, which was also included in 
Case 4 LSIs, it was clear that commercialisation was the main focus, while KE was 
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less important and only occurred as a side thought. It should be noted that the 
interview took place early in the life cycle of the Catapult, which was still in the set-up 
phase of its life cycle.  
One of the LSIs interviewed in these sector specific thematic intermediaries - Case 4 
LSIs was the Scottish Stem Cell Network, which had recently shut down. It should be 
noted that this LSI had begun in 2003 and at the time the requirement for them was 
to help companies to grow, however, no specific commercialisation targets were 
given by the funders for creating new entities.  
In the Case 5 LSIs, which include a range of TTOs, there is some commercialisation 
taking place and a desire to increase this activity. Commercialisation also includes 
the licensing of technology and accessing grant funding for translational research. 
TTOs do engage in company creation and it’s this element that we see a desire to 
increase.   
Although KEC is an embedded function in TTOs, and has gained momentum in 
recent years, it has become clear from this PhD research study that these LSIs have 
the potential to become high performing LSIs with embedded KEC activities driving 
them. Locke et al. (2005) said that some TTOs already have the expertise in-house 
to deliver tacit KE, but their inability to deliver both tacit and codified knowledge is 
preventing them from being seen as high performing LSIs. Two interview 
participants, Edinburgh Research and Innovation and Luris from The University of 
Leiden Medical School, are clearly focused on commercialisation activities and 
described how they had made it a priority to improve the processes. 
Having explored each of the Case LSIs in terms of their perspective on 
commercialisation, we can see that the Case LSIs have different frameworks and 
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targets for commercialising research and that despite this difference the LSI is 
important within the process. Some LSIs have managed to accelerate the 
commercialisation process. However, those LSIs that were solely focused on KE and 
did not have targets for commercialisation, have been perceived by their funding 
stakeholders as having less value and have closed when their funding life cycle 
ended.  
This research study has shown us that commercialisation activities varied for each of 
the different LSI Case models. Indeed, commercialisation outputs included not just 
spin-outs, start-ups, collaborations and inward investment, but also patents and 
licensing of technology and finding funding for early stage companies; a wide range 
of activities of which some did all, some did a few, and others did none. 
Something that should also be considered is the national innovation landscape and 
the factors that contribute to the success for companies. Rosiello (2007) said that, 
depending on the location of the cluster and the size of the companies, there may be 
a need for an LSI. His study looked at companies within Scotland, which needed the 
help of LSIs to access funding, plus customers and staff from outside of the country. 
This could also be attributed to the size of the company. We have noted in this study 
that fledgling companies require more support from an LSI than more established 
companies. Scotland has a higher proportion of smaller companies than the South 
East of England, which has a number of companies that are similar in scale to a 
small pharmaceutical company. These do not usually require support from an LSI.  
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7.3.2.2 RQ2.  What are the key perceptions and expectations that LSIs hold? 
The expectation gap was explored in this study and it was determined that the gap 
was created by the difference between the perceptions from stakeholders and reality 
(Figure 14).  
The objective of measuring outcomes allows us to answer RQ2 in a more meaningful 
way. The metrics used were fairly simplistic and linked to the model of Case LSI. The 
following is a description of the metrics that were used for each Case LSI model.  
 In Case 1 LSIs it was simply the number of tenants in their LSIs. 
 In Case 2 LSIs it was case studies of successes and the number of 
individuals from academia and industry who had attended their KE events.  
 In Case 3 LSIs it was spin-outs, but more importantly it was collaborations 
and research income. 
 In Case 4 LSIs, it was the number of companies spun-out or created, the 
number of entrepreneurs they helped and research income 
 In  Case 5 LSIs it was the number of patents, licences and spin-out 
companies 
Perceptions and expectations have a profound effect on these LSI Case models. In 
chapter 6 we discussed Forms of Telling, which helped the researcher delve into 
some of the revealing interviews provided. The data revealed the link to the funding 
life cycle of the LSI and how open they were about their LSI. Where they were in 
their funding life cycle determined the amount of open telling against more guarded 
telling. At the start of a new LSI, the interviewee would provide more strategic 
answers compared to those who were coming to the end of the life cycle or who had 
completed the funding life cycle and their LSI had closed. Through this process it 
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was possible to delve deeply into what the perceptions and expectations were on the 
value of these LSIs. 
Thinking critically about the range of LSIs and the RQ on expectations, we do need 
to take into consideration the age of the LSI and the funding life cycle of the LSI. The 
more recently created LSIs have had specific targets for KEC embedded within their 
LSI business model; this has reflected positively on their value and impact on KEC. 
Outwardly the LSIs chosen for this study appear similar, especially in their ability to 
bridge the gap between industry and academia. However, by using ConGTM in this 
study various components have been unravelled to reveal the main differences when 
trying to compare like with like. For example, these sector specific thematic 
intermediaries included the Scottish Stem Cell Network, which was created in 2003. 
We have already mentioned previously that the age of a LSI does have a relevance 
to whether KEC is fully embedded. No specific targets for commercialisation were 
set for creating new companies, but the network did support company growth. There 
was however an expectation from the funding stakeholders that this would be an 
outcome of the activities of the LSI. This then resulted in the LSI not achieving these 
expected targets and by 2013 when it shut down it were perceived as a failed LSI. 
The researcher has observed that the funders and policy-makers at that time 
appeared to not fully understand that commercialisation means many different things 
to different LSIs, and hence the expectation gap for this LSI was large. 
The UK Catapults and the German Fraunhofer’s are similar types of LSIs and many 
of the reports have noted the longevity of the Fraunhofer’s. Whereas, in the UK we 
have had a series of intermediaries that have closed, and are considered failures.  
Why do we now believe that the UK Catapult Centres and the Scottish Innovation 
Centres will succeed where others have failed? This study has identified the gaps 
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between expected and realistic targets that are set by the stakeholders. This means 
that if the targets are not met, the LSI is labelled as a failure. Therefore, in order to 
reduce the expectation gap funding stakeholders need to better understand what is 
achievable with the funds they provide to the LSI. If the Theoretical Concept Model is 
followed, the expectation gap will be reduced.  
 
7.3.2.3 RQ3. Why do some LSI fail to survive beyond their funding stream? 
This research question was identified from the literature in Chapter 3 of this thesis 
where we examined a few failed LSIs. These included the ITIs (Brown, Gregson and 
Mason 2016) and the Faraday Partnerships (Howells and Elder 2011, House of 
Commons Science and Technology Committee 2011). In the case of the Faraday 
Partnerships the research findings showed that there were two main causes for this 
failure: thinly spread funding and lack of engagement from industry. 
Reviewing a few of those LSIs whose funding had ended, like the Scottish Stem Cell 
Network and Nexxus, it was interesting to note that they had similar experiences with 
engagement with industry. Both said that there was a need for their intermediary 
services from the SME community they served, but that larger organisations were 
either able to do things for themselves or were directly account managed by the 
regional economic development agency. This stands out as a misplaced expectation 
from the LSI’s stakeholders that companies of all sizes would engage with the LSI.  
The analysis in this study has showed that both Nexxus and the Scottish Stem Cell 
Network, which were not funded beyond their funding periods, were perceived as 
having failed to achieve expected targets for industry engagement. It is likely that the 
Faraday Partnerships were considered a failure for the same reason.  In the case of 
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the ITIs, Brown, Gregson and Mason (2016) claim that the failure was due to a fault 
in the design and that the design should have taken into account the local 
entrepreneurial ecosystem. For the ITIs some of this failure has been associated 
with the lack of agreement between industry and academia - in particular with regard 
to ownership of IP.  The ITIs were created as not-for-profit companies and managed 
the funding with their academic partners. One of the issues was that they wanted to 
own the IP. This did not sit well with the universities. 
When we looked at the Forms of Telling section in the last chapter we noticed a link 
to the funding life cycle of the LSI and its perceived success or failure. The 
researcher asked the question: if an LSI closes when it comes to the end of its 
funding, does that mean it is perceived as having failed? If so, are those LSIs that 
get a continuation of their funding and continue to operate then perceived as 
successful? 
Despite trying to understand what failure and success means, the researcher has 
noted that the fact they have come to end of their funding is too simplistic an answer 
to the question: as to what constitutes failure? A few of the LSIs that shut down had 
been doing well, providing a service to SMEs who did not have the resources and 
know-how to accelerate their own growth. LSIs like Nexxus and the Scottish Stem 
Cell Network provided marketing channels and access to export markets as part of 
their offering. Should they have transformed their LSIs into fee paying networks like 
One Nucleus or would this have transformed themselves into something 
unrecognisable?   
These public funded LSIs are high profile failures and fit right into what Oakey, West 
and Manchester (2007) claimed was interference from policy-makers to artificially 
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grow these LSIs. They say that if the economic environment is right they will grow 
organically. This answer leads us right back to RQ1: are LSIs needed? And again, 
do we allow the LSIs we create enough time to develop, and if not, are our LSIs too 
early stage for us to make this judgement? 
7.3.2.4 RQ4. How important is an anchor organisation to a LSI? 
In the literature review it was noted that Hendry and Brown (2006) asserted that 
there was insufficient evidence to support the theory that companies succeed in a 
location because of the proximity of an anchor. This study has included a number of 
the LSIs that are located within a cluster containing an anchor. These included The 
Stevenage BioCatalyst, located on the grounds of the pharmaceutical company 
GSK, which has attracted a large number of SMEs. Rothamsted Research is another 
similar example with a world class research centre at the heart of a cluster.  
Rothamsted is one of the Research and Innovation Campus (RICs) that was 
discussed earlier. They are supported and promoted by the BBSRC and are 
committed to this more traditional ‘anchor’ view. This view of an anchor organisation 
at the centre of a cluster is reinforced by Lawton-Smith (2005) and Kenney (1986). 
Owen-Smith and Powell (2004) who concluded that biotech spin-out firms are 
strongly dependent on PROs for skilled labour and novel scientific competencies that 
feed the fledgling SMEs. 
The trend is definitely for LSIs to locate near to an anchor and it is unusual for it to 
be a standalone LSI. An exception to this is the Biocity LSI.  BioCity is of the view 
that proximity to an anchor organisation is unnecessary, and that they could grow 
their incubator without being close to an anchor organisation like a hospital, 
university, research institute or large company (Gilding 2008). This is in line with the 
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views of Hendry and Brown (2006). Their research looked at agglomerations of 
companies that link and interact, exchanging knowledge along the way and they 
concluded that one of the key features was access to suitably qualified staff. Hendry 
and Brown (2006) said that their study showed that companies performed no worse 
outside of a cluster. In the case of Biocity, although they have said they do not need 
to be located near to an anchor, they still concede they needed to be close to 
cohorts of qualified staff. For Biocity there is an agglomeration of companies within 
their incubator premises that also supply qualified staff, who can jump from one 
company to another. They do not qualify as a lone company as they are in a sense 
their own cluster. 
An interesting comparator is the IT and creative hubs springing up in city centres 
around the world (Pickford 2013). They have been proposed as the incubators of the 
future, and are usually based in renovated buildings with labs and offices set up in a 
very flexible way, where would-be entrepreneurs who can rent space for a monthly 
fee (Grens 2014, One Nucleus 2016). These are simply ‘anchorless’ incubators that 
resemble the Biocity model and have become hugely popular. 
In conclusion to this section we can draw from the existing knowledge and the 
knowledge gained from this study to see how the researcher has attempted to 
address the gaps in the existing knowledge within the substantive area. Additionally 
the answers to these research questions have helped to support the findings, 
including the emergent theoretical concepts that form the basis for the framework 
model that was recommended for new and existing LSIs to improve their 
performance in KEC. This is how the data that was collected has been re-
constructed to bring new insights to the field of knowledge. 
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7.4 The Limitations of the Study 
All research has limitations and challenges.  The main challenge in conducting a 
ConGT study like this is the time it takes to complete the study.  
“There are practical difficulties with grounded theory. The time taken to 
transcribe recordings of interviews for example can make it difficult for 
researchers especially when they have tight deadlines…” (Bryman  2012, 
p.574) 
In this study the lack of time resulted in the researcher being unable to return to the 
participants to do follow-up interviews. The decision to personally transcribe all the 
interviews - of which there were 30 - was the right choice as it enabled the 
researcher to get close to the data, rather than handing over the transcribing to 
someone else to do. 
The area of innovation intermediaries is fast moving and things change rapidly. 
Some of the participants are no longer in post, as many have moved on or the LSI 
has closed its doors. Therefore, returning to the LSI to address any outstanding 
questions or issues would have been difficult. 
It is completely understandable as to why there are so few ConGT business 
management studies available to refer to: it is a time heavy methodology. However, 
the researcher strongly felt that the theoretical concepts that emerged from the data 
to be of great value to the sector, especially to policy-makers and funders of LSIs. 
Another limitation to consider is the subjective nature of qualitative research itself. 
While completing the analysis for this thesis the researcher noted a number of issues 
regarding the allocation of the LSIs between the Cases. On reflection it may have 
been better for Case 3 LSIs to have been places in Case 4 LSIs. Moreover, 
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classifying Case 5 LSIs as Life Science specific was probably incorrect. The TTO 
LSIs that populate Case 5 work cross all technology sectors, but the TTOs chosen 
for this study have a strong focus on life sciences. 
In summary although limitations are inevitable the researcher is sanguine that the 
quality of the research methodology has clearly answered the research questions 
and has met the aims and objectives of the research as set out in Chapter 1.   
 
7.5 Recommendations for Further Research  
The researcher’s recommendation for future research in to GTM is not to fear the 
methodology, which appear quite daunting. The processes allow one to identify new 
ideas, and although the researcher would argue that new theories are very rarely if 
ever generated, it does bring out concepts that could be validated down the line as 
theory. 
“When you theorize, you reach down to fundamentals, up to abstractions, and 
probe into experiences. The content of theorising cuts to the core of studied 
life and poses new questions” (Charmaz 2010, p.13) 
This study explored the intermediaries themselves rather than the companies within 
them. This produced a better understanding of the functions of a LSI and allowed the 
researcher to develop a theoretical framework to help them perform at their peak. 
The researcher recommends that more research is done to validate this research 
and to perhaps build on the findings. For example those LSIs that have shut down 
should be investigated further to build on the knowledge gained from this study. Any 
future research should consider the following: 
1. How important are Commercialisation targets? 
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2. Should the LSI consider evolving rather than losing a strong brand 
when they run out of funding 
3. How important is having the right leadership or a champion? 
4. How do the LSIs manage the political landscape in order to keep 
going? 
5. The relevance of branding especially for international brand awareness 
Some of the 22 LSIs were deemed to be too early-stage to judge whether or not they 
were successful. Can success and failure be attributed to the funding life-cycle of the 
LSI? A longitudinal study would help to further validate what constitutes success and 
failure in these LSIs 
A final recommendation is that the performance of Case 5 LSIs, the TTOs, should be 
evaluated for the potential to perform the KEC function to a higher level, which this 
researcher believes would reduce the need for the plethora of LSI models.  
In Scotland there has in the past been a drive for all the TTOs to be centralised 
within one organisation. There was strong resistance from the academic institutions 
and the idea did not proceed. The TTOs asserted that centralising would mean the 
relationship to the academics would be lost. Clearly there is a lot of interest in TTOs 
and further research is inevitable. The TTOs scored badly in this study as a valuable 
LSI when compared to the other Case LSIs. As mentioned before they have the 
potential to do much more, and perhaps if they could carry out KEC activities more 
effectively there would be a less need for so many different LSIs. There is great 
interest in the TTO model from policy-makers, therefore a study that will measure 
their effectiveness in covering all aspects of KEC would be highly valuable (Higher 
Education Funding Council for England 2016). 
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7.6 Final Reflections 
This study has made some solid contributions to the literature on innovation 
intermediaries. A framework model was produced that can be reviewed by funders 
and practitioners in the creation of new LSIs. Applying the five emergent theoretical 
concepts that have been built into the framework should help an LSI to become a 
high-performing one. 
With regards to the question of generalisability, as this study follows the Sectoral 
Systems of Innovation (SSI) (Malerba 2005) it would not be possible to apply the 
framework to other sectors. It has been noted that even the support organisations 
working with this sector need to show they have some specialist knowledge in order 
to gain entry. 
This research has shown us some interesting ideas relating to perceptions of 
success and failure. After the review of the literature on comparing innovation 
intermediaries (in particular the study carried out by Suvinen, Konttinen and 
Nieminen (2010) where the Optoelectronic cluster appeared to more successful than 
the biotechnology cluster) it became clear to the researcher that SSI needed to be 
applied. This was why all 22 LSIs used in this study came from the life sciences 
sector.  
On reflecting on the data, including all the observations and memos, the researcher 
does believe that SSI should be used when doing a comparative analysis in the life-
sciences sector. It would present more opportunities to find like-with-like 
comparisons; however even these may not be exact. The other discovery from this 
data was that within the sector itself a supplier to the sector who does not have 
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specialist knowledge of the sector will find it difficult to gain a footing within the 
sector. 
Another observation from the data was from one of the Cluster Network 
Organisations that had shut down, said they had been prevented from marketing 
their brand internationally. At the time of the interview the researcher had asked the 
participant if they thought this had any impact on their demise. There was no 
conclusion to be made, but the question was raised: were they perceived as 
unsuccessful because they were not well marketed internationally, for instance, 
some of the other similar Cluster Network Organisations, like One Nucleus and 
BioDundee, who do actively do marketing internationally and who therefore have a 
strong brand internationally, have continued to survive? We have seen that a 
number of factors could brand an LSI as unsuccessful. Not marketing internationally 
could be one, the reasoning for this is linked to the fact that the markets for the 
majority of life-science companies are overseas. They are keen to gain access to 
international markets with the support of the LSI. If this is not a service offered, then 
the LSI could be perceived as having failed. 
 
This final chapter concludes the thesis. It started by reviewing the aims and 
objectives that were originally outlined in Chapter 1. Next the four research questions 
were addressed and linked to the literature reviewed. The limitations were discussed 
and areas for future research were suggested, and then the final reflections from the 
researcher with some further critical thinking on the study outcomes were made. 
Thinking critically and with the empirical data from this study, we have tried to 
explore why we have had so many LSIs come and go. This has led to the discussion 
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surrounding the question as to what constitutes or defines success and failure. On 
analysis of the data using a Constructivist Grounded Theory Methodology the 
researcher was able to interpret the re-constructed data in order to answer the RQs 
that are linked to the overarching question of why we have had so many LSI come 
and go. She found that there were two pathways to being labelled a failed LSI. The 
first one relates to those LSIs that have survived for longer periods, like One Nucleus 
for example, and who have done so by evolving their business model, also known as 
a paradigm shift. Those LSIs who have not done this have found that despite having 
been considered successful, they have still closed down without further funding. 
These latter LSIs are considered failed LSIs. The second path to failure is when a 
LSI does not meet the expected targets set by the funders. Here the LSI had an 
expectation placed on them to achieve targets that they were not resourced to 
achieve. In some instances the researcher believes there has been a 
misunderstanding of what a commercialisation outcome should look like. We have 
noted that for all the 5 Case LSIs commercialisation outputs are different. 
The hope had been that this study would reveal some of the key factors that allow for 
high-performing LSIs with embedded KEC activities to be successful. The framework 
model that has emerged from the data has achieved this. The one factor that struck 
a chord with the researcher, was that of time. Based on the empirical evidence and 
the literature many of the LSIs have not been allowed the luxury of time in order to 
iron out the kinks. If we want to be comparable to the Fraunhofer Institutes we must 
allow these LSIs time to re-align themselves  
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Appendix 1: The Interview Consent Form 
Consent Form 
(Face – face interview with audio-recording) 
 
Name: 
 
Organisation: 
 
Date: 
 
This interview will be conducted for the purposes of gathering the views of the interviewee 
on the subject of Life Sciences Intermediaries.  
 
Informed consent is an ethical requirement and this has to be sorted and agreed to by the 
participants of the interviews for this research. The information provided must be freely given 
on a voluntary basis and it must be understood that the information will be stored and used 
for the purposes of this research. This means that the content of this interview will be used in 
published journals or be used within the PhD thesis of the interviewer. 
 
Your identity will be made anonymous if desired. I can also guarantee commercial 
confidentiality where appropriate if required. This will be agreed verbally. 
 
Permission to audio-record this interview is requested. If you agree please initial here 
__________.  
 
You are free to stop the audio-recording at any time and are free to decline to answer any of 
the questions at any stage of the interview. 
 
I agree to participate in the interview required for this 
study_______________________________________ (a copy of this will be given to you) 
 
 
 
If you have any further questions, you are welcomed to contact me Deborah Spencer PhD 
Researcher at 1201563@live.abertay.ac.uk or phone me on 07949472399 
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Appendix 2: An example from the Interview Transcript 
(4/7 pages from the original document) 
Science Park  
 
DS: Can you provide a historical background to the Science Park 
PSP: We coming up for the 20th anniversary developed for the new home for The Institute Research 
institute which had survived for 70 years in the centre of Edinburgh, but in terms of the facilities had 
become quite antiquated and now fit for purpose and development had surrounded the institute 
and this site was acquired from the University and the park was built between 1994 and 1999 
basically and then The Institute moved out here 1998. SE and Lothian council were involved in the 
build it was pretty dramatic as the local area had been important in the mining industry. So this area 
of science was beginning to become important and so between SE and Lothian it was decided to 
build a science Park – a research commercial organisation that could produce jobs and economic 
value for the area, but also interact with the Institute Research Institute to derive benefits. 
Ds: So just to clarify the Institute Research Institute is at the heart of this science park, 
PSP: Yes its animal health, farm disease, Xxxxxxx is really important with the Xxxxxxx but we’re 
important in terms of animal health, but don’t shout as much in terms of livestock disease we are 
trying to cure diseases or existing diseases in livestock. In terms of animal behaviour we are focused 
on curing them, we are also looking at exotic diseases and trying to cure these too.  
The Institute research Institute was at one time funded by the Scottish Government, but now it’s just 
under 50% funded by the Government. So The Institute has to generate funding from other 
resources  
DS:  When did it reduce to 50%?  
PSP: It’s been 50% probably for the last 5 years but has been in decline since the 70s and there’s 
much more commercial development has an institute so its developing strategic partnerships with 
the animal health industry and pulling in money from that direction and also pulling in commercial 
grants from any where we can including the BBSRC, DEfRA, Wellcome Trust, which helps fund the 
institute and we have developed a fantastic track record in doing and we continue to do that. 
In recent times the Institute has changed its focus aside from animal health their main object and 
now we aligned yourself with food security linked to the ever increasing population and the link to 
protein and meat. So healthy animals or disease free animals will produce more food and will make 
a contribution to the population. Our director Julie Fitzpatrick she has a chair at Glasgow University 
in Food security so then we’re looking at ways to develop that field and to generate new revenue 
streams from that. So aside from the research institute the Institute group has 2 commercial 
subsidies –The Institute which is a commercial company and they animal health work on behalf of 
the industry and studies on animals including vaccine developments, they have also developed a 
safety testing service over the last ¾ years. Animal health is very cyclical with ups and down and for 
whatever reason animal health has turned off and difficult times have ensued  
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So we created Xxxxxxx limited so the university helps us manage it to help develop relationships 
between the science park tenants and The Institute. The Science Park is owned by the Institute 
Foundation which is a charity and in 4 months’ time we will have paid off the mortgage! So debt 
free. So Xxxxxxx limited manages the science park on behalf of the Foundation.  
Aside from that we try to keep the park full and ensure that people pay their rent and also that there 
are support services on site, things like security, catering, waste disposal and IT support all these 
things. So all these services are provided for the Institute group and for the tenants and some of the 
tenants can opt in to buy services but some services are mandatory others are paid for on a user 
basis, what this does is free up the tenants from having to worry about these types of services so 
they can focus on their core work. 
DS: Can you tell me a little more about the Institute Foundation, Who are they  
PSP: The Institute Foundation is a just a disease association they are a charity and the end of the 
Institute family tree their aim is to raise funds to sponsor and promote research in animal disease. 
The main source of income at the moment is from the science park, their income is roughly £2.5 
million per year so the KE work is driven through the Foundation there’s a communications team 
here, who organise various activities, newsletters 3-4 times per year to the members they update 
members on the science and can focus on a particular disease or general instruction or 
recommendations on animal welfare or husbandry that can be useful for the farmer in trying to 
minimise disease in the livestock. The Foundation has representative across the UK and board 
members from across the UK who discuss livestock issues in various parts of the country. This 
information is fed back to the main research board and will influence the direction of the sciences. 
Every year The Institute take a road show to every part of the country they address issues in various 
regions of the UK.  
DS: So A local and regional understanding of the science. Great! 
PSP: We get feedback that enables us to focus on specific animal husbandry and welfare issues. The 
Institute has influence in the main livestock countries around the world.  Lots of our senior scientists 
attend conferences on a regular basis and speak at events and then the next week we’re about to 
launch a vaccine in Australia and it target virus in the sheep stomach and our scientist cracked the 
problem so we set up a company called Xxxxxxx. In the past the vaccines that The Institute has 
developed we’ve tended to license them out to the animal health industry they get manufactured 
and The Institute would get the royalties. Like most people we’ve tried to retain the value by taking 
the process as far as you can, so we are going to produce the vaccine in Australia and we have an 
agreement with a distributor to get the vaccine out and we hope to get a modest income back from 
this. So we have all the regulatory approval for the product and it’s due to launch on the next 2 
weeks so it’s quite exciting and should be a significant revenue stream. 
DS: You are only focused on animal health companies?  
PSP: So we were focused, but there are other general LS companies here. And there is a 
pharmaceutical. They must have R7D or manufacturing to be here. 
DS: How did you work with Biosciences KTN, did that intermediary sit well or did  
PSP: I don’t think there was much engagement with this KTN. 
Ds; It would be interesting to know the engagement that went on here as the Government decided 
that this area needed a specific intermediary. Now considered failed. (Will get back to me on this) 
PSP: I have been at the PSP for 13.5 years now  
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DS: When you started were they more focused on companies in animal health and welfare or were 
you already to see general LS companies locating here? 
PSP: So while the development of the SP had been successful the early management of the SP had 
not. When I got here the Park was in a bit of a mess, people weren’t paying for services, so it was 
becoming unsustainable. So we had to change the management we were managed externally by The 
Institute Company that had spun out New Park, so a decision was taken at board level to terminate 
that contract and engage an in-house staff who would be a 100% focused on the Park. So at that 
time I focused on making the park sustainable and paid for and that process included to make sure 
the park was full so some of the ambition to have an innovation centre kind of fell by the wayside 
because we had to focus on income.  So for the period we didn’t have an active incubator as such 
because it tended to be occupied by more established businesses rather than smaller ones we’ve 
had some start-ups who have come in. At that there were only 2 start-up businesses on the park. It 
has flourished and moved on it was animal health related or even LS it was more materials 
consultancy. Which meant it needed lower cost space than a science park so it moved to a lower 
cost site. The Docherty centre was originally the innovation centre (incubator) so had flexible space 
so the idea was that it would grow. 
DS: So it followed the normal trajectory for new innovation companies they go into an incubator 
grow and then move into a SP. So your incubator failed. 
PSP:  Not necessarily, I guess you wouldn’t expect lots of businesses to spin out of animal health  
DS: So do you have spin-outs occupying the innovation centre now? 
PSP: Sometimes but the challenge that we have with start-up sand spins-outs have been initially set 
up by the university and then been allowed to incubate in university labs and when you quote the 
price to them they run a mile because they’re just not used to it. 
So once you start to quote £10.00 per sq ft they feel they can’t do it so they go to a corner 
somewhere else. So this is one of the major challenges for SPs they are not one of the cheapest 
places to locate in terms of costs.  
We need to persuade them it’s worth paying that little more for as there is added value in being 
here  that is something that all SPs continue to struggle with. I think increasingly certainly through 
the recession it impact on cost and occupation. 
PSP: Other parks can compete by cutting the price.  Lots of consultancy businesses don’t need lots of 
space so they don’t need a SP. Out in the west of Scotland the sp there offered 7 years rent free to 
tenants which we couldn’t compete with them. 
Xxxxxxx and people who built incubator put money into the company to make it happen, so they 
relocated. Seems a bit cut throat. 
For this space here we took a lot of loyalty tenants at that time we qualified for ERDF funds so we 
had funds for fit out units. So for every pound that we spent we got 25p back, so if we spent £400K 
on fitting out and we could claim £100K back. There were a number of qualifying aspects to that 
grant in terms of how many jobs you were going to create. That came to an end in 2007 and it came 
to a point where The Institute was having to spend money to get money back and there was only so 
much that Xxxxxxx could undertake and that was one of the issues that caused The Institute to get 
into any difficulties, so that why we only did so much of that. We did one for SNBTS they came on 
site here with a product testing unit and another for Xxxxxxx technology another success was with 
Xxxxxxx and that was a genuine and this was a genuine The Institute spin out. It was set by a 
retired scientist just a Xxxxxxx but within 1 year turned into a 35 man company with a £2million 
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turnover after 10 years. They are still here doing their testing, but have moved to the Xxxxxxx 
Technopole.  
Ds: What other objectives does the foundation have? 
PSP: I think the aims of the foundation are pretty true to their cause clearly generating income for 
the research institute remains absolutely fundamental because it drives so much activity here on the 
site, so we have to continue to sustain the size of the institute which is actually critical to the whole 
SP. So the strategy now is to be more commercially focused as our Govt funding will continue to be 
reduced.  
DS: Do you have plans of how you’re going to generate this income/ shortfall? 
PSP: The actual plan is to actually build a commercial hub building, we want to develop the KE 
initiatives we try to influence promote farming through education and the arts and so on and the 
case for putting exhibitions that highlight what we do. We’ve also being trying to develop with 
Lothian council stronger links with schools to encourage school kids to look at animal health as a 
career path. But also to look at the SP there are vast variety of jobs available here from researchers, 
stockman, to technicians to finance people to caters, cleaners you name it so there are lots of 
different career paths here so I’m trying to develop these aspects. 
So they’ve created a business enterprise team to exploit the work going forward and to do that we 
want to create a commercialising hub so we want people to come in and interact. So there will be an 
interface. One of the issues which have never really bothered us is that the front door is at the back 
of the building. So if we create a hub building will seem open, so as people drive in they will see it 
attractive to potential collaborators and interactive area. We have a design in plan to make it a roll 
on type design so that will be a kind place where you can have a more relaxed one to one or where 
you can have wider groups including people from Pfizer or students and we have enough space for 
20-30 people . Make presentations and we will have an enterprise team under the communications 
team. 
We have a lecture theatre that holds 120 people so we can conferences too. Part of the plan for this 
hub is to possibly expand the size of the lecture theatre. So maybe increase it to take 200 people. 
We have 3 design proposals that have been submitted. We don’t want it to be too ostentatious 
because what I want it to be is a place for farmers and scientists – so down to earth folk we don’t 
have fancy expensively designed buildings the buildings are fit for purpose. Impressive but modest at 
the same time.  So this will increase our commercial focus that The Institute has to have moving 
forward. 
Obviously there is a lot of development at Xxxxxxx with the university and the Xxxxxxx > The 
Institute has always argued to not develop new facilities when we already have these facilities here  
MEMO-Not sure this is good use of tax payer’s money. the universities and institutes will take the 
money if offered, but should they. Clearly there is some duplication going on here. 
Julie is on the board that has decided the Easter bush development but is not in agreement with it. 
What Xxxxxxx does, what The Institute does and the Scottish colleges SSE they are looking for new 
accommodation and Julie has been trying to persuade them to come with us and that’s still going on. 
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Appendix 3: Ethical Application and Approval 
Dundee Business School 
Research Projects (Staff and Students) – Application for Ethical Approval 
 
For Ethics Committee Use Only Indicate section(s) 
where corrective 
action is required 
First Submission  
Reviewer 1  Indicate Decision :             Accept         
Reject 
Section 1 Section 5 
 Initials : Date : Section 2 Section 6 
Reviewer 2  Indicate Decision :             Accept         
Reject 
Section 3 Section 7 
 Initials : Date : Section 4  
Second Submission  
Reviewer 1  Indicate Decision :             Accept         
Reject 
Section 1 Section 5 
 Initials : Date : Section 2 Section 6 
Reviewer 2  Indicate Decision :             Accept         
Reject 
Section 3 Section 7 
 Initials : Date : Section 4  
 
Prior to the completion of the Ethics Form you must read the documents: 
“Ethical Review Procedure’ and “Research Ethics Sub-Committee Remit” 
(https://portal.abertay.ac.uk/portal/page/portal/University/Schools/DBS/SchoolAdmin) 
There is also a ‘Quick Guide to Ethics Procedures’ on the same site. 
 
 
Name of Student: Deborah Spencer 
 
Registration Number: 1201563 
Name of Supervisor: Professor Reza Kouhy 
 
Module Code:  
 
Or  
 
Name of Staff member: 
 
Staff number: 
Is this an annual continuing ethical approval 
request? 
Yes   No  
 
 
 
SECTION ONE:  Nature of the research 
 
1.1 Project Title and Aim 
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Proposed Title of Project: 
An Investigation of the role of Life Science Intermediaries and their Potential for 
Knowledge Exchange and Commercialization 
 
Main Aim of Study: The aim of this PhD is to gain an understanding of the role of 
life science specific intermediaries and the value they bring to companies in the 
sector. The fundamental question in this research is do they help to provide 
competitive advantage by stimulating entrepreneurialism. Specifically what is their 
potential role in the knowledge exchange and commercialization (KEC) process? 
This question will be crucial in understanding their overall value in terms of 
economic and societal benefits. In order to decipher their KEC potential a closer 
look at the relationship between the LS intermediaries and the actors within the 
networks they operate in will help to determine the level of KEC potential within 
each intermediary case being investigated in this research. 
 
The main source of funding for intermediaries comes from public funds; however there is 
evidence that there are new innovative mechanisms for funding them, which is especially 
important in the context of the current economic climate.  
 
 
 
 
 
1.2 Will your research involve any ethical issues?   
 
Yes   No  
 
If so, tick all relevant boxes below and explain on a separate sheet how you will 
address each and every issue ticked.   
 
□ financial or other form of reward for 
participation 
□ vulnerable people, e.g.  children, juveniles, 
patients, those in care, those with only 
elementary English language, or with 
learning difficulties etc. 
□ people in custody or engaged  in illegal 
activities 
□ cross cultural issues (e.g. language, images, 
content, etc.) 
□ sensitive topics (e.g. drugs, sexual 
orientation, ethnicity, age, political/religious 
beliefs, euthanasia, poverty, or conflict 
situations, etc.)   
 
□ offensive issues – i.e. race, colour, creed, 
etc. 
□ use of audio or video recorded materials 
□ legal issues (e.g. criminal records)    
□ media coverage 
□ reputation of the University 
□ Other (please provide full details, using a 
separate sheet if necessary) 
 
 
 
1.3 Is your research to be based solely on a review of literature and/or secondary 
data, i.e. without any fieldwork or off campus activity?  
          
Yes   No     
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If YES give details of sources to be used and whether permission, if required, has 
been granted to use resources  
 
 
 
 
 
 
If YES then go directly to Section 7 (You need submit only these pages and Section 7) 
 
 
For Ethics 
Committee use 
Only 
Researcher provides a clear statement of the aim of the 
study? 
Yes  No 
  
 Action required: 
 
 
SECTION TWO:  Research method 
 
2.1  Give details of your Research Methods, e.g. use of questionnaires, interviews, 
surveys, observation, or other instruments or methods intended to collect data from 
or about people  (attach a separate page if necessary) 
 
 
The research methods will include interviews (semi-structured interviews), observations, 
documentary evidence and questionnaires 
 
 
 
 
2.2 Who are the intended research participants? Please indicate approximate 
numbers 
They will include:  (7) CEO’s or Directors of the intermediaries, (10) Business 
Development Managers, (4-5) Senior Managers from Economic development Agencies 
in UK, France, Holland and USA, (3) Policy makers and (4) Venture Capitalist/angel 
investors 
 
 
 
Chapter 8  
Chapter 9 2.3 How will you recruit / contact your research participants?  
 
I will make contact initially by email to introduce myself and to inform participants of my 
research and what I’m looking for from them. I will use a meetings and conferences to 
arrange interviews with participants. In December 2013, I will be travelling to Holland and 
hope to conduct a few interviews then. In Feb/March 2014 I will travel to France and 
again collect a few more interviews and make some observations. In June 2014 I will 
attend the Bio2014 conference in the US. I intend to pre-arrange as many interviews as 
possible prior to the conference. 
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Chapter 10  
Chapter 11 2.4  Please confirm that you will provide a copy of the permission 
sought in order to do so, prior to undertaking research  
Signature                                                                            Date 
 
 
   
 
Chapter 12  
Chapter 13 2.5 What is your intended research site?   
Chapter 14  i.e.  where will research be conducted, what type of 
organisation/facility, etc.  
 
The data collection will take place at the participant’s office. This may be in Scotland, 
England, Holland, France or in the USA. The organisations I will contact include Bio-
incubators, science parks, Pharmaceutical companies, Biotech Companies, Network 
orgamisations and Universities. 
 
The Bio2014 conference in the USA has conference meetings rooms held by Scottish 
Enterprise that can be booked and used for interviews. 
 
 
Chapter 15  (attach a separate page if necessary) 
 
 
 
 
Chapter 16 SECTION THREE: General ethical issues 
 
You indicated at 2.1. above that your research will involve the use of questionnaires, 
interviews, surveys or other instruments or methods intended to collect data from or 
about people.  As a result, your research raises automatically the following general 
ethical issues 
 
informed consent     voluntary participation 
 
opt out by participants   confidentiality    
 
anonymity of participants    privacy of participants 
 
The normal protocol for addressing these issues requires the researcher to undertake 
certain activities, as specified at 3.1 to 3.9 in the table below. 
 
Please place your initials against each and every item in the table, to indicate that you 
will comply with this protocol. 
 
For Ethics 
Committee 
use Only 
Section 2: Data collection methods are clearly identified? Yes  No 
  Action required: 
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If you feel that you are unable to comply with an item in this protocol, please explain 
in detail, on a separate sheet, why you are unable to comply with that item and how 
you propose to address the underlying ethical issue addressed by the item. 
 
  Initial 
3.1 I agree to provide the participants with a written/oral explanation of the project and 
the uses to which any data will be put  
 
3.2 I confirm I will explain to the research participants that I am a student and 
undertaking degree studies 
 
3.3 I confirm that I will explain to the research participants that they may not benefit from 
my study, except to the extent to see summary results of the study if requested. 
 
3.4 I confirm that the subject will be made aware of the length of time it will take to 
gather data e.g. fill in a questionnaire etc. 
 
3.5 I confirm that I will explain to participants that their participation is voluntary.   
 
 
3.6 I confirm that I will offer to the research participants the opportunity to decline to take 
part in any part of the research activity. Participants, for example, may decline to 
answer a particular question in a questionnaire. 
 
3.7 I confirm that I will offer to my research participants the opportunity to withdraw at 
any stage, and explain to them how data will be withdrawn that pertains to them. 
 
3.8 I confirm I will offer to my research participants a guarantee of confidentiality, 
including commercial confidentiality where appropriate and if required  
 
3.9 I confirm I will offer to my research participants a guarantee of anonymity 
 
 
3.10 I confirm that I will provide, if required, evidence that I complied with the above protocol, eg 
by submitting a copy of my consent form, and completed consent forms. 
 
 
 
 
SECTION FOUR:  Additional ethical issues 
 
4.1 In your research, could any of the procedures adopted cause any form of harm 
(including discomfort, stress, anxiety or embarrassment) to the participants?  
 
Yes   No  
 
If YES, please provide, on a separate sheet, details of  
 
4.1.1 the potential harm to participants,  
4.1.2 measures proposed to minimize the impact of such harm, and  
4.1.3 how you propose to inform participants of the potential risks to them and to 
secure their consent to participate under those conditions 
 
 
4.2 Will you be collecting ‘personal data’, i.e. anything (such as a name, address, 
phone number or description) which could allow a third party to identify participants 
in your research? 
 
Yes   No  
For Ethics 
Committee 
use Only 
Protocol will be observed for addressing general ethical 
issues? 
 
Yes  No 
  
Action required: 
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If YES, please provide, on a separate sheet, details of how you will comply with the 
requirements of applicable data protection legislation  
 
 
 
SECTION FIVE:  Risk Assessment 
 
This section is concerned with risk to you, the researcher.  It is not concerned with risk to 
research participants;  that topic is considered at question 4.1 above. 
 
Risk is defined by reference to the potential physical or psychological harm, discomfort or 
stress that the research project might generate for you. You must consider if you are: 
working alone, in unsatisfactory working conditions, potential harassment situations, working 
in vulnerable situations or if your research will involve overseas travel, etc.  
 
You must complete this section for you to obtain ethical approval. 
 
Note that it is not acceptable to simply enter “no risk” in the table below.  If you 
believe that there is no risk of any harm to you, you must explain why not.  For 
example, if you are conducting a survey, with all the survey work being conducted on-
campus, make a statement to that effect. 
 
Chapter 16 IDENTIFED RISK 
(harm, hazard, things that need 
‘control’, e.g. potential 
incident/accident, exposure to 
dangerous situations) 
Control Measures to Reduce the risk and/or 
Action to be taken in Emergency 
 
No personal risk during face 
to face interviews  
 
 
 
 
 
 
Accident or other incident 
while travelling to and from 
interviews  
 
 
 
 
No personal risk Interviewing 
participants at international 
conference 
 
 
All interviews will be conducted at the interviewee’s 
place of work during office hours and will be 
arranged by appointment. 
 
 
 
 
 
All travel will be by recognized public transport or 
by own car, which is fully insured 
 
 
 
 
Conference based interviews will be held at Scottish 
Enterprise meeting rooms at venue during 
conference hours 
 
 
 
For Ethics 
Committee 
use Only 
Question of additional ethical issues has been addressed in a 
satisfactory manner? 
Yes  No 
  
Action required: 
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Use a separate sheet if necessary 
 
 
 
 
 
SECTION SIX:  Declarations 
 
  Initials 
6.1 I confirm that I have read and understood the School’s Ethical Review Procedure 
document and Quick Guide to Ethics Procedures  
 
6.2 I confirm I understand the need for Data Protection and undertake to abide by the 
regulations.  
 
6.3 I confirm that the health and safety of the researcher has been taken into 
consideration prior to the commencement of the research. 
 
6.4 I confirm that the research undertaken will not discriminate against participants on 
the grounds of race, sex, religion or belief, sexual orientation, disability, pregnancy 
and maternity, gender reassignment, marriage and civil partnership, and/or age. 
 
 
 
Student Signature   ……………………………        Date: ……………………. 
 
The research Supervisor signs to indicate that the researcher has ‘considered’ appropriate 
ethical issues and their own safety.  The supervisor is not attesting to the adequacy of such 
consideration, merely that the student has confirmed that ethical issues and issues of 
personal safety have been considered by the student. 
 
Supervisor Signature  ……………………………       Date:………………… 
 
 
SECTION SEVEN 
 
To be completed ONLY if the research is to be based solely on a review of 
literature and/or secondary data, i.e. without any fieldwork or off campus 
activity 
 
 
7.1 Can you guarantee that your research will involve only literature review and/or 
desk research, i.e. without any fieldwork or off campus activity?  
 
Yes   No  
For Ethics 
Committee 
use Only 
Risk Assessment has been addressed in a satisfactory 
manner? 
 
Yes  No 
  
Action required: 
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7.2 Have you read and understood the School’s Research Ethics Committee’s 
“Ethical Review Procedure”, “Research Ethics Sub-Committee Remit”, and ‘Quick 
Guide to Ethics Procedures’? 
 
Yes   No  
 
 
7.3 Can you guarantee that you will comply with the University’s policy on 
Academic Deceit? 
https://portal.abertay.ac.uk/portal/page/portal/University/Schools/DBS/SchoolAdmin 
 
Yes   No  
 
 
Student Signature   ……………………………        Date: ……………………. 
 
 
Supervisor Signature ……………………………       Date:………………… 
 
 
 
Copy of Letter of Approval. 
 
 Dear Student 
  
This is to notify you that you have been granted full ethical approval to collect data for your 
project.  This is subject to the following conditions: 
  
i           You must remain in regular contact with your project supervisor 
  
ii           Your supervisor must see a copy of all questionnaires, survey materials etc and your 
procedure prior to commencing data collection 
  
iii          If you make any substantive changes to your project plan, you must submit a new ethical 
approval application to the Committee.  Application forms and the accompanying explanatory 
document are on the Intranet.  Completed forms should be handed in to the School Office, Room 
2015, Level 2, Old College. 
  
Failure to comply with these conditions will result in your ethical approval being revoked by the Ethics 
Committee. 
  
Should you have any queries please contact your Supervisor. 
  
Yours sincerely 
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Appendix 4: Case 2 Interview Questions 
Semi-Structured Questions for Cluster Network Intermediaries 
 Please provide some historical background to your intermediary  
 What type of model of funding do you use (PPP, self-financed,, ERDF etc) 
 What are/were your strategic aims 
 What funding mechanisms did you have or do you have? 
 What was or is your relationship with the academic community? 
 How inclusive are you or were you able to be? 
 Describe your interactions with the business community 
 What impact does/did your brand have? 
 Did you aim to assist with international activities? 
 Did/Do you have a programme for Knowledge exchange? 
 What achievements have you had or did you have? 
 How do you or did you measure success? 
 What are the barriers to success? 
 Did/do you play a role in the commercialisation process? 
 What are/were the expectations from your various stakeholders 
o Government 
o Business 
o Academia 
o funders 
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Appendix 5: Case 1 Interview Questions 
Questions for Science Parks and Incubator LS Intermediaries 
 Please provide some historical background to your intermediary  
 What type of model of funding do you use (PPP, self-financed,, ERDF etc) 
 What are your strategic aims 
 What mechanisms for income generation did you have or do you have? 
 Do you have plans to evolve the site? Eg going from incubation units to science park 
 What is your relationship with the academic community? 
 Describe your interactions with the business community 
 What interactions or relationship do you have with TTO’s 
 How inclusive are you able to be? 
 What are your thoughts on mixed sectors within your intermediary? 
 What impact does your brand have? 
 Do you assist with international activities for any tenants/spin-out/start-ups? 
 How do you rate inward investments? Have you looked at the economic impact and 
potential long term impact of inward locating organisations? 
 Do you have a programme for Knowledge exchange? 
 Do you play a role in the commercialisation process? 
 What achievements have you had? 
 How do you measure success? 
 What are the barriers to success? 
 How do you rate the benefits of alliances with other nations, do you think they would 
benefit the commercialisation process? 
 What are the expectations from your various stakeholders 
o Government 
o Business (various sizes) 
o Academia 
o Funders  
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Appendix 6:  Case 5 Interview Questions 
Semi-Structured Questions for Technology Transfer Office Intermediaries 
 Please provide some historical background to your intermediary  
 What type of model of funding do you use (PPP, self-financed,, ERDF etc) 
 What are your strategic aims 
 What mechanisms for income generation do you have? 
 What is your relationship with the academic community? 
 How inclusive are you able to be? 
 What other Life Sciences intermediaries do you interact with? 
 Describe your interactions with the business community 
 What impact does your brand or office have? 
 Do you have a programme for Knowledge Exchange? 
 What achievements have you had? 
 Do you aim to assist with international activities? 
 How do you rate inward investments? Have you looked at the economic impact and 
potential long term impact of inward locating organisations? 
 How do you rate the benefits of alliances with other nations, do you think they would 
benefit the commercialisation process? 
 How do you measure success? 
 What are the barriers to success? 
 Do you play a role in the commercialisation process? 
 What are the expectations from your various stakeholders 
o Government 
o Business 
o Academia 
o Funders 
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Appendix 7: Case 3 Interview Questions 
Questions for Research Institute Campus Intermediaries 
 Please provide some historical background to your intermediary  
 What type of model of funding do you use (PPP, self-financed,, ERDF etc) 
 What are your strategic aims 
 What mechanisms for income generation do you have? 
 Do you have plans to evolve the site? Eg to grow 
 What is your relationship with the academic community? 
 Describe your interactions with the business community 
 What interactions or relationship do you have with TTO’s 
 How inclusive are you able to be? 
 What are your thoughts on mixed sectors within your intermediary? 
 What impact does your brand have? 
 Do you assist with international activities for any tenants/spin-out/start-ups? 
 How do you rate inward investments? Have you looked at the economic impact and 
potential long term impact of inward locating organisations? 
 Do you have a programme for Knowledge exchange? 
 Do you play a role in the commercialisation process? 
 What achievements have you had? 
 How do you measure success? 
 What are the barriers to success? 
 How do you rate the benefits of alliances with other nations, do you think they would 
benefit the commercialisation process? 
 What are the expectations from your various stakeholders 
o Government 
o Business (various sizes) 
o Academia 
o Funders  
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Appendix 8: Case 4 Interview Questions 
Semi-Structured Questions for Thematic Intermediaries 
 Please provide some historical background to your intermediary  
 What type of model of funding do you use (PPP, self-financed,, ERDF etc) 
 What are your strategic aims 
 What mechanisms for income generation do you have? 
 What is your relationship with the academic community? 
 How inclusive are you able to be? 
 Describe your interactions with the business community 
 What impact does your brand have? 
 Do you aim to assist with international activities? 
 How do you rate inward investments? Have you looked at the economic impact and 
potential long term impact of inward locating organisations? 
 How do you rate the benefits of alliances with other nations, do you think they would 
benefit the commercialisation process? 
 Do you have a programme for Knowledge Exchange? 
 What achievements have you had or did you have? 
 How do you measure success? 
 What are the barriers to success? 
 Do you play a role in the commercialisation process? 
 What are the expectations from your various stakeholders 
o Government 
o Business 
o Academia 
o Funders 
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Appendix 9: An Example of the Initial Coding 
Case 2 LSIs are Life Science specific Cluster Network Organisations, these include 
the following: 
 One Nucleus covers the SE Of England and was created in 2010 by the 
merging of the London Biotechnology Network and the Eastern Region 
Biotechnology Initiative (ERBI), centred in Cambridge. One Nucleus is a 
membership organisation, whereby members have to pay a fee depending on 
the size of their organisation to join. 
 
 BioDundee covers the Dundee region within Scotland and was the second UK 
cluster networking organisation to be created within the UK after ERBI. This 
organisation is free to join and has been funded by the European Regional 
Development Fund and Dundee City Council. They receive nominal amounts 
of funds from some of the members including the universities and institutes.  
 
 LyonBiopole is a cluster networking organisation that straddles the region of 
Rhone-Alpes and encompasses the cities of Lyon and Grenoble. Their 
network like BioDundee is also referred to as an umbrella organisation and 
have 17 institutes and 168 life sciences SMEs. Within LyonBiopole there are 
four biopharmaceutical companies that contribute towards the funding. 
However, the main source of funding is from the regional and National 
Government.  
 
 Nexxus is a cluster network organisation that has now closed. It started in 
Glasgow and was based within the University of Glasgow. They had funding 
from Scottish Enterprise, European Regional Development Funds and the 
local council. They eventually expanded to include Edinburgh and were 
talking to BioDundee to join forces with them in order to cover the East Coast 
of Scotland. 
 
Case 2: Cluster Network Organisations 
 LyonBioPole Rhone Alpes Region France 
 BioDundee 
 Nexxus (Glasgow and Edinburgh) 
 One Nucleus (South East England, London 
and Cambridge) 
 
 
Initial Codes 
1. The life cycle of the project/funding 
Coming to an end 
2b: We never stand still, it changes from year to year adapting to what the needs 
are, which is why we’re looking at widening out into the healthcare and beyond 
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biotechnology, because that fits with the LS strategy and also what we believe might 
be the economic opportunities locally, we have a big teaching hospital and a 
university, it’s not just about LS it’s also about healthcare. 
MEMO – this LSI has been in existence for 17 years. One of the reasons they have 
survived is their ability to adapt to different needs. 
Just starting 
2. Engaging stakeholders 
Engaging with academic stakeholders 
2a: Universities may be members. We do host academic conferences. One of board 
members came out of IBM and decided that we needed to engage with academics 
and the importance of working with academia. We have workshops etc that they 
engage with. Our membership is very broad and covers lots of different areas of the 
LS including oncology infectious diseases. 
2b: One of the things that helped Dundee to move forward was that we had identified 
that we had these kinda superstar scientist, who were willing to back the idea of this 
life science community to just beyond the walls of the university.  
2b: We’ve tried to work with the academic agents and do it in a way that they’re 
happy with, so for eg with University of Dundee it is RIS and they can act like 
gatekeepers, well that’s their role and that’s fine, they’re the ones who give us 
funding so we have to work around that. 
2b: With Abertay it was much more an academic perspective that they were 
interested in from their students etc. From the James Hutton it was the 
commercialisation arm of MRS that actively engaged with us. 
2b: Over the years we’ve managed to create stories and heroes out of scientists , 
which the scientific community has recognised and has been grateful for and has 
understood that it helped them as well as helping us, so there’s a win there . For 
example would Philip Cohen have had such a high profile in another city?  
2e: We had an excellent relationship with the academic community, mostly because 
everything we did was free to attend and its incredibly difficult for academics to find 
the money unless it comes out their own pocket to attend something. 
2e: The typical spilt of people attending events was around 50:50 and we had a high 
profile amongst academics at that time 
MEMO- all their events were free, so they had a high proportion of academics 
attending 
2e: In terms of academia we worked with them right across the board. WE used to 
networking skills events with a particular focus on young researchers to get them to 
understand how they can work with industry and what they have to do is networking, 
Engaging with Industry stakeholders 
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2a: At the moment we’ve 470 organisations as members and 130 of those are R&D 
companies mainly London/Cambridge based, the rest of the membership are 
commercial service providers. So historically the companies have been from London 
Cambridge corridor and those who have joined us want access to these R&D 
companies. So the bottom line is we have so many members because of our R&D 
companies. 
2b: you know we’ve got the steering group and everyone is invited onto the steering 
group from every sector, so that’s up to them. If they’re not getting what they want 
then they need to be part of it. 
MEMO- Members from across the sector are invited to join the steering group and 
have their voice heard. Attendance from industry has not been good in recent years 
2b: That has changed slightly because in the area because we used to work much 
more closely with Xxxxxxx as they had a local focus, there was a lot more Bus Dev 
activity in terms like working with companies and that doesn’t happen anymore . The 
companies we work with are the ones we’ve met through the networking and have 
identified through networking. We are careful not to step on the toes of the account 
managers with Xxxxxxx, so there’s no point us getting in the middle of that. The 
companies might come to us because they require some skills requirement, that’s 
where we would step in with a one to one agreement, but I think it has  changed 
because Xxxxxxx don’t have so much money locally. We need to make sure they 
know what’s going on locally, like they attend the steering group, but we’re not clear 
what for. 
MEMO- engagement with industry appears to be non-existent now. It has very little 
involvement with any real engagement with companies, except through training and 
skills and networking opportunities. 
2e:  I would say especially for the business side that we were more focused on the 
SME than the large industry and this is more because of the types of things we used 
to do. For small companies important information on things like access to Clinical 
Trials, IP and funding mechanisms. 
2e: Xxxxxxx offices would be working with. They would be working with kind of 
driving at the top highegians working with large pharma, large corporations. That 
said a lot of the PR and marketing that they used to do was for smaller companies 
and individuals. 
MEMO- SE are looking to work with more established firms, which leaves a gap for 
the less established firms to get support from Nexxus 
2e: We were also able to do free PR and Marketing for companies, so we had a 
whole series of case studies, where we went round and interviewed key figures in an 
organisation, or we’d have a press release or a marketing piece on an organisation 
where they didn’t have that kind of budget or capabilities for it in house. 
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3. The power of brands 
 2b: Well we’re not being killed off anymore because Xxxxxxx have decided that they 
don’t want a brand. So what we have is a very strong band because we’ve used it 
consistently and how reputation is completely side by side. The brand would be 
worthless if we didn’t have such good reputation in life sciences sector internationally 
and the alliance with the University Xxxxxxx 
2b: So we haven’t tinkered with it we haven’t ermm it’s still our brand and ask if it’s 
still relevant to the sector we ask ... because it is Xxxxxxx and because it 
geographically places us, that’s why we invest in it. Local initiatives are really 
important, because that’s where you get buy-in from politicians from the local 
community, we’re much closer to hand to understand the problems and have that 
sense of community. Although in Scotland it’s not hard to do that. So there is a 
Scottish LS community, but saying that underneath that there is a heart which is 
Xxxxxxx, I think. 
2b: The brand is internationally recognised. People have heard it. 
2e: Significant impact on a national level I would say. People were aware of what we 
did, certainly in Glasgow and in the greater life science community across Scotland. 
We didn’t have much of a profile outside of Scotland. We did have traction with SDI 
offices globally, so some of those offices used to receive the Xxxxxxx newsletter and 
they gave us feedback and they thought it was really useful, but in terms of an 
international brand it wasn’t tremendously huge. 
 
 
4. Being in a membership Organisation 
2a: On the International front we talked to Mass Bio and worked out an agreement 
with them and now we attend Bio each year. We also have relationships with 
LyonBiopole, BioTap, and others in Europe. This enhances our membership with 
companies from these international companies who are in turn members of these 
international cluster organisations. Just last week we had BioMunich who were over 
to find out how we work and how we do things. Which means we are well known and 
respected. Other than those types of activities there’s loads of stuff going on.  
2a: We created an informal group that we chaired called BioPartners , which 
includes (UKTI< BIA< One Nucleus and OBN). BioNow was created from a 
development agency. He came to me . We have 500 plus members between them. 
They were asking how they go from a regional non-paying organisation to a 
membership one, charging a membership fee. We discussed what the added value 
would be and said that they could be part of our purchasing consortium. BioNow 
emerged about 18 months ago but they don’t have an international focus. 
2b: Perhaps there is an optimum size for a cluster network to be efficient? When you 
get too big you’re not successful, so at what point should you say OK we can’t 
extend this anymore, we’re gonna lose impact. 
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5. Measuring success 
2a: We use questionnaires. We inform UKTI and others when we have generated 
any interest or an outcome. 
2a: Members have to decide if they can justify the cost of membership therefore; 
membership is a good measure of our value. We have different levels of 
membership including gold, silver and bronze. (MEMO – Depending on the size of 
the organisation) 
2b: We don’t hear about what the companies are doing, but we do have Boots in 
Dundee as they came along to the conference. From a networking point of view..we 
get people meeting and having conversations that they wouldn’t otherwise have. 
2b: Our other achievement is lasting that long. We have that corporate memory, 
although we’ve had lots of different co-ordinators. That learning has not been lost, so 
we have continuum. So if Glasgow or Edinburgh were to start up a new network 
organisation, they would have to get people understanding what the brand is and 
buying-into –it. That corporate learning has been found not just in the council but in 
the whole community. To still be seen as worthy and worthwhile by all partners 17 
years later  
2b: We tried to get information. Because of the ERDF funding we get access to 
information from Xxxxxxx, so if they are helping to commercialise stuff in this area 
we would have access to understand where Xxxxxxx may have fitted into that. It’s 
more difficult to do that, but we do know that we need to say and show what our 
outputs are.. Our outcomes, so saying that several people attended is fine, but what 
did that actually mean?  We are looking at clever ways of doing this, like quotations 
from people, which kind of the next step really. 
2b: Some of the social type events like having a BBQ for 100 people I struggle with, 
but actually the conversations you hear at that BBQ’s money couldn’t buy it. We’ve 
got clever about the opportunities at the BBQ, we get people to sign up for things, so 
it’s become a more marketing opportunity as well. It’s important for us in the council 
too as we get information from Xxxxxxx about what needed like should we be 
building more units. 
2e: Very successful, Xxxxxxx its heart was a networking organisation, yet when we 
did that review we were able to demonstrate through interviews with individual 
people that we were helping to increase the number of people employed 
2e: So we had economic drivers eg numbers of FTEs positions created then we had 
more soft metrics around the number of events and the split between the attendees 
between the balance between academic vs NHS vs industry, the number of articles, 
pieces of PR, PR thats been picked up and circulated through a wider press and the 
number of cases we’d produced. 
2e: Yes we did but that was because we had to as it was part of our metric. A lot of 
the time it was a long process from introduction to actually doing something  
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6. The main barriers to success 
2B: Xxxxxxx was very successful at these Bio events and it meant that Xxxxxxx got 
continually harangued by Edinburgh and Glasgow, but there was nothing to stop 
them doing it too. They don’t take things out for us, but it’s wider than that.  SDI 
would take things out for us 
2b: Xxxxxxx recognise we’ve been around for so long now so they don’t hassle us 
anymore, because why would they hassle something that’s been successful.  If they 
have a brand that’s any better than we can start talking. We have had to work a little 
harder because it’s Xxxxxxx. 
2b: This is because we’re not seen as team Scotland, but we have been successful 
at promoting ourselves, but we are absolutely team Scotland and that’s always been 
the misunderstanding. If you come up with something better 
2b: It works against us that SE are based in Edinburgh and Glasgow. At least when 
we had LEP you had people batting for us. 
2b: :  It will be as money gets tighter in the council and that’s why it’s important to 
show an impact of Xxxxxxx in a less anecdotal form. We know the cuts will happen 
and the stuff that we do will be looked at, so yeah funding also remaining relevant 
talking to people. So there’s no point retaining the status quo and not doing anything 
2e: The main barriers to success was funding...there was some scepticism on the 
utility of the network from Edinburgh and the East and how well it could be used. The 
West of Scotland could see the benefits, but introducing it to Edinburgh was quite a 
hard sell, so possibly because it was twofold 1) because it came from the West of 
Scotland, the issue of the inherent East – West divide and 2) People just couldn’t 
see an absolute need for it because there hadn’t been something there before. It’s 
like if you try to convince someone of something that really good for them, they kind 
of won’t do it because of the issue of having to get off your backside and do 
something. The challenge they had in Edinburgh is Edinburgh University is so 
significant in itself. I think Xxxxxxx had already been started, so they just saw that 
they didn’t need anything else other than themselves so why would they plug into 
something that would be delivered to them. 
2e: We enjoyed a respected position in the community and that was because we 
didn’t have a subscription model. I think when you have a subscription model you get 
too much buy in from people who are paying for the subscription. The universities 
will never contribute as much as SMEs collectively and therefore you’ll be constantly 
be working for the customers who are paying for it. Doing what they want as that’s 
what they are paying for 
MEMO – barriers to why they didn’t go down the subscription path 
2e: The universities will never contribute as much as SMEs collectively and therefore 
you’ll be constantly be working for the customers who are paying for it. Doing what 
they want as that’s what they are paying for. 
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2e: We were able to present this neutral and balanced position where we were in 
favour of one thing over the other. Cos you’ll never get academics who will go into 
something that’s constantly about HR or IP protection you’ll only get companies. 
2e: They have a procurement deal that allows companies to buy in cheaper for 
services and reagents/consumables. I know that SE had talked about having a buy-
in pool but that was in competition with Xxxxxxx procurement, so as a Govt they 
were basically setting up in competition with one of your SMEs. This was a bit harsh. 
2e: Working locally in Scotland seemed bizarre to me, prior to Xxxxxxx I was 
connected to people in Xxxxxxx and the EU bio networks and it never dawn on me 
that I would have to only work in Scotland. 
2e: One of the challenges in brokerage has got to be the different players involved in 
it. It about finding out who does what and where they fit in. So it’s ok to speak to a 
SME but when you come to an academic they are governed by the TTO, so they 
want to be informed or involved. (MEMO-KEC) 
 
7. The Expectation Gap 
Customers 
2b: from academia it’s about the opportunity for further research and income. 
2b: It’s all about growing into something bigger, but underneath that its identifying 
what’s need for that, so that can be support in infrastructure it can be lab space, so 
that’s where we would come in. So that’s why we work with Xxxxxxx to help them 
achieve their commercialisation goals. 
2e: Yes we had a some key metrics that we had to report to the ERDF and they were 
reported on a quarterly basis as well as all the associated paperwork that went with 
those .The expectations from academia were that we would have the quarterly 
meetings with them and provided them with updates, they wanted to see their work 
getting the PR and the academics getting the exposure. We very much would take 
from them what they made available to us , so none of them could really say none of 
this ...a few times they would say “this is not fair, this university is getting way more 
exposure than we are at and our counter argument would be at then give us some 
more stuff’.  
2e: Yes we would do anything that anybody gave to us, we would change it to make 
sure it was targeted right, it was written well and that it had the most impact that it 
could have, but we never said we would never include it. We might have said we’re 
not going to include it this month because we have a mound of stuff this month that’s 
already very similar and it wouldn’t get as much exposure. So academia basically 
wanted us to broaden awareness and broker collaboration to which we did. The 
business perspective, we did the same sort of thing. So we did case studies for 
them, we did PR for them and introductions and the international awareness raising 
that we did. 
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Funders 
2b: Yes, also early on we wanted to get some commitment, so the Universities of 
Xxxxxxx and Xxxxxxx all put in an amount of money. We didn’t go after the biotech 
companies as they were all small and the whole purpose of what we were about was 
to build and create more of them. 
MEMO- Xxxxxxx doesn’t have a role in spinning out or starting up companies, so I 
think what is meant here is that they facilitate others to do it 
2b: The funders it’s about their expectations for jobs and growth. 
2e: Yes we got sponsorship from companies like Thermo Fisher, they sponsored a 
specific Stem Cell event which was to get researchers together who were interested 
in Stem Cell research getting them together so there could be collaboration with 
industry and research. So we had those specific interest group in Stem Cell 
research, and to kick that off we had a big event and involved the Stem Cell network 
in that too. This was all done as a response to a request from some of the SMEs to 
work in this area. We had to tread carefully as the feedback was that the SSN was 
parochial and all based in Edinburgh, however we found the SSN to be quite 
inclusive. The only challenge I had was they were happy with us doing a special 
interest Stem Cell group  
2e: So we used to get sponsorship for that and we used to get sponsorship for the 
awards we used to give out, which was brilliant at getting PR and a lot of the younger 
researchers thought that they were instrumental in raising awareness of the research 
that they did and two young researchers who won the prize have spun out from the 
universities. 
 
 
Government Bodies 
2b: The stakeholders have an interest in growth, so from a Govt perspective, from a 
business perspective it’s about growing businesses 
2e: From the Govt perspective, if its Xxxxxxx then they expected us to drive 
economic development as did the ERDF and then we were able to go back and 
demonstrate the metrics we had in terms of the engagement with the people in our 
region. Also from the Govt perspective we met with a couple of Govt advisers who 
would advise Govt in Scotland, on diff issues. It was alongside other networks like 
Xxxxxxx and BIA. 
 
8. The KEC Activities 
2a: I have a presentation in my back pocket that I can pull out if I’m at an Embassy 
or elsewhere. So I speak on behalf of our members wherever I am. 
2b: The overarching one was to grow the LS sector and to affect our economy in a 
positive way, but underneath that it’s about knowledge and skills development, 
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partnerships and collaborations, information exchange, networking. Trying to identify 
where possible where the opportunities are anything that would create strengths 
within the sector. 
2c: we publicise science etc for school children through the Science centre, it doesn’t 
cost us anything. 
2b: New companies come in they always want new stuff, esp if we have new spin-
outs they come to everything that they can because they want knowledge and skills.  
Especially if the sector is calm, you may not get the same attendance, but there’s 
certainly lots of interest in Project Management Training and other things they need 
for within their companies. The scientist want presentation skills for presenting 
whatever. We wouldn’t do it if there was no take up.  
2b: Where we add value is by getting everyone to come along. It lowers the cost 
across the board and sometimes they get that interaction with the community that 
they wouldn’t otherwise get. 
2e: We also did a whole seminar series on IP and patents, which I know we got 
feedback on from one SME that found it incredibly useful to send their staff to, so 
that their staff were made aware of when they were developing an innovation. What 
do they need to do to make sure that innovation was protected and to make sure that 
knowledge was recounted to clients? 
2e: Yes we did, we also produced a newsletter on a quarterly basis, but on top of 
that we used to circulate PR to press agencies and we had our own contacts in the 
press. We used to raise awareness of both academic research and businesses too. 
2e: So we put on events that were in area that people needed to gain understanding 
in diff areas, we did pitching and etc and we did targeted KE events a series of 3 of 
them. Where actually SMEs would stand up and pitch an issue or problem that they 
had and we would get the whole room to brain storm the problem, so we could help 
them or put them in touch with someone else we knew, then we would do a kind of 
bespoke stuff, like an introduction service as well. So we would work with people like 
Interface in its early days, or its Universities to identify who would help the SMEs 
2e: I think in terms of skills and training for early stage and even later stage 
researchers and helping them to understand the commercialisation process and to 
help them establish their own networks to take things forward. From the SME 
perspective it was raising awareness of the opportunities between academia and 
industry to raise awareness of collaboration and communication between the two. 
 
